{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "e51QLxwPdCRT"
   },
   "source": [
    "## BIOMEDICAL QUESTION - ANSWERING SYSTEM"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "nLJx34pFP-rO",
    "outputId": "aad1adad-1a72-47e6-bd1b-d74044c45537"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: transformers in /usr/local/lib/python3.7/dist-packages (4.5.1)\n",
      "Requirement already satisfied: importlib-metadata; python_version < \"3.8\" in /usr/local/lib/python3.7/dist-packages (from transformers) (3.10.1)\n",
      "Requirement already satisfied: filelock in /usr/local/lib/python3.7/dist-packages (from transformers) (3.0.12)\n",
      "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.7/dist-packages (from transformers) (1.19.5)\n",
      "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.7/dist-packages (from transformers) (4.41.1)\n",
      "Requirement already satisfied: tokenizers<0.11,>=0.10.1 in /usr/local/lib/python3.7/dist-packages (from transformers) (0.10.2)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.7/dist-packages (from transformers) (2019.12.20)\n",
      "Requirement already satisfied: packaging in /usr/local/lib/python3.7/dist-packages (from transformers) (20.9)\n",
      "Requirement already satisfied: requests in /usr/local/lib/python3.7/dist-packages (from transformers) (2.23.0)\n",
      "Requirement already satisfied: sacremoses in /usr/local/lib/python3.7/dist-packages (from transformers) (0.0.45)\n",
      "Requirement already satisfied: typing-extensions>=3.6.4; python_version < \"3.8\" in /usr/local/lib/python3.7/dist-packages (from importlib-metadata; python_version < \"3.8\"->transformers) (3.7.4.3)\n",
      "Requirement already satisfied: zipp>=0.5 in /usr/local/lib/python3.7/dist-packages (from importlib-metadata; python_version < \"3.8\"->transformers) (3.4.1)\n",
      "Requirement already satisfied: pyparsing>=2.0.2 in /usr/local/lib/python3.7/dist-packages (from packaging->transformers) (2.4.7)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (1.24.3)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (3.0.4)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (2020.12.5)\n",
      "Requirement already satisfied: idna<3,>=2.5 in /usr/local/lib/python3.7/dist-packages (from requests->transformers) (2.10)\n",
      "Requirement already satisfied: joblib in /usr/local/lib/python3.7/dist-packages (from sacremoses->transformers) (1.0.1)\n",
      "Requirement already satisfied: click in /usr/local/lib/python3.7/dist-packages (from sacremoses->transformers) (7.1.2)\n",
      "Requirement already satisfied: six in /usr/local/lib/python3.7/dist-packages (from sacremoses->transformers) (1.15.0)\n"
     ]
    }
   ],
   "source": [
    "! pip install transformers"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "Sm2GiQ19PRuN"
   },
   "source": [
    "IMPORTS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "Hdau5xt1Y0NO"
   },
   "outputs": [],
   "source": [
    "# Imports\n",
    "import pandas as pd\n",
    "import json\n",
    "import nltk\n",
    "import tensorflow as tf\n",
    "import transformers\n",
    "import os\n",
    "from transformers import AutoModel, AutoTokenizer, BertTokenizer\n",
    "from wordcloud import WordCloud, STOPWORDS, ImageColorGenerator\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "import numpy as np\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from nltk.corpus import stopwords\n",
    "import re\n",
    "import string\n",
    "import time"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "emWtjxh5hqoU",
    "outputId": "66aafb02-1147-462b-8206-8761f3175971"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
     ]
    }
   ],
   "source": [
    "from google.colab import drive\n",
    "drive.mount('/content/drive')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "-03kOmQeeKI6"
   },
   "source": [
    "# DATA INGESTION"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "BYJkZ5L1dE0n"
   },
   "source": [
    "Loading the files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "_SiuNUuehs2T",
    "outputId": "e08c65cf-53fa-4e7b-f613-b10612a19658"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['BioASQ-train-yesno.json', 'BioASQ-full-annotated.json', 'BioASQ-list-annotated.json']\n",
      "['BioASQ-train-list-6b-snippet-2sent.json', 'BioASQ-train-factoid-6b-snippet-2sent.json', 'BioASQ-train-yesno-6b-snippet-2sent.json']\n",
      "['BioASQ-train-yesno-6b-snippet.json', 'BioASQ-train-list-6b-snippet-annotated.json', 'BioASQ-train-factoid-6b-snippet-annotated.json']\n"
     ]
    }
   ],
   "source": [
    "global_l = []\n",
    "full_abstract = os.listdir('/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Full-Abstract/')\n",
    "appended_snippet = os.listdir('/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Appended-Snippet/')\n",
    "snippet = os.listdir('/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Snippet-as-is/')\n",
    "files = [full_abstract, appended_snippet, snippet]\n",
    "for f in files:\n",
    "    print(f)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "gIyab8xqdJfv"
   },
   "source": [
    "Extracting data and structuring it to dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "Kb262SXNZEba"
   },
   "outputs": [],
   "source": [
    "def extract_data(filename,global_l):\n",
    "    with open(filename,\"r\") as f:\n",
    "        data = f.read()\n",
    "        data = json.loads(data)\n",
    "        data = data[\"data\"][0]\n",
    "        for d in data[\"paragraphs\"]:\n",
    "            q_id = d[\"qas\"][0][\"id\"]\n",
    "            question = d[\"qas\"][0][\"question\"]\n",
    "            try:\n",
    "                answer = d[\"qas\"][0][\"answers\"][0][\"text\"]\n",
    "            except:\n",
    "                answer = d[\"qas\"][0][\"answers\"]\n",
    "            try:\n",
    "                answer_start = d[\"qas\"][0][\"answers\"][0][\"answer_start\"]\n",
    "            except:\n",
    "                answer_start = -1\n",
    "            context = d[\"context\"]\n",
    "            global_l.append([q_id,question,answer,answer_start,context])\n",
    "    return"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "lpkQrLOhZHdk",
    "outputId": "f77bc528-87c4-494d-8f71-7defd5dae1f9"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BioASQ-train-yesno.json\n",
      "BioASQ-full-annotated.json\n",
      "BioASQ-list-annotated.json\n",
      "BioASQ-train-list-6b-snippet-2sent.json\n",
      "BioASQ-train-factoid-6b-snippet-2sent.json\n",
      "BioASQ-train-yesno-6b-snippet-2sent.json\n",
      "BioASQ-train-yesno-6b-snippet.json\n",
      "BioASQ-train-list-6b-snippet-annotated.json\n",
      "BioASQ-train-factoid-6b-snippet-annotated.json\n"
     ]
    }
   ],
   "source": [
    "global_l = []\n",
    "dirs = [\"/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Full-Abstract/\",\n",
    "        \"/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Appended-Snippet/\",\n",
    "        \"/content/drive/My Drive/BIOASQ/BioASQ-6b/train/Snippet-as-is/\"]\n",
    "\n",
    "for dir in dirs:\n",
    "    for file in os.listdir(dir):\n",
    "        print(file)\n",
    "        if \"yesno\" not in file:\n",
    "            extract_data(dir+file,global_l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 289
    },
    "id": "Uwrw_2zyZPCl",
    "outputId": "095db9f5-f75b-4339-af05-ff91ca4ded03"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>q_id</th>\n",
       "      <th>question</th>\n",
       "      <th>answer</th>\n",
       "      <th>answer_start</th>\n",
       "      <th>context</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>54fb5c69d176fff445000003_035</td>\n",
       "      <td>Which are the 3 basic transcription factors th...</td>\n",
       "      <td>Tbx5</td>\n",
       "      <td>105</td>\n",
       "      <td>Here, we report that a combination of three de...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>54df69af1388e8454a000005_026</td>\n",
       "      <td>Which drugs are included in the FEC-75 regimen?</td>\n",
       "      <td>cyclophosphamide</td>\n",
       "      <td>137</td>\n",
       "      <td>Patients were randomised to 1 of 3 treatment g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>533ec7abc45e133714000015_020</td>\n",
       "      <td>Which factors play a role in promoter proximal...</td>\n",
       "      <td>DSIF</td>\n",
       "      <td>33</td>\n",
       "      <td>At several eukaryotic promoters, DSIF, togethe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>54df69af1388e8454a000005_033</td>\n",
       "      <td>Which drugs are included in the FEC-75 regimen?</td>\n",
       "      <td>cyclophosphamide</td>\n",
       "      <td>1285</td>\n",
       "      <td>Premenopausal patients with node-positive rese...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>58932cd87d9090f353000001_234</td>\n",
       "      <td>Which human syndromes have been detected with ...</td>\n",
       "      <td>as</td>\n",
       "      <td>476</td>\n",
       "      <td>To optimize the prenatal diagnosis platform by...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   index  ...                                            context\n",
       "0      0  ...  Here, we report that a combination of three de...\n",
       "1      1  ...  Patients were randomised to 1 of 3 treatment g...\n",
       "2      2  ...  At several eukaryotic promoters, DSIF, togethe...\n",
       "3      3  ...  Premenopausal patients with node-positive rese...\n",
       "4      4  ...  To optimize the prenatal diagnosis platform by...\n",
       "\n",
       "[5 rows x 6 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Naming the columns, shuffling rows\n",
    "df = pd.DataFrame(global_l, columns =['q_id', 'question', 'answer','answer_start','context'])\n",
    "df = df.sample(frac=1).reset_index(drop=True)\n",
    "df.reset_index(level=0, inplace=True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "MhpQNNYnEIlr"
   },
   "outputs": [],
   "source": [
    "#Exporting data to csv\n",
    "df.shape\n",
    "df.to_csv(\"/content/drive/My Drive/BIOASQ/data_colab.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "xT4DtrCpeXr-"
   },
   "source": [
    "# DATA INGESTION & PRE-PROCESSING"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 353,
     "referenced_widgets": [
      "5b4fec121b414af88d342af401404d4e",
      "93786ab1189c4216a84824836f9a01bf",
      "90949f61c18848d1993ea7ea7b2f4a1d",
      "3140ccdc23844960b900999992b29133",
      "a366a274843843eabb84a941522f5020",
      "f578af6b1e294e12917782058cbd1fb8",
      "79140fd422ff4b65be8a723d7c4d0583",
      "c41809e4c7574dc09794fdb9771a7cc5",
      "e8f47a9e3c4d44498ed5ba806a1de264",
      "4d58fd777ba248fba5fc5cd715f12db1",
      "8813981eb1c043359684b9edfb3cc981",
      "c92417d178454f5babd6b07eddc74827",
      "7da7904811574b87b346d08c9d3d9e02",
      "90387d98cb7e49d6a163470d6f1a994c",
      "8bd9a3ef24ad4de9938d24b5469319da",
      "0f4003882ad446f9bbf0b143996b9bef",
      "32662d0c5a144fa8bbdb42775dde4da2",
      "e06163d0cdb749e0a911ccca37391813",
      "af51752b13344cdda32d4e624f18a5db",
      "8bcf3e2656dd4d29b3010aa148356e0e",
      "6c7932f43a78445abe53f8fd56aa30e7",
      "8cbab68b9c514a75a850fa3e919757f8",
      "51b3c3a1152049d7bf86f0cf3dc6ccc1",
      "a077d23a80ab47ad8cae6b4f28f36ab8",
      "aaea45e6f2fd45a0ac8949b488a48333",
      "29522003c73e4ad7a64d40557f31a3b8",
      "fcf55c27666a41518774ea50e0317507",
      "d4ebd7fcf49c41d8b126b0603739230b",
      "0ffc567f09a54b048d97ba1f0df4f1c4",
      "a1ea464ffe5f476b8f49720c74c0b63e",
      "5654be802fef4fd38708401579275bc1",
      "933173b68595402b8ed0d3e54deb665e",
      "f091e98f1ca0465f98ad2f2d43f4d2e1",
      "12883e0b70c34dcead9d2d23a6d652cf",
      "e0f4b0a77aa24c6d86de94109ee83a73",
      "7fdec03f16644691b9d80a148d0a577c",
      "c8585febbb5c4fcab0c7601ef760fd54",
      "d60ec5a0f64649fb95455fc2da2e1fa9",
      "d653135e5f03472b951109d65a441d15",
      "ce9b47f041074b24b5b5192cf59c246e"
     ]
    },
    "id": "ln9v3RTar8o2",
    "outputId": "b0b140b5-41d3-4321-d3b1-b6c5e7e3349b"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5b4fec121b414af88d342af401404d4e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, description='Downloading', max=443.0, style=ProgressStyle(description_…"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e8f47a9e3c4d44498ed5ba806a1de264",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, description='Downloading', max=231508.0, style=ProgressStyle(descripti…"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "32662d0c5a144fa8bbdb42775dde4da2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, description='Downloading', max=466062.0, style=ProgressStyle(descripti…"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "aaea45e6f2fd45a0ac8949b488a48333",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, description='Downloading', max=28.0, style=ProgressStyle(description_w…"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f091e98f1ca0465f98ad2f2d43f4d2e1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(FloatProgress(value=0.0, description='Downloading', max=1341090760.0, style=ProgressStyle(descr…"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "All model checkpoint layers were used when initializing TFBertForQuestionAnswering.\n",
      "\n",
      "All the layers of TFBertForQuestionAnswering were initialized from the model checkpoint at bert-large-uncased-whole-word-masking-finetuned-squad.\n",
      "If your task is similar to the task the model of the checkpoint was trained on, you can already use TFBertForQuestionAnswering for predictions without further training.\n"
     ]
    }
   ],
   "source": [
    "from transformers import AutoTokenizer, TFAutoModelForQuestionAnswering\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"bert-large-uncased-whole-word-masking-finetuned-squad\")\n",
    "model = TFAutoModelForQuestionAnswering.from_pretrained('bert-large-uncased-whole-word-masking-finetuned-squad')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "rPcnJH5IilZA"
   },
   "outputs": [],
   "source": [
    "# Adding special tokens\n",
    "CLS = tokenizer.cls_token\n",
    "SEP = tokenizer.sep_token"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "uQRmceL1vJyc"
   },
   "outputs": [],
   "source": [
    "def token_df(df,CLS,SEP,tokenizer):\n",
    "    tokens = []\n",
    "    q = df['question']\n",
    "    p = df[\"context\"]\n",
    "    for i in range(len(p)):\n",
    "        temp = []\n",
    "        temp.append(CLS)\n",
    "        [temp.append(t) for t in tokenizer.tokenize(q[i])]\n",
    "            \n",
    "        temp.append(SEP)\n",
    "        [temp.append(t) for t in tokenizer.tokenize(p[i])]\n",
    "        tokens.append(temp)  \n",
    "    return tokens"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "r33kscrXeBVL"
   },
   "source": [
    "Tokenization and converting tokens to ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "yTYCuSKEil2k"
   },
   "outputs": [],
   "source": [
    "def token_to_ids(tokens):\n",
    "    token_ids = []\n",
    "    for t in tokens:\n",
    "        token_ids.append(tokenizer.convert_tokens_to_ids(t))\n",
    "    return token_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "QTc2ANGai0Zw",
    "outputId": "ea7071ad-45ed-4c35-cb64-206b44634f2c",
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Token indices sequence length is longer than the specified maximum sequence length for this model (937 > 512). Running this sequence through the model will result in indexing errors\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['[CLS]', 'which', 'drugs', 'are', 'included', 'in', 'the', 'fe', '##c', '-', '75', 'regime', '##n', '?', '[SEP]', 'patients', 'were', 'random', '##ised', 'to', '1', 'of', '3', 'treatment', 'groups', ':', 'group', 'a', '(', 'n', '=', '207', ')', 'received', 'fe', '##c', '50', '(', 'flu', '##oro', '##ura', '##ci', '##l', '500', 'mg', '/', 'm2', ',', 'ep', '##ir', '##ub', '##ici', '##n', '50', 'mg', '/', 'm2', 'plus', 'cy', '##cl', '##op', '##hos', '##pha', '##mide', '500', 'mg', '/', 'm2', ')', 'every', '21', 'days', 'for', '6', 'cycles', ';', 'group', 'b', '(', 'n', '=', '193', ')', 'received', 'fe', '##c', '50', 'every', '21', 'days', 'for', '3', 'cycles', ';', 'group', 'c', '(', 'n', '=', '195', ')', 'received', 'fe', '##c', '75', '(', 'flu', '##oro', '##ura', '##ci', '##l', '500', 'mg', '/', 'm2', ',', 'ep', '##ir', '##ub', '##ici', '##n', '75', 'mg', '/', 'm2', 'plus', 'cy', '##cl', '##op', '##hos', '##pha', '##mide', '500', 'mg', '/', 'm2', ')', 'every', '21', 'days', 'for', '3', 'cycles', '.'], ['[CLS]', 'which', 'factors', 'play', 'a', 'role', 'in', 'promoter', 'pro', '##xi', '##mal', 'pausing', 'of', 'rna', 'polymer', '##ase', 'ii', '?', '[SEP]', 'at', 'several', 'eu', '##kar', '##yo', '##tic', 'promoters', ',', 'ds', '##if', ',', 'together', 'with', 'ne', '##lf', '(', 'negative', 'el', '##onga', '##tion', 'factor', ')', ',', 'leads', 'to', 'promoter', '-', 'pro', '##xi', '##mal', 'pausing', 'of', 'rna', 'polymer', '##ase', 'ii'], ['[CLS]', 'which', 'drugs', 'are', 'included', 'in', 'the', 'fe', '##c', '-', '75', 'regime', '##n', '?', '[SEP]', 'prem', '##eno', '##pa', '##usa', '##l', 'patients', 'with', 'node', '-', 'positive', 'res', '##ect', '##able', 'breast', 'cancer', '.', 'preliminary', 'results', 'of', 'a', 'random', '##ised', 'trial', 'comparing', '3', 'ad', '##ju', '##vant', 'regime', '##ns', ':', 'fe', '##c', '50', 'x', '6', 'cycles', 'vs', 'fe', '##c', '50', 'x', '3', 'cycles', 'vs', 'fe', '##c', '75', 'x', '3', 'cycles', '.', 'the', 'french', 'ad', '##ju', '##vant', 'study', 'group', '.', 'ant', '##hra', '##cy', '##cl', '##ines', 'are', 'among', 'the', 'most', 'active', 'drugs', 'for', 'the', 'treatment', 'of', 'advanced', 'breast', 'cancer', '.', 'ep', '##ir', '##ub', '##ici', '##n', 'has', 'been', 'found', 'to', 'be', 'as', 'effective', 'as', 'do', '##x', '##or', '##ub', '##ici', '##n', 'at', 'e', '##qui', '##mo', '##lar', 'doses', 'but', 'significantly', 'better', 'tolerated', ',', 'especially', 'in', 'terms', 'of', 'al', '##ope', '##cia', ',', 'le', '##uc', '##open', '##ia', ',', 'and', 'cardiac', 'toxicity', '.', 'the', 'role', 'of', 'ant', '##hra', '##cy', '##cl', '##ine', '-', 'containing', 'regime', '##ns', 'in', 'ad', '##ju', '##vant', 'treatment', 'of', 'breast', 'cancer', 'has', 'been', 'studied', 'by', 'only', 'a', 'few', 'clinical', 'trial', 'teams', '.', 'in', '1986', ',', 'the', 'french', 'ad', '##ju', '##vant', 'study', 'group', '(', 'fa', '##sg', ')', 'began', 'a', 'random', '##ised', 'trial', 'aimed', 'to', 'investigate', 'the', 'concept', 'of', 'dose', 'intensity', 'as', 'well', 'as', 'the', 'optimal', 'duration', 'of', 'treatment', 'in', 'patients', 'with', 'early', 'breast', 'cancer', '.', 'between', '1986', 'and', '1990', ',', '62', '##1', 'patients', 'were', 'included', 'in', 'the', 'trial', ',', 'of', 'whom', '59', '##5', 'were', 'eva', '##lu', '##able', '.', 'patients', 'were', 'random', '##ised', 'to', '1', 'of', '3', 'treatment', 'groups', ':', 'group', 'a', '(', 'n', '=', '207', ')', 'received', 'fe', '##c', '50', '(', 'flu', '##oro', '##ura', '##ci', '##l', '500', 'mg', '/', 'm2', ',', 'ep', '##ir', '##ub', '##ici', '##n', '50', 'mg', '/', 'm2', 'plus', 'cy', '##cl', '##op', '##hos', '##pha', '##mide', '500', 'mg', '/', 'm2', ')', 'every', '21', 'days', 'for', '6', 'cycles', ';', 'group', 'b', '(', 'n', '=', '193', ')', 'received', 'fe', '##c', '50', 'every', '21', 'days', 'for', '3', 'cycles', ';', 'group', 'c', '(', 'n', '=', '195', ')', 'received', 'fe', '##c', '75', '(', 'flu', '##oro', '##ura', '##ci', '##l', '500', 'mg', '/', 'm2', ',', 'ep', '##ir', '##ub', '##ici', '##n', '75', 'mg', '/', 'm2', 'plus', 'cy', '##cl', '##op', '##hos', '##pha', '##mide', '500', 'mg', '/', 'm2', ')', 'every', '21', 'days', 'for', '3', 'cycles', '.', 'loco', '##region', '##al', 'radio', '##therapy', 'was', 'administered', 'after', 'the', 'third', 'cycle', 'of', 'chemotherapy', 'in', 'all', 'treatment', 'arms', '.', 'clinical', 'pro', '##gno', '##stic', 'factors', 'were', 'similar', 'between', 'treatment', 'groups', '.', 'approximately', '62', '%', 'of', 'all', 'patients', 'had', '1', 'to', '3', 'positive', 'l', '##ym', '##ph', 'nodes', ';', '50', '%', 'of', 'patients', 'were', 'hormone', 'receptor', 'positive', 'and', '73', '%', 'were', 'scarf', '##f', '-', 'bloom', 'richardson', '(', 'sb', '##r', ')', 'grade', '2', 'to', '3', '.', 'toxicity', 'was', 'evaluated', 'in', '59', '##5', 'patients', '(', '207', ',', '193', 'and', '195', 'patients', 'in', 'groups', 'a', ',', 'b', 'and', 'c', ',', 'respectively', ')', ',', 'who', 'received', 'a', 'total', 'of', '230', '##1', 'chemotherapy', 'cycles', '.', '(', 'abstract', 'truncated', 'at', '250', 'words', ')'], ['[CLS]', 'which', 'human', 'syndrome', '##s', 'have', 'been', 'detected', 'with', 'flu', '##orescence', 'in', 'situ', 'hybrid', '##ization', '(', 'fish', ')', '?', '[SEP]', 'to', 'opt', '##imi', '##ze', 'the', 'pre', '##nat', '##al', 'diagnosis', 'platform', 'by', 'using', 'domestically', 'made', 'flu', '##orescence', 'in', 'situ', 'hybrid', '##ization', '(', 'fish', ')', 'kit', 'and', 'to', 'explore', 'the', 'clinical', 'application', 'of', 'fish', 'to', 'rapid', 'pre', '##nat', '##al', 'diagnosis', 'of', 'a', 'wide', 'range', 'of', 'ch', '##rom', '##osomal', 'abnormalities', '.', 'am', '##nio', '##tic', 'fluid', 'samples', 'from', '110', 'pregnant', 'women', 'were', 'studied', 'with', 'the', 'rapid', 'pre', '##nat', '##al', 'diagnosis', 'method', 'of', 'fish', 'and', 'the', 'conventional', 'cell', 'culture', 'method', 'of', 'ka', '##ry', '##ot', '##yp', '##ing', ',', 'the', 'results', 'from', 'both', 'methods', 'were', 'compared', '.', 'four', 'cases', 'of', 'tri', '##som', '##y', '21', ',', '1', 'case', 'of', 'tri', '##som', '##y', '18', ',', '58', 'cases', 'of', '46', ',', 'xx', ',', 'and', '47', 'cases', 'of', '46', ',', 'x', '##y', 'were', 'detected', 'by', 'fish', 'in', 'the', '110', 'am', '##nio', '##tic', 'fluid', 'samples', '.'], ['[CLS]', 'which', 'enzyme', 'does', 'ml', '##n', '##49', '##24', 'inhibit', '?', '[SEP]', 'quan', '##ti', '##fia', '##ble', 'analysis', 'of', 'cellular', 'pathway', 'inhibition', 'of', 'a', 'ned', '##d', '##8', '-', 'act', '##ivating', 'enzyme', 'inhibitor', ',', 'ml', '##n', '##49', '##24', ',', 'using', 'alpha', '##screen', '.', 'cellular', 'effects', 'of', 'a', 'ned', '##d', '##8', '-', 'act', '##ivating', 'enzyme', '(', 'na', '##e', ')', 'inhibitor', ',', 'ml', '##n', '##49', '##24', ',', 'using', 'the', 'alpha', '##screen', 'format', 'were', 'explored', '.', 'ml', '##n', '##49', '##24', 'acts', 'as', 'a', 'substrate', '-', 'assisted', 'inhibitor', 'of', 'na', '##e', 'by', 'forming', 'a', 'tight', 'binding', 'ned', '##d', '##8', '-', 'ml', '##n', '##49', '##24', 'add', '##uc', '##t', '.', 'the', 'inhibit', '##ed', 'enzyme', 'can', 'no', 'longer', 'transfer', 'ned', '##d', '##8', 'downstream', 'to', 'modify', 'and', 'activate', 'the', 'e', '##3', 'cu', '##llin', '-', 'ring', 'liga', '##ses', '.', 'this', 'results', 'in', 'the', 'stabilization', 'of', 'proteins', 'regulated', 'by', 'the', 'pro', '##tea', '##some', ',', 'leading', 'to', 'cell', 'death', '.', 'these', 'studies', 'monitored', 'the', 'end', '##ogen', '##ous', 'cellular', 'changes', 'to', '[UNK]', 'th', '##io', '##ester', ',', 'the', 'formation', 'of', 'the', 'ned', '##d', '##8', '-', 'ml', '##n', '##49', '##24', 'add', '##uc', '##t', ',', 'and', 'the', 'reduction', 'in', 'the', 'cu', '##l', '##1', '-', 'ned', '##d', '##8', '.', 'l', '##ys', '##ates', 'derived', 'from', 'ml', '##n', '##49', '##24', '-', 'treated', 'hc', '##t', '##11', '##6', 'cells', 'showed', 'that', 'whereas', 'the', 'β', '-', 'subunit', 'of', 'na', '##e', 'remained', 'constant', ',', 'reductions', 'of', 'both', '[UNK]', 'th', '##io', '##ester', 'and', 'cu', '##l', '##1', '-', 'ned', '##d', '##8', 'levels', 'occurred', 'with', 'a', 'con', '##com', '##itan', '##t', 'rise', 'of', 'the', 'add', '##uc', '##t', '.', 'moreover', ',', 'the', 'formation', 'of', 'the', 'ned', '##d', '##8', '-', 'ml', '##n', '##49', '##24', 'add', '##uc', '##t', 'was', 'approximately', 'st', '##oic', '##hi', '##ometric', 'with', 'the', 'concentration', 'of', 'na', '##e', '##β', '.', 'higher', 'density', '38', '##4', '-', 'well', 'cell', '-', 'based', 'ass', '##ays', 'illustrated', 'the', 'kinetic', '##s', 'of', 'enzyme', 'ina', '##ct', '##ivation', 'across', 'a', 'wider', 'range', 'of', 'ml', '##n', '##49', '##24', 'concentrations', ',', 'showing', 'a', 'rapid', 'loss', 'of', '[UNK]', 'th', '##io', '##ester', 'and', 'cu', '##l', '##1', '-', 'ned', '##d', '##8', '.', 'the', 'reduction', 'of', '[UNK]', 'th', '##io', '##ester', 'pre', '##cede', '##s', 'the', 'loss', 'of', 'cu', '##l', '##1', '-', 'ned', '##d', '##8', 'at', 'twice', 'the', 'rate', '.', 'finally', ',', 'these', 'results', 'clearly', 'demonstrate', 'the', 'utility', 'of', 'the', 'homogeneous', 'ass', '##ay', 'for', 'quantitative', 'assessment', 'of', 'these', 'end', '##ogen', '##ous', 'cellular', 'components', 'in', 'a', '38', '##4', '-', 'well', 'plate', 'in', 'response', 'to', 'inhibition', 'of', 'na', '##e', 'by', 'ml', '##n', '##49', '##24', '.'], ['[CLS]', 'which', 'cl', '##otti', '##ng', 'factor', 'is', 'inhibit', '##ed', 'by', 'bet', '##rix', '##aba', '##n', '?', '[SEP]', 'practical', 'use', 'of', 'da', '##bi', '##gat', '##ran', 'et', '##ex', '##ila', '##te', 'for', 'stroke', 'prevention', 'in', 'at', '##rial', 'fi', '##bri', '##llation', '.', 'at', '##rial', 'fi', '##bri', '##llation', '(', 'af', ')', 'is', 'associated', 'with', 'an', 'increased', 'risk', 'of', 'th', '##rom', '##bo', '##em', '##bol', '##ism', ',', 'and', 'is', 'the', 'most', 'prevalent', 'factor', 'for', 'card', '##io', '##em', '##bolic', 'stroke', '.', 'vitamin', 'k', 'antagonist', '##s', '(', 'v', '##kas', ')', 'have', 'been', 'the', 'standard', 'of', 'care', 'for', 'stroke', 'prevention', 'in', 'patients', 'with', 'af', 'since', 'the', 'early', '1990s', '.', 'they', 'are', 'very', 'effective', 'for', 'the', 'prevention', 'of', 'card', '##io', '##em', '##bolic', 'stroke', ',', 'but', 'are', 'limited', 'by', 'factors', 'such', 'as', 'drug', '-', 'drug', 'interactions', ',', 'food', 'interactions', ',', 'slow', 'onset', 'and', 'offset', 'of', 'action', ',', 'ha', '##em', '##or', '##rh', '##age', 'and', 'need', 'for', 'routine', 'anti', '##co', '##ag', '##ulation', 'monitoring', 'to', 'maintain', 'a', 'therapeutic', 'international', 'normal', '##ised', 'ratio', '(', 'in', '##r', ')', '.', 'multiple', 'new', 'oral', 'anti', '##co', '##ag', '##ula', '##nts', 'have', 'been', 'developed', 'as', 'potential', 'replacements', 'for', 'v', '##kas', 'for', 'stroke', 'prevention', 'in', 'af', '.', 'most', 'are', 'small', 'synthetic', 'molecules', 'that', 'target', 'th', '##rom', '##bin', '(', 'e', '.', 'g', '.', 'da', '##bi', '##gat', '##ran', 'et', '##ex', '##ila', '##te', ')', 'or', 'factor', 'x', '##a', '(', 'e', '.', 'g', '.', 'ri', '##var', '##ox', '##aba', '##n', ',', 'api', '##xa', '##ban', ',', 'edo', '##xa', '##ban', ',', 'bet', '##rix', '##aba', '##n', ',', 'y', '##m', '##15', '##0', ')', '.', 'these', 'drugs', 'have', 'predictable', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', 'that', 'allow', 'fixed', 'dos', '##ing', 'without', 'routine', 'laboratory', 'monitoring', '.', 'da', '##bi', '##gat', '##ran', 'et', '##ex', '##ila', '##te', ',', 'the', 'first', 'of', 'these', 'new', 'oral', 'anti', '##co', '##ag', '##ula', '##nts', 'to', 'be', 'approved', 'by', 'the', 'united', 'states', 'food', 'and', 'drug', 'administration', 'and', 'the', 'european', 'medicines', 'agency', 'for', 'stroke', 'prevention', 'in', 'patients', 'with', 'non', '-', 'val', '##vu', '##lar', 'af', ',', 'represents', 'an', 'effective', 'and', 'safe', 'alternative', 'to', 'v', '##kas', '.', 'under', 'the', 'auspices', 'of', 'the', 'regional', 'anti', '##co', '##ag', '##ulation', 'working', 'group', ',', 'a', 'multi', '##dis', '##ci', '##plin', '##ary', 'group', 'of', 'experts', 'in', 'th', '##rom', '##bos', '##is', 'and', 'ha', '##em', '##osta', '##sis', 'from', 'central', 'and', 'eastern', 'europe', ',', 'an', 'expert', 'panel', 'with', 'expertise', 'in', 'af', 'convened', 'to', 'discuss', 'practical', ',', 'clinical', '##ly', 'important', 'issues', 'related', 'to', 'the', 'long', '-', 'term', 'use', 'of', 'da', '##bi', '##gat', '##ran', 'for', 'stroke', 'prevention', 'in', 'non', '-', 'val', '##vu', '##lar', 'af', '.', 'the', 'practical', 'information', 'reviewed', 'in', 'this', 'article', 'will', 'help', 'clinic', '##ians', 'make', 'appropriate', 'use', 'of', 'this', 'new', 'therapeutic', 'option', 'in', 'daily', 'clinical', 'practice', '.'], ['[CLS]', 'which', 'are', 'the', '3', 'basic', 'transcription', 'factors', 'that', 'have', 'been', 'used', 'for', 'the', 'direct', 'rep', '##ro', '##gram', '##ming', 'of', 'fi', '##bro', '##bla', '##sts', 'into', 'card', '##iom', '##yo', '##cytes', 'or', 'card', '##iom', '##yo', '##cy', '##te', 'like', '-', 'cells', '?', '[SEP]', 'here', ',', 'we', 'report', 'that', 'a', 'combination', 'of', 'three', 'developmental', 'transcription', 'factors', '(', 'i', '.', 'e', '.', ',', 'ga', '##ta', '##4', ',', 'me', '##f', '##2', '##c', ',', 'and', 'tb', '##x', '##5', ')', 'rapidly', 'and', 'efficiently', 'rep', '##ro', '##gram', '##med', 'post', '##nat', '##al', 'cardiac', 'or', 'der', '##mal', 'fi', '##bro', '##bla', '##sts', 'directly', 'into', 'differentiated', 'card', '##iom', '##yo', '##cy', '##te', '-', 'like', 'cells', '.', 'induced', 'card', '##iom', '##yo', '##cytes', 'expressed', 'cardiac', '-', 'specific', 'markers', ',', 'had', 'a', 'global', 'gene', 'expression', 'profile', 'similar', 'to', 'card', '##iom', '##yo', '##cytes', ',', 'and', 'contracted', 'spontaneously', '.'], ['[CLS]', 'abnormalities', 'in', 'which', 'chromosomes', 'were', 'linked', 'to', 'the', 'mo', '##yam', '##oya', 'disease', '?', '[SEP]', 'her', 'features', 'were', 'consistent', 'with', 'ts', 'and', 'chromosome', 'analysis', 'revealed', 'mosaic', '##ism', 'in', 'which', '17', '%', 'of', 'the', 'cells', 'showed', 'a', 'pseudo', '##iso', '##dice', '##nt', '##ric', 'y', 'chromosome', ':', '45', ',', 'x', '(', '25', ')', '/', '46', ',', 'x', 'ps', '##u', 'id', '##ic', '(', 'y', ')', '(', '11', '.', '2', ')', '(', '5', ')', '.'], ['[CLS]', 'what', 'are', 'the', 'main', 'clinical', 'characteristics', 'of', 'pen', '##dre', '##d', 'syndrome', '?', '[SEP]', 'two', 'common', 'and', 'three', 'novel', 'pd', '##s', 'mutations', 'in', 'thai', 'patients', 'with', 'pen', '##dre', '##d', 'syndrome', '.', 'pen', '##dre', '##d', 'syndrome', 'is', 'an', 'auto', '##som', '##al', 'recess', '##ive', 'disorder', 'characterized', 'by', 'congenital', 'sensor', '##ine', '##ural', 'deaf', '##ness', ',', 'go', '##iter', ',', 'and', 'impaired', 'io', '##di', '##de', 'organ', '##ification', '.', 'it', 'is', 'caused', 'by', 'mutations', 'in', 'the', 'pd', '##s', 'gene', '.', 'most', 'published', 'mutation', 'studies', 'of', 'pen', '##dre', '##d', 'syndrome', 'have', 'dealt', 'with', 'western', 'populations', '.', 'in', 'this', 'study', ',', 'we', 'examined', 'clinical', 'and', 'molecular', 'characteristics', 'of', '16', 'affected', 'individuals', 'in', '6', 'unrelated', 'thai', 'families', '.', 'of', 'all', 'the', 'affected', ',', '100', '%', '(', '16', '/', '16', ')', 'had', 'bilateral', 'deaf', '##ness', ',', '68', '.', '8', '%', '(', '11', '/', '16', ')', 'go', '##iter', '##s', ',', 'and', '25', '%', '(', '4', '/', '16', ')', 'h', '##yp', '##oth', '##yr', '##oid', '##ism', '.', 'f', '##oll', '##icular', 'thyroid', 'car', '##cino', '##ma', 'and', 'hurt', '##hl', '##e', 'cell', 'aden', '##oma', 'were', 'found', 'in', 'affected', 'members', 'of', 'a', 'family', ',', 'raising', 'the', 'possibility', 'of', 'an', 'increased', 'risk', 'of', 'thyroid', 'car', '##cino', '##ma', 'in', 'pen', '##dre', '##d', 'syndrome', 'patients', '.', 'sequence', 'analysis', 'of', 'the', 'entire', 'coding', 'region', 'of', 'the', 'pd', '##s', 'gene', 'successfully', 'identified', 'all', '12', 'mutant', 'all', '##eles', 'in', 'these', '6', 'families', '.', 'the', '12', 'identified', 'mutant', 'all', '##eles', 'constituted', '6', 'distinct', 'mutations', 'including', '3', 'sp', '##lice', 'site', 'mutations', '(', 'iv', '##s', '##4', '-', '1', '##g', '>', 'a', ',', 'iv', '##s', '##7', '-', '2a', '>', 'g', ',', 'iv', '##s', '##9', '-', '1', '##g', '>', 'a', ')', ',', 'one', 'frame', 'shift', 'mutation', '(', '154', '##8', '##ins', '##c', ')', 'and', '2', 'miss', '##ense', 'mutations', '(', 't', '##6', '##7', '##s', ',', 'h', '##7', '##23', '##r', ')', '.', 'eight', 'mutations', 'out', 'of', '12', 'were', 'constituted', 'by', 'iv', '##s', '##7', '-', '2a', '>', 'g', 'and', '154', '##8', '##ins', '##c', ',', 'each', 'one', 'being', 'present', 'in', '4', 'distinct', 'all', '##eles', 'in', 'our', 'studied', 'group', '.', 'the', 'identification', 'of', 'these', 'two', 'frequent', 'pd', '##s', 'mutations', 'will', 'facilitate', 'the', 'molecular', 'diagnosis', 'of', 'pen', '##dre', '##d', 'syndrome', 'in', 'thai', 'populations', '.', 'in', 'addition', ',', 'three', 'newly', 'identified', 'mutations', ',', 't', '##6', '##7', '##s', ',', 'iv', '##s', '##4', '-', '1', '##g', '>', 'a', ',', 'and', 'iv', '##s', '##9', '-', '1', '##g', '>', 'a', ',', 'were', 'not', 'observed', 'in', '50', 'unrelated', 'healthy', 'thai', 'controls', '.'], ['[CLS]', 'list', 'the', 'components', 'of', 'mt', '##or', 'complex', '2', '(', 'mt', '##or', '##c', '##2', ')', '.', '[SEP]', 'sin', '##1', 'regulates', 'tre', '##g', '-', 'cell', 'development', 'but', 'is', 'not', 'required', 'for', 't', '-', 'cell', 'growth', 'and', 'proliferation', '.', 'mammalian', 'sin', '##1', 'plays', 'key', 'roles', 'in', 'the', 'regulation', 'of', 'mit', '##ogen', '-', 'activated', 'protein', 'kinase', '(', 'map', '##k', ')', 'and', 'mammalian', 'target', 'of', 'rap', '##amy', '##cin', '(', 'mt', '##or', ')', 'signaling', '.', 'sin', '##1', 'is', 'an', 'essential', 'component', 'of', 'mt', '##or', 'complex', '2', '(', 'mt', '##or', '##c', '##2', ')', '.', 'the', 'functions', 'of', 'sin', '##1', 'and', 'mt', '##or', '##c', '##2', 'remain', 'largely', 'unknown', 'in', 't', 'cells', '.', 'here', ',', 'we', 'investigate', 'sin', '##1', 'function', 'in', 't', 'cells', 'using', 'mice', 'that', 'lack', 'sin', '##1', 'in', 'the', 'hem', '##ato', '##po', '##ie', '##tic', 'system', '.'], ['[CLS]', 'which', 'genes', '/', 'proteins', 'have', 'been', 'found', 'to', 'inhibit', 'cy', '##cl', '##in', 'dependent', 'kinase', '4', '(', 'cd', '##k', '##4', ')', '?', '[SEP]', 'one', 'of', 'the', 'ink', '##4', 'molecules', ',', 'p', '##16', ',', 'is', 'also', 'known', 'as', 'multiple', 'tumor', 'suppress', '##or', 'and', 'has', 'been', 'found', 'to', 'be', 'mu', '##tated', 'or', 'deleted', 'in', 'various', 'tumors', 'and', 'cell', 'lines', '.', 'we', 'have', 'previously', 'identified', 'p', '##18', 'as', 'a', 'member', 'of', 'the', 'ink', '##4', 'family', '.'], ['[CLS]', 'list', 'bacterial', 'species', 'identified', 'in', 'the', 'ice', '##man', 'tissues', '.', '[SEP]', 'sequence', 'analysis', 'of', 'bacterial', 'dna', 'in', 'the', 'colon', 'and', 'stomach', 'of', 'the', 'tyrol', '##ean', 'ice', '##man', '.', 'the', 'male', 'human', 'body', 'found', 'in', 'an', 'alpine', 'glacier', 'on', 'september', '19', ',', '1991', '(', '\"', 'tyrol', '##ean', 'ice', '##man', '\"', ')', 'has', ',', 'for', 'the', 'first', 'time', 'in', 'history', ',', 'given', 'scientists', 'a', 'chance', 'to', 'perform', 'detailed', 'anatomical', ',', 'his', '##to', '##logical', ',', 'and', 'molecular', 'investigations', 'on', 'the', 'organs', 'of', 'a', 'person', 'from', 'the', 'neolithic', 'age', '(', '53', '##50', '-', '510', '##0', 'b', '.', 'p', '.', ')', '.', 'in', 'the', 'present', 'study', ',', 'tissue', 'samples', 'as', '##ept', '##ically', 'taken', 'from', 'the', 'stomach', 'and', 'the', 'colon', 'of', 'the', 'mummy', 'were', 'utilized', 'for', 'dna', 'extraction', ',', 'and', 'the', 'dna', 'was', 'pc', '##r', '-', 'amplified', ',', 'using', 'prime', '##r', 'pairs', 'designed', 'to', 'bind', 'to', 'fragments', 'of', 'the', '16', '##s', 'rib', '##osomal', 'rna', 'gene', '(', '16', '##s', 'rd', '##na', ')', 'of', 'a', 'broad', 'range', 'of', 'bacteria', '.', 'the', 'pc', '##r', 'products', 'were', 'clone', '##d', 'in', 'pl', '##as', '##mi', '##d', 'vectors', ',', 'and', 'the', 'rec', '##om', '##bina', '##nt', 'clones', '(', 'amp', '##lic', '##ons', ')', 'were', 'sequence', '##d', '.', 'the', 'sequence', 'data', 'were', 'finally', 'used', 'for', 'scanning', 'data', 'libraries', 'containing', 'the', 'corresponding', 'sequences', 'of', 'present', '-', 'day', 'bacteria', ',', 'to', 'in', '##fer', 'the', 'put', '##ative', 'eco', '##phy', '##sio', '##logy', 'of', 'the', 'ancient', 'ones', '.', 'the', 'same', 'procedure', 'was', 'repeated', 'on', 'some', 'fragments', 'of', 'grass', 'from', 'the', 'clothing', 'found', 'near', 'the', 'corpse', '.', 'these', 'fragments', 'were', 'taken', 'as', 'a', 'control', 'of', 'the', 'micro', '##bio', '##logical', 'situation', 'of', 'the', 'glacier', '.', 'the', 'results', 'show', 'that', 'the', 'flora', 'of', 'the', 'ice', '##man', \"'\", 's', 'stomach', 'is', 'entirely', 'composed', 'of', 'bu', '##rk', '##holder', '##ia', 'picket', '##ti', '##i', ',', 'an', 'organism', 'commonly', 'found', 'in', 'aquatic', 'habitats', '.', 'the', 'colon', ',', 'on', 'the', 'other', 'hand', ',', 'contains', 'several', 'members', 'of', 'the', 'fe', '##cal', 'flora', 'of', 'humans', ',', 'such', 'as', 'cl', '##ost', '##rid', '##ium', 'per', '##fr', '##ingen', '##s', ',', 'c', '.', 'g', '##hon', '##ii', ',', 'c', '.', 'so', '##rde', '##lli', '##i', ',', 'eu', '##ba', '##cter', '##ium', 'ten', '##ue', ',', 'and', 'ba', '##cter', '##oides', 'sp', '.', 'the', 'ice', '##man', \"'\", 's', 'colon', ',', 'however', ',', 'was', 'found', 'to', 'contain', ',', 'rather', 'unexpectedly', ',', 'also', 'some', 'members', 'of', 'the', 'genus', 'vi', '##bri', '##o', '.', 'the', 'results', 'are', 'discussed', 'in', 'light', 'of', 'what', 'is', 'known', 'about', 'the', 'preservation', 'of', 'micro', '##bial', 'dna', 'at', 'the', 'ice', '##man', \"'\", 's', 'site', 'and', 'of', 'previous', 'para', '##sit', '##ological', 'studies', 'performed', 'on', 'the', 'ice', '##man', 'himself', 'and', 'on', 'human', 'cop', '##rol', '##ites', '.'], ['[CLS]', 'which', 'factors', 'are', 'considered', 'in', 'the', 'abc', '##d', '##2', 'score', '?', '[SEP]', 'study', 'objective', ':', 'we', 'evaluate', ',', 'in', 'admitted', 'patients', 'with', 'transient', 'is', '##che', '##mic', 'attack', ',', 'the', 'accuracy', 'of', 'the', 'abc', '##d', '(', '2', ')', '(', 'age', '[', 'a', ']', ',', 'blood', 'pressure', '[', 'b', ']', ',', 'clinical', 'features', '[', 'weakness', '/', 'speech', 'disturbance', ']', '[', 'c', ']', ',', 'transient', 'is', '##che', '##mic', 'attack', 'duration', '[', 'd', ']', ',', 'and', 'diabetes', 'history', '[', 'd', ']', ')', 'score', 'in', 'predicting', 'is', '##che', '##mic', 'stroke', 'within', '7', 'days', '.'], ['[CLS]', 'which', 'cl', '##otti', '##ng', 'factor', 'is', 'inhibit', '##ed', 'by', 'bet', '##rix', '##aba', '##n', '?', '[SEP]', 'api', '##xa', '##ban', ',', 'bet', '##rix', '##aba', '##n', ',', 'edo', '##xa', '##ban', ',', 'and', 'ri', '##var', '##ox', '##aba', '##n', 'are', 'small', '-', 'molecule', ',', 'selective', 'inhibitors', 'that', 'directly', 'and', 'rev', '##ers', '##ibly', 'bind', 'to', 'the', 'active', 'site', 'of', 'factor', 'x', '##a', '.'], ['[CLS]', 'which', 'gene', 'mutations', 'cause', 'the', 'mar', '##fan', 'syndrome', '?', '[SEP]', 'novel', 'f', '##bn', '##1', 'gene', 'mutation', 'and', 'maternal', 'ge', '##rmin', '##al', 'mosaic', '##ism', 'as', 'the', 'cause', 'of', 'neon', '##atal', 'form', 'of', 'mar', '##fan', 'syndrome', '.', 'mar', '##fan', 'syndrome', '(', 'm', '##fs', ')', 'is', 'an', 'auto', '##som', '##al', 'dominant', 'disorder', 'caused', 'by', 'mutations', 'in', 'the', 'fi', '##bri', '##llin', '1', 'gene', '(', 'f', '##bn', '##1', ')', '.', 'neon', '##atal', 'form', 'of', 'm', '##fs', 'is', 'rare', 'and', 'is', 'associated', 'with', 'severe', 'ph', '##eno', '##type', 'and', 'a', 'poor', 'pro', '##gno', '##sis', '.', 'we', 'report', 'on', 'a', 'newborn', 'girl', 'with', 'neon', '##atal', 'm', '##fs', 'who', 'displayed', 'cy', '##ano', '##sis', 'and', 'd', '##ys', '##p', '##nea', 'on', 'the', 'first', 'day', 'of', 'life', '.', 'the', 'main', 'clinical', 'features', 'included', 'mit', '##ral', 'and', 'tri', '##cus', '##pid', 'valve', 'ins', '##uf', '##fi', '##ciency', ',', 'ao', '##rti', '##c', 'root', 'dil', '##ata', '##tion', ',', 'ara', '##ch', '##no', '##da', '##ct', '##yl', '##y', ',', 'and', 'loose', 'skin', '.', 'despite', 'the', 'presence', 'of', 'severe', 'and', 'in', '##oper', '##able', 'heart', 'an', '##oma', '##lies', ',', 'the', 'girl', 'was', 'quite', 'stable', 'on', 'sy', '##mpt', '##oma', '##tic', 'treatment', 'and', 'lived', 'up', 'to', 'the', '7th', 'month', 'of', 'age', 'when', 'she', 'died', 'due', 'to', 'card', '##ior', '##es', '##pi', '##rator', '##y', 'failure', '.', 'molecular', '-', 'genetic', 'studies', 'revealed', 'a', 'novel', 'intro', '##nic', 'c', '.', '421', '##1', '-', '32', '_', '-', '13', '##del', 'mutation', 'in', 'the', 'f', '##bn', '##1', 'gene', '.', 'subsequent', 'in', 'vitro', 'sp', '##lic', '##ing', 'analysis', 'showed', 'this', 'mutation', 'led', 'to', 'ex', '##on', '35', 'skipping', ',', 'presumably', 'resulting', 'in', 'a', 'del', '##eti', '##on', 'of', '42', 'amino', 'acids', '(', 'p', '.', 'le', '##u', '##14', '##0', '##5', '_', 'as', '##p', '##14', '##46', '##del', ')', '.', 'interesting', '##ly', ',', 'this', 'mutation', 'is', 'localized', 'outside', 'the', 'region', 'of', 'ex', '##ons', '24', '-', '32', ',', 'whose', 'mutation', 'is', 'responsible', 'for', 'the', 'substantial', 'majority', 'of', 'cases', 'of', 'neon', '##atal', 'm', '##fs', '.', 'although', 'the', 'family', 'history', 'of', 'm', '##fs', 'was', 'negative', ',', 'the', 'subsequent', 'molecular', 'genetic', 'examination', 'documented', 'a', 'mosaic', '##ism', 'of', 'the', 'same', 'mutation', 'in', 'the', 'maternal', 'blood', 'cells', '(', '10', '-', '25', '%', 'of', 'gen', '##omic', 'dna', ')', 'and', 'the', 'detailed', 'clinical', 'examination', 'showed', 'un', '##ila', '##tera', '##l', 'lens', 'ec', '##top', '##y', '.'], ['[CLS]', 'which', 'are', 'the', 'known', 'human', 'trans', '##me', '##mb', '##rane', 'nu', '##cle', '##op', '##orin', '##s', '?', '[SEP]', 'the', 'conserved', 'trans', '##me', '##mb', '##rane', 'nu', '##cle', '##op', '##orin', 'n', '##dc', '##1', 'is', 'required', 'for', 'nuclear', 'por', '##e', 'complex', 'assembly', 'in', 've', '##rte', '##brate', 'cells', '.', 'nuclear', 'por', '##e', 'complexes', '(', 'np', '##cs', ')', 'are', 'large', 'protein', '##aceous', 'channels', 'embedded', 'in', 'the', 'nuclear', 'envelope', '(', 'ne', ')', ',', 'through', 'which', 'exchange', 'of', 'molecules', 'between', 'the', 'nucleus', 'and', 'cy', '##tos', '##ol', 'occurs', '.', 'bio', '##genesis', 'of', 'np', '##cs', 'is', 'complex', 'and', 'poorly', 'understood', '.'], ['[CLS]', 'which', 'transcription', 'factor', 'is', 'considered', 'as', 'a', 'master', 'regulator', 'of', 'l', '##ys', '##osomal', 'genes', '?', '[SEP]', 'we', 'recently', 'discovered', 'the', 'clear', '(', 'coordinated', 'l', '##ys', '##osomal', 'expression', 'and', 'regulation', ')', 'gene', 'network', 'and', 'its', 'master', 'gene', 'transcription', 'factor', 'e', '##b', '(', 't', '##fe', '##b', ')', ',', 'which', 'regulates', 'l', '##ys', '##osomal', 'bio', '##genesis', 'and', 'function', '.'], ['[CLS]', 'which', 'molecule', 'is', 'targeted', 'by', 'dar', '##at', '##um', '##uma', '##b', '?', '[SEP]', 'dar', '##at', '##um', '##uma', '##b', 'is', 'a', 'novel', 'human', 'cd', '##38', 'mono', '##cl', '##onal', 'antibody', 'which', 'kills', 'cd', '##38', '+', 'multiple', 'my', '##elo', '##ma', 'cells', 'via', 'antibody', '-', 'dependent', 'cell', '-', 'mediated', 'cy', '##to', '##to', '##xi', '##city', ',', 'complement', '-', 'dependent', 'cy', '##to', '##to', '##xi', '##city', 'and', 'ap', '##op', '##tosis', '.', 'design', 'and', 'methods', ':', 'to', 'explore', 'the', 'effect', 'of', 'lena', '##lid', '##omi', '##de', 'combined', 'with', 'dar', '##at', '##um', '##uma', '##b', ',', 'we', 'first', 'carried', 'out', 'standard', 'antibody', '-', 'dependent', 'cell', '-', 'mediated', 'cy', '##to', '##to', '##xi', '##city', 'and', 'complement', '-', 'dependent', 'cy', '##to', '##to', '##xi', '##city', 'ass', '##ays', 'in', 'which', 'the', 'cd', '##38', '+', 'multiple', 'my', '##elo', '##ma', 'cell', 'line', 'um', '-', '9', 'and', 'primary', 'multiple', 'my', '##elo', '##ma', 'cells', 'isolated', 'from', 'patients', 'were', 'used', 'as', 'target', 'cells', '.'], ['[CLS]', 'which', 'enzyme', 'is', 'involved', 'in', 'the', 'maintenance', 'of', 'dna', '(', 'cy', '##tos', '##ine', '-', '5', '-', ')', '-', 'methyl', '##ation', '?', '[SEP]', 'ph', '##os', '##ph', '##ory', '##lation', 'of', 'ser', '##ine', '-', '51', '##5', 'activate', '##s', 'the', 'mammalian', 'maintenance', 'methyl', '##tra', '##ns', '##fera', '##se', 'd', '##n', '##mt', '##1', '.', 'dna', 'methyl', '##tra', '##ns', '##fera', '##se', '1', 'methyl', '##ates', 'hem', '##i', '-', 'methyl', '##ated', 'c', '##g', 'sites', 'generated', 'during', 'dna', 'replication', '.', 'ser', '##ine', '51', '##5', 'of', 'this', 'enzyme', 'has', 'been', 'shown', 'to', 'be', 'ph', '##os', '##ph', '##ory', '##lated', '.'], ['[CLS]', 'which', 'proteins', 'are', 'involved', 'in', 'act', '##in', 'bun', '##dling', 'and', 'fi', '##lo', '##pod', '##ia', 'formation', 'and', 'function', '?', '[SEP]', 'treatment', 'with', 'tumor', 'promoter', '12', '-', 'o', '-', 'te', '##tra', '##de', '##cano', '##yl', '##ph', '##or', '##bol', '-', '13', '-', 'ace', '##tate', '(', 't', '##pa', ')', ',', 'which', 'ph', '##os', '##ph', '##ory', '##lates', 'fa', '##sc', '##in', 'and', 'decreases', 'its', 'affinity', 'for', 'act', '##in', ',', 'resulted', 'in', 'loss', 'of', 'all', 'act', '##in', 'bundles', 'from', 'growth', 'cones', '.'], ['[CLS]', 'which', 'are', 'the', 'types', 'of', 'viral', 'men', '##ing', '##itis', '?', '[SEP]', 'we', 'found', 'that', 'il', '-', '8', ',', 'il', '-', '10', ',', 'il', '-', '12', ',', 'il', '-', '13', 'and', 'if', '##n', '-', 'γ', 'showed', 'a', 'statistical', '##ly', 'significant', 'increase', 'in', 'cs', '##f', 'from', 'mum', '##ps', 'men', '##ing', '##itis', 'when', 'compared', 'to', 'other', 'types', 'of', 'viral', 'men', '##ing', '##itis', 'and', 'fever', 'without', 'neurological', 'complications', '.'], ['[CLS]', 'what', 'are', 'the', 'names', 'of', 'anti', '-', 'cd', '##52', 'mono', '##cl', '##onal', 'antibody', 'that', 'is', 'used', 'for', 'treatment', 'of', 'multiple', 'sc', '##ler', '##osis', 'patients', '?', '[SEP]', 'since', 'then', ',', 'one', 'phase', 'ii', 'and', 'two', 'phase', 'iii', 'trials', 'have', 'shown', 'that', 'ale', '##mt', '##uz', '##uma', '##b', 'reduces', 'the', 're', '##la', '##pse', 'rate', ',', 'compared', 'with', 'the', 'active', 'com', '##para', '##tor', 'inter', '##fer', '##on', 'beta', '-', '1a', '(', 'if', '##n', '##β', '-', '1a', ')', ',', 'in', 'treatment', '-', 'naive', 'and', 'treatment', '-', 'experienced', 'ms', 'up', 'to', '10', 'years', 'from', 'disease', 'onset', '.', 'furthermore', ',', 'in', 'two', 'of', 'these', 'trials', ',', 'ale', '##mt', '##uz', '##uma', '##b', 'reduced', 'the', 'risk', 'of', 'acc', '##um', '##ulating', 'disability', 'compared', 'with', 'if', '##n', '##β', '-', '1a', ';', 'indeed', 'ale', '##mt', '##uz', '##uma', '##b', 'treatment', 'led', 'to', 'an', 'improvement', 'in', 'disability', 'and', 'reduction', 'in', 'cerebral', 'at', '##rop', '##hy', '.'], ['[CLS]', 'which', 'are', 'the', 'bio', '##in', '##form', '##atics', 'tools', 'for', 'gene', 'structure', 'prediction', '?', '[SEP]', 'the', 'sp', '##lice', 'site', 'prediction', 'tool', '(', 'sp', '##lice', '##pre', '##dict', '##or', ')', 'is', 'distributed', 'with', 'the', 'genes', '##e', '##q', '##er', 'code', '.', 'a', 'sp', '##lice', '##pre', '##dict', '##or', 'web', 'server', 'is', 'available', 'at', 'http', ':', '/', '/', 'bio', '##in', '##form', '##atics', '.', 'ia', '##sta', '##te', '.', 'ed', '##u', '/', 'c', '##gi', '-', 'bin', '/', 'sp', '.', 'c', '##gi'], ['[CLS]', 'list', 'programs', 'suitable', 'for', 'ph', '##arm', '##aco', '##ph', '##ore', 'modelling', '[SEP]', 'ph', '##arm', '##aco', '##ph', '##ore', 'identification', ',', 'synthesis', ',', 'and', 'biological', 'evaluation', 'of', 'car', '##box', '##yla', '##ted', 'cha', '##lco', '##ne', 'derivatives', 'as', 'cy', '##sl', '##t', '##1', 'antagonist', '##s', '.', 'the', 'ph', '##arm', '##aco', '##ph', '##ore', 'model', '(', 'h', '##yp', '##o', '##1', ')', 'with', 'a', 'well', 'prediction', 'capacity', 'for', 'cy', '##sl', '##t', '(', '1', ')', 'antagonist', '##s', 'was', 'developed', 'using', 'catalyst', '/', 'h', '##yp', '##ogen', 'program', '.', 'virtual', 'screening', 'against', 'an', 'in', '-', 'house', 'database', 'consisted', 'of', 'car', '##box', '##yla', '##ted', 'cha', '##lco', '##nes', 'using', 'h', '##yp', '##o', '##1', 'was', 'performed', '.', 'retrieved', 'hits', '26', '##a', ',', '26', '##b', ',', '27', '##a', ',', 'and', '27', '##b', 'were', 'synthesized', 'and', 'biological', 'evaluated', ',', 'the', 'results', 'of', 'which', 'demonstrated', 'that', 'these', 'compounds', 'showed', 'moderate', 'to', 'good', 'cy', '##sl', '##t', '(', '1', ')', 'antagonist', '##ic', 'activities', '.', 'this', 'study', 'indicated', 'that', 'the', 'generated', 'model', '(', 'h', '##yp', '##o', '##1', ')', 'is', 'a', 'reliable', 'and', 'useful', 'tool', 'in', 'lead', 'optimization', 'for', 'novel', 'cy', '##sl', '##t', '(', '1', ')', 'antagonist', '##s', '.'], ['[CLS]', 'which', 'human', 'disease', 'is', 'associated', 'with', 'mu', '##tated', 'u', '##b', '##q', '##ln', '##2', '[SEP]', 'from', 'animal', 'models', 'to', 'human', 'disease', ':', 'a', 'genetic', 'approach', 'for', 'personal', '##ized', 'medicine', 'in', 'als', '.', 'amy', '##ot', '##rop', '##hic', 'lateral', 'sc', '##ler', '##osis', '(', 'als', ')', 'is', 'the', 'most', 'frequent', 'motor', 'ne', '##uron', 'disease', 'in', 'adults', '.', 'classical', 'als', 'is', 'characterized', 'by', 'the', 'death', 'of', 'upper', 'and', 'lower', 'motor', 'neurons', 'leading', 'to', 'progressive', 'paralysis', '.', 'approximately', '10', '%', 'of', 'als', 'patients', 'have', 'fa', '##mi', '##lia', '##l', 'form', 'of', 'the', 'disease', '.', 'numerous', 'different', 'gene', 'mutations', 'have', 'been', 'found', 'in', 'fa', '##mi', '##lia', '##l', 'cases', 'of', 'als', ',', 'such', 'as', 'mutations', 'in', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '1', '(', 'so', '##d', '##1', ')', ',', 'tar', 'dna', '-', 'binding', 'protein', '43', '(', 'td', '##p', '-', '43', ')', ',', 'fused', 'in', 'sar', '##com', '##a', '(', 'fu', '##s', ')', ',', 'c', '##9', '##orf', '##7', '##2', ',', 'u', '##bi', '##quil', '##in', '-', '2', '(', 'u', '##b', '##q', '##ln', '##2', ')', ',', 'opt', '##ine', '##uri', '##n', '(', 'opt', '##n', ')', 'and', 'others', '.', 'multiple', 'animal', 'models', 'were', 'generated', 'to', 'mimic', 'the', 'disease', 'and', 'to', 'test', 'future', 'treatments', '.', 'however', ',', 'no', 'animal', 'model', 'fully', 'replicate', '##s', 'the', 'spectrum', 'of', 'ph', '##eno', '##type', '##s', 'in', 'the', 'human', 'disease', 'and', 'it', 'is', 'difficult', 'to', 'assess', 'how', 'a', 'therapeutic', 'effect', 'in', 'disease', 'models', 'can', 'predict', 'efficacy', 'in', 'humans', '.', 'importantly', ',', 'the', 'genetic', 'and', 'ph', '##eno', '##typic', 'het', '##ero', '##gen', '##eit', '##y', 'of', 'als', 'leads', 'to', 'a', 'variety', 'of', 'responses', 'to', 'similar', 'treatment', 'regime', '##ns', '.', 'from', 'this', 'has', 'emerged', 'the', 'concept', 'of', 'personal', '##ized', 'medicine', '(', 'pm', ')', ',', 'which', 'is', 'a', 'medical', 'scheme', 'that', 'combines', 'study', 'of', 'genetic', ',', 'environmental', 'and', 'clinical', 'diagnostic', 'testing', ',', 'including', 'bio', '##mark', '##ers', ',', 'to', 'individual', '##ized', 'patient', 'care', '.', 'in', 'this', 'perspective', ',', 'we', 'used', 'subgroup', '##s', 'of', 'specific', 'als', '-', 'linked', 'gene', 'mutations', 'to', 'go', 'through', 'existing', 'animal', 'models', 'and', 'to', 'provide', 'a', 'comprehensive', 'profile', 'of', 'the', 'differences', 'and', 'similarities', 'between', 'animal', 'models', 'of', 'disease', 'and', 'human', 'disease', '.', 'finally', ',', 'we', 'reviewed', 'application', 'of', 'bio', '##mark', '##ers', 'and', 'gene', 'the', '##ra', '##pies', 'relevant', 'in', 'personal', '##ized', 'medicine', 'approach', '.', 'for', 'instance', ',', 'this', 'includes', 'viral', 'delivering', 'of', 'anti', '##sen', '##se', 'ol', '##igo', '##nu', '##cle', '##otide', 'and', 'small', 'interfering', 'rna', 'in', 'so', '##d', '##1', ',', 'td', '##p', '-', '43', 'and', 'c', '##9', '##orf', '##7', '##2', 'mice', 'models', '.', 'promising', 'gene', 'the', '##ra', '##pies', 'raised', 'possibilities', 'for', 'treating', 'differently', 'the', 'major', 'mutations', 'in', 'fa', '##mi', '##lia', '##l', 'als', 'cases', '.'], ['[CLS]', 'list', 'active', 'ingredients', 'of', 'the', 'st', '##ri', '##bil', '##d', 'poly', '##pi', '##ll', '.', '[SEP]', 'to', 'evaluate', 'do', '##lu', '##te', '##gra', '##vir', 'and', 'el', '##vite', '##gra', '##vir', '/', 'co', '##bic', '##ista', '##t', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', 'in', 'hiv', '-', 'negative', 'volunteers', 'up', 'to', '10', 'days', 'after', 'drug', 'ce', '##ssa', '##tion', '.', 'healthy', 'volunteers', 'received', '50', 'mg', 'of', 'do', '##lu', '##te', '##gra', '##vir', 'once', '-', 'daily', 'for', '10', 'days', ',', 'then', 'underwent', 'a', '9', 'day', 'wash', '-', 'out', 'period', ',', 'and', 'then', 'received', 'el', '##vite', '##gra', '##vir', '/', 'co', '##bic', '##ista', '##t', 'as', 'part', 'of', 'st', '##ri', '##bil', '##d', '(', '®', ')', '(', '245', 'mg', 'of', 'ten', '##of', '##ov', '##ir', ',', '200', 'mg', 'of', 'em', '##tric', '##ita', '##bine', ',', '150', 'mg', 'of', 'el', '##vite', '##gra', '##vir', 'and', '150', 'mg', 'of', 'co', '##bic', '##ista', '##t', ')', 'for', '10', 'days', '.'], ['[CLS]', 'which', 'components', 'of', 'the', 'stress', 'gran', '##ules', 'are', 'known', 'to', 'be', 'related', 'to', 'motor', 'ne', '##uron', 'de', '##gen', '##eration', 'in', 'amy', '##ot', '##rop', '##hic', 'lateral', 'sc', '##ler', '##osis', '?', '[SEP]', 'here', ',', 'we', 'demonstrate', 'that', 'c', '-', 'terminal', 'als', 'mutations', 'disrupt', 'the', 'nuclear', 'local', '##izing', 'signal', '(', 'nl', '##s', ')', 'of', 'fu', '##s', 'resulting', 'in', 'cy', '##top', '##las', '##mic', 'accumulation', 'in', 'trans', '##fect', '##ed', 'cells', 'and', 'patient', 'fi', '##bro', '##bla', '##sts', '.', 'fu', '##s', 'mis', '##lo', '##cal', '##ization', 'is', 'rescued', 'by', 'the', 'addition', 'of', 'the', 'wild', '-', 'type', 'fu', '##s', 'nl', '##s', 'to', 'mutant', 'proteins', '.', 'we', 'also', 'show', 'that', 'ox', '##ida', '##tive', 'stress', 'recruits', 'mutant', 'fu', '##s', 'to', 'cy', '##top', '##las', '##mic', 'stress', 'gran', '##ules', 'where', 'it', 'is', 'able', 'to', 'bind', 'and', 'se', '##quest', '##er', 'wild', '-', 'type', 'fu', '##s', '.'], ['[CLS]', 'which', 'disease', 'is', 'associated', 'with', 'the', 'ec', '##top', '##ic', 'expression', 'of', 'the', 'protein', 'encoded', 'by', 'the', 'gene', 'du', '##x', '##4', '?', '[SEP]', 'fa', '##cio', '##sca', '##pu', '##loh', '##ume', '##ral', 'muscular', 'd', '##yst', '##rop', '##hy', '(', 'f', '##sh', '##d', ')', 'is', 'a', 'dominant', 'disease', 'linked', 'to', 'contraction', '##s', 'of', 'the', 'd', '##4', '##z', '##4', 'repeat', 'array', 'in', '4', '##q', '##35', '.', 'we', 'have', 'previously', 'identified', 'a', 'double', 'home', '##ob', '##ox', 'gene', '(', 'du', '##x', '##4', ')', 'within', 'each', 'd', '##4', '##z', '##4', 'unit', 'that', 'en', '##codes', 'a', 'transcription', 'factor', 'expressed', 'in', 'f', '##sh', '##d', 'but', 'not', 'control', 'my', '##ob', '##las', '##ts', '.', 'du', '##x', '##4', 'and', 'its', 'target', 'genes', 'contribute', 'to', 'the', 'global', 'd', '##ys', '##re', '##gul', '##ation', 'of', 'gene', 'expression', 'observed', 'in', 'f', '##sh', '##d', '.'], ['[CLS]', 'which', 'gene', 'is', 'responsible', 'for', 'the', 'development', 'of', 'the', 'mo', '##wat', '-', 'wilson', 'syndrome', '?', '[SEP]', 'neural', 'crest', '-', 'specific', 'removal', 'of', 'z', '##f', '##h', '##x', '##1', '##b', 'in', 'mouse', 'leads', 'to', 'a', 'wide', 'range', 'of', 'ne', '##uro', '##cr', '##isto', '##path', '##ies', 'reminiscent', 'of', 'mo', '##wat', '-', 'wilson', 'syndrome', '.', 'mo', '##wat', '-', 'wilson', 'syndrome', 'is', 'a', 'recently', 'del', '##ine', '##ated', 'auto', '##som', '##al', 'dominant', 'developmental', 'anomaly', ',', 'whereby', 'het', '##ero', '##zy', '##go', '##us', 'mutations', 'in', 'the', 'z', '##f', '##h', '##x', '##1', '##b', 'gene', 'cause', 'mental', 're', '##tar', '##dation', ',', 'delayed', 'motor', 'development', ',', 'ep', '##ile', '##psy', 'and', 'a', 'wide', 'spectrum', 'of', 'clinical', '##ly', 'het', '##ero', '##gen', '##eous', 'features', ',', 'suggest', '##ive', 'of', 'ne', '##uro', '##cr', '##isto', '##path', '##ies', 'at', 'the', 'ce', '##pha', '##lic', ',', 'cardiac', 'and', 'va', '##gal', 'levels', '.', 'however', ',', 'our', 'understanding', 'of', 'the', 'et', '##iology', 'of', 'this', 'condition', 'at', 'the', 'cellular', 'level', 'remains', 'vague', '.', 'this', 'study', 'presents', 'the', 'z', '##f', '##h', '##x', '##1', '##b', 'protein', 'expression', 'domain', 'in', 'mouse', 'embryo', '##s', 'and', 'co', '##rre', '##lates', 'this', 'with', 'a', 'novel', 'mouse', 'model', 'involving', 'a', 'conditional', 'mutation', 'in', 'the', 'z', '##f', '##h', '##x', '##1', '##b', 'gene', 'in', 'neural', 'crest', 'precursor', 'cells', '.', 'these', 'mutant', 'mice', 'display', 'cr', '##ani', '##of', '##ac', '##ial', 'and', 'gas', '##tro', '##int', '##estinal', 'mal', '##form', '##ations', 'that', 'show', 'resemblance', 'to', 'those', 'found', 'in', 'human', 'patients', 'with', 'mo', '##wat', '-', 'wilson', 'syndrome', '.', 'in', 'addition', 'to', 'these', 'clinical', '##ly', 'recognized', 'alterations', ',', 'we', 'document', 'developmental', 'defects', 'in', 'the', 'heart', ',', 'mel', '##ano', '##bla', '##sts', 'and', 'sympathetic', 'and', 'para', '##sy', '##mp', '##ath', '##etic', 'an', '##lage', '##n', '.', 'the', 'latter', 'observations', 'in', 'our', 'mouse', 'model', 'for', 'mo', '##wat', '-', 'wilson', 'suggest', 'a', 'hit', '##her', '##to', 'unknown', 'role', 'for', 'z', '##f', '##h', '##x', '##1', '##b', 'in', 'the', 'development', 'of', 'these', 'particular', 'neural', 'crest', 'derivatives', ',', 'which', 'is', 'a', 'set', 'of', 'observations', 'that', 'should', 'be', 'acknowledged', 'in', 'the', 'clinical', 'management', 'of', 'this', 'genetic', 'disorder', '.'], ['[CLS]', 'what', 'disease', 'is', 've', '##lc', '##ade', '(', 'bo', '##rte', '##zo', '##mi', '##b', ')', 'mainly', 'used', 'for', '?', '[SEP]', 'bo', '##r', 'showed', 'a', 'higher', 'rate', 'of', 'effectiveness', 'than', 'tha', '##l', 'for', 'ref', '##rac', '##tory', 'multiple', 'my', '##elo', '##ma', ',', 'and', 'its', 'effects', 'were', 'rapid', '.', 'bo', '##r', 'treatment', 'prolonged', 'the', 'survival', 'time', 'of', 'tha', '##l', '-', 'resistant', 'patients', '.', 'the', 'efficacy', 'of', 'bo', '##r', 'was', 'unrelated', 'to', 'patient', 'age', ',', 'the', 'number', 'of', 'previous', 'therapeutic', 'regime', '##ns', ',', 'or', 'the', 'disease', 'period', '.'], ['[CLS]', 'which', 'are', 'the', 'ya', '##mana', '##ka', 'factors', '?', '[SEP]', 'induced', 'pl', '##uri', '##pot', '##ent', 'stem', '(', 'ip', '##s', ')', 'cells', 'have', 'the', 'potential', 'to', 'become', 'a', 'universal', 'resource', 'for', 'cell', '-', 'based', 'the', '##ra', '##pies', 'in', 'reg', '##ener', '##ative', 'medicine', ';', 'however', ',', 'prior', 'to', 'the', 'use', 'of', 'such', 'ip', '##s', 'cell', '-', 'based', 'the', '##ra', '##pies', ',', 'pre', '##cl', '##ini', '##cal', 'assessment', 'of', 'their', 'safety', 'and', 'efficacy', 'is', 'essential', '.', 'non', '-', 'human', 'primate', '##s', 'serve', 'as', 'valuable', 'animal', 'models', 'for', 'human', 'diseases', 'or', 'biomedical', 'research', ';', 'therefore', ',', 'in', 'this', 'study', ',', 'we', 'generated', 'cy', '##no', '##mo', '##l', '##gus', 'monkey', 'ip', '##s', 'cells', 'from', 'adult', 'skin', 'and', 'fetal', 'fi', '##bro', '##bla', '##st', 'cells', 'by', 'the', 'retro', '##vira', '##lly', 'mediated', 'introduction', 'of', 'four', 'human', 'transcription', 'factors', ':', 'c', '-', 'my', '##c', ',', 'k', '##lf', '##4', ',', 'oct', '##3', '/', '4', ',', 'and', 'sox', '##2', '(', 'the', 'so', '-', 'called', '\"', 'ya', '##mana', '##ka', 'factors', '\"', ')', '.', 'twenty', 'to', '30', 'days', 'after', 'the', 'introduction', 'of', 'these', 'factors', ',', 'several', 'cy', '##no', '##mo', '##l', '##gus', 'monkey', 'embryo', '##nic', 'stem', '(', 'es', ')', 'cell', '-', 'like', 'colonies', 'appeared', 'on', 's', '##nl', 'and', 'mouse', 'embryo', '##nic', 'fi', '##bro', '##bla', '##st', '(', 'me', '##f', ')', 'feeder', 'layers', '.', 'these', 'colonies', 'were', 'picked', 'and', 'cultivated', 'in', 'primate', 'es', 'medium', '.'], ['[CLS]', 'which', 'diseases', 'are', 'caused', 'by', 'mutations', 'in', 'cal', '##se', '##quest', '##rin', '2', '(', 'cas', '##q', '##2', ')', 'gene', '?', '[SEP]', 'an', 'australian', 'co', '##hort', 'of', '252', 'unrelated', 'fa', '##mi', '##lia', '##l', 'hyper', '##tro', '##phic', 'card', '##iom', '##yo', '##pathy', 'patients', 'were', 'screened', 'for', 'mutations', 'in', 'the', 'ca', '(', '2', '+', ')', 'regulatory', 'genes', ',', 'so', '##rc', '##in', '(', 'sri', ')', ',', 'cal', '##sta', '##bin', '(', 'fk', '##b', '##p', '##1', '##b', ')', ',', 'cal', '##se', '##quest', '##rin', '(', 'cas', '##q', '##2', ')', ',', 'ph', '##os', '##ph', '##ola', '##mba', '##n', '(', 'pl', '##n', ')', ',', 'sar', '##col', '##ip', '##in', '(', 'sl', '##n', ')', ',', 'cal', '##ret', '##ic', '##ulin', '(', 'cal', '##r', '##3', ')', 'and', 'calm', '##od', '##ulin', '(', 'calm', ')', '.', 'a', 'total', 'of', '17', 'ex', '##onic', 'dna', 'variants', 'were', 'identified', 'in', 'the', '7', 'ca', '(', '2', '+', ')', 'regulatory', 'genes', 'studied', ',', 'of', 'which', '4', 'were', 'considered', 'of', 'pathogen', '##ic', 'significance', '.', 'two', 'novel', 'mutations', 'in', 'the', 'cal', '##r', '##3', 'gene', 'were', 'identified', '(', 'l', '##ys', '##8', '##2', '##ar', '##g', ',', 'ar', '##g', '##7', '##3', '##gl', '##n', ')', 'and', 'one', 'tr', '##un', '##cation', 'mutation', 'in', 'the', 'pl', '##n', 'gene', '(', 'le', '##u', '##39', '##ter', ')', '.', 'a', 'variant', 'was', 'also', 'identified', 'in', 'the', 'cas', '##q', '##2', 'gene', '(', 'as', '##p', '##6', '##3', '##gl', '##u', ')', '.', 'these', 'four', 'variants', 'were', 'all', 'novel', ',', 'resulted', 'in', 'changes', 'in', 'conserved', 'amino', 'acids', 'and', 'were', 'not', 'identified', 'in', 'a', 'normal', 'population', '.'], ['[CLS]', 'which', 'proteins', 'participate', 'in', 'the', 'formation', 'of', 'the', 'ryan', '##od', '##ine', 'receptor', 'qu', '##ater', '##nary', 'macro', '##mo', '##le', '##cular', 'complex', '?', '[SEP]', 'cal', '##se', '##quest', '##rin', ',', 'the', 'major', 'calcium', 'se', '##quest', '##ering', 'protein', 'in', 'the', 'sar', '##co', '##pl', '##as', '##mic', 're', '##tic', '##ulum', 'of', 'muscle', ',', 'forms', 'a', 'qu', '##ater', '##nary', 'complex', 'with', 'the', 'ryan', '##od', '##ine', 'receptor', 'calcium', 'release', 'channel', 'and', 'the', 'intrinsic', 'membrane', 'proteins', 'triad', '##in', 'and', 'jun', '##ct', '##in', '.'], ['[CLS]', 'list', 'receptors', 'of', 'the', 'drug', 'ci', '##len', '##git', '##ide', '[SEP]', 'abstract', 'the', 'r', '##g', '##d', 'cyclic', 'pen', '##ta', '##pet', '##ide', ',', 'ci', '##len', '##git', '##ide', ',', 'is', 'a', 'selective', 'inhibitor', 'of', 'α', '##v', '##β', '##3', 'and', 'α', '##v', '##β', '##5', 'int', '##eg', '##rin', '##s', 'and', 'was', 'developed', 'for', 'anti', '##ang', '##io', '##genic', 'therapy', '.'], ['[CLS]', 'which', 'enzyme', 'is', 'inhibit', '##ed', 'by', 'ni', '##ra', '##par', '##ib', '?', '[SEP]', 'the', 'poly', '(', 'ad', '##p', '-', 'rib', '##ose', ')', 'polymer', '##ase', 'inhibitor', 'ni', '##ra', '##par', '##ib', '(', 'mk', '##48', '##27', ')', 'in', 'br', '##ca', 'mutation', 'carriers', 'and', 'patients', 'with', 'sporadic', 'cancer', ':', 'a', 'phase', '1', 'dose', '-', 'es', '##cala', '##tion', 'trial', '.', 'background', ':', 'poly', '(', 'ad', '##p', '-', 'rib', '##ose', ')', 'polymer', '##ase', '(', 'par', '##p', ')', 'is', 'implicated', 'in', 'dna', 'repair', 'and', 'transcription', 'regulation', '.', 'ni', '##ra', '##par', '##ib', '(', 'mk', '##48', '##27', ')', 'is', 'an', 'oral', 'potent', ',', 'selective', 'par', '##p', '-', '1', 'and', 'par', '##p', '-', '2', 'inhibitor', 'that', 'induce', '##s', 'synthetic', 'lethal', '##ity', 'in', 'pre', '##cl', '##ini', '##cal', 'tu', '##mour', 'models', 'with', 'loss', 'of', 'br', '##ca', 'and', 'pt', '##en', 'function', '.', 'we', 'investigated', 'the', 'safety', ',', 'to', '##ler', '##ability', ',', 'maximum', 'tolerated', 'dose', ',', 'ph', '##arm', '##aco', '##kin', '##etic', 'and', 'ph', '##arm', '##aco', '##dy', '##nami', '##c', 'profiles', ',', 'and', 'preliminary', 'anti', '##tum', '##our', 'activity', 'of', 'ni', '##ra', '##par', '##ib', '.', 'methods', ':', 'in', 'a', 'phase', '1', 'dose', '-', 'es', '##cala', '##tion', 'study', ',', 'we', 'enrolled', 'patients', 'with', 'advanced', 'solid', 'tu', '##mour', '##s', 'at', 'one', 'site', 'in', 'the', 'uk', 'and', 'two', 'sites', 'in', 'the', 'usa', '.', 'eligible', 'patients', 'were', 'aged', 'at', 'least', '18', 'years', ';', 'had', 'a', 'life', 'expect', '##ancy', 'of', 'at', 'least', '12', 'weeks', ';', 'had', 'an', 'eastern', 'cooperative', 'on', '##cology', 'group', 'performance', 'status', 'of', '2', 'or', 'less', ';', 'had', 'assess', '##able', 'disease', ';', 'were', 'not', 'suitable', 'to', 'receive', 'any', 'established', 'treatments', ';', 'had', 'adequate', 'organ', 'function', ';', 'and', 'had', 'discontinued', 'any', 'previous', 'anti', '##can', '##cer', 'treatments', 'at', 'least', '4', 'weeks', 'previously', '.', 'in', 'part', 'a', ',', 'co', '##hort', '##s', 'of', 'three', 'to', 'six', 'patients', ',', 'enriched', 'for', 'br', '##ca', '##1', 'and', 'br', '##ca', '##2', 'mutation', 'carriers', ',', 'received', 'ni', '##ra', '##par', '##ib', 'daily', 'at', 'ten', 'es', '##cala', '##ting', 'doses', 'from', '30', 'mg', 'to', '400', 'mg', 'in', 'a', '21', '-', 'day', 'cycle', 'to', 'establish', 'the', 'maximum', 'tolerated', 'dose', '.', 'dose', 'expansion', 'at', 'the', 'maximum', 'tolerated', 'dose', 'was', 'pursued', 'in', '15', 'patients', 'to', 'confirm', 'to', '##ler', '##ability', '.', 'in', 'part', 'b', ',', 'we', 'further', 'investigated', 'the', 'maximum', 'tolerated', 'dose', 'in', 'patients', 'with', 'sporadic', 'platinum', '-', 'resistant', 'high', '-', 'grade', 'ser', '##ous', 'o', '##var', '##ian', 'cancer', 'and', 'sporadic', 'prostate', 'cancer', '.', 'we', 'obtained', 'blood', ',', 'circulating', 'tu', '##mour', 'cells', ',', 'and', 'optional', 'paired', 'tu', '##mour', 'bio', '##ps', '##ies', 'for', 'ph', '##arm', '##aco', '##kin', '##etic', 'and', 'ph', '##arm', '##aco', '##dy', '##nami', '##c', 'assessments', '.', 'toxic', 'effects', 'were', 'assessed', 'by', 'common', 'toxicity', 'criteria', 'and', 'tu', '##mour', 'responses', 'ascribed', 'by', 'response', 'evaluation', 'criteria', 'in', 'solid', 'tumors', '(', 'rec', '##ist', ')', '.', 'circulating', 'tu', '##mour', 'cells', 'and', 'archival', 'tu', '##mour', 'tissue', 'in', 'prostate', 'patients', 'were', 'anal', '##yse', '##d', 'for', 'ex', '##pl', '##ora', '##tory', 'put', '##ative', 'predict', '##ive', 'bio', '##mark', '##ers', ',', 'such', 'as', 'loss', 'of', 'pt', '##en', 'expression', 'and', 'et', '##s', 'rear', '##rang', '##ement', '##s', '.', 'this', 'trial', 'is', 'registered', 'with', 'clinical', '##tri', '##als', '.', 'gov', ',', 'nc', '##t', '##00', '##7', '##49', '##50', '##2', '.', 'findings', ':', 'between', 'sept', '15', ',', '2008', ',', 'and', 'jan', '14', ',', '2011', ',', 'we', 'enrolled', '100', 'patients', ':', '60', 'in', 'part', 'a', 'and', '40', 'in', 'part', 'b', '.', '300', 'mg', '/', 'day', 'was', 'established', 'as', 'the', 'maximum', 'tolerated', 'dose', '.', 'dose', '-', 'limiting', 'toxic', 'effects', 'reported', 'in', 'the', 'first', 'cycle', 'were', 'grade', '3', 'fatigue', '(', 'one', 'patient', 'given', '30', 'mg', '/', 'day', ')', ',', 'grade', '3', 'p', '##ne', '##um', '##oni', '##tis', '(', 'one', 'given', '60', 'mg', '/', 'day', ')', ',', 'and', 'grade', '4', 'th', '##rom', '##bo', '##cy', '##top', '##enia', '(', 'two', 'given', '400', 'mg', '/', 'day', ')', '.', 'common', 'treatment', '-', 'related', 'toxic', 'effects', 'were', 'ana', '##emia', '(', '48', 'patients', '[', '48', '%', ']', ')', ',', 'nausea', '(', '42', '[', '42', '%', ']', ')', ',', 'fatigue', '(', '42', '[', '42', '%', ']', ')', ',', 'th', '##rom', '##bo', '##cy', '##top', '##enia', '(', '35', '[', '35', '%', ']', ')', ',', 'an', '##ore', '##xia', '(', '26', '[', '26', '%', ']', ')', ',', 'ne', '##ut', '##rop', '##enia', '(', '24', '[', '24', '%', ']', ')', ',', 'con', '##sti', '##pati', '##on', '(', '23', '[', '23', '%', ']', ')', ',', 'and', 'vomiting', '(', '20', '[', '20', '%', ']', ')', ',', 'and', 'were', 'predominantly', 'grade', '1', 'or', '2', '.', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', 'were', 'dose', 'proportional', 'and', 'the', 'mean', 'terminal', 'elimination', 'half', '-', 'life', 'was', '36', '·', '4', 'h', '(', 'range', '32', '·', '8', '-', '46', '·', '0', ')', '.', 'ph', '##arm', '##aco', '##dy', '##nami', '##c', 'analyses', 'confirmed', 'par', '##p', 'inhibition', 'exceeded', '50', '%', 'at', 'doses', 'greater', 'than', '80', 'mg', '/', 'day', 'and', 'anti', '##tum', '##our', 'activity', 'was', 'documented', 'beyond', 'doses', 'of', '60', 'mg', '/', 'day', '.', 'eight', '(', '40', '%', '[', '95', '%', 'ci', '19', '-', '64', ']', ')', 'of', '20', 'br', '##ca', '##1', 'or', 'br', '##ca', '##2', 'mutation', 'carriers', 'with', 'o', '##var', '##ian', 'cancer', 'had', 'rec', '##ist', 'partial', 'responses', ',', 'as', 'did', 'two', '(', '50', '%', '[', '7', '-', '93', ']', ')', 'of', 'four', 'mutation', 'carriers', 'with', 'breast', 'cancer', '.', 'anti', '##tum', '##our', 'activity', 'was', 'also', 'reported', 'in', 'sporadic', 'high', '-', 'grade', 'ser', '##ous', 'o', '##var', '##ian', 'cancer', ',', 'non', '-', 'small', '-', 'cell', 'lung', 'cancer', ',', 'and', 'prostate', 'cancer', '.', 'we', 'recorded', 'no', 'correlation', 'between', 'loss', 'of', 'pt', '##en', 'expression', 'or', 'et', '##s', 'rear', '##rang', '##ement', '##s', 'and', 'measures', 'of', 'anti', '##tum', '##our', 'activity', 'in', 'patients', 'with', 'prostate', 'cancer', '.', 'interpretation', ':', 'a', 'recommended', 'phase', '2', 'dose', 'of', '300', 'mg', '/', 'day', 'ni', '##ra', '##par', '##ib', 'is', 'well', 'tolerated', '.', 'ni', '##ra', '##par', '##ib', 'should', 'be', 'further', 'assessed', 'in', 'inherited', 'and', 'sporadic', 'cancers', 'with', 'homo', '##log', '##ous', 'rec', '##om', '##bina', '##tion', 'dna', 'repair', 'defects', 'and', 'to', 'target', 'par', '##p', '-', 'mediated', 'transcription', 'in', 'cancer', '.', 'funding', ':', 'mer', '##ck', 'sharp', 'and', 'do', '##hm', '##e', '.'], ['[CLS]', 'in', 'which', 'yeast', 'chromosome', 'does', 'the', 'rd', '##na', 'cluster', 'reside', '?', '[SEP]', 'the', 'sizes', 'of', 'the', 'two', 'chromosome', 'xii', 'homo', '##logue', '##s', 'were', 'very', 'different', ':', '260', '##0', '(', 'l', '-', 'type', ')', 'and', '145', '##0', 'kb', '(', 's', '-', 'type', ')', '.'], ['[CLS]', 'which', 'disease', 'is', 'associated', 'with', 'the', 'ec', '##top', '##ic', 'expression', 'of', 'the', 'protein', 'encoded', 'by', 'the', 'gene', 'du', '##x', '##4', '?', '[SEP]', 'dig', '##eni', '##c', 'inheritance', 'of', 'an', 'sm', '##ch', '##d', '##1', 'mutation', 'and', 'an', 'f', '##sh', '##d', '-', 'per', '##missive', 'd', '##4', '##z', '##4', 'all', '##ele', 'causes', 'fa', '##cio', '##sca', '##pu', '##loh', '##ume', '##ral', 'muscular', 'd', '##yst', '##rop', '##hy', 'type', '2', '.', 'fa', '##cio', '##sca', '##pu', '##loh', '##ume', '##ral', 'd', '##yst', '##rop', '##hy', '(', 'f', '##sh', '##d', ')', 'is', 'characterized', 'by', 'ch', '##rom', '##atin', 'relaxation', 'of', 'the', 'd', '##4', '##z', '##4', 'macro', '##sat', '##elli', '##te', 'array', 'on', 'chromosome', '4', 'and', 'expression', 'of', 'the', 'd', '##4', '##z', '##4', '-', 'encoded', 'du', '##x', '##4', 'gene', 'in', 'skeletal', 'muscle', '.', 'the', 'more', 'common', 'form', ',', 'auto', '##som', '##al', 'dominant', 'f', '##sh', '##d', '##1', ',', 'is', 'caused', 'by', 'contraction', 'of', 'the', 'd', '##4', '##z', '##4', 'array', ',', 'whereas', 'the', 'genetic', 'deter', '##mina', '##nts', 'and', 'inheritance', 'of', 'd', '##4', '##z', '##4', 'array', 'contraction', '-', 'independent', 'f', '##sh', '##d', '##2', 'are', 'unclear', '.', 'here', ',', 'we', 'show', 'that', 'mutations', 'in', 'sm', '##ch', '##d', '##1', '(', 'encoding', 'structural', 'maintenance', 'of', 'chromosomes', 'flexible', 'hi', '##nge', 'domain', 'containing', '1', ')', 'on', 'chromosome', '18', 'reduce', 'sm', '##ch', '##d', '##1', 'protein', 'levels', 'and', 'se', '##gre', '##gate', 'with', 'genome', '-', 'wide', 'd', '##4', '##z', '##4', 'cp', '##g', 'h', '##yp', '##ome', '##thy', '##lation', 'in', 'human', 'kind', '##red', '##s', '.', 'f', '##sh', '##d', '##2', 'occurs', 'in', 'individuals', 'who', 'inherited', 'both', 'the', 'sm', '##ch', '##d', '##1', 'mutation', 'and', 'a', 'normal', '-', 'sized', 'd', '##4', '##z', '##4', 'array', 'on', 'a', 'chromosome', '4', 'ha', '##pl', '##otype', 'per', '##missive', 'for', 'du', '##x', '##4', 'expression', '.', 'reducing', 'sm', '##ch', '##d', '##1', 'levels', 'in', 'skeletal', 'muscle', 'results', 'in', 'd', '##4', '##z', '##4', 'contraction', '-', 'independent', 'du', '##x', '##4', 'expression', '.', 'our', 'study', 'identifies', 'sm', '##ch', '##d', '##1', 'as', 'an', 'ep', '##igen', '##etic', 'mod', '##ifier', 'of', 'the', 'd', '##4', '##z', '##4', 'meta', '##sta', '##ble', 'ep', '##ial', '##le', '##le', 'and', 'as', 'a', 'causal', 'genetic', 'deter', '##mina', '##nt', 'of', 'f', '##sh', '##d', '##2', 'and', 'possibly', 'other', 'human', 'diseases', 'subject', 'to', 'ep', '##igen', '##etic', 'regulation', '.'], ['[CLS]', 'which', 'proteins', 'control', 'the', 'degradation', 'of', 'cryptic', 'unstable', 'transcript', '##s', '(', 'cuts', ')', 'in', 'yeast', '?', '[SEP]', 'in', 'sac', '##cha', '##rom', '##yce', '##s', 'ce', '##re', '##vis', '##iae', ',', 'non', '-', 'coding', 'rna', '##s', ',', 'including', 'cryptic', 'unstable', 'transcript', '##s', '(', 'cuts', ')', ',', 'are', 'subject', 'to', 'degradation', 'by', 'the', 'ex', '##oso', '##me', '.', 'the', 'tr', '##f', '##4', '/', '5', '-', 'air', '##1', '/', '2', '-', 'mt', '##r', '##4', 'poly', '##ade', '##ny', '##lation', '(', 'tram', '##p', ')', 'complex', 'in', 's', '.', 'ce', '##re', '##vis', '##iae', 'is', 'a', 'nuclear', 'ex', '##oso', '##me', 'co', '##fa', '##ctor', 'that', 'recruits', 'the', 'ex', '##oso', '##me', 'to', 'de', '##grade', 'rna', '##s'], ['[CLS]', 'mat', '##uz', '##uma', '##b', 'has', 'been', 'tested', 'for', 'treatment', 'of', 'which', 'cancers', '?', '[SEP]', 'mat', '##uz', '##uma', '##b', 'and', 'pan', '##it', '##um', '##uma', '##b', 'are', 'antibodies', 'against', 'the', 'ep', '##ider', '##mal', 'growth', 'factor', 'receptor', '(', 'e', '##gf', '##r', ')', 'that', 'are', 'being', 'evaluated', 'in', 'several', 'mali', '##gnan', '##cies', 'including', 'non', '-', 'small', 'cell', 'lung', 'cancer', '(', 'ns', '##cl', '##c', ')', '.', 'in', 'phase', 'i', 'trials', 'of', 'single', '-', 'agent', 'mat', '##uz', '##uma', '##b', 'in', 'patients', 'with', 'e', '##gf', '##r', '-', 'positive', 'cancer', ',', 'three', 'tumor', 'responses', 'were', 'documented', 'in', 'es', '##op', '##ha', '##ge', '##al', 'sq', '##ua', '##mous', 'cell', 'car', '##cino', '##ma', 'as', 'well', 'as', 'color', '##ect', '##al', 'car', '##cino', '##ma', '.'], ['[CLS]', 'please', 'list', 'the', '3', 'findings', 'in', 'hell', '##p', 'syndrome', '.', '[SEP]', 'human', 'serum', 'complement', 'c', '##3', 'and', 'factor', 'h', 'in', 'the', 'syndrome', 'of', 'hem', '##ol', '##ysis', ',', 'elevated', 'liver', 'enzymes', ',', 'and', 'low', 'plate', '##let', 'count', '.', 'problem', ':', 'hem', '##ol', '##ysis', ',', 'elevated', 'liver', 'enzymes', ',', 'and', 'low', 'plate', '##let', 'count', 'syndrome', '(', 'hell', '##p', 'syndrome', ')', 'is', 'a', 'life', '-', 'threatening', 'variant', 'of', 'severe', 'pre', '-', 'ec', '##lam', '##ps', '##ia', 'in', 'pregnant', 'women', '.', 'the', 'complement', 'system', 'may', 'play', 'a', 'role', 'in', 'the', 'pathogen', '##esis', 'of', 'this', 'condition', '.', 'we', 'sought', 'to', 'determine', 'serum', 'complement', '3', '(', 'c', '##3', ')', 'levels', 'and', 'its', 'regulatory', 'protein', 'complement', 'factor', 'h', '(', 'f', '##h', ')', 'in', 'the', 'hell', '##p', 'syndrome', '.'], ['[CLS]', 'what', 'is', 'the', 'ca', '##usa', '##tive', 'agent', 'of', 'the', '\"', 'panama', 'disease', '\"', 'affecting', 'bananas', '?', '[SEP]', 'fu', '##sari', '##um', 'wil', '##t', 'of', 'banana', '(', 'also', 'known', 'as', 'panama', 'disease', ')', 'is', 'caused', 'by', 'fu', '##sari', '##um', 'ox', '##ys', '##por', '##um', 'f', '.', 'sp', '.', 'cube', '##nse'], ['[CLS]', 'which', 'drug', 'should', 'be', 'used', 'as', 'an', 'anti', '##dote', 'in', 'benz', '##od', '##ia', '##ze', '##pine', 'overdose', '?', '[SEP]', 'a', '67', '-', 'year', '-', 'old', 'man', 'with', 'ch', '##lord', '##ia', '##ze', '##po', '##xide', 'toxicity', 'required', 'a', '9', '-', 'day', 'in', '##fusion', 'of', 'flu', '##ma', '##zen', '##il', 'to', 'prevent', 'res', '##eda', '##tion', 'and', 'respiratory', 'ins', '##uf', '##fi', '##ciency', ';', 'he', 'initially', 'was', 'admitted', 'to', 'the', 'hospital', 'for', 'alcohol', 'det', '##ox', '##ification', '.', 'con', '##com', '##itan', '##t', 'medical', 'conditions', 'and', 'the', 'metabolism', 'characteristics', 'of', 'each', 'benz', '##od', '##ia', '##ze', '##pine', 'must', 'di', '##cta', '##te', 'the', 'agent', 'of', 'choice', '.', 'when', 'measures', 'are', 'required', 'to', 'ensure', 'adequate', 'recovery', 'of', 'a', 'patient', \"'\", 's', 'respiratory', 'function', 'and', 'mental', 'awareness', ',', 'such', 'as', 'in', 'patients', 'with', 'benz', '##od', '##ia', '##ze', '##pine', 'toxicity', ',', 'consideration', 'of', 'continuous', '-', 'in', '##fusion', 'flu', '##ma', '##zen', '##il', 'is', 'warrant', '##ed', '.'], ['[CLS]', 'please', 'list', 'the', '3', 'findings', 'in', 'hell', '##p', 'syndrome', '.', '[SEP]', 'hem', '##ol', '##ysis', ',', 'elevated', 'liver', 'enzymes', ',', 'and', 'low', 'plate', '##let', 'count', '(', 'hell', '##p', ')', 'syndrome'], ['[CLS]', 'what', 'is', 'the', 'mode', 'of', 'inheritance', 'of', 'romano', 'ward', 'long', 'q', '##t', 'syndrome', '?', '[SEP]', 'the', 'long', 'q', '-', 't', 'syndrome', '##s', '.', 'loss', 'of', 'consciousness', 'in', 'childhood', 'may', 'be', 'due', 'to', 'cardiovascular', 'causes', ',', 'and', 'the', 'long', 'q', '-', 't', 'syndrome', '##s', 'can', 'present', 'with', 'seizures', '.', 'the', 'romano', '-', 'ward', 'syndrome', 'is', 'of', 'auto', '##som', '##al', 'dominant', 'inheritance', ',', 'and', 'the', 'je', '##r', '##vel', '##l', 'and', 'lange', '-', 'ni', '##els', '##on', 'syndrome', ',', 'with', 'associated', 'deaf', '##ness', ',', 'of', 'auto', '##som', '##al', 'recess', '##ive', 'inheritance', '.', 'the', 'diagnosis', 'is', 'often', 'delayed', ',', 'but', 'a', 'careful', 'history', 'can', 'avoid', 'this', '.', 'the', 'syndrome', '##s', 'can', 'appear', 'to', 'be', 'due', 'to', 'an', 'im', '##balance', 'in', 'the', 'sympathetic', 'nerve', 'to', 'the', 'vent', '##ric', '##ular', 'my', '##oca', '##rdi', '##um', ',', 'and', 'pre', '##ci', '##pit', '##ating', 'causes', 'such', 'as', 'stress', 'suggest', 'a', 'cn', '##s', 'influence', 'on', 'this', '.', 'the', 'electro', '##card', '##io', '##gram', 'can', 'confirm', 'the', 'prolonged', 'q', '-', 't', 'interval', ',', 'but', 'this', 'is', 'not', 'always', 'present', ',', 'at', 'least', 'without', 'an', 'exercise', 'test', '.', 'treatment', 'with', 'beta', '-', 'block', '##ers', 'is', 'often', 'successful', '.', 'if', 'a', 'wrong', 'diagnosis', 'of', 'ep', '##ile', '##psy', 'is', 'made', 'a', 'chance', 'may', 'be', 'missed', 'of', 'avoiding', 'sudden', 'death', ',', 'quite', 'apart', 'from', 'all', 'the', 'medical', ',', 'and', 'social', 'consequences', 'that', 'can', 'result', 'from', 'such', 'a', 'diagnosis', '.'], ['[CLS]', 'which', 'enzyme', 'is', 'inhibit', '##ed', 'by', 'ix', '##az', '##omi', '##b', '?', '[SEP]', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', 'of', 'ix', '##az', '##omi', '##b', ',', 'an', 'oral', 'pro', '##tea', '##some', 'inhibitor', ',', 'in', 'solid', 'tu', '##mour', 'patients', 'with', 'moderate', 'or', 'severe', 'he', '##pati', '##c', 'impairment', '.', 'aim', ':', 'the', 'aim', 'of', 'the', 'present', 'study', 'was', 'to', 'character', '##ize', 'the', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', 'of', 'the', 'oral', 'pro', '##tea', '##some', 'inhibitor', ',', 'ix', '##az', '##omi', '##b', ',', 'in', 'patients', 'with', 'solid', 'tu', '##mour', '##s', 'and', 'moderate', 'or', 'severe', 'he', '##pati', '##c', 'impairment', ',', 'to', 'provide', 'po', '##sol', '##ogy', 'recommendations', '.', 'methods', ':', 'eligible', 'adults', 'with', 'advanced', 'mali', '##gnan', '##cies', 'for', 'which', 'no', 'further', 'effective', 'therapy', 'was', 'available', 'received', 'a', 'single', 'dose', 'of', 'ix', '##az', '##omi', '##b', 'on', 'day', '1', 'of', 'the', 'ph', '##arm', '##aco', '##kin', '##etic', 'cycle', ';', 'patients', 'with', 'normal', 'he', '##pati', '##c', 'function', ',', 'moderate', 'he', '##pati', '##c', 'impairment', 'or', 'severe', 'he', '##pati', '##c', 'impairment', 'received', '4', 'mg', ',', '2', '.', '3', 'mg', 'or', '1', '.', '5', 'mg', ',', 'respectively', '.', 'blood', 'samples', 'for', 'single', '-', 'dose', 'ph', '##arm', '##aco', '##kin', '##etic', 'characterization', 'were', 'collected', 'over', '336', 'h', 'post', '##dos', '##e', '.', 'after', 'sampling', ',', 'patients', 'could', 'continue', 'to', 'receive', 'ix', '##az', '##omi', '##b', 'on', 'days', '1', ',', '8', 'and', '15', 'in', '28', '-', 'day', 'cycles', '.', 'results', ':', 'of', '48', 'enrolled', 'patients', '(', '13', ',', '15', 'and', '20', 'in', 'the', 'normal', ',', 'moderate', 'and', 'severe', 'groups', ',', 'respectively', ')', ',', '43', 'were', 'ph', '##arm', '##aco', '##kin', '##etic', '##s', '-', 'eva', '##lu', '##able', '.', 'ix', '##az', '##omi', '##b', 'was', 'rapidly', 'absorbed', '(', 'median', 'time', 'to', 'reach', 'peak', 'concentration', 'was', '0', '.', '95', '-', '1', '.', '5', 'h', ')', 'and', 'highly', 'bound', 'to', 'plasma', 'proteins', ',', 'with', 'a', 'similar', 'mean', 'fraction', 'bound', '(', '~', '99', '%', ')', 'across', 'the', 'three', 'groups', '.', 'in', 'patients', 'with', 'moderate', '/', 'severe', 'he', '##pati', '##c', 'impairment', '(', 'combined', 'group', ')', ',', 'the', 'geometric', 'least', 'squares', 'mean', 'ratios', '(', '90', '%', 'confidence', 'interval', ')', 'for', 'un', '##bound', 'and', 'total', 'dose', '-', 'normal', '##ized', 'area', 'under', 'the', 'plasma', 'concentration', 'vs', '.', 'time', 'curve', 'from', 'time', 'zero', 'to', 'the', 'time', 'of', 'the', 'last', 'quan', '##ti', '##fia', '##ble', 'concentration', 'in', 'reference', 'to', 'the', 'normal', 'he', '##pati', '##c', 'function', 'group', 'were', '1', '.', '27', '(', '0', '.', '75', ',', '2', '.', '16', ')', 'and', '1', '.', '20', '(', '0', '.', '79', ',', '1', '.', '82', ')', ',', 'respectively', '.', 'seven', '(', '15', '%', ')', 'of', 'the', '48', 'patients', 'experienced', 'a', 'grade', '3', 'drug', '-', 'related', 'adverse', 'event', ';', 'there', 'were', 'no', 'drug', '-', 'related', 'grade', '4', 'adverse', 'events', '.', 'conclusions', ':', 'in', 'patients', 'with', 'moderate', '/', 'severe', 'he', '##pati', '##c', 'impairment', ',', 'un', '##bound', 'and', 'total', 'systemic', 'exposure', '##s', 'of', 'ix', '##az', '##omi', '##b', 'were', '27', '%', 'and', '20', '%', 'higher', ',', 'respectively', ',', 'vs', '.', 'normal', 'he', '##pati', '##c', 'function', '.', 'a', 'reduced', 'ix', '##az', '##omi', '##b', 'starting', 'dose', 'of', '3', 'mg', 'is', 'recommended', 'for', 'patients', 'with', 'moderate', 'or', 'severe', 'he', '##pati', '##c', 'impairment', '.'], ['[CLS]', 'which', 'receptors', 'can', 'be', 'evaluated', 'with', 'the', '[', '18', '##f', ']', 'alta', '##nse', '##rin', '?', '[SEP]', 'methods', ':', 'fifteen', 'women', 'ill', 'with', 'an', '(', 'ill', 'an', ')', 'were', 'compared', 'with', '29', 'healthy', 'control', 'women', '(', 'cw', ')', ';', 'pet', 'and', '[', '11', '##c', ']', 'way', '##100', '##6', '##35', 'were', 'used', 'to', 'assess', 'binding', 'potential', '(', 'bp', ')', 'of', 'the', '5', '-', 'h', '##t', '##1', '##a', 'receptor', ',', 'and', '[', '18', '##f', ']', 'alta', '##nse', '##rin', 'was', 'used', 'to', 'assess', 'posts', '##yna', '##ptic', '5', '-', 'h', '##t', '##2', '##a', 'receptor', 'bp', '.'], ['[CLS]', 'which', 'mu', '##tated', 'enzyme', 'is', 'responsible', 'for', 'o', '##cu', '##lo', '##cut', '##aneous', '1', '(', 'o', '##ca', '##1', ')', '-', 'type', 'al', '##bin', '##ism', '?', '[SEP]', 'to', 'explore', 'the', 'patients', 'gen', '##otype', '##s', 'and', 'the', 'mutation', 'spectrum', 'of', 'ty', '##ros', '##inas', '##e', '(', 'ty', '##r', ')', 'gene', 'and', 'the', 'effects', 'on', 'protein', 'structure', 'and', 'function', 'in', 'o', '##cu', '##lo', '##cut', '##aneous', 'al', '##bin', '##ism', 'type', '1', '(', 'o', '##ca', '##1', ')', '.', 'the', 'polymer', '##ase', 'chain', 'reaction', '(', 'pc', '##r', ')', 'and', 'sequencing', 'techniques', 'were', 'applied', 'to', 'amp', '##li', '##fy', 'and', 'analyze', 'the', 'regions', 'of', 'ex', '##on', ',', 'ex', '##oni', '##nt', '##ron', 'and', 'promoter', 'of', 'ty', '##r', 'gene', 'of', '15', 'o', '##ca', '##1', 'pro', '##band', '##s', 'and', 'some', 'of', 'their', 'parents'], ['[CLS]', 'which', 'components', 'of', 'the', 'stress', 'gran', '##ules', 'are', 'known', 'to', 'be', 'related', 'to', 'motor', 'ne', '##uron', 'de', '##gen', '##eration', 'in', 'amy', '##ot', '##rop', '##hic', 'lateral', 'sc', '##ler', '##osis', '?', '[SEP]', 'trans', '##active', 'response', 'dna', '-', 'binding', 'protein', '43', '(', 'td', '##p', '-', '43', ')', 'forms', 'abnormal', 'u', '##bi', '##qui', '##tina', '##ted', 'and', 'ph', '##os', '##ph', '##ory', '##lated', 'inclusion', '##s', 'in', 'brain', 'tissues', 'from', 'patients', 'with', 'amy', '##ot', '##rop', '##hic', 'lateral', 'sc', '##ler', '##osis', '(', 'als', ')', 'and', 'front', '##ote', '##mp', '##ora', '##l', 'lo', '##bar', 'de', '##gen', '##eration', '.', 'td', '##p', '-', '43', 'is', 'a', 'dna', '/', 'rna', '-', 'binding', 'protein', 'involved', 'in', 'rna', 'processing', ',', 'such', 'as', 'transcription', ',', 'pre', '-', 'mrna', 'sp', '##lic', '##ing', ',', 'mrna', 'stabilization', 'and', 'transport', 'to', 'den', '##dr', '##ites', '.', 'we', 'found', 'that', 'in', 'response', 'to', 'ox', '##ida', '##tive', 'stress', 'and', 'to', 'environmental', 'insults', 'of', 'different', 'types', 'td', '##p', '-', '43', 'is', 'capable', 'to', 'assemble', 'into', 'stress', 'gran', '##ules', '(', 'sg', '##s', ')', ',', 'rib', '##on', '##uc', '##le', '##op', '##rot', '##ein', 'complexes', 'where', 'protein', 'synthesis', 'is', 'temporarily', 'arrested', '.'], ['[CLS]', 'which', 'diseases', 'can', 'be', 'treated', 'with', 'af', '##ame', '##lan', '##otide', '?', '[SEP]', 'conclusions', ':', 'af', '##ame', '##lan', '##otide', 'appears', 'to', 'have', 'anti', '-', 'inflammatory', 'effects', 'in', 'patients', 'with', 'mild', '-', 'to', '-', 'moderate', 'ac', '##ne', 'vulgar', '##is', '.']]\n"
     ]
    }
   ],
   "source": [
    "#Special tokens along with question tokens\n",
    "tokens = token_df(df, CLS,SEP,tokenizer)\n",
    "print(tokens[1:50])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "mOwFb-SJi_RN",
    "outputId": "14ea0886-0113-49ac-d7d4-a440ca3291b3"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[101, 2029, 2024, 1996, 1017, 3937, 14193, 5876, 2008, 2031, 2042, 2109, 2005, 1996, 3622, 16360, 3217, 13113, 6562, 1997, 10882, 12618, 28522, 12837, 2046, 4003, 18994, 7677, 27321, 2030, 4003, 18994, 7677, 5666, 2618, 2066, 1011, 4442, 1029, 102, 2182, 1010, 2057, 3189, 2008, 1037, 5257, 1997, 2093, 13908, 14193, 5876, 1006, 1045, 1012, 1041, 1012, 1010, 11721, 2696, 2549, 1010, 2033, 2546, 2475, 2278, 1010, 1998, 26419, 2595, 2629, 1007, 5901, 1998, 18228, 16360, 3217, 13113, 7583, 2695, 19833, 2389, 15050, 2030, 4315, 9067, 10882, 12618, 28522, 12837, 3495, 2046, 24374, 4003, 18994, 7677, 5666, 2618, 1011, 2066, 4442, 1012], [101, 2029, 5850, 2024, 2443, 1999, 1996, 10768, 2278, 1011, 4293, 6939, 2078, 1029, 102, 5022, 2020, 6721, 5084, 2000, 1015, 1997, 1017, 3949, 2967, 1024, 2177, 1037, 1006, 1050, 1027, 19843, 1007, 2363, 10768, 2278, 2753, 1006, 19857, 14604, 4648, 6895, 2140, 3156, 11460, 1013, 25525, 1010, 4958, 4313, 12083, 28775, 2078, 2753, 11460, 1013, 25525, 4606, 22330, 20464, 7361, 15006, 21890, 24284, 3156, 11460, 1013, 25525, 1007, 2296, 2538, 2420, 2005, 1020, 12709, 1025, 2177, 1038, 1006, 1050, 1027, 19984, 1007, 2363, 10768, 2278, 2753, 2296, 2538, 2420, 2005, 1017, 12709, 1025, 2177, 1039, 1006, 1050, 1027, 17317, 1007, 2363, 10768, 2278, 4293, 1006, 19857, 14604, 4648, 6895, 2140, 3156, 11460, 1013, 25525, 1010, 4958, 4313, 12083, 28775, 2078, 4293, 11460, 1013, 25525, 4606, 22330, 20464, 7361, 15006, 21890, 24284, 3156, 11460, 1013, 25525, 1007, 2296, 2538, 2420, 2005, 1017, 12709, 1012], [101, 2029, 5876, 2377, 1037, 2535, 1999, 15543, 4013, 9048, 9067, 20490, 1997, 12987, 17782, 11022, 2462, 1029, 102, 2012, 2195, 7327, 6673, 7677, 4588, 26512, 1010, 16233, 10128, 1010, 2362, 2007, 11265, 10270, 1006, 4997, 3449, 26356, 3508, 5387, 1007, 1010, 5260, 2000, 15543, 1011, 4013, 9048, 9067, 20490, 1997, 12987, 17782, 11022, 2462], [101, 2029, 5850, 2024, 2443, 1999, 1996, 10768, 2278, 1011, 4293, 6939, 2078, 1029, 102, 26563, 16515, 4502, 10383, 2140, 5022, 2007, 13045, 1011, 3893, 24501, 22471, 3085, 7388, 4456, 1012, 8824, 3463, 1997, 1037, 6721, 5084, 3979, 13599, 1017, 4748, 9103, 18941, 6939, 3619, 1024, 10768, 2278, 2753, 1060, 1020, 12709, 5443, 10768, 2278, 2753, 1060, 1017, 12709, 5443, 10768, 2278, 4293, 1060, 1017, 12709, 1012, 1996, 2413, 4748, 9103, 18941, 2817, 2177, 1012, 14405, 13492, 5666, 20464, 10586, 2024, 2426, 1996, 2087, 3161, 5850, 2005, 1996, 3949, 1997, 3935, 7388, 4456, 1012, 4958, 4313, 12083, 28775, 2078, 2038, 2042, 2179, 2000, 2022, 2004, 4621, 2004, 2079, 2595, 2953, 12083, 28775, 2078, 2012, 1041, 15549, 5302, 8017, 21656, 2021, 6022, 2488, 25775, 1010, 2926, 1999, 3408, 1997, 2632, 17635, 7405, 1010, 3393, 14194, 26915, 2401, 1010, 1998, 15050, 22423, 1012, 1996, 2535, 1997, 14405, 13492, 5666, 20464, 3170, 1011, 4820, 6939, 3619, 1999, 4748, 9103, 18941, 3949, 1997, 7388, 4456, 2038, 2042, 3273, 2011, 2069, 1037, 2261, 6612, 3979, 2780, 1012, 1999, 3069, 1010, 1996, 2413, 4748, 9103, 18941, 2817, 2177, 1006, 6904, 28745, 1007, 2211, 1037, 6721, 5084, 3979, 6461, 2000, 8556, 1996, 4145, 1997, 13004, 8015, 2004, 2092, 2004, 1996, 15502, 9367, 1997, 3949, 1999, 5022, 2007, 2220, 7388, 4456, 1012, 2090, 3069, 1998, 2901, 1010, 5786, 2487, 5022, 2020, 2443, 1999, 1996, 3979, 1010, 1997, 3183, 5354, 2629, 2020, 9345, 7630, 3085, 1012, 5022, 2020, 6721, 5084, 2000, 1015, 1997, 1017, 3949, 2967, 1024, 2177, 1037, 1006, 1050, 1027, 19843, 1007, 2363, 10768, 2278, 2753, 1006, 19857, 14604, 4648, 6895, 2140, 3156, 11460, 1013, 25525, 1010, 4958, 4313, 12083, 28775, 2078, 2753, 11460, 1013, 25525, 4606, 22330, 20464, 7361, 15006, 21890, 24284, 3156, 11460, 1013, 25525, 1007, 2296, 2538, 2420, 2005, 1020, 12709, 1025, 2177, 1038, 1006, 1050, 1027, 19984, 1007, 2363, 10768, 2278, 2753, 2296, 2538, 2420, 2005, 1017, 12709, 1025, 2177, 1039, 1006, 1050, 1027, 17317, 1007, 2363, 10768, 2278, 4293, 1006, 19857, 14604, 4648, 6895, 2140, 3156, 11460, 1013, 25525, 1010, 4958, 4313, 12083, 28775, 2078, 4293, 11460, 1013, 25525, 4606, 22330, 20464, 7361, 15006, 21890, 24284, 3156, 11460, 1013, 25525, 1007, 2296, 2538, 2420, 2005, 1017, 12709, 1012, 28046, 23784, 2389, 2557, 20900, 2001, 8564, 2044, 1996, 2353, 5402, 1997, 27144, 1999, 2035, 3949, 2608, 1012, 6612, 4013, 26745, 10074, 5876, 2020, 2714, 2090, 3949, 2967, 1012, 3155, 5786, 1003, 1997, 2035, 5022, 2018, 1015, 2000, 1017, 3893, 1048, 24335, 8458, 14164, 1025, 2753, 1003, 1997, 5022, 2020, 18714, 10769, 3893, 1998, 6421, 1003, 2020, 18982, 2546, 1011, 13426, 9482, 1006, 24829, 2099, 1007, 3694, 1016, 2000, 1017, 1012, 22423, 2001, 16330, 1999, 5354, 2629, 5022, 1006, 19843, 1010, 19984, 1998, 17317, 5022, 1999, 2967, 1037, 1010, 1038, 1998, 1039, 1010, 4414, 1007, 1010, 2040, 2363, 1037, 2561, 1997, 11816, 2487, 27144, 12709, 1012, 1006, 10061, 25449, 2012, 5539, 2616, 1007], [101, 2029, 2529, 8715, 2015, 2031, 2042, 11156, 2007, 19857, 20030, 1999, 26179, 8893, 3989, 1006, 3869, 1007, 1029, 102, 2000, 23569, 27605, 4371, 1996, 3653, 19833, 2389, 11616, 4132, 2011, 2478, 27143, 2081, 19857, 20030, 1999, 26179, 8893, 3989, 1006, 3869, 1007, 8934, 1998, 2000, 8849, 1996, 6612, 4646, 1997, 3869, 2000, 5915, 3653, 19833, 2389, 11616, 1997, 1037, 2898, 2846, 1997, 10381, 21716, 27642, 28828, 1012, 2572, 27678, 4588, 8331, 8168, 2013, 7287, 6875, 2308, 2020, 3273, 2007, 1996, 5915, 3653, 19833, 2389, 11616, 4118, 1997, 3869, 1998, 1996, 7511, 3526, 3226, 4118, 1997, 10556, 2854, 4140, 22571, 2075, 1010, 1996, 3463, 2013, 2119, 4725, 2020, 4102, 1012, 2176, 3572, 1997, 13012, 25426, 2100, 2538, 1010, 1015, 2553, 1997, 13012, 25426, 2100, 2324, 1010, 5388, 3572, 1997, 4805, 1010, 22038, 1010, 1998, 4700, 3572, 1997, 4805, 1010, 1060, 2100, 2020, 11156, 2011, 3869, 1999, 1996, 7287, 2572, 27678, 4588, 8331, 8168, 1012], [101, 2029, 9007, 2515, 19875, 2078, 26224, 18827, 26402, 1029, 102, 24110, 3775, 22749, 3468, 4106, 1997, 12562, 12732, 23586, 1997, 1037, 12311, 2094, 2620, 1011, 2552, 17441, 9007, 24054, 1010, 19875, 2078, 26224, 18827, 1010, 2478, 6541, 18182, 1012, 12562, 3896, 1997, 1037, 12311, 2094, 2620, 1011, 2552, 17441, 9007, 1006, 6583, 2063, 1007, 24054, 1010, 19875, 2078, 26224, 18827, 1010, 2478, 1996, 6541, 18182, 4289, 2020, 10641, 1012, 19875, 2078, 26224, 18827, 4490, 2004, 1037, 16305, 1011, 7197, 24054, 1997, 6583, 2063, 2011, 5716, 1037, 4389, 8031, 12311, 2094, 2620, 1011, 19875, 2078, 26224, 18827, 5587, 14194, 2102, 1012, 1996, 26402, 2098, 9007, 2064, 2053, 2936, 4651, 12311, 2094, 2620, 13248, 2000, 19933, 1998, 20544, 1996, 1041, 2509, 12731, 21202, 1011, 3614, 8018, 8583, 1012, 2023, 3463, 1999, 1996, 28715, 1997, 8171, 12222, 2011, 1996, 4013, 27058, 14045, 1010, 2877, 2000, 3526, 2331, 1012, 2122, 2913, 17785, 1996, 2203, 23924, 3560, 12562, 3431, 2000, 100, 16215, 3695, 20367, 1010, 1996, 4195, 1997, 1996, 12311, 2094, 2620, 1011, 19875, 2078, 26224, 18827, 5587, 14194, 2102, 1010, 1998, 1996, 7312, 1999, 1996, 12731, 2140, 2487, 1011, 12311, 2094, 2620, 1012, 1048, 7274, 8520, 5173, 2013, 19875, 2078, 26224, 18827, 1011, 5845, 16731, 2102, 14526, 2575, 4442, 3662, 2008, 6168, 1996, 1156, 1011, 24312, 1997, 6583, 2063, 2815, 5377, 1010, 25006, 1997, 2119, 100, 16215, 3695, 20367, 1998, 12731, 2140, 2487, 1011, 12311, 2094, 2620, 3798, 4158, 2007, 1037, 9530, 9006, 25451, 2102, 4125, 1997, 1996, 5587, 14194, 2102, 1012, 9308, 1010, 1996, 4195, 1997, 1996, 12311, 2094, 2620, 1011, 19875, 2078, 26224, 18827, 5587, 14194, 2102, 2001, 3155, 2358, 19419, 4048, 28993, 2007, 1996, 6693, 1997, 6583, 2063, 29720, 1012, 3020, 4304, 4229, 2549, 1011, 2092, 3526, 1011, 2241, 4632, 22916, 7203, 1996, 20504, 2015, 1997, 9007, 27118, 6593, 25761, 2408, 1037, 7289, 2846, 1997, 19875, 2078, 26224, 18827, 14061, 1010, 4760, 1037, 5915, 3279, 1997, 100, 16215, 3695, 20367, 1998, 12731, 2140, 2487, 1011, 12311, 2094, 2620, 1012, 1996, 7312, 1997, 100, 16215, 3695, 20367, 3653, 22119, 2015, 1996, 3279, 1997, 12731, 2140, 2487, 1011, 12311, 2094, 2620, 2012, 3807, 1996, 3446, 1012, 2633, 1010, 2122, 3463, 4415, 10580, 1996, 9710, 1997, 1996, 24854, 4632, 4710, 2005, 20155, 7667, 1997, 2122, 2203, 23924, 3560, 12562, 6177, 1999, 1037, 4229, 2549, 1011, 2092, 5127, 1999, 3433, 2000, 23586, 1997, 6583, 2063, 2011, 19875, 2078, 26224, 18827, 1012], [101, 2029, 18856, 21325, 3070, 5387, 2003, 26402, 2098, 2011, 6655, 17682, 19736, 2078, 1029, 102, 6742, 2224, 1997, 4830, 5638, 20697, 5521, 3802, 10288, 11733, 2618, 2005, 6909, 9740, 1999, 2012, 14482, 10882, 23736, 20382, 1012, 2012, 14482, 10882, 23736, 20382, 1006, 21358, 1007, 2003, 3378, 2007, 2019, 3445, 3891, 1997, 16215, 21716, 5092, 6633, 14956, 2964, 1010, 1998, 2003, 1996, 2087, 15157, 5387, 2005, 4003, 3695, 6633, 18647, 6909, 1012, 17663, 1047, 17379, 2015, 1006, 1058, 13716, 1007, 2031, 2042, 1996, 3115, 1997, 2729, 2005, 6909, 9740, 1999, 5022, 2007, 21358, 2144, 1996, 2220, 4134, 1012, 2027, 2024, 2200, 4621, 2005, 1996, 9740, 1997, 4003, 3695, 6633, 18647, 6909, 1010, 2021, 2024, 3132, 2011, 5876, 2107, 2004, 4319, 1011, 4319, 10266, 1010, 2833, 10266, 1010, 4030, 14447, 1998, 16396, 1997, 2895, 1010, 5292, 6633, 2953, 25032, 4270, 1998, 2342, 2005, 9410, 3424, 3597, 8490, 9513, 8822, 2000, 5441, 1037, 17261, 2248, 3671, 5084, 6463, 1006, 1999, 2099, 1007, 1012, 3674, 2047, 8700, 3424, 3597, 8490, 7068, 7666, 2031, 2042, 2764, 2004, 4022, 23936, 2005, 1058, 13716, 2005, 6909, 9740, 1999, 21358, 1012, 2087, 2024, 2235, 12553, 10737, 2008, 4539, 16215, 21716, 8428, 1006, 1041, 1012, 1043, 1012, 4830, 5638, 20697, 5521, 3802, 10288, 11733, 2618, 1007, 2030, 5387, 1060, 2050, 1006, 1041, 1012, 1043, 1012, 15544, 10755, 11636, 19736, 2078, 1010, 17928, 18684, 8193, 1010, 18314, 18684, 8193, 1010, 6655, 17682, 19736, 2078, 1010, 1061, 2213, 16068, 2692, 1007, 1012, 2122, 5850, 2031, 21425, 6887, 27292, 22684, 4939, 16530, 2015, 2008, 3499, 4964, 9998, 2075, 2302, 9410, 5911, 8822, 1012, 4830, 5638, 20697, 5521, 3802, 10288, 11733, 2618, 1010, 1996, 2034, 1997, 2122, 2047, 8700, 3424, 3597, 8490, 7068, 7666, 2000, 2022, 4844, 2011, 1996, 2142, 2163, 2833, 1998, 4319, 3447, 1998, 1996, 2647, 20233, 4034, 2005, 6909, 9740, 1999, 5022, 2007, 2512, 1011, 11748, 19722, 8017, 21358, 1010, 5836, 2019, 4621, 1998, 3647, 4522, 2000, 1058, 13716, 1012, 2104, 1996, 20153, 1997, 1996, 3164, 3424, 3597, 8490, 9513, 2551, 2177, 1010, 1037, 4800, 10521, 6895, 28296, 5649, 2177, 1997, 8519, 1999, 16215, 21716, 15853, 2483, 1998, 5292, 6633, 28696, 6190, 2013, 2430, 1998, 2789, 2885, 1010, 2019, 6739, 5997, 2007, 11532, 1999, 21358, 19596, 2000, 6848, 6742, 1010, 6612, 2135, 2590, 3314, 3141, 2000, 1996, 2146, 1011, 2744, 2224, 1997, 4830, 5638, 20697, 5521, 2005, 6909, 9740, 1999, 2512, 1011, 11748, 19722, 8017, 21358, 1012, 1996, 6742, 2592, 8182, 1999, 2023, 3720, 2097, 2393, 9349, 7066, 2191, 6413, 2224, 1997, 2023, 2047, 17261, 5724, 1999, 3679, 6612, 3218, 1012], [101, 2029, 2024, 1996, 1017, 3937, 14193, 5876, 2008, 2031, 2042, 2109, 2005, 1996, 3622, 16360, 3217, 13113, 6562, 1997, 10882, 12618, 28522, 12837, 2046, 4003, 18994, 7677, 27321, 2030, 4003, 18994, 7677, 5666, 2618, 2066, 1011, 4442, 1029, 102, 2182, 1010, 2057, 3189, 2008, 1037, 5257, 1997, 2093, 13908, 14193, 5876, 1006, 1045, 1012, 1041, 1012, 1010, 11721, 2696, 2549, 1010, 2033, 2546, 2475, 2278, 1010, 1998, 26419, 2595, 2629, 1007, 5901, 1998, 18228, 16360, 3217, 13113, 7583, 2695, 19833, 2389, 15050, 2030, 4315, 9067, 10882, 12618, 28522, 12837, 3495, 2046, 24374, 4003, 18994, 7677, 5666, 2618, 1011, 2066, 4442, 1012, 10572, 4003, 18994, 7677, 27321, 5228, 15050, 1011, 3563, 16387, 1010, 2018, 1037, 3795, 4962, 3670, 6337, 2714, 2000, 4003, 18994, 7677, 27321, 1010, 1998, 11016, 27491, 1012], [101, 28828, 1999, 2029, 26874, 2020, 5799, 2000, 1996, 9587, 14852, 18232, 4295, 1029, 102, 2014, 2838, 2020, 8335, 2007, 24529, 1998, 16706, 4106, 3936, 16061, 2964, 1999, 2029, 2459, 1003, 1997, 1996, 4442, 3662, 1037, 18404, 19565, 24598, 3372, 7277, 1061, 16706, 1024, 3429, 1010, 1060, 1006, 2423, 1007, 1013, 4805, 1010, 1060, 8827, 2226, 8909, 2594, 1006, 1061, 1007, 1006, 2340, 1012, 1016, 1007, 1006, 1019, 1007, 1012], [101, 2054, 2024, 1996, 2364, 6612, 6459, 1997, 7279, 16200, 2094, 8715, 1029, 102, 2048, 2691, 1998, 2093, 3117, 22851, 2015, 14494, 1999, 7273, 5022, 2007, 7279, 16200, 2094, 8715, 1012, 7279, 16200, 2094, 8715, 2003, 2019, 8285, 25426, 2389, 28290, 3512, 8761, 7356, 2011, 27480, 13617, 3170, 11137, 12419, 2791, 1010, 2175, 21646, 1010, 1998, 18234, 22834, 4305, 3207, 5812, 9031, 1012, 2009, 2003, 3303, 2011, 14494, 1999, 1996, 22851, 2015, 4962, 1012, 2087, 2405, 16221, 2913, 1997, 7279, 16200, 2094, 8715, 2031, 9411, 2007, 2530, 7080, 1012, 1999, 2023, 2817, 1010, 2057, 8920, 6612, 1998, 8382, 6459, 1997, 2385, 5360, 3633, 1999, 1020, 15142, 7273, 2945, 1012, 1997, 2035, 1996, 5360, 1010, 2531, 1003, 1006, 2385, 1013, 2385, 1007, 2018, 17758, 12419, 2791, 1010, 6273, 1012, 1022, 1003, 1006, 2340, 1013, 2385, 1007, 2175, 21646, 2015, 1010, 1998, 2423, 1003, 1006, 1018, 1013, 2385, 1007, 1044, 22571, 14573, 12541, 9314, 2964, 1012, 1042, 14511, 21412, 29610, 2482, 21081, 2863, 1998, 3480, 7317, 2063, 3526, 16298, 9626, 2020, 2179, 1999, 5360, 2372, 1997, 1037, 2155, 1010, 6274, 1996, 6061, 1997, 2019, 3445, 3891, 1997, 29610, 2482, 21081, 2863, 1999, 7279, 16200, 2094, 8715, 5022, 1012, 5537, 4106, 1997, 1996, 2972, 16861, 2555, 1997, 1996, 22851, 2015, 4962, 5147, 4453, 2035, 2260, 15527, 2035, 26741, 1999, 2122, 1020, 2945, 1012, 1996, 2260, 4453, 15527, 2035, 26741, 11846, 1020, 5664, 14494, 2164, 1017, 11867, 13231, 2609, 14494, 1006, 4921, 2015, 2549, 1011, 1015, 2290, 1028, 1037, 1010, 4921, 2015, 2581, 1011, 23409, 1028, 1043, 1010, 4921, 2015, 2683, 1011, 1015, 2290, 1028, 1037, 1007, 1010, 2028, 4853, 5670, 16221, 1006, 16666, 2620, 7076, 2278, 1007, 1998, 1016, 3335, 16700, 14494, 1006, 1056, 2575, 2581, 2015, 1010, 1044, 2581, 21926, 2099, 1007, 1012, 2809, 14494, 2041, 1997, 2260, 2020, 11846, 2011, 4921, 2015, 2581, 1011, 23409, 1028, 1043, 1998, 16666, 2620, 7076, 2278, 1010, 2169, 2028, 2108, 2556, 1999, 1018, 5664, 2035, 26741, 1999, 2256, 3273, 2177, 1012, 1996, 8720, 1997, 2122, 2048, 6976, 22851, 2015, 14494, 2097, 10956, 1996, 8382, 11616, 1997, 7279, 16200, 2094, 8715, 1999, 7273, 7080, 1012, 1999, 2804, 1010, 2093, 4397, 4453, 14494, 1010, 1056, 2575, 2581, 2015, 1010, 4921, 2015, 2549, 1011, 1015, 2290, 1028, 1037, 1010, 1998, 4921, 2015, 2683, 1011, 1015, 2290, 1028, 1037, 1010, 2020, 2025, 5159, 1999, 2753, 15142, 7965, 7273, 7711, 1012], [101, 2862, 1996, 6177, 1997, 11047, 2953, 3375, 1016, 1006, 11047, 2953, 2278, 2475, 1007, 1012, 102, 8254, 2487, 26773, 29461, 2290, 1011, 3526, 2458, 2021, 2003, 2025, 3223, 2005, 1056, 1011, 3526, 3930, 1998, 20250, 1012, 26524, 8254, 2487, 3248, 3145, 4395, 1999, 1996, 7816, 1997, 10210, 23924, 1011, 8878, 5250, 21903, 1006, 4949, 2243, 1007, 1998, 26524, 4539, 1997, 9680, 24079, 15459, 1006, 11047, 2953, 1007, 14828, 1012, 8254, 2487, 2003, 2019, 6827, 6922, 1997, 11047, 2953, 3375, 1016, 1006, 11047, 2953, 2278, 2475, 1007, 1012, 1996, 4972, 1997, 8254, 2487, 1998, 11047, 2953, 2278, 2475, 3961, 4321, 4242, 1999, 1056, 4442, 1012, 2182, 1010, 2057, 8556, 8254, 2487, 3853, 1999, 1056, 4442, 2478, 12328, 2008, 3768, 8254, 2487, 1999, 1996, 19610, 10610, 6873, 2666, 4588, 2291, 1012], [101, 2029, 9165, 1013, 8171, 2031, 2042, 2179, 2000, 26402, 22330, 20464, 2378, 7790, 21903, 1018, 1006, 3729, 2243, 2549, 1007, 1029, 102, 2028, 1997, 1996, 10710, 2549, 10737, 1010, 1052, 16048, 1010, 2003, 2036, 2124, 2004, 3674, 13656, 16081, 2953, 1998, 2038, 2042, 2179, 2000, 2022, 14163, 16238, 2030, 17159, 1999, 2536, 21434, 1998, 3526, 3210, 1012, 2057, 2031, 3130, 4453, 1052, 15136, 2004, 1037, 2266, 1997, 1996, 10710, 2549, 2155, 1012], [101, 2862, 17341, 2427, 4453, 1999, 1996, 3256, 2386, 14095, 1012, 102, 5537, 4106, 1997, 17341, 6064, 1999, 1996, 16844, 1998, 4308, 1997, 1996, 27193, 11219, 3256, 2386, 1012, 1996, 3287, 2529, 2303, 2179, 1999, 2019, 10348, 10046, 2006, 2244, 2539, 1010, 2889, 1006, 1000, 27193, 11219, 3256, 2386, 1000, 1007, 2038, 1010, 2005, 1996, 2034, 2051, 1999, 2381, 1010, 2445, 6529, 1037, 3382, 2000, 4685, 6851, 28141, 1010, 2010, 3406, 9966, 1010, 1998, 8382, 9751, 2006, 1996, 11595, 1997, 1037, 2711, 2013, 1996, 19061, 2287, 1006, 5187, 12376, 1011, 23475, 2692, 1038, 1012, 1052, 1012, 1007, 1012, 1999, 1996, 2556, 2817, 1010, 8153, 8168, 2004, 23606, 15004, 2579, 2013, 1996, 4308, 1998, 1996, 16844, 1997, 1996, 22788, 2020, 12550, 2005, 6064, 14676, 1010, 1998, 1996, 6064, 2001, 7473, 2099, 1011, 26986, 1010, 2478, 3539, 2099, 7689, 2881, 2000, 14187, 2000, 10341, 1997, 1996, 2385, 2015, 19395, 27642, 12987, 4962, 1006, 2385, 2015, 16428, 2532, 1007, 1997, 1037, 5041, 2846, 1997, 10327, 1012, 1996, 7473, 2099, 3688, 2020, 17598, 2094, 1999, 20228, 3022, 4328, 2094, 19019, 1010, 1998, 1996, 28667, 5358, 21114, 3372, 24418, 1006, 23713, 10415, 5644, 1007, 2020, 5537, 2094, 1012, 1996, 5537, 2951, 2020, 2633, 2109, 2005, 13722, 2951, 8860, 4820, 1996, 7978, 10071, 1997, 2556, 1011, 2154, 10327, 1010, 2000, 1999, 7512, 1996, 2404, 8082, 17338, 21281, 20763, 6483, 1997, 1996, 3418, 3924, 1012, 1996, 2168, 7709, 2001, 5567, 2006, 2070, 10341, 1997, 5568, 2013, 1996, 5929, 2179, 2379, 1996, 11547, 1012, 2122, 10341, 2020, 2579, 2004, 1037, 2491, 1997, 1996, 12702, 26282, 9966, 3663, 1997, 1996, 10046, 1012, 1996, 3463, 2265, 2008, 1996, 10088, 1997, 1996, 3256, 2386, 1005, 1055, 4308, 2003, 4498, 3605, 1997, 20934, 8024, 14528, 2401, 28972, 3775, 2072, 1010, 2019, 15923, 4141, 2179, 1999, 13582, 10746, 1012, 1996, 16844, 1010, 2006, 1996, 2060, 2192, 1010, 3397, 2195, 2372, 1997, 1996, 10768, 9289, 10088, 1997, 4286, 1010, 2107, 2004, 18856, 14122, 14615, 5007, 2566, 19699, 15542, 2015, 1010, 1039, 1012, 1043, 8747, 6137, 1010, 1039, 1012, 2061, 25547, 6894, 2072, 1010, 7327, 3676, 21162, 5007, 2702, 5657, 1010, 1998, 8670, 21162, 25064, 11867, 1012, 1996, 3256, 2386, 1005, 1055, 16844, 1010, 2174, 1010, 2001, 2179, 2000, 5383, 1010, 2738, 14153, 1010, 2036, 2070, 2372, 1997, 1996, 3562, 6819, 23736, 2080, 1012, 1996, 3463, 2024, 6936, 1999, 2422, 1997, 2054, 2003, 2124, 2055, 1996, 8347, 1997, 12702, 21102, 6064, 2012, 1996, 3256, 2386, 1005, 1055, 2609, 1998, 1997, 3025, 11498, 28032, 10091, 2913, 2864, 2006, 1996, 3256, 2386, 2370, 1998, 2006, 2529, 8872, 13153, 7616, 1012], [101, 2029, 5876, 2024, 2641, 1999, 1996, 5925, 2094, 2475, 3556, 1029, 102, 2817, 7863, 1024, 2057, 16157, 1010, 1999, 4914, 5022, 2007, 25354, 2003, 5403, 7712, 2886, 1010, 1996, 10640, 1997, 1996, 5925, 2094, 1006, 1016, 1007, 1006, 2287, 1031, 1037, 1033, 1010, 2668, 3778, 1031, 1038, 1033, 1010, 6612, 2838, 1031, 11251, 1013, 4613, 16915, 1033, 1031, 1039, 1033, 1010, 25354, 2003, 5403, 7712, 2886, 9367, 1031, 1040, 1033, 1010, 1998, 14671, 2381, 1031, 1040, 1033, 1007, 3556, 1999, 29458, 2003, 5403, 7712, 6909, 2306, 1021, 2420, 1012], [101, 2029, 18856, 21325, 3070, 5387, 2003, 26402, 2098, 2011, 6655, 17682, 19736, 2078, 1029, 102, 17928, 18684, 8193, 1010, 6655, 17682, 19736, 2078, 1010, 18314, 18684, 8193, 1010, 1998, 15544, 10755, 11636, 19736, 2078, 2024, 2235, 1011, 13922, 1010, 13228, 25456, 2008, 3495, 1998, 7065, 2545, 17296, 14187, 2000, 1996, 3161, 2609, 1997, 5387, 1060, 2050, 1012], [101, 2029, 4962, 14494, 3426, 1996, 9388, 15143, 8715, 1029, 102, 3117, 1042, 24700, 2487, 4962, 16221, 1998, 11062, 16216, 27512, 2389, 16061, 2964, 2004, 1996, 3426, 1997, 16231, 27815, 2433, 1997, 9388, 15143, 8715, 1012, 9388, 15143, 8715, 1006, 1049, 10343, 1007, 2003, 2019, 8285, 25426, 2389, 7444, 8761, 3303, 2011, 14494, 1999, 1996, 10882, 23736, 21202, 1015, 4962, 1006, 1042, 24700, 2487, 1007, 1012, 16231, 27815, 2433, 1997, 1049, 10343, 2003, 4678, 1998, 2003, 3378, 2007, 5729, 6887, 16515, 13874, 1998, 1037, 3532, 4013, 26745, 6190, 1012, 2057, 3189, 2006, 1037, 20662, 2611, 2007, 16231, 27815, 1049, 10343, 2040, 6913, 22330, 6761, 6190, 1998, 1040, 7274, 2361, 22084, 2006, 1996, 2034, 2154, 1997, 2166, 1012, 1996, 2364, 6612, 2838, 2443, 10210, 7941, 1998, 13012, 7874, 23267, 10764, 16021, 16093, 8873, 29125, 1010, 20118, 28228, 2278, 7117, 29454, 6790, 3508, 1010, 19027, 2818, 3630, 2850, 6593, 8516, 2100, 1010, 1998, 6065, 3096, 1012, 2750, 1996, 3739, 1997, 5729, 1998, 1999, 25918, 3085, 2540, 2019, 9626, 11983, 1010, 1996, 2611, 2001, 3243, 6540, 2006, 25353, 27718, 9626, 4588, 3949, 1998, 2973, 2039, 2000, 1996, 5504, 3204, 1997, 2287, 2043, 2016, 2351, 2349, 2000, 4003, 25346, 2229, 8197, 16259, 2100, 4945, 1012, 8382, 1011, 7403, 2913, 3936, 1037, 3117, 17174, 8713, 1039, 1012, 29403, 2487, 1011, 3590, 1035, 1011, 2410, 9247, 16221, 1999, 1996, 1042, 24700, 2487, 4962, 1012, 4745, 1999, 25714, 11867, 10415, 2075, 4106, 3662, 2023, 16221, 2419, 2000, 4654, 2239, 3486, 25978, 1010, 10712, 4525, 1999, 1037, 3972, 20624, 2239, 1997, 4413, 13096, 12737, 1006, 1052, 1012, 3393, 2226, 16932, 2692, 2629, 1035, 2004, 2361, 16932, 21472, 9247, 1007, 1012, 5875, 2135, 1010, 2023, 16221, 2003, 22574, 2648, 1996, 2555, 1997, 4654, 5644, 2484, 1011, 3590, 1010, 3005, 16221, 2003, 3625, 2005, 1996, 6937, 3484, 1997, 3572, 1997, 16231, 27815, 1049, 10343, 1012, 2348, 1996, 2155, 2381, 1997, 1049, 10343, 2001, 4997, 1010, 1996, 4745, 8382, 7403, 7749, 8832, 1037, 16061, 2964, 1997, 1996, 2168, 16221, 1999, 1996, 11062, 2668, 4442, 1006, 2184, 1011, 2423, 1003, 1997, 8991, 22026, 6064, 1007, 1998, 1996, 6851, 6612, 7749, 3662, 4895, 11733, 14621, 2140, 10014, 14925, 14399, 2100, 1012], [101, 2029, 2024, 1996, 2124, 2529, 9099, 4168, 14905, 18053, 16371, 14321, 7361, 28741, 2015, 1029, 102, 1996, 19995, 9099, 4168, 14905, 18053, 16371, 14321, 7361, 28741, 1050, 16409, 2487, 2003, 3223, 2005, 4517, 18499, 2063, 3375, 3320, 1999, 2310, 19731, 22008, 4442, 1012, 4517, 18499, 2063, 15420, 1006, 27937, 6169, 1007, 2024, 2312, 5250, 25560, 6833, 11157, 1999, 1996, 4517, 11255, 1006, 11265, 1007, 1010, 2083, 2029, 3863, 1997, 10737, 2090, 1996, 13502, 1998, 22330, 13122, 4747, 5158, 1012, 16012, 23737, 1997, 27937, 6169, 2003, 3375, 1998, 9996, 5319, 1012], [101, 2029, 14193, 5387, 2003, 2641, 2004, 1037, 3040, 21618, 1997, 1048, 7274, 27642, 9165, 1029, 102, 2057, 3728, 3603, 1996, 3154, 1006, 14206, 1048, 7274, 27642, 3670, 1998, 7816, 1007, 4962, 2897, 1998, 2049, 3040, 4962, 14193, 5387, 1041, 2497, 1006, 1056, 7959, 2497, 1007, 1010, 2029, 26773, 1048, 7274, 27642, 16012, 23737, 1998, 3853, 1012], [101, 2029, 13922, 2003, 9416, 2011, 18243, 4017, 2819, 12248, 2497, 1029, 102, 18243, 4017, 2819, 12248, 2497, 2003, 1037, 3117, 2529, 3729, 22025, 18847, 20464, 16026, 27781, 2029, 8563, 3729, 22025, 1009, 3674, 2026, 18349, 2863, 4442, 3081, 27781, 1011, 7790, 3526, 1011, 19872, 22330, 3406, 3406, 9048, 12972, 1010, 13711, 1011, 7790, 22330, 3406, 3406, 9048, 12972, 1998, 9706, 7361, 25950, 1012, 2640, 1998, 4725, 1024, 2000, 8849, 1996, 3466, 1997, 14229, 21273, 20936, 3207, 4117, 2007, 18243, 4017, 2819, 12248, 2497, 1010, 2057, 2034, 3344, 2041, 3115, 27781, 1011, 7790, 3526, 1011, 19872, 22330, 3406, 3406, 9048, 12972, 1998, 13711, 1011, 7790, 22330, 3406, 3406, 9048, 12972, 4632, 22916, 1999, 2029, 1996, 3729, 22025, 1009, 3674, 2026, 18349, 2863, 3526, 2240, 8529, 1011, 1023, 1998, 3078, 3674, 2026, 18349, 2863, 4442, 7275, 2013, 5022, 2020, 2109, 2004, 4539, 4442, 1012], [101, 2029, 9007, 2003, 2920, 1999, 1996, 6032, 1997, 6064, 1006, 22330, 13122, 3170, 1011, 1019, 1011, 1007, 1011, 25003, 3370, 1029, 102, 6887, 2891, 8458, 10253, 13490, 1997, 14262, 3170, 1011, 4868, 2629, 20544, 2015, 1996, 26524, 6032, 25003, 6494, 3619, 27709, 3366, 1040, 2078, 20492, 2487, 1012, 6064, 25003, 6494, 3619, 27709, 3366, 1015, 25003, 8520, 19610, 2072, 1011, 25003, 4383, 1039, 2290, 4573, 7013, 2076, 6064, 21647, 1012, 14262, 3170, 4868, 2629, 1997, 2023, 9007, 2038, 2042, 3491, 2000, 2022, 6887, 2891, 8458, 10253, 13776, 1012]]\n"
     ]
    }
   ],
   "source": [
    "# Tokens to ids\n",
    "tokens_ids = token_to_ids(tokens)\n",
    "print(tokens_ids[:20])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "0Of9bmL9i_fp",
    "outputId": "15ad094f-513b-451d-eb1f-e02a0748e1eb"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "35696\n"
     ]
    }
   ],
   "source": [
    "input_mask=[]\n",
    "for i in tokens_ids:\n",
    "    temp=[1]*len(i)\n",
    "    for j in range(len(temp), 512):\n",
    "        temp.append(0)\n",
    "    input_mask.append(temp)\n",
    "\n",
    "print(len(input_mask))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "NFmOrwZqenFF"
   },
   "source": [
    "Adding input mask"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "Ju4Wg9NwfSun"
   },
   "source": [
    "BERT requires sequence length of 512. \n",
    "\n",
    "In the next cells zeros are padded to make the input data reach that length."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "sROup-WXjJMY"
   },
   "outputs": [],
   "source": [
    "max_seq_len = 512\n",
    "for i in range(len(tokens_ids)):\n",
    "    for j in range(len(tokens_ids[i]),max_seq_len): \n",
    "        tokens_ids[i].append(0)\n",
    "    tokens_ids[i] = tokens_ids[i][:512]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "_RHHWn0nXOQr"
   },
   "outputs": [],
   "source": [
    "for i in range (len(input_mask),max_seq_len): \n",
    "        input_mask.append(0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "fvMeseLx0JyU",
    "outputId": "d2801f9d-786a-4512-9096-8e05f9900dc1"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]\n"
     ]
    }
   ],
   "source": [
    "print(input_mask[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "y_Wmk4ksjJUD"
   },
   "outputs": [],
   "source": [
    "count = 0\n",
    "for i in range(len(tokens_ids)):\n",
    "    if len(tokens_ids[i]) > 512:\n",
    "        count += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "zkjfRSisZSoq"
   },
   "outputs": [],
   "source": [
    "def data_cleaning(text, lemmatizer=nltk.stem.wordnet.WordNetLemmatizer()):\n",
    "    lower_text = text.lower()\n",
    "    stop_words = set(stopwords.words('english')) \n",
    "    reg=lower_text.replace(\".\", \" \")\n",
    "    reg = re.sub(\" \\d+\", \" \", reg)\n",
    "    reg=reg.replace(\" ' \", \" \")\n",
    "    reg=reg.replace(\"'\", \" \")\n",
    "    reg=reg.replace(\"-\",\" \")\n",
    "    reg=reg.replace(\":\",\" \")\n",
    "    reg=reg.replace(\"(\",\" \")\n",
    "    reg=reg.replace(\")\",\" \")\n",
    "    \n",
    "    punc=str.maketrans(string.punctuation,32*\" \")\n",
    "    pt=reg.translate(punc)\n",
    "    tokens=nltk.word_tokenize(pt)\n",
    "    filtered_token = [t for t in tokens if t not in stop_words] \n",
    "    ps=nltk.pos_tag(filtered_token)\n",
    "    \n",
    "    lt= []\n",
    "    for word in ps:\n",
    "        lemmatized_word = lemmatizer.lemmatize(word[0])\n",
    "        lt.append(str(lemmatized_word))\n",
    "    return lt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "id": "E_8rEWhdZaDL"
   },
   "outputs": [],
   "source": [
    "def process_all(df, lemmatizer=nltk.stem.wordnet.WordNetLemmatizer()):\n",
    "    p=[]\n",
    "    for val in df['context']:\n",
    "        p.append(data_cleaning(val,lemmatizer))\n",
    "    \n",
    "    return p"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "959weFvIENaW"
   },
   "source": [
    "### VISUALIZATIONS"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "eRZM21-UPRuf"
   },
   "source": [
    "Data Cleaning for Visualizations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "H3YBvfs0F01I",
    "outputId": "58abe3d4-1ab5-46b9-e949-e39f11e828f9"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
      "[nltk_data]   Unzipping corpora/stopwords.zip.\n",
      "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
      "[nltk_data]   Unzipping tokenizers/punkt.zip.\n",
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     /root/nltk_data...\n",
      "[nltk_data]   Unzipping taggers/averaged_perceptron_tagger.zip.\n",
      "[nltk_data] Downloading package wordnet to /root/nltk_data...\n",
      "[nltk_data]   Unzipping corpora/wordnet.zip.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 33,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "nltk.download('stopwords')\n",
    "nltk.download('punkt')\n",
    "nltk.download('averaged_perceptron_tagger')\n",
    "nltk.download('wordnet')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "et039-sxPRug"
   },
   "source": [
    "Words around which answers to most questions revolve"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {
    "id": "8NE-RdiXZjaz"
   },
   "outputs": [],
   "source": [
    "from nltk.probability import FreqDist\n",
    "tokens_processed = process_all(df)  \n",
    "\n",
    "t2 = []\n",
    "\n",
    "counter=0\n",
    "for t in tokens_processed:\n",
    "    for i in t:\n",
    "        t2.append(i)\n",
    "        counter+=1\n",
    "fdist1 = FreqDist(t2)\n",
    "f=fdist1.most_common(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "VXHZwurnZkld",
    "outputId": "6f363867-73c8-4f28-be28-2a98bc613de8"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('patient', 26470), ('cell', 20855), ('gene', 19290), ('protein', 17236), ('mutation', 14719), ('syndrome', 12684), ('study', 11888), ('disease', 11567), ('treatment', 9216), ('result', 8811)]\n"
     ]
    }
   ],
   "source": [
    "print(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 323
    },
    "id": "w6-B1x4kZoFQ",
    "outputId": "a16142d2-85d9-4493-ee24-ddf25c01825a"
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAZQAAAEyCAYAAADdgCZTAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjIsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+WH4yJAAAgAElEQVR4nOzdeUCU9drw8e8MiyzDMgMIIqAiIqAiFqaRCyKZqZknbbGsbO9Y2XLqVJ7Tds6x9CmP5Wu7tmhllpVZlhmaoiKIsZigAoIgILLMsO/MvH/4zDySWZPNPYRen7+Ye4a5rrkZ5prfeqtMJpMJIYQQ4g9S93QCQgghzg9SUIQQQtiEFBQhhBA2IQVFCCGETUhBEUIIYRNSUIQQQtiEFBQhhBA24djTCfS08vJyu8Tx9fWlurraLrEk9p8jvsSW2Odr7MDAwF88Li0UIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYxAW/sPFcdd0183c9/uQ5xHB4e9M5/JYQQvQMaaEIIYSwCSkoQgghbEIKihBCCJuQgiKEEMImpKAIIYSwCSkoQgghbEIKihBCCJuwyzqU6upqXn31VWpra1GpVCQmJjJt2jQ++eQTtm3bhqenJwBz587loosuAuCLL75g+/btqNVqbrvtNmJiYgDIysri3XffxWg0MnnyZGbNmgVAZWUlL7/8Mg0NDYSGhvLAAw/g6CjLbIQQwl7s8onr4ODAzTffTGhoKC0tLTzxxBNER0cDMH36dGbO7L5IsLS0lJSUFP773/9iMBj497//zSuvvALA6tWr+ec//4mPjw9PPvkksbGxBAUF8cEHHzB9+nQuu+wy3nrrLbZv386UKVPs8fKEEEJgpy4vrVZLaGgoAK6urvTv3x+9Xn/Wx6enpxMXF4eTkxN9+/YlICCAgoICCgoKCAgIwN/fH0dHR+Li4khPT8dkMpGTk8PYsWMBiI+PJz093R4vTQghxP+y+xhKZWUlRUVFhIWFAfDdd9/x6KOP8tprr9HY2AiAXq/Hx8fH8js6nQ69Xn/GcR8fH/R6PQ0NDbi5ueHg4NDt8UIIIezHroMMra2tLFu2jPnz5+Pm5saUKVOYM2cOAOvXr2fNmjUsWLBA0RySkpJISkoCYMmSJfj6+p7T85zL3ly/17nm9nOOjo42e67eFLun40tsiX0hxO6Wh70CdXZ2smzZMsaPH8+YMWMA8Pb2ttw/efJkli5dCpxqYdTU1Fju0+v16HQ6gG7Ha2pq0Ol0eHh40NzcTFdXFw4ODt0e/3OJiYkkJiZabldXV9vuRdqYrXLz9fXtsdfZk7F7Or7Eltjna+zAwMBfPG6XLi+TycQbb7xB//79mTFjhuW4wWCw/Lxv3z6Cg4MBiI2NJSUlhY6ODiorKzlx4gRhYWEMHjyYEydOUFlZSWdnJykpKcTGxqJSqRg2bBipqakA7Nixg9jYWHu8NCGEEP/LLi2UI0eOkJycTEhICI899hhwaorwnj17OHbsGCqVCj8/P+6++24AgoODufTSS3nkkUdQq9XccccdqNWnat/tt9/O4sWLMRqNTJo0yVKEbrrpJl5++WU+/vhjBg0aREJCgj1emhBCiP+lMplMpp5OoieVl5ef0+/93uuhnAtbXQ/lQmqK/5niS2yJfb7G7tEuLyGEEOc/KShCCCFsQgqKEEIIm5CCIoQQwiakoAghhLAJKShCCCFsQgqKEEIIm5CCIoQQwiakoAghhLAJKShCCCFsQgqKEEIIm5CCIoQQwias2m24o6ODDRs2sGfPHhoaGnj//ffJzs7mxIkTTJ06VekchRBC9AJWtVDef/99jh8/zsKFC1GpVMCpLea3bt2qaHJCCCF6D6taKPv27WPFihW4uLhYCopct10IIcTprGqhODo6YjQaux2rr6/Hw8NDkaSEEEL0PlYVlLFjx7Jy5UoqKyuBU5fuXb16NXFxcYomJ4QQovewqqDceOON9O3bl7/97W80NzezcOFCtFotc+bMUTo/IYQQvYRVYyiOjo7Mnz+f+fPnW7q6zGMpQgghBFjZQtm5cyfFxcUAeHp6olKpOHbsGMnJyYomJ4QQovewqqCsX78eHx+fbsd8fX35+OOPFUlKCCFE72NVQWlpacHNza3bMTc3N5qamhRJSgghRO9jVUEJCgoiNTW127F9+/YRFBSkSFJCCCF6H6sG5W+66SZeeOEFUlJSCAgIoKKigp9++oknn3xS6fyEEEL0ElYVlIiICF566SX27NlDdXU1YWFhzJ8/H19fX6XzE0II0UtYVVAA/Pz8mDVrlpK5CCGE6MWsKiiNjY1s2rSJ4uJiWltbu9333HPPKZKYEEKI3sWqgvLKK6/Q2dnJpZdeirOzs9I5id/QddfM3/X4k+cQw+HtTefwW0KIC5lVBSUvL49Vq1bh5OSkdD5CCCF6KaumDYeEhFBTU6N0LkIIIXoxq1oow4cP5/nnnyc+Ph5vb+9u9yUkJPzm71dXV/Pqq69SW1uLSqUiMTGRadOm0djYyPLly6mqqsLPz4+HH34YjUaDyWTi3XffJTMzkz59+rBgwQJCQ0MB2LFjB59//jkA11xzDfHx8QAUFhby6quv0t7ezqhRo7jttttkvzEhhLAjqwrK4cOH8fHx4aeffjrjPmsKioODAzfffDOhoaG0tLTwxBNPEB0dzY4dOxgxYgSzZs1i48aNbNy4kXnz5pGZmUlFRQUrVqwgPz+fVatW8fzzz9PY2MiGDRtYsmQJAE888QSxsbFoNBrefvtt7rnnHoYMGcILL7xAVlYWo0aN+p2nQwghxLmyqqA888wzfyiIVqtFq9UC4OrqSv/+/dHr9aSnp/Pss88CMHHiRJ599lnmzZvH/v37mTBhAiqVivDwcJqamjAYDOTk5BAdHY1GowEgOjqarKwshg0bRktLC+Hh4QBMmDCB9PR0KShCCGFHVo2hADQ0NJCcnMymTadm/+j1+nMaV6msrKSoqIiwsDDq6uoshcbb25u6ujrLc5++aNLHxwe9Xo9er++2SaX5MsQ/P25+vBBCCPuxqoWSm5vLsmXLCA0N5ciRI8ycOZOKigo2bdrEE088YXWw1tZWli1bxvz588/YbFKlUtllzCMpKYmkpCQAlixZcs6r/c9lKu7vdbbcejL27+Xo6NijOyr0ZHyJLbEvhNjd8rDmQe+99x4PPfQQI0aM4LbbbgMgLCyMo0ePWh2os7OTZcuWMX78eMaMGQOAl5cXBoMBrVaLwWDA09MTONXyqK6utvxuTU0NOp0OnU5Hbm6u5bherycqKgqdTtettWR+/C9JTEwkMTHRcvv0OH82PZmbrWL7+vr26OvoyfgSW2Kfr7EDAwN/8bhVXV5VVVWMGDGi2zFHR0e6urqsCm4ymXjjjTfo378/M2bMsByPjY1l586dwKmLeI0ePdpyPDk5GZPJRF5eHm5ubmi1WmJiYsjOzqaxsZHGxkays7OJiYlBq9Xi6upKXl4eJpOJ5ORkYmNjrcpNCCGEbVjVQgkKCiIrK4uYmBjLsZ9++omQkBCrghw5coTk5GRCQkJ47LHHAJg7dy6zZs1i+fLlbN++3TJtGGDUqFFkZGSwcOFCnJ2dWbBgAQAajYbZs2dbdjmeM2eOZYD+zjvv5LXXXqO9vZ2YmBgZkBdCCDtTmUwm0289KC8vj6VLlzJq1Cj27t3LxIkT+fHHH3nssccICwuzR56KKS8vP6ff+73bn5yLs21/0pOxfy/p8pLYEvv8i322Li+rWihhYWG8+OKL7Nq1CxcXF3x9fXn++efPuCywEEKIC9dvFhSj0cjNN9/Me++9x9VXX22PnMSfmGxMKYQ4m98clFer1QQGBtLQ0GCPfIQQQvRSVnV5jRs3jqVLl3LllVfi4+PTbb3I8OHDFUtOCCFE72FVQdm6dSsAn376abfjKpWKlStX2j4rIYQQvY5VBeXVV19VOg8hhBC9nNV7eQkhhBC/xqoWyl//+tez3vf666/bLBkhhBC9l1UF5YEHHuh222Aw8M0333DZZZcpkpQQQojex6qCEhUVdcaxYcOGsXjxYqZNm2bzpIQQQvQ+5zyG4ujoSGVlpS1zEUII0YtZ1UJZv359t9ttbW1kZmbKBoxCCCEsrCooP78yY58+fZgxYwYTJkxQJCkhhBC9j1UFxbx9vBBCCHE2Vo2hbNy4kYKCgm7HCgoK+PLLLxVJSgghRO9jVUH55ptvCAoK6nYsKCiIb775RpGkhBBC9D5WFZTOzk4cHbv3jjk6OtLe3q5IUkIIIXofq8ZQQkND+e6775g+fbrl2NatWwkNDVUsMSF+7lyuVPl7r8ci12IR4txZVVBuvfVW/vOf/5CcnIy/vz8nT56ktraWp556Sun8hBBC9BJWFZTg4GBeeeUVfvzxR2pqahgzZgwXX3wxLi4uSucnhBCil7CqoOj1epydnbvt3dXY2Iher0en0ymWnBBCiN7DqkH5F198Eb1e3+2YXq/npZdeUiQpIYQQvY9VBaW8vJyQkJBux0JCQigrK1MkKSGEEL2PVQXF09OTioqKbscqKirw8PBQJCkhhBC9j1VjKJMmTWLZsmXccMMN+Pv7U1FRwfr160lISFA6PyGEEL2EVQVl1qxZODo6snbtWmpqavDx8SEhIYEZM2YonZ8QQohewqqColarmTlzJjNn/v6FZUIIIS4MVhUUgJycHHbu3InBYECr1TJhwgSGDx+uZG5CCCF6EasG5bdt28by5cvx9vbmkksuQavV8sorr5CUlKR0fkIIIXoJq1oomzZt4p///CcDBw60HIuLi2PZsmUkJiYqlZsQQohexKqC0tDQcMb29YGBgTQ2NloV5LXXXiMjIwMvLy+WLVsGwCeffMK2bdvw9PQEYO7cuVx00UUAfPHFF2zfvh21Ws1tt91GTEwMAFlZWbz77rsYjUYmT57MrFmzAKisrOTll1+moaGB0NBQHnjggTN2RxZCCKEsq7q8IiIiWLNmDW1tbQC0traydu1awsPDrQoSHx/PokWLzjg+ffp0XnzxRV588UVLMSktLSUlJYX//ve//OMf/2D16tUYjUaMRiOrV69m0aJFLF++nD179lBaWgrABx98wPTp0/l//+//4e7uzvbt263KSwghhO1YVVDuuusuiouLmT9/PnfddRe33XYbxcXF3H333VYFiYqKQqPRWPXY9PR04uLicHJyom/fvgQEBFBQUEBBQQEBAQH4+/vj6OhIXFwc6enpmEwmcnJyGDt2LHCqeKWnp1sVSwghhO1Y1S+k1Wp57rnnqKmpsczy8vHx+cPBv/vuO5KTkwkNDeWWW25Bo9Gg1+sZMmSI5TE6nc6yj9jpMX18fMjPz6ehoQE3NzccHBzOeLwQQgj7+V0DDT4+PjYpJABTpkxhzpw5AKxfv541a9awYMECmzz3r0lKSrLMTluyZAm+vr7n9Dy/98JN5+JsuUls+8c+F46OjjZ9Poktsf+Msbvl0VOBvb29LT9PnjyZpUuXAqdaGDU1NZb7Tt8i//TjNTU16HQ6PDw8aG5upqurCwcHh9/cUj8xMbHbzLTq6mqbvSZb68ncJPYf5+vr22OvRWJLbCUFBgb+4vEeKyjmrjOAffv2ERwcDEBsbCwrVqxgxowZGAwGTpw4QVhYGCaTiRMnTlBZWYlOpyMlJYWFCxeiUqkYNmwYqampXHbZZezYsYPY2NieelniPCWXHxbit521oGzZsoWpU6cCp3YWDggIOOcgL7/8Mrm5uTQ0NHDvvfdy3XXXkZOTw7Fjx1CpVPj5+VkG+IODg7n00kt55JFHUKvV3HHHHajVp+YO3H777SxevBij0cikSZMsReimm27i5Zdf5uOPP2bQoEGyaaUQQvSAsxaUdevWWQrK448/zvvvv3/OQR566KEzjv3ah/4111zDNddcc8bxiy66yDK9+HT+/v688MIL55yfEEKIP+6sBcXf3581a9YQFBREZ2fnWdd2SGtACCEE/EpBeeihh9i0aRN79uyhq6uLXbt2/eLjpKAIIYSAXykogYGB3HvvvQD861//4umnn7ZbUkIIIXofq2Z5Pf3003R1dXHkyBH0ej0+Pj6Eh4dbFhMKIYQQVhWU8vJylixZQnt7Oz4+PtTU1ODk5MTjjz9+xqaRQgghLkxWFZS3336bxMRErrrqKlQqFXBqS/vVq1fzzDPPKJqgEEKI3sGqzSGPHTvGjBkzLMUETu0UfOzYMaXyEkII0ctYVVB0Oh25ubndjh06dMiy0l0IIYSwqstr7ty5LF26lIsvvtiyZ0xGRgYPPPCA0vkJIYToJawqKLGxsSxdupS9e/diMBgIDg7muuuuO+sGYUIIIS48Vm8OGRgYyOzZs5XMRQghRC9m1RiKEEII8VukoAghhLCJHrseihDCOnItFtFbWNVCSU9Pp6urS+lchBBC9GJWFZRPPvmEu+++m9WrV5Ofn690TkIIIXohq7q8XnzxRY4dO8auXbtYtmwZffr0YcKECYwfP56+ffsqnaMQQohewOoxlIEDBzJw4EDmzZvHTz/9xNq1a/nkk0+IiIggMTGRyy67zHKpXiGEEBee3zUoX1FRwa5du9i1axcqlYrrr78eX19ftmzZQlpaGo8++qhSeQohhPiTs6qgbNmyhV27dnHixAni4uK4//77CQ8Pt9w/ZswY7rzzTsWSFEII8ednVUHJyspixowZxMbG4uTkdMb9ffr0kdaJEOchmbIsfg+rCsojjzyCWq3G0fH/Ht7Z2YnJZLIUmJEjRyqToRBCiF7BqoKyePFibrrppm7dXIWFhXz00Uc8++yzSuUmhLiASeuo97FqWlZxcTFDhgzpdiwsLIzi4mJFkhJCCNH7WFVQ3N3dqaur63asrq6OPn36KJKUEEKI3seqgjJmzBheeeUVSkpKaGtro6SkhJUrV3LppZcqnZ8QQohewqoxlBtuuIE1a9awaNEiOjo6cHZ2Jj4+nrlz5yqdnxBCiF7CqoLi7OzMnXfeyR133EFDQwMeHh6oVCqlcxNCCNGLWL1Svrm5mfLyclpbW7sdHz58uM2TEkII0ftYVVB27NjB6tWrcXFxwdnZ2XJcpVKxcuVKxZITQgjRe1hVUNatW8cjjzzCqFGjzinIa6+9RkZGBl5eXixbtgyAxsZGli9fTlVVFX5+fjz88MNoNBpMJhPvvvsumZmZ9OnThwULFhAaGgqcKmyff/45ANdccw3x8fHAqTUxr776Ku3t7YwaNYrbbrtNuuSEEMLOrJrlZTQa/9BK+Pj4eBYtWtTt2MaNGxkxYgQrVqxgxIgRbNy4EYDMzEwqKipYsWIFd999N6tWrQJOFaANGzbw/PPP8/zzz7NhwwYaGxsBePvtt7nnnntYsWIFFRUVZGVlnXOuQgghzo1VBeXqq6/ms88+w2g0nlOQqKgoNBpNt2Pp6elMnDgRgIkTJ5Keng7A/v37mTBhAiqVivDwcJqamjAYDGRlZREdHY1Go0Gj0RAdHU1WVhYGg4GWlhbCw8NRqVRMmDDB8lxCCCHsx6our82bN1NbW8umTZvOKAyvv/76OQWuq6tDq9UC4O3tbVk4qdfr8fX1tTzOx8cHvV6PXq/Hx8fHclyn0/3icfPjhRBC2JdVBeWBBx5QNAmVSmW3MY+kpCSSkpIAWLJkSbfi9Xv83j2DzsXZcpPYEltiKxv7XDg6Otr0+XpL7G55WPOgqKgomwf28vLCYDCg1WoxGAx4enoCp1oe1dXVlsfV1NSg0+nQ6XTk5uZajuv1eqKiotDpdNTU1Jzx+LNJTEwkMTHRcvv0WH82PZmbxJbYEvv38fX17bHXYu/YgYGBv3jcqjGUjo4O1q1bx/3338+tt94KQHZ2Nlu2bDnnhGJjY9m5cycAO3fuZPTo0ZbjycnJmEwm8vLycHNzQ6vVEhMTQ3Z2No2NjTQ2NpKdnU1MTAxarRZXV1fy8vIwmUwkJycTGxt7znkJIYQ4N1a1UN5//330ej0LFy7k+eefByA4OJj333+fqVOn/ubvv/zyy+Tm5tLQ0MC9997Lddddx6xZs1i+fDnbt2+3TBsGGDVqFBkZGSxcuBBnZ2cWLFgAgEajYfbs2Tz55JMAzJkzxzKec+edd/Laa6/R3t5OTEzMOU9vFkIIce6sKij79u1jxYoVuLi4WMY6zIPi1njooYd+8fjTTz99xjGVSnXWywknJCSQkJBwxvHBgwdb1rcIIYToGVZ1eTk6Op4xZbi+vh4PDw9FkhJCCNH7WNVCGTt2LCtXrmT+/PkAGAwG3nvvPeLi4pTMTQgheoRcLfLcWNVCufHGG+nbty9/+9vfaG5uZuHChWi1Wq699lql8xNCCNFLWNVCcXR0ZP78+cyfP9/S1SV7ZQkhhDidVQXl5MnujbmWlhbLz/7+/rbNSAghRK9kVUFZuHDhWe9bv369zZIRQogLXW8ev7GqoPy8aNTW1vLpp58SGRmpSFJCCCF6H6sG5X/O29ub+fPn89FHH9k6HyGEEL3UORUUgPLyctra2myZixBCiF7Mqi6vp59+utusrra2No4fP86cOXMUS0wIIUTvYlVB+fl2Jy4uLgwYMIB+/fopkpQQQojex6qCYr52uxBCCHE25zTL62yuv/76P5SMEEKI3suqgnLixAnS0tIICwuzXMiloKCAMWPG4OzsrHSOQgghegGrCgrAgw8+yNixYy2309LS2Lt3r+V6JUIIIS5sVk0bzszM5JJLLul2LDY2lszMTEWSEkII0ftYVVACAgLOuNzv1q1bCQgIUCQpIYQQvY9VXV733nsvL730Eps2bbJcqdHBwYG//e1vSucnhBCil7CqoAwaNIhXXnmF/Px8DAYD3t7ehIeH4+ho9RCMEEKI89w5bb0SFRVFZ2cnra2tts5HCCFEL2VVE6OkpISlS5fi5ORETU0NcXFx5ObmsnPnTh5++GGlcxRCCNELWNVCefvtt7n++ut5+eWXLd1cUVFRHD58WNHkhBBC9B5WFZTS0lLGjx/f7ZiLiwvt7e2KJCWEEKL3saqg+Pn5UVhY2O1YQUGBTBsWQghhYdUYyvXXX8+SJUu4/PLL6ezs5IsvvuD777/nnnvuUTo/IYQQvYRVLZSLL76YRYsWUV9fT1RUFFVVVTz66KOMHDlS6fyEEEL0Er/ZQjEajTz44IP897//5c4777RHTkIIIXqh32yhqNVq1Go1HR0d9shHCCFEL2XVGMq0adNYvnw5f/nLX9DpdN0uB+zv769YckIIIXoPqwrKO++8A8CBAwfOuM/ai28JIYQ4v/1qQamtrcXb21uKhhBCiN/0qwXlwQcf5P3337fcfumll3j00UdtmsB9992Hi4sLarUaBwcHlixZQmNjI8uXL6eqqgo/Pz8efvhhNBoNJpOJd999l8zMTPr06cOCBQsIDQ0FYMeOHXz++ecAXHPNNcTHx9s0TyGEEL/uVwuKyWTqdjsnJ0eRJJ555hk8PT0ttzdu3MiIESOYNWsWGzduZOPGjcybN4/MzEwqKipYsWIF+fn5rFq1iueff57GxkY2bNjAkiVLAHjiiSeIjY1Fo9Eokq8QQogz/eosr9MH3+0pPT2diRMnAjBx4kTS09MB2L9/PxMmTEClUhEeHk5TUxMGg4GsrCyio6PRaDRoNBqio6PJysrqkdyFEOJC9astlK6uLg4ePGi5bTQau90GGD58+B9OYvHixQBcfvnlJCYmUldXh1arBcDb25u6ujoA9Ho9vr6+lt/z8fFBr9ej1+vx8fGxHDdfBOyXJCUlkZSUBMCSJUu6Pd/vcfKcfuv3OVtuEltiS2yJrUTsP+pXC4qXlxevv/665bZGo+l2W6VSsXLlyj+UwL///W90Oh11dXX85z//ITAwsNv9KpXKpi2lxMREEhMTLberq6tt9ty21pO5SWyJLbEl9tn8/HPa7FcLyquvvvqHglpDp9MBp4rX6NGjKSgowMvLC4PBgFarxWAwWMZXdDpdtxNRU1ODTqdDp9ORm5trOa7X64mKilI8dyGEEP/nnK7YaCutra20tLRYfj5w4AAhISHExsayc+dOAHbu3Mno0aMBiI2NJTk5GZPJRF5eHm5ubmi1WmJiYsjOzqaxsZHGxkays7OJiYnpsdclhBAXoh69KHxdXR0vvfQScGq8Zty4ccTExDB48GCWL1/O9u3bLdOGAUaNGkVGRgYLFy7E2dmZBQsWAKe64mbPns2TTz4JwJw5c2SGlxBC2FmPFhR/f39efPHFM457eHjw9NNPn3FcpVKddYPKhIQEEhISbJ6jEEII6/Rol5cQQojzhxQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNiEFRQghhE1IQRFCCGETUlCEEELYhBQUIYQQNuHY0wnYUlZWFu+++y5Go5HJkycza9asnk5JCCEuGOdNC8VoNLJ69WoWLVrE8uXL2bNnD6WlpT2dlhBCXDDOm4JSUFBAQEAA/v7+ODo6EhcXR3p6ek+nJYQQF4zzpqDo9Xp8fHwst318fNDr9T2YkRBCXFhUJpPJ1NNJ2EJqaipZWVnce++9ACQnJ5Ofn88dd9zR7XFJSUkkJSUBsGTJErvnKYQQ56vzpoWi0+moqamx3K6pqUGn053xuMTERJYsWWL3YvLEE0/YNZ7E7vn4EltiXwixT3feFJTBgwdz4sQJKisr6ezsJCUlhdjY2J5OSwghLhjnzbRhBwcHbr/9dhYvXozRaGTSpEkEBwf3dFpCCHHBcHj22Wef7ekkbKVfv35ceeWVTJs2jcjIyJ5O5wyhoaES+wKLL7El9oUQ2+y8GZQXQgjRs86bMRQhhBA9SwqKEEIIm5CC0gNKS0tpbW3t6TTEBcZkMmGPHu6Ojg46OzsxGo12ifdnVVlZadd4f4ZzLQXFTjo7O6murqamppR0LyAAACAASURBVIa3334bFxcX4P/eBLZ+MxgMBr7++msOHz5MQ0ODTZ+7tzp58iSNjY09nUaPUalUqFQqxZ7faDQCkJGRQXZ2Nmq1WtF4v8T8f2Q0Guno6CA/P9+uO2aYz0FraysbNmywHFPyw76trQ2APXv2kJaWplgca5w304b/7Gpra8nOzmbfvn10dXVRXV2Nm5sbbm5uAGRmZnLRRRfZLF5lZSVlZWVUV1fj6uqKv78/ISEh9O/fnz59+tgszm85fvw4VVVVNDU1MWzYsF9cbKoUo9GIWq0mPT2dpKQktFotnp6e+Pn5MXDgQAYMGICzs7Pd8tm/fz9NTU0EBwej0+nQaDQ4Oir3L2h+/U1NTRQVFZGWlsbll19OSEiIIvHU6lPfT1taWvjss8/Iz89n1qxZuLi4WHJRmslkQqVSsX37doqKiqioqGDMmDFMmTKF+vp6PDw8FC1ylZWVrF+/nvLycgYNGgT833mprq5Gr9cTHh5u05hHjx6lubmZL7/8kmuvvbbbffX19Wg0GrucezjPpg3/mTk6OmI0Gtm7dy+enp5UV1dz7Ngx2tvb2bx5M8XFxYwePdryD/FHeXt7M2rUKDw9Pamvr6esrIzi4mJKS0uprKzE29vb0kpSSnt7O6+99hr19fUkJSUxefJkHB0daWhoUDy2mUqlYu3atVx00UVERkZiMpmorq4mNzcXgKCgIEXjG41GVCoVe/fuZdOmTZSVlXHkyBGOHj1KY2MjKpUKb29vRWKb30tvvvkmDg4O7N+/H7VaTVRUFMeOHcPFxUWRgjZw4EDGjRtHTk4O9fX1DBo0yG4tFXOc119/nfnz55OSksKYMWMICAjghx9+wM3NDU9PT8Xiu7q64uPjw86dO6mvryctLY36+nqGDh3K119/TWNjI0OGDLFpzLq6Or755hsKCgoICgqivr4eo9GIu7s7L774IpGRkWg0GpvGPBtpodiJs7MzQ4cO5YknnqBPnz4UFhZy+PBhMjIyqK2t5aqrrgKwSUE5fvw4n3/+OZGRkURFRTFjxgyamprIz8+nsLCQgwcPMnz4cFu8rF+VnJxMSEgI11xzDaWlpWi1WkpKStiwYQMPP/ywoh8y5vPY0NCAl5cXV1xxheW+iooKCgsLLf/Ytiriv8T8vNnZ2dx8881ERERQU1NDdnY26enp1NbWMnDgQEViq9Vq2tvbKSsr47777mP//v2MHj0agM2bN3P55Zfb7NtyV1cXDg4O1NfX09DQQP/+/YmKimLVqlXk5uYyd+5cu7VOS0tL6d+/PwEBAQCMHDkSgC1btii+e4aDgwNhYWH89a9/Zfjw4aSmprJv3z7uu+8+NBoNf//7320a7+DBgwQFBTFv3jzGjRtnKWLOzs44OzvT2tqKv7+/TWP+GikodmBu7peXl1NSUkJVVRUjR45kzpw5dHR04OTkZHmsLZqmjo6ODBs2jOrqajZt2oSrqytDhgwhKiqKmJgYamtrFftWfLqOjg6CgoL49NNPGTNmDHDqH8DFxQWVSqVoN4j5gzwvL48dO3Zw8uRJ5syZw/DhwwkICLB82Jz+WKXyaGtrw2AwcODAAYKDg/Hx8SEhIYGEhATFJ2ecPHmSYcOGcfz4cZycnAgJCaG9vZ38/HzLRqq24ODgQEdHBx9++CEtLS2Ul5dz2WWXERoayvHjx1m3bh033ngjWq3WZjHPRqvV4uvry9///ndL915GRgY+Pj74+voqFtf8fm5oaMDR0ZHGxkbi4uKIi4ujtbWVhoaGbjui2yJeZmYmycnJeHp6EhUVRWxsLImJieTl5dHZ2cmMGTNsFs8asrDRjh577DEiIyNxdnamuLgYJycnBg0axBVXXGHzZrjJZMJgMGAwGCgoKKCiooLW1lYcHR2ZPn16tw9Upej1er744gsyMjK47bbbcHFx4dNPP2XOnDmMGDFC0YLS3t5uGR8pLCwkNTWVQ4cOYTQaGTBgANdddx1eXl526YqpqKjg22+/pbi4mODgYPz8/AgPD2fIkCE4ODgoHv+jjz5iy5YtXHTRRSxYsIB169bR2trKPffcY5O/QWpqKlqtlqFDh1JSUkJwcDA1NTXU1dUxePBgampq2Lx5M0ajkZtvvtkur7myspKNGzeiUqkoKirC19eX+Ph4m45T/hKTycSzzz5LW1sbTU1NDBo0iNjYWEaOHImXl5fNY5WVlVFTU0NxcTEVFRV0dXXRr18/hg8fTlBQkN26ls1kDEVh5u6Uqqoqjh49yn333cfQoUMZMWIEXl5eHD16lIiICMvg/B9l7rNXqVSWPvro6GgCAgLw9vamra2NYcOGdWsVKcXV1ZX+/fvT0NBAeXk52dnZjB8/3tJaUerD/ODBg2zfvp2wsDByc3OJjIxkxIgRxMfH069fP4qKihg6dKjd+pU1Gg2jRo0iNDQUtVpNbW0tGRkZqNVqu+w3N2LECAYMGMChQ4fYtGkTERERTJ48GY1GY5Puvl27dvHee++xZ88ePDw88PHxwcfHx9LF5ebmhpeXFzt27CAhIcEWL+kM5vd9bm4uxcXFDBkyhJCQEFxcXIiPj2fs2LGWQXIlmM/j/v37qays5KmnnmL8+PG0tbWxe/dukpKSSEhIsOkXKJVKhaenJz4+PkRFRTFo0CBcXFwwGAz8+OOP6PV6hg4darN4VuUkLRRlmb8Bbt26lYKCAubMmUPfvn0t93V0dNh01pU53kcffURHRwfffPMNd999N5MnT7bbTBs41dWUkZHB8OHDGT58uKLjFKczx+no6ODQoUO88sor+Pj4EBMTw4QJExQfhP95Hq2trRw4cICUlBQuvvhiBg0aREBAAIcPHyYkJESRAWLz3/nIkSOUlZVRV1dHSEgIkZGRuLi4KPIeMBqNrFixgiNHjtDc3Iy/vz/Tpk1j3LhxODo6UldXR0dHh2JdTubXvHjxYuLj47nssstISUmhrKyMYcOGERUVpUhcM/Pfe/PmzZSXlzNv3jxcXV0t9xsMBkW6+4xGI4sXL8bf35+xY8cyfPhw1Go1JSUlODs726Un4nTSQlGY+UM0NTXVMm24tbUVHx8f3N3dbT7Lxjw2sXbtWh577DEOHz7MxIkT0Wq1vPvuu/j5+Sk6ywVOXY75zTffxM/Pj02bNvHFF19w8uRJvL290el0dhkEd3BwwN/fn6uvvpqwsDAOHjzIV199xZYtW4iIiFB8DMn8Gj/66CNKSkro378/R48e5bvvvqOjo4Nx48YpNn3bfA6WLl2Kg4MD7u7ulJSUkJGRwaFDh9BqtTbrfuns7EStVvPFF1/g7u7Ogw8+yLXXXktTUxNr165l9+7dXHnllbi4uNisFf5LzC3yzZs3c+utt5Kamsr27dvx8vLi4MGDDB06VNHuH/OXmJSUFIqKiqiqqqKurg6j0Yibm5tireGuri769+9Pe3s7qamp/PDDD+j1egIDA+nfv78iMX+NDMrbyU033cRNN91ETk4O3377LVu2bMHf359FixbZvKjk5uYyePBgysrKaG9vtzT1c3JymDdvnk1j/ZIDBw4QHx/PjBkzuPnmmykpKeHLL79kzZo1PPfcc4ovrlOr1ej1eoqLiykrKyMiIoIFCxYAsHfvXrvMejG3AvLz83nooYcsg7ElJSV8/vnn6PV6RWc91dbWEhYWxp133klLSwtVVVVUVFRw7Ngxm36hML93jxw5QlxcHC4uLnR2djJr1ixUKpWlS6+zs1PRNTdw6sM1OjqaDRs2kJ+fzwMPPICLiwv/+te/7DIJxcnJiRtuuAG9Xs/+/fspLCwkPz8ff39/pk+frkhMR0dHwsPDCQ0NZcKECezevZsffviBtrY2xdYb/Wo+do94ATF/uO3fv98yhjJv3jweffRR2traOHTokGV9ii27IYYNG0ZJSQlvvfUWEydOBODzzz+320K+lpYWamtrqaiowMfHh5CQEB544AHL/fboetuwYQOurq4cPHjQMpWzrKyMSy+9VNG4pzN3/aSkpDBp0iTc3NwICQmhqKjIsqLa1szntrW1FZPJxO7duxk3bhwhISGEhIQwfPhwm7YUzC2xq666im+//ZaAgACGDh1KU1MTO3bs4LHHHgNQvJgAeHl5ERsbS3FxMTfddBM6nY7PPvvMbtu6l5eXs2fPHoKCgrjqqqss//Ond33ZUmtrK4cOHWLkyJE4Ojri6enJtGnTKC0tZfz48YrE/C1SUBRkXgfw2WefceWVV1JQUEBraystLS0cP36cmJgYy+P+qNPXXaxfv56oqCicnZ35+OOPOXDgABqNhmnTpv3hOL/FvL1MfX0927dvZ8CAAQQEBODj42P5lqhkMTGf80OHDrF8+XKeeuopy5qbTz75hOnTp9t8pfLPtbS04OrqipubG9OnT+eLL76gq6sLNzc3jh49ysCBAxUbSzCf27feegtnZ2fWrFnDDz/8wJgxYxgzZgxeXl4263I8fSX+8OHDKS8vZ8WKFTg4ODBkyBAiIyMJDAxUtIvz9Oeur6/Hy8vLMlXWPFBvj6mzx48f55133iE6OprXXnuNSy65BC8vL0aOHKlYd1dpaSlvvPEGXl5ejBgxgri4OBoaGsjMzOTuu+9WJOZvkYKiEPM/2+7du4mMjGTkyJFs27aNgIAA9Ho9H330Ec8884zN/tHM/1g7duwAsMx/r6qq4vDhw4waNUrxWU0mkwlfX18WLlxIfX09u3fv5sCBA6SlpXHJJZcwbtw4ReOb1dTUMGLECDIyMnB2diY4OJjm5mbKysoICwtTNHZjYyPvvPMOCxcuJDU1lbFjx3LLLbewe/duTp48SWRkpGIFzfyey83NxdXVlccee4zOzk52797Nrl27+Oyzz3j55Zdt9o3ZXLw+/PBDPD09iYuLY8qUKZw8eRIXFxebT5P9Jeb3/caNG2lsbCQ7OxuTyUR4eDhTpkzhmmuusUv8PXv2cOmllxISEsLo0aNxcHDg4MGDpKWlcf/99ysSOywsjDfffJP8/HySk5N56623GDRoENdff70i8awhBUUh5n82Pz8/GhsbWbduHRMmTABO9eP37dvXpov7zM9x6NAhZs6cCZxaWOjn50dqaio7duxQ/JtaV1cX6enp7Nq1iwEDBnD99dfT0dFBXl6e5cPFHt9W+/Xrx4ABA3jnnXcYNmwYubm5ZGVlMXDgQNRqtaJdbhqNhjvuuIOGhga+/PJLNm7cSHR0NBMnTlR8kNR8XgsLC2lvb6e8vJzAwEDi4+OJj4+nqakJV1dXm77+1tZWoqOjqaio4Ouvv8ZoNBIVFUVISIjlb67kmJn5daSlpfHwww9z/PhxRo8eTWZmJo8//jj33nsvkyZNUiy++bV1dXUxaNAgvvrqKxITE4FTY5m2Hq8zv8crKirYunUrN9xwA0OGDCE0NBQHB4du6696gszyUkBnZydw6s2m1WpJTU0lPT0dHx8fKioq2LdvH1deeSV9+/a1+Qdsc3MzW7duJTg4GG9vb9RqNe+88w7Tpk1TfJXy9u3bLes+9u/fT0JCAsXFxXh4eFg+TJVeld7Q0MCWLVuYPHkyHh4etLe3k5aWRlBQENOnT8fV1VXxKczOzs4cO3aMq666iqFDh1JaWsq3337Ll19+ibu7OwMGDFAkrkqlwmQyUVRUxIkTJ8jPz+fYsWM0Nzdb9rCyZTExGo04OTkRFBREv379CA4Opr6+nuTkZJydne12Ge6CggIKCwtJSEjgq6++4t5772XAgAG4urqSmJholzVXAQEBrF27lkOHDjF79mwOHjzIrl27uOmmmxQZs9qwYQMajYYRI0awfft21q1bR15eHhdffLHdd3g+nRQUBWzduhV3d3dMJhNqtZqYmBgCAgJob2/n6NGjXHvttZYFR7b+4wcHB1NdXU1JSQnJycls374dX1/fbntZKWXdunVce+21HD58mMGDBxMeHs7OnTspKipi2LBhisYuKCigtLSU/fv309HRQXR0NMHBwQwaNIgJEyYQFRVl6epR6h+uvb2dlpYWHB0dWbVqFQkJCWi1Wkv/9oABAwgKCsLDw0OR+HDqtYWFhXHxxRfj4uJCW1sb+fn5lm5PW7bMurq62L9/P/3798fFxQVvb2+ioqI4cuQI48ePR6vVWsYxlGQymRg8eDDNzc2UlpYSFhZGQUEB2dnZTJ48WdHYZu7u7kRERNDW1sann34KwPjx422+sNB8Lr/44gsmT55MXl4eBw8eJD4+npKSElxcXOy6d9fPSZeXAkJDQ/H39+fNN9+ksbGR2NhYwsLCiImJUXwrBGdnZ2bNmkVBQQEtLS04OTkpPm4Ap76tjho1ira2NnJycli8eDEAWVlZzJkzx/IYpbqanJ2d+fDDD8nNzbXsWzZ8+HA8PT3ZtGkTnp6exMfHKxLbTK/Xs2HDBnJycs6YEtzZ2UltbS3R0dGKxDZ/cy0pKWHr1q34+voSERFBdHQ01dXVNDc3W1owtvqAr6qq4u2332bVqlWMHDnSst4kJyfHMk3bHgtpzSvzAfr378+qVatwcHCwy5ideSbd8ePH8fT05KqrruL2229XPOb48ePZsmULR48e5R//+Af+/v58+umnPbL25HSyUl4h7e3tdHZ2sn//fjIyMqivrycgIICIiAguu+wyu+xnZE8VFRUcPnyYTz/9lLa2Nu6++25OnDjBjz/+yL/+9S+75fHee+/Rt29ftm3bhsFg4JJLLqGoqIj777+f4OBgxbu7Ojo6+Pe//23Zpt/f35+EhAQKCwtpbm7mlltusXlM82uqrq5m6dKlJCQkUFZWRnl5OU5OTjz00EOKTF09dOgQkZGRlJaWsmXLFtLS0hg8eDDR0dFMmzZN0S8Q5ueurKwkOzubtLQ0Zs+eTUREBAUFBfTv31/RhZTmc56cnMzGjRu5+uqrqaiooLi4GLVaTVhYGFdffbVi77WmpibKysrw9vamb9++pKam8t133/HMM88oEs9aUlBszNxf/eabbxIeHm4ZEKysrCQ1NRW9Xs/8+fN7NkkFrF+/HoPBQEBAAEePHqWiooJJkyZxySWX4Ovrq+iHy8+njvbp0wdnZ2cqKyvZuXMnQUFBxMXFKRL7l1RVVeHn50dVVRU//vgje/fuRa1Wc+eddyryDdJ8bjdv3kxlZSW33XYbcKpVtHbtWoYMGWKzb+utra20t7djNBp57rnnWL58+S/mAspOwDh9q5XJkyfz2WefMX78eGbOnElBQQEBAQF22astKSkJb29vYmNjLeuv8vPz6erqUmQygMlkYteuXdTW1qJSqbjiiivo7OykpKSEPn36KLpfmTWky8uGjEYj+/bto6ysjNzcXEv/bXt7O3379rV8uIKy/2z2VlxcTF5eHn369MHNzc2yPbxGo7H8UyvZ9WE+j2vWrKG4uBhfX19UKhWTJk3iuuuuUyzu6cwfcLW1tRw5coRjx44RGRnJ1KlTmTp1qqIrxc3nVqfTkZeXR0VFBVqtlj59+uDu7k5hYSHjxo2zSVGvqanhgw8+4MiRIwQHB1uugwKnWqkpKSmWqbpKz+5qaGigtbWVsWPH8u2331q+NKxfv55rr71W8fVG5m1nUlNTCQwMJCAggH79+hEQEGDzS/6a/3a7du0iOzsbBwcHqqurueqqq6ivr0en01n2COxJMihvQ+bdPzMyMigtLaWqqory8nJcXFzo6Ojg73//O1OmTKFPnz7nTTEB+PTTTxk2bBi33HILgwcPpquri927d1NfX09hYSFRUVGKdfGZB3337dtHZmYmd911FyEhIZYNOQcOHGiX9RDmv+fzzz+Pq6srq1evZt++fZbdEAIDAxXblFGlUqHX69FoNFRUVJCfn09LSwtpaWkcOHCA66+/Hg8PD5t8ifH09GTcuHGcPHmS5uZmPv/8c3JycvDw8GDbtm20tbVx0UUX2WUwvrq6mra2Nurr66mpqSEhIYH6+nq2bNnCjTfeqFhc82vbunUrqampVFZWkp+fT2lpKSaTCXd3d5uPlZrP5SeffMLcuXNpb29Hq9USGRnJt99+y8GDBxk1apRNY54L+2w9ewHR6XTceuutPPvss1xzzTU0NzfzwQcfsH79ehITE/Hw8FBs242e4u7uTmVlJW1tbWg0GsaMGcOgQYMYNmwYBoOBQ4cOKRbb/CFdVlbGyJEj8ff3JzQ0lMmTJzNo0CD279+vWGwz89/T/MF63XXXER4ezuOPP05dXR2rVq2iublZ0Rw+++wzdu/ezbx589BqtRw5cgQ3NzduuOEGAgMDgT/eSjS/zqKiIjo7O3n66adZunQparWa1157DY1Go/hCwtOZZ5e98847wKl909555x0uvvhiReOaz2Nubi533XUXL774IldffTVdXV2sXbuWtLQ0m8Yzt3ZaWloYMGAAP/30E99//73lUgCHDx+27LrR06TLy8Y6Oztpbm7GYDDg5eVl+abU0NBg6f45n1onAAkJCXz44Yd89dVXeHp6olarycnJ4c477yQ5ORl3d3dF4xuNRsLCwnjrrbcwmUxcfPHFBAYGcvz4ccveXUqO4Zy+qDQ2NpY9e/bQv39/AgMDmT17NocOHVJsqrA5dm1tLaNHj0atVnP11VcDym3IuG3bNsv+WElJSbi6uhIXF8eMGTMsG08qPV7W2NhIbW0tM2fOZPDgwXz//fds3LiR8ePHK75VPZya0VdWVsbBgwcJCAggMjKSyMhI5s6dS1tbm01jmV/zzp07KS4upqmpCTc3Nw4ePMixY8dob2//U7ROQLq8bMbcDE5JSWHTpk389NNPZGZmUlRUhMFgwMnJydLHeb4VFI1Gw9ChQzl58iS1tbWcOHGC6dOn09XVRVZWlmLfWs3nPD09nfb2diZNmkRhYSEpKSls2LCBgQMHWna9VfqcG41Gy0WdGhoayM3NxWQy8fXXX1sufqQU84SP7777DoPBgKOjI3379rX5h7r5HG7evJmhQ4eSmppKY2MjiYmJZGZm4uLiovj1Zswfrps2baKiooKIiAg8PDwYPHgwU6dOJSgoSLHLApwev76+nqamJvbu3cuBAwcs283odDocHR1t+n4zP9euXbu49NJLGTduHAaDgdraWlxcXJg5c6ZdunWtIbO8bMT8RnvmmWe499572bx5M05OTqjVan788Udmz57dYzuA2tPpg7SlpaVUV1cr1hw3n/M1a9YQERHBJZdcQmlpKc7OznR2duLr64uzs7NdZhsdPnyYgoICy/Y2W7ZsoaKiApVKxdy5cxXZDiMrK8tybltbW8nLyyM3N5fy8nKamppISEjgsssus3nc3NxckpOTKS0tZdGiRbi5ufH444/zj3/8Q/Fr7Zg99NBDLF68mIaGBtatW8fBgwe59NJLueWWW+yy9cjnn3/OpEmTaGtro6SkhLy8PPLz85k+fTqXXHKJzePV1dXxxBNPAHDzzTczZsyYP+XSA+nyshHztxYPDw/69evH4cOH+Z//+R/UajWlpaWWb6jn0+yuX3L6mzwoKEjRb6wqlcoyTdPJyYnY2NhfjKfk+U5PT6ewsJCDBw92a4lNnTqVvLw8Bg0apMjWH83NzaxevZrGxkbGjBnD5ZdfTnR0NNHR0dTW1pKdnW0ZO7F1d19ERAQhISE4Ozvj7OxMSkoKffv2tfnWLmdTWVmJj48PJ0+e5Pvvv2fYsGE8/PDDPPXUU4ruZWW++mZraysFBQWWv7d5EWl5ebliW+V7eXmxePFi9u3bxw8//MDGjRvp168fU6ZMUXwXit9DurxsyMnJCR8fH1xdXamtraWhoYH29nZ++OEHy/TV87mY9ISuri5ycnLIycnh0KFDdHR04O3trfiOBGYajYZDhw5x4MABjh8/TnV1NZ6ennh5ebF+/Xp0Op1lFbctOTk5MW3aNAYOHMj27dv59ttv+e6776ivr2fQoEFERUVZ9m6z9XtOpVLh7OyMg4MDRqMRd3d3Ro4ciZubm6JfmGpra3F2dsbd3Z2Wlhbef/99Bg8ezF/+8hcyMjIoKiqybMyohJaWFjIyMvj444/p7OzE3d0dLy8v3NzcOHnyJBkZGYrthADg6upKWFiYZSuh6upqnJ2dFdsb7lxIl5cN7d69m/LycioqKjhx4gTHjh0jIiKCCRMmMGnSJLte0/1CkZaWhsFgIC8vjyNHjuDg4IDBYOCOO+5QfKsVs8rKSg4cOEBoaCjbtm3jyJEjqFQqHB0deeGFFxSJaR5wX7lyJaNHj2bo0KFUV1ezdu1aDh8+zOzZs+22BsceGhsb2bdvn2XXgcDAwG5fGlasWMGwYcPssnfXG2+8QWhoKAcPHuTEiRP07duXuro6EhISLDOvLlRSUP4g8zeyo0ePsnLlSq644goCAgKoqKigtbWVxMREy+yu8727y15OP+crVqzgiiuuICgoiPLycpqbm5kwYQLu7u6K7yx8+uyb4OBgS3dHa2srRUVFuLq6MnDgQEViw6ldARYtWsRLL71k+XCtra3lq6++IiEhgf79+583X2IOHz5MZWUlgwcPZv369QwcOJB+/frh7++PVqu1rAGz92s9efIkmZmZdHR0cOWVV9rlypR/ZtLl9QeZP1T27dtHREQEU6ZMwdvbG19fX3bs2EFdXZ1iOwtfqE4/55GRkVxxxRV4eXnh5+fHzp07aW1ttUwdVXq7/Pb2dr766it++OEH0tLSqK+vx9fXl4EDByp+HfM+ffrQ0NBAXl6epR+9rKyMrVu38pe//MWS4/lg7969lJeXU19fj7u7Ow0NDRw/fpyKigrKy8vx8vI6Y0NOWzLPKExNTeWTTz4hJSUFBwcHgoODiYyMZOjQoedF4f6jLuxyagPmN9EPP/yAi4sLUVFRlub46d+Yzpdvin8Gv3XOzQvw7HHOnZ2deeihhzAajaSlpbF161bWrl3LrFmzmDt3rqKxAcaNG8eaNWuYP38+Q4cOpU+fPsTGxgLnz3vOZDIxcuRI8vPzycnJoaamF4jP/gAAEhpJREFUhpEjR6LT6Sz7WI0ePVrRHNRqNXV1daxfv56HH36Yf/7zn5w8eZI33niD0aNHc+uttyq+3qo3kC4vGzBfF2L79u2Ul5fj7e2Nv78/XV1dPPjggz2d3nnpz3LOzQvbTr9G/DvvvGMZPLU1c+uso6ODpqYmqqurGThwIO3t7Rw5coSwsDDc3d1Rq9XnTReruTBu3bqVwsJChgwZQltbG4WFhTQ0NDBq1CimTp2qWHzzefz6669pbGwkLi6ODRs28Mgjj7Bu3Try8/N5+umnFYvfm0gLxQYcHBwYM2YMY8aMwWAwkJaWRmpqKi0tLbzyyiskJib+qab2nQ/+DOe8srKSlJQU/Pz80Gg09OvXj6CgIIqKihRbzGn+cPvkk084duwYWq2Wzs5OAgICGDp0KA4ODpZWyflQTOD/Xkdqaiq33HKLZVyqurqaN954Q/GWgTm+uTX8008/WRYSenl5Kb7VS28iYyg2Zp7aN3HiRKKioqiqqvrTTe0739j7nJs/1I1GI+Xl5bS2tna7zreHh4di1zE//Yp98+bNY/jw4fj5+dHS0sL+/fvx9PQkICBAkdg9RaVS0dXVRVVVFXv27KFfv354eHig0WjYtm0bkyZNsstK8dDQULRaLZ6enmRmZnL48GF27NjBzJkzFb+8dm8hXV5CnAOj0chLL72ETqejqKiIjo4OwsPDmfH/27v3mCavNw7gX0qtlfutRQsY5rwwgg7UbOAFUbZlEaITYTCnjtkJKA1eoo7gHNucMW6Jm1M33SYg0YHIDAtO3ZSL9TZBqSgMjeCQciltgVKgtLXt+f1B+v6ssI1pES/n8xft2573eVvyPj3nPe9zIiOHpOyJeZ8sFgu1tbVMIUjzrKKuri60tbXB29v7mZ1ppNVqUVBQAJPJBLVaDZVKBQDMHeRD4f5SKzKZDCwWC3w+H7W1tejs7IS7u/uQ3nvytKEJhaIeQnl5OU6dOoUtW7agra0NVVVVKCsrQ2trK3bs2DGkZTFOnTqFzMxMeHt7Izo6mimA+TzQ6XSoq6tDV1cXWCwWxo0bNyQ3jj5o165dAPrK3Wzbtg0CgYC5K/9ZuVZlDTShUNRDaG5uRlVVFebMmWNRjFCpVFpcoLc2o9GI7u5u2NnZ4eTJk8zUdF9fX6xZs+ax1dJ6HpgTxY0bN3Dy5Els2rQJGzduxJdffgm5XI6ffvoJSUlJj60qw9Pg2ewbU9QQMJ9genp6cOzYMdy8eZO5z4jP58PV1XVIkwnQtzrm0aNHkZiYiAULFmDBggWQy+U4c+bMkJXIf16Zex1SqRQBAQE4ceIEc39TY2Mjenp6aDJ5AL0oT1GDZE4oZ86cgUKhwIIFCyCTyXDr1i389ddf6OnpGfI1vUeNGgW1Wo1Dhw7BZDLBx8cHzs7OmDx5MoBnZ2bXk+TFF19EZWUlSkpKEBERARaLhV9++QXTp08fsmKQTyvaQ6GoQTJfaJfL5YiIiMCECRMwffp0tLa24urVq0O6DoeZef0LPz8/XLt2DXV1dY+lKsDzxvzjobS0FM3NzQgICMDdu3chFouh0Wjg4+ODOXPmDHeYTxx6DYWi/gO1Wo3U1FQQQrB48WLMmjVryIc9zLO7qquroVAo4OXlhbq6OkgkEty+fRthYWF466236PUTKzInlMzMTEyePBnTp0+HXq9HfX093N3dH8tEgKcRTSgU9R+1t7ejvLwcEokEbW1t8PT0xJtvvomAgIAh3W9JSQnOnz8PHo+HcePGQS6XY+TIkejp6YGvry/CwsLojCMr6u7uxvbt2+Hg4IB33nlnSAt9PitoQqGoR9DU1MRUGx6KFTnNvZM7d+5ALBYjPj4eBoMBd+7cYRa1kslk2LZtGzZu3EhPelZUXFyMy5cvw8HBAd3d3bC3t4e/vz9effVVOgHib9BrKBT1CLy8vLBkyZIh309xcTG8vLwAAIWFhaiqqoKbmxuEQiEEAgFeeOEFmkyspKysDCqVCmKxGImJifDx8UF9fT2am5tRWFjIlKqn+nv6S5FS1DPMPBGgpaUFjo6OyMvLQ3d3N+Lj42E0GlFRUQEA2LBhw3CG+cwghGDMmDGoqKiAVCpFTk4OxGIxxowZgxkzZoDD4dC6fP+A9lAo6imwePFiiMViNDY2Ii0tDXZ2dmhqakJ8fDwAunibtdjY2MDHxwfLli1DVVUVHB0dIRaLcezYMbi7u4PFYmHs2LHDHeYTiyYUinoK+Pn5YezYseBwOOBwOLh48SJzDeVZWffkSeLl5cUMMQYHB0Mul6O2thYCgWCYI3uy0YvyFPWUMZlM6OjoACEEHh4eNKFQTwyaUCiKoiiroD9rKIqiKKugCYWiKIqyCppQKIqiKKugCYV6KuXm5kIoFGLlypXDHcoz6dy5c/j888+HO4x/9f333yM/P3+4w6DMCEX9R6tXryZxcXGks7PT4vmNGzeSmJgY0tra+kjtx8TEkJaWlr/drlAoyJIlS4hKpXqk/QyH9PR0cubMmeEOw0JrayuJiYkhBoNhyPdVVVVFEhMTh3w/1PCgPRTqofD5fFy4cIF53NDQAJ1O91j2rVQq4ejoCGdn5wG3G43GxxIHRVGW6LRh6j9LTk7GvHnzcOXKFWzfvh0AkJ2dDQcHB+Tm5mLPnj3g8/nQaDTIyMiARCLByJEjER4ejkWLFoHFYkEmk+G7775DfX092Gw2AgICsG7dOqSnp6OmpoZZW2TVqlWYMWMGs+/r169jx44dMBgM4HA4CA4ORkxMDEQiEZKSknD06FHw+Xx8+umnKC4uRmFhIVQqFcaPH4+EhATweDymnYyMDHR0dCA0NBQNDQ0IDQ1FeHg48vLyIJPJkJKSAqBv/RORSIScnBzY2tpCo9Hg4MGDkEgksLGxwdy5c/H222+DxWKhtLQURUVFmDBhAkpKSmBnZ4cPPvgAQUFByMnJQUFBAdhsNlgsFsLCwiAUCvt9vmKxGLm5udBqtYiMjERRURESExMxZcoU7N27F+7u7oiLiwMAVFdXY/fu3di3bx+AvkrIGRkZqKmpAZfLRUREBObPnw8AqK2txY8//oiWlhZwOBzMmjUL7733HlatWoW2tjbmM9+yZQuam5tRVFSErVu3AgBu3bqFrKwsNDc3QyAQID4+HpMmTQIAfPLJJ/Dz80N1dTXu3r2LiRMnIiUlpV85fa1WC6FQyHx3QN9a7Y6Ojjh8+DAuXboEAAgJCcG7776LESNGMMf3xhtv4NdffwWXy0VcXBxTiPPBz6O8vBx5eXmQy+VwcnKCUChEYGAgSktLkZ+fD7VaDUdHR4s2KCsa7i4S9fRZvXo1qaysJCkpKUQqlRKj0UgSExOJXC63GPLavXs32bFjB9FoNKS1tZWkpKSQoqIiQgghX331Ffn555+J0WgkOp2O1NTUMO3/25DXg8Mm5iGb3bt3k97eXqLT6UhZWRkRiUREKpUSg8FA8vPzyebNmwkhhHR2dpJly5aRS5cukXv37pHCwkISGxvLDEUdOXKE7Nq1q1/75iGhL774guzfv5/09vYSlUpFUlNTye+//04IIaSkpITExcWR06dPE6PRSH777TeSkJBATCYTIeTfh7ykUilZunQpqa6uJnq9nmRlZZHY2FhSWVlJCCFkz549JCcnZ8DPwmg0kk2bNpGjR4+Se/fuEZlMRpKTk4lEIiGEEJKWlkbOnj1LCCGkt7eX3Lp1a8DjMx/HRx99RAghpKuri8THx5OzZ88Sg8FAzp07R+Lj44larWaOSSQSkaamJqLT6Uh6ejo5dOjQoL47QgjJzc0laWlpRKVSkc7OTrJ582bmGKuqqkhsbCzJysoier2eVFdXk6VLl5KmpqZ+n8ft27fJ8uXLSWVlJTEajaStrY00NjaS3t5esnz5cuY97e3tpKGh4W+/A+rh0SEv6qGFhoZCLBbj+vXr8PLygpubG7PNZDLhwoULWLJkCUaNGgU+n4/IyEiIxWIAAJvNhkKhQEdHBzgcDvz8/B45npiYGHC5XHA4HJw+fRqLFi2Ct7c3bG1tsWjRItTX10OhUEAikcDHxwfBwcFgs9mIiIiAi4vLoPahUqkgkUgQHx8PLpcLZ2dnRERE4OLFi8xrPDw88Nprr4HFYmHOnDno6OhAZ2fnoNr/448/MG3aNPj7+2PEiBGIjY0ddI2uuro6qNVqREdHg81mw9PTE+Hh4UxsbDYbMpkMarUaXC4XEydOHFS7FRUVGD16NEJDQ2Fra4tZs2ZBIBDg6tWrzGvCwsIgEAjA4XAQEhKC+vr6QbUNAOfPn8fixYvh7OwMJycnREdH49y5cxaviY2NxYgRI+Dv74+goCCLz9usuLgYc+fOxZQpU8BiseDm5saUT7GxsUFDQwP0ej1cXV3h4+Mz6PiowaO1vKiHFhoaivT0dMjl8n7LoarVahiNRnh4eDDP8Xg8tLe3AwCWLl2K3NxcpKWlwd7eHpGRkZg3b94jxXP/KnoKhQKZmZnIzs5mniOEoL29HR0dHRavtbGxGfQKfEqlEkajEQkJCRbt3v/++5OTeRhJq9UOqv329naLtrhc7qDX3jAnaHPBSKAvsb/00ksAgKSkJBw5cgTr1q0Dn89HdHQ0pk2bNqiYzEOFZvd/l0D/Yx7s8Q7U/oNt29vbW6yKyePx0NHR0a+dtrY2BAUF9Xuey+Vi7dq1KCwsxL59+zBp0iQsX76cSTaU9dCEQj00Ho8HPp8PiUSCpKQki21OTk6wtbWFUqmEt7c3gL6TsbkX4+Liwrzn5s2b2Lp1K/z9/TF69OiHjuf+X/IeHh6IiooacJy8paUFbW1tzGNCiMVjLpcLvV7PPFapVMzf7u7uYLPZOHDgAGxtbR8pxoG4urqiqamJeazT6dDV1cU8HjlypMXkh/tj8/DwAJ/PxzfffDNg22PGjMHatWthMplQVlaGnTt34sCBA/8ak5ubGy5fvmzxnFKpRGBg4D++byAD7cvNzQ0KhYLpNdz/fwIAPT090Gq1TFJRKpUD9jDc3d0hk8kG3G9gYCACAwOh1+uRm5uL/fv347PPPvvP8VP/jA55UY8kKSkJH3/8cb911VksFkJCQpCTk4Pe3l4oFAocP36cOcFfunSJOYnb29sD+P/JxtnZGa2trY8U1+uvv46CggJIpVIAgEajYS76Tp06FVKpFJcvX4bRaMTJkyctTsy+vr6oqamBUqmERqNBQUEBs83V1RUvv/wysrOzodFoYDKZIJPJ8Oeffw4qrn87tuDgYFy9ehU3b96EwWDAkSNHQO6bN+Pr6wuJRILu7m6oVCqcOHGC2TZ+/HiMGjUKBQUF0Ov1MJlMaGhoQG1tLYC+i/1qtRosFgt2dnYA+r4nJycn2NjY/G1cQUFBaGlpwfnz52E0GnHx4kU0NjZi6tSpgzrmB4+/q6sLGo2GeW7mzJk4duwY1Go11Go18vPz+/0QyMvLg8FgQE1NDSoqKhASEtKv7Xnz5qG0tBQ3btyAyWRCe3s7mpqaoFKpUF5eDq1WCzabDS6XS0v9DxHaQ6EeyT/1KFasWIGMjAyIRCJwOByEh4dj7ty5APrG+7OysqDRaODi4oL3338fnp6eAPquhezduxd6vR4JCQkWs7wG65VXXoFWq8XXX38NpVIJOzs7TJ48GSEhIXBycsL69euRmZmJb7/9FqGhocyMJQCYMmUKQkJCsGHDBjg6OmLhwoW4cuUKs10kEuHw4cNYv349ent74enpiYULFw4qrvnz52Pv3r04ffo0Zs+ejRUrVlhs9/HxgVAoxK5du6DT6RAZGWkxBBYaGoobN24gOTkZPB4PYWFhOH78OIC+5PDhhx8iOzsbycnJMBgMEAgEiI2NBQBcu3YN2dnZ0Ol04PF4WLNmDTPbKioqClu2bIHRaERaWppFTI6OjkhNTUVmZiZ++OEHjB49Gqmpqf1mcQ2Gl5cXZs6cCZFIBJPJhJ07dyIqKgoajYZZJCw4OBhRUVHMe1xcXODg4IDExERwOBysXLlywOGq8ePHY/Xq1Th48CDkcjmcnZ0hFAphZ2eH48ePY8+ePbCxsYGvry+9IXaI0GnDFIW+qa+zZ89GeHj4cIfST3JyMjNt+Hnz4LRo6slGh7woiqIoq6AJhaIoirIKOuRFURRFWQXtoVAURVFWQRMKRVEUZRU0oVAURVFWQRMKRVEUZRU0oVAURVFWQRMKRVEUZRX/A3JF1uTPgyfmAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "plt.style.use('ggplot')\n",
    "\n",
    "plt.bar(range(len(f)), [val[1] for val in f], align='center')\n",
    "plt.xticks(range(len(f)), [val[0] for val in f])\n",
    "plt.xticks(rotation=70)\n",
    "plt.xlabel(\"Most frequent question topics\")\n",
    "plt.ylabel(\"Frequency of occurence\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "em8UVD9wHpdq",
    "outputId": "a78e5d0e-c7c0-4c54-e5ff-ab2b0e9b369f"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The word cancer is present 6097 times \n",
      "The word pandemic is present 3 times \n"
     ]
    }
   ],
   "source": [
    "# Count of occurence of the words 'cancer' and 'pandemic'\n",
    "cancer=t2.count(\"cancer\")\n",
    "pandemic = t2.count(\"pandemic\")\n",
    "print(f\"The word cancer is present {cancer} times \")\n",
    "print(f\"The word pandemic is present {pandemic} times \")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "P97jPIAWPRui"
   },
   "source": [
    "Wordcloud to visualize the most frequently occuring words in the passages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 467
    },
    "id": "bu2BwfJzHpth",
    "outputId": "e19bada7-ea47-4dae-98f8-dd68c32b2977"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(-0.5, 399.5, 199.5, -0.5)"
      ]
     },
     "execution_count": 38,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "tags": []
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique_string = \" \"\n",
    "for t in tokens_processed:\n",
    "     unique_string=(\" \").join(t)\n",
    "\n",
    "wordcloud = WordCloud(max_font_size=50, max_words=100, background_color=\"white\").generate(unique_string)\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.imshow(wordcloud)\n",
    "\n",
    "plt.axis(\"off\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "CpoZj9-Uilod",
    "outputId": "cb8482da-580e-4e01-c812-7257a078f274"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1;30;43mStreaming output truncated to the last 5000 lines.\u001b[0m\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: abelson murine leukemia\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: junctin, calsequestrin, triadin\n",
      "Question: For which type of diabetes can empagliflozin be used?\n",
      "Answer: type 2\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: ichthyosis follicularis, alopecia and photophobia\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: cytochrome p450 ( cyp ) 2c9 ( cyp2c9 ) and vitamin k epoxide reductase complex subunit 1 ( vkorc1 )\n",
      "Question: What is being measured with an accelerometer in back pain patients\n",
      "Answer: whole - body acceleration\n",
      "Question: Which drugs may interfere thyroxine absorption?\n",
      "Answer: sevelamer hydrochloride and chromium picolinate\n",
      "Question: Name the major classes of small  non coding RNAs in mammalians?\n",
      "Answer: micrornas and snornas\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: \n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: trisomy 8\n",
      "Question: What is the major adverse effect of adriamycin(doxorubicin)?\n",
      "Answer: cardiotoxicity\n",
      "Question: Which are the subunits of the IkB protein kinase (IKK)?\n",
      "Answer: ikk1, ikk2 and nemo\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: snf2 - like family of atpases\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: How is oprozomib administered?\n",
      "Answer: orally\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: recessive\n",
      "Question: What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?\n",
      "Answer: id1, id3, and msx2\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: wnt\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: digeorge syndrome ( dgs ) and the velo - cardio - facial syndrome ( vcfs )\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: haddock\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: x - linked dominant disorder\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: transcription factors, oct4, sox2, klf4 and cmyc\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: mechanical, chemical, thermal and infectious\n",
      "Question: Which are the main NMD factors in Saccharomyces cerevisiae?\n",
      "Answer: upf1p, nmd2p, and upf3p\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1\n",
      "Question: Which receptors are targeted by a drug Macitentan?\n",
      "Answer: endothelin\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: mammals\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: individual classification models\n",
      "Question: Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?\n",
      "Answer: phospholamban\n",
      "Question: ROSIER scale is used for which disorder?\n",
      "Answer: stroke\n",
      "Question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.\n",
      "Answer: subsets of gata - 1 gene targets are bound in vivo by distinct complexes\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: cavity program\n",
      "Question: Which G protein is essential in the formation and function of lamellipodia?\n",
      "Answer: g - protein - coupled receptor - 2 - interacting protein - 1\n",
      "Question: Magnetic beads has been used in numerous applications. List some coatings used.\n",
      "Answer: coatings used. [SEP]\n",
      "Question: List protein gel staining methods visualizing the entire protein set.\n",
      "Answer: \n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: ep - dnn\n",
      "Question: List available genetic multicolor cell labeling techiniques in Drosophila\n",
      "Answer: melanogaster\n",
      "Question: List clinical features of the IMAGe syndrome.\n",
      "Answer: intra - uterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita and genital abnormalities\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter spp.\n",
      "Question: Which enzyme is targeted by the drug Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which disease is treated with ZMapp?\n",
      "Answer: ebola virus disease\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: ataxia, hypomyelination, hypodontia, and hypogonadotropic hypogonadism\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: 1, 4 - benzothiazepine\n",
      "Question: What is apelin?\n",
      "Answer: a small regulatory peptide\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: dna / rna binding protein\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: same\n",
      "Question: How is oprozomib administered?\n",
      "Answer: orally\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: [CLS] what is the characteristic domain of histone methyltransferases? [SEP]\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: met1, cmt3 and drm\n",
      "Question: List clinical features of EEM syndrome.\n",
      "Answer: ectodermal dysplasia, ectrodactyly and macular dystrophy\n",
      "Question: Which are the typical symptoms of Ménière's disease?\n",
      "Answer: vertigo, tinnitus or hearing loss\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: clustering algorithms using six different interaction datasets. we parameterized the mcl, spectral, rnsc and affinity propagation algorithms\n",
      "Question: RTS S AS01 vaccine was developed to prevent which disease?\n",
      "Answer: malaria\n",
      "Question: Orteronel was developed for treatment of which cancer?\n",
      "Answer: prostate cancer ( elm - pc 4 ) : a double - blind, multicentre, phase 3, randomised, placebo - controlled trial. background : orteronel is an investigational, partially selective inhibitor of cyp 17, 20 - lyase in the androgen signalling pathway, a validated therapeutic target for metastatic castration - resistant prostate cancer\n",
      "Question: What organism causes tularemia?\n",
      "Answer: francisella tularensis\n",
      "Question: What is MRSA?\n",
      "Answer: community - associated methicillin resistant staphylococcus aureus\n",
      "Question: Which enzyme is inhibited by Orteronel?\n",
      "Answer: 17, 20 - lyase\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: oncogenesis\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase ( th ), aromatic l - amino acid decarboxylase ( aaad ), dopamine - β - hydroxylase ( dbh ) and phenylethanolamine n - methyltransferase ( pnmt )\n",
      "Question: List 3 features of IRVAN syndrome.\n",
      "Answer: \n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: List functional roles of the FtsZ protein.\n",
      "Answer: cell elongation, gtpase, cell division, and bacterial cytoskeleton\n",
      "Question: Which genes are implicated in short QT syndrome?\n",
      "Answer: kcnh2, kcnq1 and kcnj2\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: essential initiation and elongation factor, cdc45, the checkpoint mediator mrc1\n",
      "Question: Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?\n",
      "Answer: pyridostigmine bromide\n",
      "Question: List non-surgical treatment modalities that are included in the Stupp protocol.\n",
      "Answer: [CLS] list non - surgical treatment modalities that are included in the stupp protocol. [SEP] dna methylation in glioblastoma : impact on gene expression and clinical outcome. background : changes in promoter dna methylation pattern of genes involved in key biological pathways have been reported in glioblastoma. genome - wide assessments of dna methylation levels are now required to decipher the epigenetic events involved in the aggressive phenotype of glioblastoma, and to guide new treatment strategies. results : we performed a whole - genome integrative analysis of methylation and gene expression profiles in 40 newly diagnosed glioblastoma patients. we also screened for associations between the level of methylation of cpg sites and overall survival in a cohort of 50 patients uniformly treated by surgery, radiotherapy and chemotherapy\n",
      "Question: Which are the genes thought to be regulated by EWS/FLI?\n",
      "Answer: \n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: mk - 0974\n",
      "Question: Which are the subunits of the IkB protein kinase (IKK)?\n",
      "Answer: ikkα and ikkβ\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: lqt1\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: pedla\n",
      "Question: Which genes are regulated by MEF-2 in the heart?\n",
      "Answer: [CLS]\n",
      "Question: List the existing methods for genetic manipulation of cells.\n",
      "Answer: agrobacterium - mediated as well as direct delivery methods\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: zdock program for rigid - body protein - protein docking\n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: dkc1, terc, tert, nop10, nhp2, tin2, c16orf57, and tcab1\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3, 6, 8, 12, and 17\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarate\n",
      "Question: List 3 features of IRVAN syndrome.\n",
      "Answer: symmetric multiple aneurysmal dilations, retinal vasculitis, and severe hard exudation in the macula bilaterally\n",
      "Question: which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?\n",
      "Answer: previous cardiac arrest or sustained ventricular tachycardia\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor x\n",
      "Question: Name the major classes of small  non coding RNAs in mammalians?\n",
      "Answer: micrornas and snornas\n",
      "Question: What are the main clinical characteristics of Pendred syndrome?\n",
      "Answer: profound deafness in childhood and defective organic binding of iodine in the thyroid gland\n",
      "Question: What disease is Velcade (bortezomib) mainly used for?\n",
      "Answer: [CLS]\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: stage iv metastatic melanoma\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: for treating insomnia\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: [CLS]\n",
      "Question: Which disease can be treated with Delamanid?\n",
      "Answer: multidrug - resistant pulmonary tuberculosis\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: h3, as well as cse4, h4, h2a, and h2b\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which enzyme is deficient in Gaucher's disease?\n",
      "Answer: beta glucocerebrosidase\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: ncx )\n",
      "Question: Which R / bioconductor package is used for performing SNP enrichment analysis?\n",
      "Answer: traser\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fibrillin - 1\n",
      "Question: Which are the key players on radial glial specification to ependymal cells?\n",
      "Answer: mcidas and gemc1 / lynkeas\n",
      "Question: Which protein is associated with hyperemesis gravidarum during pregrancy?\n",
      "Answer: papp - a\n",
      "Question: Which two drugs are included in the Harvoni pill?\n",
      "Answer: sofosbuvir ( sovaldi ) and ledipasvir\n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: ferritin\n",
      "Question: Mutation of which gene is implicated in the Brain-lung-thyroid syndrome?\n",
      "Answer: thyroid transcription factor 1\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Please list 3 diseases associated with the PIEZO2 gene.\n",
      "Answer: distal arthrogryposis type 5 and marden - walker syndrome\n",
      "Question: Which are the mammalian orthologs of Drosophila Yki?\n",
      "Answer: yorkie ortholog yap\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: tuberculosis\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: [CLS] list the diseases for which there are point - of - care breath tests [SEP]\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: vancomycin and ampicillin\n",
      "Question: What is the major adverse effect of adriamycin(doxorubicin)?\n",
      "Answer: [CLS]\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: [CLS]\n",
      "Question: Which R package could be used for the identification of pediatric brain tumors?\n",
      "Answer: methped\n",
      "Question: Which is the histone residue methylated by MLL1?\n",
      "Answer: h3k4\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: autosomal dominant parkinsonism, depression, severe weight loss, and hypoventilation\n",
      "Question: Which interleukins are inhibited by Dupilumab?\n",
      "Answer: interleukin - 4\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: ulcerative colitis ( uc ) and crohn's disease ( cd )\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: abl\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which genes have been found mutated in Gray platelet syndrome patients?\n",
      "Answer: gata1\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zfhx1b\n",
      "Question: Which heat shock protein is found to be upregulated during Hsp90 inhibition?\n",
      "Answer: hsp70\n",
      "Question: Which are the subunits of the IkB protein kinase (IKK)?\n",
      "Answer: ikkalpha and ikkbeta\n",
      "Question: Which post-translational histone modifications are characteristic of facultative heterochromatin?\n",
      "Answer: h3k36me3\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: direct and indirect fxa inhibitors\n",
      "Question: What molecule is targeted by Avelumab?\n",
      "Answer: pd - l1\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: 17\n",
      "Question: What enzyme is inhibied by Opicapone?\n",
      "Answer: [CLS]\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: cdc45, ctf4, and gins complex subunits, the polymerase processivity clamp pcna and the single - stranded dna - binding complex rpa\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: sepsis\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which enzyme is inhibited by Orteronel?\n",
      "Answer: 17, 20 - lyase\n",
      "Question: Is APOBEC3B protein predominantly cytoplasmic or nuclear?\n",
      "Answer: nuclear\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: heritable mutations in alpha - synuclein, parkin, dj - 1 and pink1\n",
      "Question: Which gene harbors the mutation T790M?\n",
      "Answer: egfr c797s\n",
      "Question: List genes associated with hypolipidemia.\n",
      "Answer: angptl3 gene cause familial combined hypolipidemia\n",
      "Question: Which ApoE isoform is associated with hyperlipoproteinemia?\n",
      "Answer: apoe2\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: ncx\n",
      "Question: What is the cause of Phthiriasis Palpebrarum?\n",
      "Answer: blepharoconjunctivitis\n",
      "Question: What is the mode of inheritance of Wilson's disease?\n",
      "Answer: autosomal recessive\n",
      "Question: Which gene strand is targeted by transcription-coupled repair (TCR)?\n",
      "Answer: transcribed strands\n",
      "Question: What is the target of tanezumab?\n",
      "Answer: rapidly progressive osteoarthritis\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: \n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: alzheimer's disease\n",
      "Question: How is bladder wall thickness measured?\n",
      "Answer: automatic\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: short stature, mental retardation, seizures, follicular ichthyosis, generalized alopecia, hypohydrosis, enamel dysplasia, photophobia, congenital aganglionic megacolon, inguinal hernia, vertebral, renal and other anomalies, and a normal chromosome constitution. the clinical findings include all the features that dermotrichic and ichthyosis follicularis - alopecia - photophobia ( ifap ) syndrome have in common and in addition those that characterize ifap syndrome ( photophobia, recurrent respiratory infections, etc.\n",
      "Question: Which is the major symptom of the Doose syndrome?\n",
      "Answer: \n",
      "Question: Which kinase is inhibited by Tripolin A?\n",
      "Answer: aurora a\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: junctin, and junctate\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?\n",
      "Answer: polc and dnae\n",
      "Question: DX-88 is investigational name of which drug?\n",
      "Answer: ecallantide\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3p\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: p73\n",
      "Question: List inflammatory caspase proteins?\n",
      "Answer: caspase - 4\n",
      "Question: Which tool is used for the identification of recurrent variants in noncoding regions?\n",
      "Answer: larva\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which genes have been associated with Cerebral Cavernous Malformation?\n",
      "Answer: krit1 / ccm1\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: homozygous truncating mutation\n",
      "Question: List two common features of Tay syndrome.\n",
      "Answer: peculiar anomaly of hair growth\n",
      "Question: Which histone modifications are associated with Polycomb group (PcG) proteins?\n",
      "Answer: h3k27me3\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: [CLS]\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban compared with warfarin\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: recurrent facial nerve palsy, facial swelling, and fissured tongue\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: abcd and diabetes\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: park2, park7 and pink1\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: brooke - spiegler syndrome\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: silver syndrome / spastic paraplegia 17, distal hereditary motor neuropathy type v, and charcot - marie - tooth disease type 2 ( cmt2 ) with predominant hand involvement\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: dna - dependent rna polymerase ii\n",
      "Question: What causes Katayama Fever?\n",
      "Answer: schistosoma spp. infection\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: everolimus\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism\n",
      "Question: Which genes are regulated by MEF-2 in the heart?\n",
      "Answer: pgam - m mef - 2 and muscle creatine kinase mef - 2 oligomers but not by a mutant pgam - m mef - 2 oligomer. these observations define the pgam - m\n",
      "Question: Which type of cells is affected in Amyotrophic Lateral Sclerosis?\n",
      "Answer: motor neurons\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: glial cell line - derived neurotrophic factor ( gdnf ) and its receptor molecule gdnfr - alpha\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf2 / c - jun, irf1, and p50 / p65 of nf - kappa b\n",
      "Question: Hy's law measures failure for what organ?\n",
      "Answer: liver\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which are the different isoforms of the mammalian Notch receptor?\n",
      "Answer: notch - 1 to - 4\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: ifn regulatory factor ( irf ) 3, nuclear factor ( nf ) - kappab, activating transcription factor ( atf ) - 2 and c - jun\n",
      "Question: Orteronel was developed for treatment of which cancer?\n",
      "Answer: prostate cancer\n",
      "Question: List fish anti-freeze proteins.\n",
      "Answer: skin - type anti - freeze protein - 3\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which computational frameworks are available for predicting enhancers?\n",
      "Answer: deep\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: dnmt3 family\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: [CLS] list algorithms suitable for predicting protein complexes [SEP]\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: \n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: chromosomes 13, 14 and 21. the presence of this alpha subfamily may allow pairing between these chromosomes leading to the observed non - random participation of these chromosomes in t ( 13q14q ) and t ( 14q21q )\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: situs inversus, bronchiectasis and sinusitis\n",
      "Question: What are the main indications of lacosamide?\n",
      "Answer: epilepsy\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 10 ( acta2 ) and 17\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: collagen\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: What tissue is commonly affected in Marfan's syndrome\n",
      "Answer: connective tissue\n",
      "Question: What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.\n",
      "Answer: seizures\n",
      "Question: Which is the molecular target of the immunosuppressant drug Rapamycin?\n",
      "Answer: mtor\n",
      "Question: Which calcium/calmodulin dependent protein phosphatase is involved in the activation of the family of NFAT transcription factors (Nuclear Factors of Activated T cells)?\n",
      "Answer: 2b / calcineurin\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: mammalian egfr ligands\n",
      "Question: Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?\n",
      "Answer: icatibant\n",
      "Question: What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.\n",
      "Answer: cerebral hemiatrophy, homolateral skull hyperplasia, hyperpneumatization of the paranasal sinuses, seizures with or without mental retardation, and contralateral hemiparesis\n",
      "Question: Which class of genes are mutated in Diamond Blackfan Anemia patients?\n",
      "Answer: ribosomal protein genes rps10 and rps26\n",
      "Question: Which is the protein implicated in Spinocerebellar ataxia type 3?\n",
      "Answer: ataxin - 3\n",
      "Question: What is the inheritance pattern of Emery-Dreifuss muscular dystrophy? \n",
      "Answer: x - linked recessive\n",
      "Question: Which R package is used for visualization of linear and circular karyotypes?\n",
      "Answer: chromdraw\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: kras, braf and pik3ca mutations are frequently observed in colorectal cancer ( crc ). in particular, kras\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: Which treatment methods were compared in the EXCEL Trial?\n",
      "Answer: xience everolimus eluting stent versus coronary artery bypass surgery\n",
      "Question: The protein NONO forms heterodimers. With which proteins?\n",
      "Answer: pspc1\n",
      "Question: In which yeast chromosome does the rDNA cluster reside?\n",
      "Answer: xii\n",
      "Question: Dracorhodin perchlorate was tested for treatment of which cancers?\n",
      "Answer: human prostate cancer, human gastric tumor cells and human melanoma\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: 5q35. 1 )\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: desert hedgehog ( dhh ), indian hedgehog ( ihh ) and sonic hedgehog ( shh )\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: collagen\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: facioscapulohumeral muscular dystrophy\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: 3, 5 - dimethyl - 3'- isopropyl - l - thyronine ( dimit ) and 3, 5 - diiodo - 3'- isopropylthyroacetic acid ( ipta2 ) on body weight gain and lipid metabolism in genetically obese zucker rats. 3, 5 - dimethyl - 3'- isopropyl - l - thyronine ( dimit ) and 3, 5 - diiodo - 3'- isopropylthyroacetic acid ( ipta2 )\n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: dkc1, terc, tert, nop10, nhp2, and tcab1\n",
      "Question: To the ligand of which receptors does Denosumab (Prolia) bind?\n",
      "Answer: rankl\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: a31s\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: how many tap73 isoforms have been identified in humans? [SEP] the role of various p73 isoforms in tumorigenesis has been controversial. however, as we have recently shown, the generation of tap73 - deficient ( tap73 ( - / - ) ) mice\n",
      "Question: Which variables are included in the SPAN-100 score?\n",
      "Answer: age and stroke severity\n",
      "Question: What is the mode of inheritance of short QT syndrome?\n",
      "Answer: autosomal dominant\n",
      "Question: DX-88 is investigational name of which drug?\n",
      "Answer: ecallantide\n",
      "Question: Which are the typical symptoms of Ménière's disease?\n",
      "Answer: vertigo, hearing loss and tinnitus\n",
      "Question: RTS S AS01 vaccine was developed to prevent which disease?\n",
      "Answer: malaria\n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: co2\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin, junctin, and calsequestrin\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: trisomy 8\n",
      "Question: Which fusion protein is involved in the development of Ewing sarcoma?\n",
      "Answer: ews / fli1\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: scgpred\n",
      "Question: Which tool is used for the identification of recurrent variants in noncoding regions?\n",
      "Answer: larva\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: \n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: myc\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: alirocumab ( sar236553 / regn727 ) and amg 145\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter species\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Matuzumab has been tested for treatment of which cancers?\n",
      "Answer: non - small cell lung cancer\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: benzothiazepine\n",
      "Question: Which human disease is associated with mutated UBQLN2\n",
      "Answer: amyotrophic lateral sclerosis\n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: dzcyt\n",
      "Question: Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?\n",
      "Answer: resins, fibrates, niacin, statins and cholesterol absorption - inhibiting drugs\n",
      "Question: List common symptoms of patients with the DOORS syndrome.\n",
      "Answer: [CLS]\n",
      "Question: Which R package is used for the detection of chromosomal abnormalities from microarray data?\n",
      "Answer: cafe\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase ( th ), dopamine beta - hydroxylase ( dbh ), and phenylethanolamine n - methyltransferase ( pnmt )\n",
      "Question: List Pentalogy of Fallot.\n",
      "Answer: pentalogy of fallot ; overriding aorta ; ventricular septal defect ; atrial septal defect ; pulmonary atresia ; doppler echocardiography\n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: calcitonin gene - related peptide\n",
      "Question: What is the mode of inheritance of Wilson's disease?\n",
      "Answer: autosomal recessive\n",
      "Question: How are ultraconserved elements called when they form clusters?\n",
      "Answer: gene regulatory blocks\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: new indication\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: tumour - suppressor genes\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: ser154\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: warfarin\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: uhrf1\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 10 ( acta2 ) and 17\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: renal phosphate wasting\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zeb2\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv type 1 isolates from different clades. furthermore, dapivirine demonstrated potent activity against a wide range of nnrti - resistant isolates. in human cervical explant cultures, dapivirine was able not only to inhibit direct infection of mucosal tissue\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: cytochrome p450 2c9 enzyme ( cyp2c9 ) and the vitamin k epoxide reductase ( vkorc1 )\n",
      "Question: The pathogen Fusarium graminearum affects what type of plant species?\n",
      "Answer: cereal\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: 5 - ht2a\n",
      "Question: List the different subtypes of thyroid cancer.\n",
      "Answer: provide an overview of the subtypes of papillary thyroid carcinoma and their prognosis\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: bacitracin and vancomycin\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: significant decrease in polr3a levels\n",
      "Question: What genes are related to breast cancer?\n",
      "Answer: breast cancer gene 1\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gfralpha1 - 4\n",
      "Question: What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations?\n",
      "Answer: fanconi anemia\n",
      "Question: Symptoms of which disorder are evaluated with the Davidson Trauma Scale?\n",
      "Answer: ptsd\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: hypertrophic cardiomyopathy\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: facioscapulohumeral dystrophy\n",
      "Question: List 3 features of IRVAN syndrome.\n",
      "Answer: visual acuity was affected due to ocular inflammation and presence of macular edema due to exudation around the optic nerve\n",
      "Question: Mutation of which gene is implicated in the Christianson syndrome?\n",
      "Answer: slc9a6\n",
      "Question: Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?\n",
      "Answer: p65 and p50\n",
      "Question: List markers for autophagy.\n",
      "Answer: \n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: dexamethasone, cytarabine, and cisplatin\n",
      "Question: How is active neurotoxin of Clostridium botulinum detected?\n",
      "Answer: peptide cleavage assay\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: [CLS] list causative genes for autosomal recessive forms of monogenic parkinson's disease [SEP]\n",
      "Question: Which is the database of molecular recognition features in membrane proteins?\n",
      "Answer: mpmorfsdb\n",
      "Question: For which type of diabetes can empagliflozin be used?\n",
      "Answer: type 2\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acintobacter baumannii, pseudomonas aeruginosa and enterobacter spp.\n",
      "Question: Which transcription factor is considered as a master regulator of lysosomal genes?\n",
      "Answer: transcription factor eb\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: maternal immune activation\n",
      "Question: Which disease is linked to mutations within BRAG1?\n",
      "Answer: x - linked intellectual disability\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dnmt1\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which disease can be categorized using the Koos grading system?\n",
      "Answer: vestibular schwannomas\n",
      "Question: Which are the typical symptoms of Ménière's disease?\n",
      "Answer: unilateral fluctuating hearing loss of sensorineural type, tinnitus and vertiginous attacks lasting minutes to hours\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism\n",
      "Question: Which disease phenotypes are associated to PRPS1 mutations?\n",
      "Answer: arts syndrome, charcot - marie - tooth disease - 5 ( cmtx5 ) and x - linked non - syndromic sensorineural deafness ( dfn2 )\n",
      "Question: Which is the protein implicated in Spinocerebellar ataxia type 3?\n",
      "Answer: ataxin - 3\n",
      "Question: Which disease phenotypes are associated to PRPS1 mutations?\n",
      "Answer: superactivity of the prs - i protein whereas the loss - of - function mutations result in x - linked nonsyndromic sensorineural deafness type 2 ( dfn2 ), or in syndromic deafness including arts syndrome and x - linked charcot - marie - tooth disease - 5 ( cmtx5 )\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: What is the inheritance pattern of Li–Fraumeni syndrome?\n",
      "Answer: autosomal dominant\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: \n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: eag\n",
      "Question: Which sports have a risk for commotio cordis?\n",
      "Answer: competitive sports, dangers implicit in such blows can extend into many other life activities. objective : to describe the comprehensive spectrum of commotio cordis events. design and setting : analysis of confirmed cases from the general community assembled in the us commotio cordis registry occurring up to september 1, 2001. main outcome measure : commotio cordis event. results : of 128 confirmed cases, 122 ( 95 % ) were in males and the mean ( sd ) age was 13. 6 ( 8. 2 ) years ( median, 14 years ; range, 3 months to 45 years ) ; only 28 ( 22 % ) cases were aged 18 years or older. commotio cordis events occurred most commonly during organized sporting events ( 79 [ 62 % ] ), such as baseball\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: gamma - aminobutyric acid receptor - associated protein - like 1\n",
      "Question: What is the indication for isradipine?\n",
      "Answer: mild - to - moderate hypertension\n",
      "Question: List RNA modifications databases\n",
      "Answer: known pathways of rna modification from the modomics database\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: fibrillin - 1 gene\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: enzyme titration and kinetic studies of inhibition suggest that methyl transfer to the complex occurred only during the first turnover of the reaction\n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: iron\n",
      "Question: Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: ino80 promotes homologous recombination. the mammalian ino80 remodelling complex facilitates homologous recombination ( hr ), but the mechanism by which it does this is unclear. budding yeast ino80\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: tetrac inhibits binding of thyroid hormone analogs to the receptor on alphavbeta3\n",
      "Question: Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?\n",
      "Answer: pse - in - one\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: peripheral facial nerve palsy, recurrent or persistent oral or facial swelling, and fissured tongue\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: galactocerebrosidase\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: [CLS] list braf inhibitors that have been tested in clinical trials for treatment of melanoma patients [SEP]\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: headache, palpitations, and diaphoresis\n",
      "Question: Which cell types are known to be driving Rheumatoid Arthritis?\n",
      "Answer: fibroblast - like synoviocytes\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: ROSIER scale is used for which disorder?\n",
      "Answer: stroke\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: efficacy and safety of everolimus\n",
      "Question: Which genes have been proposed as potential candidates for gene therapy of heart failure?\n",
      "Answer: [CLS] which genes have been proposed as potential candidates for gene therapy of heart failure? [SEP]\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: c. 363dupg or p. gln122alafsx30\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: dystonia - parkinsonism\n",
      "Question: Which transcription factor is considered as a master regulator of lysosomal genes?\n",
      "Answer: transcription factor eb\n",
      "Question: List inhibtors targeting the mitochondrial permeability transition pore.\n",
      "Answer: nim - 811\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: common chromosomal abnormalities\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical symptoms, duration of symptoms, and diabetes\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: \n",
      "Question: Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?\n",
      "Answer: human and rhesus apobec3d, apobec3f, apobec3g, and apobec3h\n",
      "Question: Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?\n",
      "Answer: phospholamban\n",
      "Question: Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?\n",
      "Answer: mir - 200a, mir - 100, mir - 141, mir - 200b, and mir - 200c ) were reported with the consistent direction in four or more studies. mir - 200a, mir - 200b, mir - 200c, and mir - 141, all of them belong to mir - 200 family, were reported with consistently up - regulated in at least 4 studies, whereas mir - 100 was reported with down - regulated in 4 studies. furthermore, we validated these mirnas in a clinical setting using qrt - pcr and their dysregulations in eoc tissues confirmed the findings. conclusively, the five most consistently expressed mirnas\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: clobutinol\n",
      "Question: Which R package is used for the analysis of genome-wide DNA methylation profiles?\n",
      "Answer: methylkit\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: distal hereditary motor neuropathy type v ( dhmn - v ) and silver syndrome\n",
      "Question: What are the symptoms of abacavir hypersensitivity?\n",
      "Answer: fever, skin rash and gastrointestinal disorders\n",
      "Question: Which miRNA is targeted by SRY/Sox9?\n",
      "Answer: mir - 138\n",
      "Question: What are the symptoms of Rotor syndrome?\n",
      "Answer: conjugated hyperbilirubinemia, coproporphyrinuria, and near - absent hepatic uptake of anionic diagnostics\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: steven - johnson syndrome ( sjs ) and toxic epidermal necrolysis ( ten )\n",
      "Question: What is the incidence of cystic fibrosis in the caucasian population?\n",
      "Answer: 1 : 7000\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: galactocerebrosidase\n",
      "Question: List omics technologies comprised in system biology.\n",
      "Answer: transcriptomics\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter spp.\n",
      "Question: What are the side effects of Nalmefene?\n",
      "Answer: fatigue, lightheadedness, nausea and vomiting\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: junctin, and calsequestrin\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: homozygous or compound heterozygous mutations in the phosphatase and tensin homolog - induced putative kinase 1\n",
      "Question: Which sports have a risk for commotio cordis?\n",
      "Answer: [CLS] which sports have a risk for commotio cordis? [SEP] global epidemiology and demographics of commotio cordis. background : the commotio cordis literature has largely focused on events occurring in the united states. however, with enhanced public awareness, commotio cordis has been increasingly recognized internationally as a cause of cardiac arrest and sudden death due to blunt nonpenetrating chest blows. objective : this study sought to characterize the demographics of commotio cordis globally in comparison to the u. s. experience. methods : this study used interrogation of the commotio cordis registry ( minneapolis, minnesota ). results : we report 60 cases of commotio cordis occurring outside the united states from 19 countries ( most commonly the united kingdom and canada ) on 5 continents and compared these events to 2 : 3 occuring in the u. s. in the 2 groups, events were largely similar demographically, including frequency of survival ( 26 % in u. s. vs 25 % ; p =. 84 ), and the striking male predominance evident in both groups ( i. e., 95 % ), although non - u. s. victims were somewhat older ( 19 ± 13 vs 15 ± 9 ; p =. 002 ). not unexpectedly, the groups differed with baseball / softball and football predominant in the united states ( 55 % of events ) and soccer, cricket, and hockey most common internationally ( 47 % of events ). notably, the frequency with which soccer participation caused commotio cordis was much more common than expected, particularly in non - u. s. athletes ( 20 % vs 3 % u. s. ; p <. 001 ). conclusion : commotio cordis demonstrates a global occurrence, very similar demographically in the united states and internationally. however, the frequency with which chest blows from soccer balls caused commotio cordis events ( particularly during sports played internationally\n",
      "Question: List selective estrogen receptor degraders.\n",
      "Answer: gdc - 0810\n",
      "Question: Which type of myeloma is ixazomib being evaluated for?\n",
      "Answer: multiple myeloma\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical features, duration of symptoms and diabetes\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: two sibs with typical pws presenting deletion of snrpn\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: vkorc1, cyp2c9, ephx1, and cyp4f2\n",
      "Question: Which are the supplemental antioxidant in athletes?\n",
      "Answer: quercetin and vitamin c\n",
      "Question: List all the available databases of super enhancers\n",
      "Answer: dbsuper lists genes associated with super - enhancers\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: r222g\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: List kinases that phosphorylates the protein Bora.\n",
      "Answer: cell cycle kinases, including aurora a and plk1\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: striae distensae and striae gravidarum\n",
      "Question: Please list the 3 findings in HELLP syndrome.\n",
      "Answer: [CLS] please list the 3 findings in hellp syndrome. [SEP] using case reports to determine when liver bleeding occurs during disease progression in hellp syndrome. background : hepatic hemorrhage occurs in less than 5 % of patients with hemolysis, elevated liver enzymes, low platelets ( hellp ) syndrome but it is a profound cause of maternal / perinatal morbidity and mortality. objectives : to determine when liver bleeding occurs during the development of hellp syndrome. search strategy : the english literature was searched for all reports of hellp syndrome associated with liver bleeding. selection criteria : eighty - seven case summaries of liver bleeding in the setting of hellp syndrome were included. the standard definition of hellp syndrome was used with expansion into the mississippi classification system, supplemented by patients with partial hellp syndrome. data collection and analysis : demographic and clinical data were collected and recorded in an excel database. main results : liver bleeding was detected in 18 ( 20. 7 % ) patients with class 1 hellp syndrome, 24 ( 27. 6 % ) with class 2 hellp syndrome, and 12 ( 13. 8 % ) with class 3 or partial hellp syndrome\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: ophthalmologic abnormalities\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: acute myocardial infarction\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dna methyltransferase 1\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: glycosyl - phosphatidylinositol ( gpi ) - linked protein ( designated gdnfr - alpha\n",
      "Question: What is the definitive treatment for low pressure headache?\n",
      "Answer: prophylactic epidural blood patch\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which enzyme is deficient in Gaucher's disease?\n",
      "Answer: beta glucocerebrosidase\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: canagliflozin was the first sglt2 inhibitor to be approved by the us fda for use in the treatment of type 2 diabetes, and recently dapagliflozin has also been approved\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: docktrina\n",
      "Question: which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?\n",
      "Answer: previous cardiac arrest or sustained ventricular tachycardia ; 2 ) family history of sudden cardiac death ; 3 ) high - risk genetic mutations ; 4 ) syncope ; 5 ) non - sustained ventricular tachycardia ; 6 ) hypotensive response to exercise ; and 7 ) marked left ventricular hypertrophy\n",
      "Question: Which are the genes thought to be regulated by EWS/FLI?\n",
      "Answer: nkx2. 2\n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: parn, nocturnin, and angel\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct4, sox2, klf4 and c - myc\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: hypertrophic cardiomyopathy\n",
      "Question: What is the most prominent sequence consensus for the polyadenylation site?\n",
      "Answer: the appropriate spacing\n",
      "Question: Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?\n",
      "Answer: extopodb\n",
      "Question: What molecule is targeted by brodalumab?\n",
      "Answer: interleukin - 17\n",
      "Question: Which genome browser database for DNA shape annotations is available?\n",
      "Answer: gbshape\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: met, cmt, and drm\n",
      "Question: Which neuroendocrine tumors are associated with specific tumor syndromes?\n",
      "Answer: \n",
      "Question: What is the inheritance pattern of Emery-Dreifuss muscular dystrophy? \n",
      "Answer: x - linked recessive\n",
      "Question: Which gene strand is targeted by transcription-coupled repair (TCR)?\n",
      "Answer: xp - c\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: autosomal dominant parkinsonism, depression, weight loss, and central hypoventilation\n",
      "Question: What are the generic versions of Viagra?\n",
      "Answer: sildenafil\n",
      "Question: Which are the musculoskeletal manifestations of Marfan syndrome?\n",
      "Answer: otto pelvis\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: cyp2c9 and vkorc1\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 10 ( acta2 ) and 17\n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: parn, nocturnin and angel\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: toxic epidermal necrolysis ( ten ) and stevens - johnson syndrome ( sjs )\n",
      "Question: List human diseases involving genomic imprinting.\n",
      "Answer: beckwith - wiedemann syndrome, prader - willi / angelman syndromes and cancer\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: hedgehog ( hh ) and wnt\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zfhx1b\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: hglt - 1 and hglut - 1\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndrome ( mds ). a total of 344 patients with de novo mds from june 2008 to october 2012 were detected by 6 pairs of probes, including csf1r / d5s23 - d5s721 ( 5q33 ), egr1 / d5s23 - d5s721 ( 5q31 ), d7s486 ( 7q31 ) / csp7, d7s522 ( 7q31 ) / csp7, d20s108 / csp8 ( 20q12 / csp8 ) and cspx / cspy\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: mtor, rictor, msin1, mlst8 / gβl and prr5\n",
      "Question: Which is the chromosome area that the human gene coding for the dopamine transporter (DAT1) is located to?\n",
      "Answer: 5p15. 3\n",
      "Question: List mutations that are implicated in the Gray Platelet Syndrome.\n",
      "Answer: biallelic mutations in the nbeal2 gene\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: pedla\n",
      "Question: List available biomedical question answering systems.\n",
      "Answer: three\n",
      "Question: Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?\n",
      "Answer: uvra and uvrb\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: What condition is usually represented by the acronym SUDEP?\n",
      "Answer: sudden unexpected death in epilepsy\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which protein is the E3-ubiquitin ligase that targets the tumor suppressor p53 for proteasomal degradation?\n",
      "Answer: mdm2\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: kras\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: \n",
      "Question: Which receptors are targeted by a drug Macitentan?\n",
      "Answer: endothelin\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: ichthyosis follicularis, atrichia, and photophobia\n",
      "Question: Which protein does empagliflozin inhibit?\n",
      "Answer: renal glucose reabsorption\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: [CLS]\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: interferon regulatory factor 3\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: epilepsy and developmental delay\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: vkorc1 and cyp2c9\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: \n",
      "Question: What do nerve-associated peripheral glial progenitors give rise to?\n",
      "Answer: parasympathetic neurons\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: campath - 1h\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: activated\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3, 6, 8, 12, and 17\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [SEP]\n",
      "Question: Which fusion protein is involved in the development of Ewing sarcoma?\n",
      "Answer: ews / fli1\n",
      "Question: Which are the key players on radial glial specification to ependymal cells?\n",
      "Answer: mcidas and gemc1 / lynkeas\n",
      "Question: Which is the main calcium pump of the sarcoplasmic reticulum?\n",
      "Answer: ca ( 2 + ) - atpase\n",
      "Question: What is the main component of the Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: canagliflozin and dapagliflozin\n",
      "Question: Which protein complexes contain mitofilin?\n",
      "Answer: minos\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct4, sox2, klf4 and cmyc\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: ataxia, hypomyelination, hypodontia, and hypogonadotropic hypogonadism\n",
      "Question: Which is the most common type of pediatric cerebellar tumor?\n",
      "Answer: medulloblastoma\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: ndc1 is required for nuclear pore complex assembly in vertebrate cells. nuclear pore complexes ( npcs ) are large proteinaceous channels embedded in the nuclear envelope ( ne ), through which exchange of molecules between the nucleus and cytosol occurs. biogenesis of npcs is complex and poorly understood. in particular, almost nothing is known about how npcs are anchored in the ne. here, we characterize vertebrate ndc1 - - a transmembrane nucleoporin conserved between yeast and metazoans. we show by rna interference ( rnai ) and biochemical depletion that ndc1 plays an important role in npc and ne assembly in vivo and in vitro. rnai experiments suggest a functional link between ndc1 and the soluble nucleoporins nup93, nup53, and nup205\n",
      "Question: Which heat shock protein is found to be upregulated during Hsp90 inhibition?\n",
      "Answer: hsp70\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: Where do the Schwann cells and melanocytes originate from?\n",
      "Answer: the skin\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: set - domain histone methyltransferase and chromodomain dna methyltransferase 3 ( cmt3\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts1 and mutl\n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: adenosylmethionine\n",
      "Question: Which syndromes are associated with mutations in the EZH2 gene?\n",
      "Answer: weaver syndrome\n",
      "Question: Matuzumab has been tested for treatment of which cancers?\n",
      "Answer: esophageal squamous cell carcinoma as well as colorectal carcinoma\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: [CLS]\n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: dedd family members, pan2 and parn\n",
      "Question: Mutations in which genes have been associated with Aicardi-Goutieres syndrome?\n",
      "Answer: trex1, rnaseh2a, rnaseh2b, rnaseh2c, samhd1, and adar\n",
      "Question: Where can we find the protein lacritin?\n",
      "Answer: human lacrimal gland\n",
      "Question: Which gene is responsible for the development of Sotos syndrome?\n",
      "Answer: nsd1\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil 500 mg / m ( 2 ), epirubicin 75 mg / m ( 2 ), and cyclophosphamide 500 mg / m ( 2 )\n",
      "Question: Which protein does empagliflozin inhibit?\n",
      "Answer: sodium glucose cotransporter 2\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: 17\n",
      "Question: Which agents are included in the FLAMSA chemotherapy regimen?\n",
      "Answer: fludarabine, ara - c and amsacrine\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: collagen\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 8q23\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: amphiregulin and heparin - binding epidermal growth factor - like growth factor ( hb - egf ), from airway epithelial cells. amphiregulin and hb - egf were expressed in airway epithelium of patients with asthma. histamine up - regulated their mrna expression ( amphiregulin 3. 2 - fold, p < 0. 001 ; hb - egf 2. 3 - fold, p < 0. 05 ) and triggered their release ( amphiregulin ec ( 50 ) 0. 50 μm, 31. 2 ± 2. 7 pg / ml with 10 μm histamine, p < 0. 01 ; hb - egf ec ( 50 ) 0. 54 μm, 78. 5 ± 1. 8 pg / ml with 10 μm histamine, p < 0. 001 ) compared to vehicle control ( amphiregulin 19. 3 ± 0. 9 pg / ml ; hb - egf 60. 2 ± 1. 0 pg / ml ), in airway epithelial cells. histamine increased egfr phosphorylation ( 2. 1 - fold by western blot analysis ) and induced goblet cell differentiation ( clca1 up - regulation by real - time qpcr ) in normal human bronchial epithelial ( nhbe ) cells. moreover, amphiregulin and hb - egf caused proliferation and migration of both nhbe cells and human airway smooth muscle cells. these results suggest that histamine may induce airway remodeling via the epithelial - derived egfr ligands amphiregulin and hb - egf\n",
      "Question: What was the purpose of the FANTOM4 project?\n",
      "Answer: to better understand the transcriptional network that regulates macrophage differentiation and to uncover novel components of the transcriptome\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: prader - willi and angelman syndromes\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: dna - binding protein 4\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: [CLS]\n",
      "Question: Symptoms of which disorder are evaluated with the Davidson Trauma Scale?\n",
      "Answer: post - traumatic stress disorder\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: collagen\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: \n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: btg / tob family\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: fxa\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: fibrillin - 1\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: dmi - 2 ( bl12 )\n",
      "Question: What disease is Velcade (bortezomib) mainly used for?\n",
      "Answer: multiple myeloma\n",
      "Question: Mutations in which gene determine response to both erlotinib and gefitinib?\n",
      "Answer: egfr\n",
      "Question: Which are the subunits of the IkB protein kinase (IKK)?\n",
      "Answer: ikkalpha, ikkbeta, and ikkgamma\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: controlling hot flashes\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: headaches, sweating, palpitations\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts, facial dysmorphism and peripheral neuropathy\n",
      "Question: Which R package is used for visualization of linear and circular karyotypes?\n",
      "Answer: chromdraw\n",
      "Question: What are the breath test biomarkers of pulmonary tuberculosis\n",
      "Answer: [CLS] what are the breath test biomarkers of pulmonary tuberculosis [SEP]\n",
      "Question: Which are the common symptoms of Cushing's syndrome?\n",
      "Answer: weight gain, growth retardation, hirsutism, obesity, striae, acne and hypertension\n",
      "Question: What does mTOR stands for?\n",
      "Answer: mammalian target of rapamycin\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase - related oculocutaneous albinism ( oca1 ). mutations of the tyrosinase\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: ulcerative colitis ( uc ) and crohn's disease ( cd )\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin and junctin\n",
      "Question: What is the gene mutated in the Gaucher disease?\n",
      "Answer: glucocerebrosidase\n",
      "Question: Which are the key players on radial glial specification to ependymal cells?\n",
      "Answer: mcidas and gemc1\n",
      "Question: List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).\n",
      "Answer: the combination of neurological symptoms, thrombocytopenia, fever, renal failure and hemolytic anemia\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: [CLS] intetumumab has been tested in clinical trials for treatment of which cancers? [SEP] a randomised, phase ii study of intetumumab, an anti - αv - integrin mab, alone and with dacarbazine in stage iv melanoma\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: transcription elongation factors\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: h3 and cse4\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: [SEP]\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: nox organizer 1\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: benzothiazepine\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: \n",
      "Question: Which drug is benserazide usually co-administered with?\n",
      "Answer: osu6162\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: adamtsl4\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: chronic maxillary sinusitis, bronchiectasis and \" situs inversus totalis \"\n",
      "Question: List markers for autophagy.\n",
      "Answer: multiple autophagy markers\n",
      "Question: which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: pln - 42 c > g\n",
      "Question: Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?\n",
      "Answer: tolcapone and entacapone\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: ditpa, t ( 4 ), and t ( 4 ) - agarose\n",
      "Question: Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?\n",
      "Answer: zeb1\n",
      "Question: How is active neurotoxin of Clostridium botulinum detected?\n",
      "Answer: mouse lethality assay\n",
      "Question: Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?\n",
      "Answer: nestin\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: [CLS]\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: \n",
      "Question: What are the indications for alteplase?\n",
      "Answer: rt - pa ) and urokinase ( uk )\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: chromosomes 1 ( lod = 3. 07, p = 3 × 10 ( - 3 ) ) and 22 ( lod = 3. 45, p = 6 × 10 ( - 5 ) )\n",
      "Question: Which gene is involved in Giant Axonal Neuropathy?\n",
      "Answer: gan\n",
      "Question: Which enzyme does MLN4924 inhibit?\n",
      "Answer: nedd8 - activating enzyme\n",
      "Question: Which is the chromosome area that the human gene coding for the dopamine transporter (DAT1) is located to?\n",
      "Answer: 5p15. 33\n",
      "Question: Which hormone receptor function is altered in patients with Donohue syndrome?\n",
      "Answer: insulin\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, klf4, sox2 and c - myc\n",
      "Question: Which method is used for prediction of novel microRNA genes in cancer-associated genomic regions?\n",
      "Answer: combined computational and experimental approach\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: How many tissue kallikrein genes are present in the human genome?\n",
      "Answer: [CLS]\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: confusional symptoms, ocular alterations and ataxia\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: xk\n",
      "Question: What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?\n",
      "Answer: [CLS] what is the name of the stem loop present in the 3'end of genes encoding for selenoproteins? [SEP] recoding elements located adjacent to a subset of eukaryal selenocysteine - specifying uga codons. incorporation of the 21st amino acid, selenocysteine, into proteins is specified in all three domains of life by dynamic translational redefinition of uga codons. in eukarya and archaea, selenocysteine insertion requires a cis - acting selenocysteine insertion sequence ( secis ) usually located in the 3'utr of selenoprotein mrnas. here we present comparative sequence analysis and experimental data supporting the presence of a second stop codon redefinition element located adjacent to a selenocysteine - encoding uga codon in the eukaryal gene, sepn1. this element is sufficient to stimulate high - level ( 6 % ) translational redefinition of the sepn1 uga codon in human cells. readthrough levels further increased to 12 % when tested in the presence of the sepn1 3'utr secis. directed mutagenesis and phylogeny of the sequence context strongly supports the importance of a stem loop starting six nucleotides 3'of the uga codon. sequences capable of forming strong rna structures were also identified 3'adjacent to, or near, selenocysteine - encoding uga codons in the sps2, selh, selo, and selt\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid function\n",
      "Question: Which diseases that can be treated using the focused ultrasound thalamotomy.\n",
      "Answer: [CLS]\n",
      "Question: What tissue is commonly affected in Marfan's syndrome\n",
      "Answer: connective tissue\n",
      "Question: Which enzyme is inhibited by Varespladib?\n",
      "Answer: human secretory phospholipase groups iia, v and x\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38 + multiple myeloma cells\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: brooke - spiegler, familial cylindromatosis, and multiple familial trichoepithelioma\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: epidermal growth factor ( egf ) and amphiregulin ( areg )\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: developmental delay, epilepsy, neonatal diabetes\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: ep - dnn\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: rituximab\n",
      "Question: What is the inheritance pattern of Apert syndrome?\n",
      "Answer: autosomal dominant\n",
      "Question: Please list the 3 findings in HELLP syndrome.\n",
      "Answer: using case reports to determine when liver bleeding occurs during disease progression in hellp syndrome. background : hepatic hemorrhage occurs in less than 5 % of patients with hemolysis, elevated liver enzymes, low platelets\n",
      "Question: Which disease is treated with taliglucerase alfa?\n",
      "Answer: gaucher disease\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: adamtsl4\n",
      "Question: Magnetic beads has been used in numerous applications. List some coatings used.\n",
      "Answer: coatings used. [SEP]\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: dnmt3\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: cbx3\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: dopamine and serotonin\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: t4 ( 3, 3 ', 5, 5'- tetraiodo - l - thyronine ), rt3 ( 3, 3 ', 5'- triiodo - l - thyronine )\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv - 1\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Matuzumab has been tested for treatment of which cancers?\n",
      "Answer: egfr - expressing advanced non - small cell lung cancer\n",
      "Question: List FDA approved treatments for androgenetic allopecia\n",
      "Answer: minoxidil and finasteride\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: [CLS] which are the atg8 homologs in human? [SEP]\n",
      "Question: The pathogen Fusarium graminearum affects what type of plant species?\n",
      "Answer: cereal\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which library is used for fixed-length approximate string matching?\n",
      "Answer: libflasm\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which syndromes are associated with heterochromia iridum?\n",
      "Answer: waardenburg syndrome\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv - 1\n",
      "Question: Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?\n",
      "Answer: p65 and p50\n",
      "Question: List scaffold proteins of the ERK signaling pathway.\n",
      "Answer: hdlg\n",
      "Question: What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome?\n",
      "Answer: overexpression\n",
      "Question: How is oprozomib administered?\n",
      "Answer: orally\n",
      "Question: Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?\n",
      "Answer: statins\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: \n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: cardiac troponin c - l29q\n",
      "Question: What are the indications for hydrochlorothiazide?\n",
      "Answer: \n",
      "Question: Which R package is used for visualization of linear and circular karyotypes?\n",
      "Answer: chromdraw\n",
      "Question: Which histone modifications are associated with Polycomb group (PcG) proteins?\n",
      "Answer: k27me3\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: warfarin\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which disease has been associated to a disruptive ALX1 protein?\n",
      "Answer: autosomal - recessive alx - related frontonasal dysplasia\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: several\n",
      "Question: What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?\n",
      "Answer: ret\n",
      "Question: List 3 indications for Bupropion\n",
      "Answer: aid to smoking cessation\n",
      "Question: What are the computational methods for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: tmbpro\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: facioscapulohumeral muscular dystrophy\n",
      "Question: Which are the common symptoms of Cushing's syndrome?\n",
      "Answer: weight gain, growth retardation, hirsutism, obesity, striae, acne and hypertension\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: \n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: List bacterial species identified in the iceman tissues.\n",
      "Answer: bacteria\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: mersacidin\n",
      "Question: Which protein is found to be mutated in Friedreich's ataxia?\n",
      "Answer: frataxin\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: DX-88 is investigational name of which drug?\n",
      "Answer: ecallantide\n",
      "Question: Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?\n",
      "Answer: chronic diarrhea and diffuse edema\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: swr1\n",
      "Question: List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.\n",
      "Answer: [CLS]\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: hypomyelination, hypodontia, hypogonadotropic hypogonadism\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: uhrf1\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: \n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: dkc1 ( x - linked ), terc and tinf2 ( autosomal dominant ), tert ( autosomal dominant or autosomal recessive ), ctc1, wrap53, nhp2, and nop10 ( autosomal recessive )\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: hypomyelination, hypogonadotropic hypogonadism, and hypodontia\n",
      "Question: List symptoms of EAST syndrome.\n",
      "Answer: epilepsy, ataxia, sensorineural deafness and tubulopathy\n",
      "Question: What is the triple screening test performed during pregnancy measuring?\n",
      "Answer: lpha - fetoprotein\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: csbb - coneexclusion\n",
      "Question: Which gene harbors the mutation T790M?\n",
      "Answer: exon 20\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: hypertrophic cardiomyopathy\n",
      "Question: List symptoms of EAST syndrome.\n",
      "Answer: epilepsy, ataxia, sensorineural deafness, and ( a renal salt - wasting ) tubulopathy\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: tyrosine kinase inhibitors\n",
      "Question: Which drugs may interfere thyroxine absorption?\n",
      "Answer: sevelamer hydrochloride or chromium picolinate\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: hypothyroidism\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: vemurafenib\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: ncx\n",
      "Question: Which gene strand is targeted by transcription-coupled repair (TCR)?\n",
      "Answer: transcribed strand\n",
      "Question: What molecule is targeted by Avelumab?\n",
      "Answer: pd - l1\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: abetah - j - j locus is a genomic sequence which generates three functionally distinct proteins, the enzyme aspartyl - beta - hydroxylase ( abetah ), the structural protein of sarcoplasmic reticulum junctin, and the membrane - bound calcium binding protein junctate\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: eaac1\n",
      "Question: Which are the major characteristics of cellular senescence?\n",
      "Answer: slower proliferation and altered morphology\n",
      "Question: Which gene is responsible for the development of Sotos syndrome?\n",
      "Answer: nsd1\n",
      "Question: Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?\n",
      "Answer: t68\n",
      "Question: What is the role of TAD protein domain?\n",
      "Answer: essential for retaining p53 in the cytoplasmic body\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: Which protein is found to be mutated in Friedreich's ataxia?\n",
      "Answer: frataxin\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: \n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin, calsequestrin\n",
      "Question: What histone variants play a role in the DNA damage reponse?\n",
      "Answer: h2a. x\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: yeast ortholog of gate - 16 is the autophagocytosis factor aut7p\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which are the different members/isoforms of the Ras oncogenes?\n",
      "Answer: h - ras, k - ras, and n - ras\n",
      "Question: Tumor-treating fields are effective for treatment of which cancers?\n",
      "Answer: recurrent glioblastoma\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: nox1 and nox4\n",
      "Question: List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?\n",
      "Answer: pser - xaa - xaa - ser\n",
      "Question: What imaging modalities have been listed as method of choice  to diagnose CSF leak?\n",
      "Answer: ctc\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gfralpha1\n",
      "Question: Which receptors are targeted by a drug Macitentan?\n",
      "Answer: endothelin\n",
      "Question: Which is the transcript responsible for X-chromosome inactivation?\n",
      "Answer: xist\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: stage iv metastatic melanoma\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: chronic rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus\n",
      "Question: Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?\n",
      "Answer: chaperone - mediated autophagy\n",
      "Question: Against which protein is the antibody used for immonostaining of Lewy bodies raised?\n",
      "Answer: alpha - synuclein\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: toxic epidermal necrolysis ( ten ) and stevens - johnson syndrome ( sjs )\n",
      "Question: Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: ino80 promotes homologous recombination. the mammalian ino80 remodelling complex facilitates homologous recombination ( hr ), but the mechanism by which it does this is unclear. budding yeast ino80\n",
      "Question: What are the main clinical characteristics of Pendred syndrome?\n",
      "Answer: congenital sensorineural deafness, goiter, and impaired iodide organification\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: [SEP]\n",
      "Question: What are the symptoms of abacavir hypersensitivity?\n",
      "Answer: fever, skin rash and gastrointestinal disorders\n",
      "Question: In which types of DNA repair is the UvrAB complex involved?\n",
      "Answer: transcription - coupled repair ( tcr ) is a subpathway of nucleotide excision repair\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: stevens - johnson syndrome and toxic epidermal necrolysis\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: intracisternal a - particle family\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: microdeletion\n",
      "Question: What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.\n",
      "Answer: cerebral hemiatrophy\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: To the ligand of which receptors does Denosumab (Prolia) bind?\n",
      "Answer: \n",
      "Question: List programs suitable for protein docking\n",
      "Answer: sol\n",
      "Question: Which genes are regulated by MEF-2 in the heart?\n",
      "Answer: ctnt\n",
      "Question: Which gene is involved in CADASIL?\n",
      "Answer: notch3\n",
      "Question: What is the structural fold of bromodomain proteins?\n",
      "Answer: alpha - helical\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: tumour - suppressor genes\n",
      "Question: In which genomic positions is the histone variant macroH2A enriched?\n",
      "Answer: inactive x chromosomes\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: \n",
      "Question: List the different subtypes of thyroid cancer.\n",
      "Answer: less differentiated ( and thus less iodine - avid and clinically more aggressive ) subtypes, such as tall cell variant and hurthle cell carcinoma, but in particular poorly differentiated and anaplastic carcinoma\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: enteroviruses ( ev ) and parechoviruses ( hpev )\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase ( th ), dopamine - beta - hydroxylase ( dbh ) and phenylethanolamine - n - methyltransferase ( pnmt )\n",
      "Question: Which syndrome is NHE6 associated with?\n",
      "Answer: christianson syndrome\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: fbn1\n",
      "Question: Which diseases that can be treated using the focused ultrasound thalamotomy.\n",
      "Answer: essential tremor\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: alirocumab ( praluent® ; sanofi / regeneron ) and evolocumab ( repatha® ; amgen )\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: Which kinase is inhibited by the small molecule KN-93?\n",
      "Answer: \n",
      "Question: List Hemolytic Uremic Syndrome Triad.\n",
      "Answer: renal failure, microangiopathic hemolytic anemia, and thrombocytopenia without a prodrome of hemorrhagic diarrhea\n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: alzheimer's disease\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: descendancy in myocardial infarction, ascendancy in stroke\n",
      "Question: Which proteins are the different isoforms of the p38 MAP kinase?\n",
      "Answer: p38α, p38β, p38γ, and p38δ\n",
      "Question: Abnormality in which vertebral region is important in the Bertolotti's syndrome?\n",
      "Answer: lumbosacral transitional\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: [CLS] list the human acrocentric chromosomes that are involved in robertsonian translocation. [SEP]\n",
      "Question: Matuzumab has been tested for treatment of which cancers?\n",
      "Answer: advanced gastric and esophagogastric adenocarcinomas\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban\n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: iron\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: lrsam1\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: dna - dependent rna polymerase ii\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: hypogonadotropic hypogonadism\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: neurofibromin\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: myh7 )\n",
      "Question: List Hemolytic Uremic Syndrome Triad.\n",
      "Answer: hemolytic uremic syndrome consists of a triad of acquired hemolytic anemia, thrombocytopenia and renal failure\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: pruritic skin lesions\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: 46, xy, del ( 1 ) ( q23q31. 2 )\n",
      "Question: Which are the inhibitors of histone methyltransferases?\n",
      "Answer: trichostatin a ( tsa ) and sodium butyrate ( nabt )\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acintobacter baumannii, pseudomonas aeruginosa and enterobacter spp.\n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: mg2 + - dependent dnase / phosphatase family\n",
      "Question: List scaffold proteins of the ERK signaling pathway.\n",
      "Answer: iqgap1\n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: iron\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban with warfarin\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone 0. 8 mg s. q. and naloxone 0. 4 mg i. v.\n",
      "Question: List variants of the MC1R gene.\n",
      "Answer: mc1r gene. [SEP] all of the investigated variants showed positive associations with nmsc, with consistent significant results obtained for v60l, d84e, v92m, r151c, r160w, r163q and d294h\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: [CLS]\n",
      "Question: Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?\n",
      "Answer: parathyroid glands, pancreatic islet cells, and anterior pituitary gland\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: [CLS] what is the typical rash associated with gluten? [SEP]\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: a8v and e134d\n",
      "Question: List selective estrogen receptor degraders.\n",
      "Answer: gdc - 0810\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: gli1, gli2 and gli3\n",
      "Question: What is the causative agent of the \"Panama disease\" affecting bananas?\n",
      "Answer: \n",
      "Question: How many tissue kallikrein genes are present in the human genome?\n",
      "Answer: 15\n",
      "Question: Which class of genes are mutated in Diamond Blackfan Anemia patients?\n",
      "Answer: ribosomal protein\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: Which disease of the central nervous system is characterized by the presence of Lewy bodies?\n",
      "Answer: parkinson's disease\n",
      "Question: List omics technologies comprised in system biology.\n",
      "Answer: \n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: episodic headache, excessive sweating and palpitation\n",
      "Question: Where do the Schwann cells and melanocytes originate from?\n",
      "Answer: multipotent neural crest cells\n",
      "Question: List metalloenzyme inhibitors.\n",
      "Answer: carbonic anhydrase\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which variables are included in the SPAN-100 score?\n",
      "Answer: age and nih stroke scale ( span ) index by combining age in years plus nih stroke scale\n",
      "Question: What chromosome is affected in Turner's syndrome?\n",
      "Answer: x\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: raptor and mlst8\n",
      "Question: Which drugs affect insulin resistance in obesity?\n",
      "Answer: estrogen\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: adamtsl4\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: \n",
      "Question: Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?\n",
      "Answer: ink4a / arf proteins\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: active helicobacter pylori infection\n",
      "Question: Which tool employs self organizing maps for analyzing synonymous codon usage?\n",
      "Answer: inca\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: pdt in the treatment of braf inhibitor - associated kas and sccs\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: vascular disorders other than acute myocardial infarction\n",
      "Question: Which diseases can Oncotype DX be used for?\n",
      "Answer: node - negative\n",
      "Question: List diseases that could be targeted by disaggregases?\n",
      "Answer: amyotrophic lateral sclerosis ( als ), parkinson's disease ( pd ), and alzheimer's disease ( ad )\n",
      "Question: Dracorhodin perchlorate was tested for treatment of which cancers?\n",
      "Answer: human prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of dp on human breast cancer\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: List symptoms of EAST syndrome.\n",
      "Answer: epilepsy, ataxia, sensorineural deafness and a renal tubulopathy\n",
      "Question: Which genome browser database for DNA shape annotations is available?\n",
      "Answer: gbshape\n",
      "Question: List peptide fragmentations methods in mass spectrometry\n",
      "Answer: \n",
      "Question: List programs suitable for protein docking\n",
      "Answer: [CLS]\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: Hy's law measures failure for what organ?\n",
      "Answer: liver\n",
      "Question: What is the color of the protein Ranasmurfin?\n",
      "Answer: blue\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?\n",
      "Answer: tofacitinib\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: toxic epidermal necrolysis and stevens - johnson syndrome\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: diaphoresis ( lr + 2. 2, lr - 0. 45 ), palpitation ( lr + 1. 9, lr - 0. 52 ) and headache ( lr + 1. 6, lr - 0. 24 )\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: miller - dieker syndrome\n",
      "Question: Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?\n",
      "Answer: human cytidine deaminases apobec3g ( a3g ) and apobec3f ( a3f )\n",
      "Question: Which genetic defects are observed in Prader-Willi syndrome?\n",
      "Answer: 15q11 - q13 deletions of paternal origin and maternal chromosome 15 uniparental disomy ( upd )\n",
      "Question: ROSIER scale is used for which disorder?\n",
      "Answer: acute stroke\n",
      "Question: Which are currently available software tools for detecting rare codon clusters in coding sequences?\n",
      "Answer: latcom\n",
      "Question: List clinical features of EEM syndrome.\n",
      "Answer: ectodermal dysplasia, ectrodactyly, and macular dystrophy\n",
      "Question: Which are the major transcription factors regulating glycolysis in mammals?\n",
      "Answer: c - myc\n",
      "Question: Which human genes are more commonly related to craniosynostosis?\n",
      "Answer: pro250arg\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: hypertrophic cardiomyopathy\n",
      "Question: Which proteins are involved in actin bundling and filopodia formation and function?\n",
      "Answer: actin - crosslinking proteins\n",
      "Question: List scaffold proteins of the ERK signaling pathway.\n",
      "Answer: ksr ( kinase suppressor of ras ), beta - arrestin, mek partner - 1, sef and iqgap1\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin and junctin\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: tomita scores more accurately predicted survival than tokuhashi scores\n",
      "Question: Which drugs may interfere thyroxine absorption?\n",
      "Answer: bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium - containing antacids, phosphate binders, raloxifene and proton - pump inhibitors\n",
      "Question: Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?\n",
      "Answer: p15 and p16\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: ndc1\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl fusion protein\n",
      "Question: Which proteins act as factors that promote transcription-coupled repair in bacteria?\n",
      "Answer: [CLS] which proteins act as factors that promote transcription - coupled repair in bacteria? [SEP]\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: shh / patched and pi3k\n",
      "Question: Which human genes are more commonly related to craniosynostosis?\n",
      "Answer: nell - 1\n",
      "Question: Which genes of the marmoset genome exhibit rapid sequence evolution?\n",
      "Answer: both protein - coding and microrna genes related to reproduction\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter in a child with moyamoya. a 7 - year - old white girl presented with left hemiparesis and ischemic stroke secondary to moyamoya syndrome, a progressive cerebrovascular occlusive disorder of uncertain but likely multifactorial etiology. past medical history revealed hearing loss and developmental delay / intellectual disability. routine karyotype demonstrated extra chromosomal material on 6p. single nucleotide polymorphism microarray revealed a previously unreported complex de novo genetic rearrangement involving subtelomeric segments on chromosomes 6p and 12q\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: headaches, sweating, palpitations\n",
      "Question: Which are the genes thought to be regulated by EWS/FLI?\n",
      "Answer: gstm4\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: e327k\n",
      "Question: List the main proteases used for sample digestion in proteomics.\n",
      "Answer: [CLS]\n",
      "Question: List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment.\n",
      "Answer: rationale, therapeutic potential and clinical experience\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: gdc - 0973\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: echo virus infections on one hand, and mumps\n",
      "Question: What are the computational methods for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: betaware\n",
      "Question: Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?\n",
      "Answer: extopodb\n",
      "Question: Which disorder is rated by Palmini classification?\n",
      "Answer: [CLS] which disorder is rated by palmini classification? [SEP] post - surgical outcome for epilepsy associated with type i focal cortical dysplasia subtypes. focal cortical dysplasias are a well - recognized cause of medically intractable seizures. the clinical relevance of certain subgroups of the international league against epilepsy ( ilae ) classification scheme remains to be determined. the aim of the present work is to assess the effect of the focal cortical dysplasia type ib and ic histologic subtypes on surgical outcome with respect to seizure frequency. this study also provides an opportunity to compare the predictive value of the ilae and palmini et al classification schemes with regard to the type i focal cortical dysplasias. we retrospectively reviewed 91 focal cortical dysplasia patients ( 55 % female ; median age : 19 years ( interquartile range 8 - 34 ) ; median seizure duration : 108 months ( interquartile range 36 - 204 ) ) with chronic epilepsy who underwent surgery. we compared the pathological subtypes, evaluating the patients'post - surgical outcome with respect to seizure frequency according to the engel's classification and the ilae outcome classification. both the ilae classification scheme and palmini et al classification scheme were utilized to classify the histologic subtype. using χ ( 2 ) and fisher's exact tests, we compared the post - surgical outcomes among these groups. of the 91 patients, there were 50 patients with ilae focal cortical dysplasia type ib, 41 with ilae focal cortical dysplasia type ic, 63 with palmini et al focal cortical dysplasia type ia, and 28 with palmini et al focal cortical dysplasia type ib\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: bwa - mt\n",
      "Question: Which is the most common editing modification in eukaryotic mRNA?\n",
      "Answer: a - to - i\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: rassf1a, hic1 and casp8\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: the most severe form, which includes epilepsy and developmental delay, is called developmental delay, epilepsy, and neonatal diabetes\n",
      "Question: What tissue is most affected in Ehlers-Danlos syndromes?\n",
      "Answer: connective tissue\n",
      "Question: What is the mode of inheritance of Wilson's disease?\n",
      "Answer: autosomal recessive\n",
      "Question: Which disorder is rated by Palmini classification?\n",
      "Answer: \n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: dna - dependent rna polymerase ii\n",
      "Question: What are clinical features of the de Morsier syndrome?\n",
      "Answer: midline brain abnormalities, optic nerve hypoplasia and pituitary endocrine dysfunction\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: epirubicin 75 mg / m2 plus cyclophosphamide 500 mg / m2\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: tomita scoring system\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: x\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: dabrafenib\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban when compared with warfarin\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: [CLS]\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: ly191145\n",
      "Question: List the endoscopic diagnoses that have been reported in children with autism\n",
      "Answer: chronic diarrhea, gaseousness, and abdominal discomfort and distension\n",
      "Question: List available methods for transmembrane protein topology prediction.\n",
      "Answer: [CLS] list available methods for transmembrane protein topology prediction. [SEP]\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: List symptoms of EAST syndrome.\n",
      "Answer: epilepsy, ataxia, sensorineural deafness, and tubulopathy\n",
      "Question: Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?\n",
      "Answer: extopodb\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 146a, mir - 155 and mir - 223\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: chromosome 9\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: dopamine and serotonin\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: scgpred\n",
      "Question: RTS S AS01 vaccine was developed to prevent which disease?\n",
      "Answer: malaria\n",
      "Question: List selective estrogen receptor degraders.\n",
      "Answer: [CLS]\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: central venous catheter ( cvc ) occlusions\n",
      "Question: Which multiple kinase inhibitors are used in cancer therapy?\n",
      "Answer: zd6474, su11248, aee 788, sorafenib, vatalanib, and ag - 013736\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: hrv - a to hrv - c\n",
      "Question: Which are the clinical characteristics of Diamond-Blackfan anemia?\n",
      "Answer: red cell aplasia, congenital anomalies, and a predisposition to cancer\n",
      "Question: The protein NONO forms heterodimers. With which proteins?\n",
      "Answer: sfpq ( psf ) and nono ( p54 ) are nuclear proteins that interact with each other and have diverse roles in nucleic acids metabolism. the sfpq\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25 - ter\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: List human proteins that are subject to a dimer-to-tetramer transition.\n",
      "Answer: human orai1 and orai3 channels\n",
      "Question: Which gene harbors the mutation T790M?\n",
      "Answer: egfr\n",
      "Question: Which receptors are bound by Tasimelteon?\n",
      "Answer: melatonin mt1 and mt2\n",
      "Question: Which protein mediates gene loop formation in the yeast S. cerevisiae?\n",
      "Answer: transcription factor iib\n",
      "Question: List cardinal features of the Triple A syndrome.\n",
      "Answer: adrenal insufficiency and alacrima\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: unresponsive to sulfonylureas\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: [CLS] which are the different proteins / isoforms encoded but the asph ( aspartate beta - hydroxylase ) gene in humans? [SEP]\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: \n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: x - linked dominant\n",
      "Question: List the main proteases used for sample digestion in proteomics.\n",
      "Answer: trypsin, chymotrypsin, asp - n, or trypsin plus asp - n\n",
      "Question: Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?\n",
      "Answer: p16ink4\n",
      "Question: Which drug is benserazide usually co-administered with?\n",
      "Answer: l - dopa\n",
      "Question: Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"\n",
      "Answer: delta - distance\n",
      "Question: Which cellular processes are regulated by Nanog?\n",
      "Answer: proliferation, differentiation, motility, and invasion\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: dopamine, serotonin and norepinephrine\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS] how many tap73 isoforms have been identified in humans? [SEP]\n",
      "Question: Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?\n",
      "Answer: pyridostigmine\n",
      "Question: Which proteins participate in the formation of the Notch transcriptional activation complex?\n",
      "Answer: csl and a transcriptional co - activator of the mastermind family ( maml )\n",
      "Question: List two common features of Tay syndrome.\n",
      "Answer: pibids syndrome\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: gdap1 q218e\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: nelf ( negative elongation factor ) and dsif ( drb sensitivity - inducing factor )\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: [CLS] list kartagener syndrome triad. [SEP]\n",
      "Question: Which gene strand is targeted by transcription-coupled repair (TCR)?\n",
      "Answer: transcribed strand of active structural genes\n",
      "Question: Name five popular  computer  programs used to identify genes in genomic sequences\n",
      "Answer: genscan and hmmgene\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: What are the symptoms of Rotor syndrome?\n",
      "Answer: chronic fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia with normal hepatic histology\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: 5 - ht2a\n",
      "Question: Which gene is associated with the Mitchell-Riley syndrome?\n",
      "Answer: rfx6\n",
      "Question: Which are the main NMD factors in Saccharomyces cerevisiae?\n",
      "Answer: upf1p, upf2p, and upf3p\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: mutations in the parkin gene, in dj - 1 and pink1\n",
      "Question: Which domain allowing self-association do exist in TDP-43 and FUS proteins?\n",
      "Answer: prion - like domains\n",
      "Question: Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome?\n",
      "Answer: mct8\n",
      "Question: Which methyl-CpG-binding protein when mutant becomes the hallmark for Rett syndrome?\n",
      "Answer: incessant hand movements\n",
      "Question: Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins.\n",
      "Answer: proteomic analyses have revealed proteins associated with the triple - negative breast cancers. list some proposed proteins. [SEP]\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: \n",
      "Question: List tele monitoring applications of miniaturised sensors\n",
      "Answer: mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes : a pilot study\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: [CLS]\n",
      "Question: Where is the histone variant CENPA preferentially localized?\n",
      "Answer: centromeric region of eukaryotic chromosomes\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: \n",
      "Question: List human diseases involving genomic imprinting.\n",
      "Answer: beckwith - wiedemann syndrome ( bws ), prader - willi syndrome ( pws ), angelman syndrome and hydatidiform mole\n",
      "Question: Which is the molecular target of the immunosuppressant drug Rapamycin?\n",
      "Answer: mtor\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: tap63\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: mersacidin\n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: l - smm or ( s, s ) - adomet\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which is the most widely used model for the study of multiple sclerosis (MS)?\n",
      "Answer: experimental autoimmune encephalomyelitis ( eae ) in the rat\n",
      "Question: Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?\n",
      "Answer: parathyroid, pancreatic islets and anterior pituitary glands\n",
      "Question: Where do the Schwann cells and melanocytes originate from?\n",
      "Answer: [CLS]\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: smar1\n",
      "Question: ROSIER scale is used for which disorder?\n",
      "Answer: [CLS] rosier scale is used for which disorder? [SEP] the recognition of stroke in the emergency room ( rosier ) scale : development and validation of a stroke recognition instrument. background : in patients with acute stroke\n",
      "Question: Which is the human selenoprotein that contains several Se-Cys residues?\n",
      "Answer: selenoprotein p\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: epirubicin 75 mg / m2 plus cyclophosphamide 500 mg / m2\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: lung cancer and cervical cancer\n",
      "Question: The antibodies MK-3475 and CT-011 have shown promising results in treating malignancies. Which protein are they targeting?\n",
      "Answer: [CLS]\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: mammalian egfr ligands\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: bone collagen\n",
      "Question: List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.\n",
      "Answer: [CLS]\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: ophthalmoplegia, ataxia and confusion\n",
      "Question: List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).\n",
      "Answer: microangiopathic hemolytic anemia with thrombocytopenia, neurologic symptoms and renal disease\n",
      "Question: Which genes does thyroid hormone receptor beta1 regulate in the heart?\n",
      "Answer: alpha - and beta - myosin heavy chain ( myhc ) and sarcoplasmic reticulum ca ( 2 + ) - atpase ( serca )\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase ( tyr ) gene deduced protein. a feral donkey population ( equus asinus ), living in the asinara national park ( an island north - west of sardinia, italy ), includes a unique white albino donkey subpopulation or colour morph that is a major attraction of this park. disrupting mutations in the tyrosinase\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: dopamine, norepinephrine and serotonin\n",
      "Question: What are the symptoms of Rotor syndrome?\n",
      "Answer: conjugated hyperbilirubinemia, coproporphyrinuria, and near - absent hepatic uptake of anionic diagnostics\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: xk\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism\n",
      "Question: What is the definitive treatment for low pressure headache?\n",
      "Answer: analgesia, caffeine, and fluids\n",
      "Question: Which syndromes are associated with mutations in the EZH2 gene?\n",
      "Answer: \n",
      "Question: List programs suitable for protein docking\n",
      "Answer: haddock\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: bwa - mt\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: rapamycin inhibitor everolimus\n",
      "Question: List omics technologies comprised in system biology.\n",
      "Answer: the resulting lists of metabolites and their steady state concentrations in combination with transcriptomics can be used in system biology approaches\n",
      "Question: Which are the common symptoms of Cushing's syndrome?\n",
      "Answer: weight gain, hirsutism, acne, secondary amenorrhea and facial lentiginosis\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: modified tokuhashi score was the highest among all four scoring systems\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: [CLS] which deep learning - based algorithms are used for enhancer prediction? [SEP]\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: open - access database of annotated, high - quality, matrix - based transcription factor binding site profiles for multicellular eukaryotes\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: bacitracin and vancomycin\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: intractable epilepsy\n",
      "Question: Which diseases that can be treated using the focused ultrasound thalamotomy.\n",
      "Answer: essential tremor\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: modified tomita and tokuhashi scoring systems\n",
      "Question: What is being measured with an accelerometer in back pain patients\n",
      "Answer: activity levels\n",
      "Question: Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?\n",
      "Answer: chaperone - mediated autophagy\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: trβ - selective gc - 24 and the trα - selective co23\n",
      "Question: Where is the TAZ (G4.5) is located in humans?\n",
      "Answer: xq28\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: elevated tsh serum values ( 37. 9 % in our sample ) and thyroid gland hypoplasia\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: [CLS] list the human acrocentric chromosomes that are involved in robertsonian translocation. [SEP]\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS] how many tap73 isoforms have been identified in humans? [SEP]\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin and junctin\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: tomita and tokuhashi scores\n",
      "Question: What are the symptoms of abacavir hypersensitivity?\n",
      "Answer: rash, fever and, occasionally, multisystemic involvement\n",
      "Question: Tumor-treating fields are effective for treatment of which cancers?\n",
      "Answer: \n",
      "Question: Which is the process that Conserved noncoding elements mostly regulate?\n",
      "Answer: development\n",
      "Question: What is the triple screening test performed during pregnancy measuring?\n",
      "Answer: false positive results\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: selective serotonin reuptake inhibitors\n",
      "Question: Which are the smallest known subviral pathogens of plants?\n",
      "Answer: viroids\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: pentasomy 49, xxxxy\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: [CLS] list algorithms suitable for predicting protein complexes [SEP]\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: autodock vina\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: park7\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 8q23\n",
      "Question: Which currently known mitochondrial diseases have been attributed to POLG mutations?\n",
      "Answer: childhood myocerebrohepatopathy spectrum disorders ( mchs ), 2 ) alpers syndrome, 3 ) ataxia neuropathy spectrum ( ans ) disorders\n",
      "Question: Is Rheumatoid Arthritis more common in men or women?\n",
      "Answer: men\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: \n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndrome\n",
      "Question: Which are the cellular targets of imatinib mesylate?\n",
      "Answer: abl, platelet - derived growth factor receptor ( pdgfr ), and c - kit kinases\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: childhood spinal muscular atrophy\n",
      "Question: List disorders that have been associated to the polymorphism rs2535629.\n",
      "Answer: schizophrenia and major depressive disorder ( mdd ) in japanese subjects\n",
      "Question: Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?\n",
      "Answer: p15ink4b and p16ink4a\n",
      "Question: Which protein phosphatase has been found to interact with the heat shock protein, HSP20?\n",
      "Answer: pp1\n",
      "Question: Which genome browser database for DNA shape annotations is available?\n",
      "Answer: gbshape\n",
      "Question: What is the role of TAD protein domain?\n",
      "Answer: essential for retaining p53 in the cytoplasmic body\n",
      "Question: Which proteins participate in the formation of the Notch transcriptional activation complex?\n",
      "Answer: notch and suppressor of hairless\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: chronic sinusitis, bronchiectasis and situs inversus with dextrocardia\n",
      "Question: Which is the major RNA editing enzyme in Drosophila melanogaster?\n",
      "Answer: adar\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: tgmyst - a and - b\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: stevens - johnson syndrome ( sjs ), toxic epidermal necrolysis ( ten ), and drug reaction with eosinophilia and systemic symptoms\n",
      "Question: Which is the branch site consensus sequence in U12-dependent introns?\n",
      "Answer: uuccuuaac\n",
      "Question: Which disorder is rated by Palmini classification?\n",
      "Answer: \n",
      "Question: Where do the Schwann cells and melanocytes originate from?\n",
      "Answer: neural tube\n",
      "Question: Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?\n",
      "Answer: tofacitinib\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38 + hl60\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: noxa1\n",
      "Question: List the human genes encoding for the dishevelled proteins?\n",
      "Answer: mouse dishevelled - 1 ( dvl - 1 ) and dishevelled - 2 genes\n",
      "Question: Which tool is used for promoterome mining using CAGE data?\n",
      "Answer: cager\n",
      "Question: Which is the most common editing modification in eukaryotic mRNA?\n",
      "Answer: [CLS] which is the most common editing modification in eukaryotic mrna? [SEP]\n",
      "Question: List fluorescent reporter proteins.\n",
      "Answer: beta - phycoerythrin\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: adamtsl4 and fbn1\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: In which kingdom do microsporidia belong, according to their current classification scheme?\n",
      "Answer: fungal\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: familial trichoepithelioma ( mft ) and familial cylindromatosis\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: dopamine, 5 - hydroxytryptamine ( 5 - ht, serotonin ), and norepinephrine\n",
      "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
      "Answer: maternal nanog, pou5f1 and soxb1\n",
      "Question: Which post-translational histone modifications are characteristic of constitutive heterochromatin?\n",
      "Answer: h4k20me3, h3k9me3, and h3k79me3\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: developmental delay, epilepsy, and neonatal diabetes ( dend ) syndrome\n",
      "Question: How early during pregnancy does non-invasive cffDNA testing allow sex determination of the fetus?\n",
      "Answer: first trimester\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which heat shock protein is found to be upregulated during Hsp90 inhibition?\n",
      "Answer: hsp70\n",
      "Question: List the three most abundant bacterial phyla present in mouse feces.\n",
      "Answer: bacteroidetes and proteobacteria\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: classic triad of wernicke & apos ; s encephalopathy with ocular symptoms, ataxia and confusion\n",
      "Question: Which cell types are known to be driving Rheumatoid Arthritis?\n",
      "Answer: synovial fibroblasts\n",
      "Question: List angiocrine factors\n",
      "Answer: ccl4 and neurotensin ( nts )\n",
      "Question: List symptoms of Gradenigo's syndrome.\n",
      "Answer: suppurative otitis media, abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve\n",
      "Question: Which gene is involved in Giant Axonal Neuropathy?\n",
      "Answer: \n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 146a, mirna - 155, mirna - 124a, mir - 203, mir - 223, mir - 346, mir - 132, mir - 363, mir - 498, mir - 15a, and mir - 16\n",
      "Question: Which are the synonyms of prostate-specific antigen?\n",
      "Answer: psa\n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: dkc1, terc, tert, nop10, nhp2, and tcab1\n",
      "Question: Which kinase is inhibited by the small molecule KN-93?\n",
      "Answer: \n",
      "Question: Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?\n",
      "Answer: single - cell gel electrophoresis, or the comet assay\n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: same\n",
      "Question: Which domain allowing self-association do exist in TDP-43 and FUS proteins?\n",
      "Answer: prion - like domain\n",
      "Question: What organism causes tularemia?\n",
      "Answer: francisella tularensis\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndrome\n",
      "Question: Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?\n",
      "Answer: entacapone ( or - 611 )\n",
      "Question: In which yeast chromosome does the rDNA cluster reside?\n",
      "Answer: xii\n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: ccr4 family\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: t1r1 and t1r3 ( taste receptor 1, subtypes 1 and 3 ), mglurs ( metabotropic glutamate receptors ), eaac - 1 ( excitatory amino acid carrier - 1 ), glast - 1 ( glutamate - aspartate transporter - 1 ), and glt - 1 ( glutamate transporter - 1 )\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: cardiac troponin c - l29q\n",
      "Question: What are the reported adverse effects of gabapentin used in children?\n",
      "Answer: hyperactivity, irritability, and agitation\n",
      "Question: List Hemolytic Uremic Syndrome Triad.\n",
      "Answer: hemolytic uremic syndrome ( hus ) consists ofa triad of acquired hemolytic anemia, thrombocytopenia, and renal failure\n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: calcitonin\n",
      "Question: Magnetic beads has been used in numerous applications. List some coatings used.\n",
      "Answer: [SEP]\n",
      "Question: List diseases where protein citrullination plays an important role.\n",
      "Answer: tolerance break\n",
      "Question: What is the indication for isradipine?\n",
      "Answer: antihypertensive\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which genes does thyroid hormone receptor beta1 regulate in the heart?\n",
      "Answer: hcn4\n",
      "Question: What are clinical features of the de Morsier syndrome?\n",
      "Answer: optic nerve hypoplasia, absence of the septum pellucidum and hypothalamo - pituitary abnormalities\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: stevens - johnson syndrome ( sjs ), toxic epidermal necrolysis ( ten ), and drug reaction with eosinophilia and systemic symptoms ( dress )\n",
      "Question: What are the computational methods for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: betaware\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: west nile virus and other arthropod - transmitted viruses\n",
      "Question: What is plantar fasciitis\n",
      "Answer: sonographic characteristics of plantar fasciitis include pf thickening, loss of fibrillar structure, perifascial collections, calcifications and hyperaemia on doppler imaging\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3, 6, 8, 12, and 17\n",
      "Question: Which genes are associated with Ehlers-Danlos syndrome type I/II?\n",
      "Answer: col5a1 and the col5a2\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53 gene\n",
      "Question: List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?\n",
      "Answer: [CLS]\n",
      "Question: What hand deformities do patients with Apert syndrome present with?\n",
      "Answer: a short thumb with radial clinodactyly, complex syndactyly with a bony fusion involving the index, long and ring fingers, symphalangism and simple syndactyly of the fourth web space\n",
      "Question: Which enzyme is targeted by Evolocumab?\n",
      "Answer: proprotein convertase subtilisin / kexin type 9\n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: s - adenosylmethionine\n",
      "Question: Which proteins act as histone-like molecules in prokaryotes?\n",
      "Answer: hu and ihf\n",
      "Question: Which R package is used for visualization of linear and circular karyotypes?\n",
      "Answer: chromdraw\n",
      "Question: Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?\n",
      "Answer: convulsion and fatigue\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: ras / braf\n",
      "Question: For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?\n",
      "Answer: friedreich's ataxia ( frda ) and huntington's disease ( hd )\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: geneseqer and splicepredictor\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: missense mutation, pe96k, in the cardiac troponin t gene\n",
      "Question: Name five programs for transcript quantification from RNASeq experiments\n",
      "Answer: cufflinks\n",
      "Question: What is the inheritance pattern of Emery-Dreifuss muscular dystrophy? \n",
      "Answer: autosomal recessive\n",
      "Question: Which proteins form part of the NRD complex in S. cerevisiae?\n",
      "Answer: hdac1, mta1, and mta2\n",
      "Question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.\n",
      "Answer: \n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: y chromosome\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: [CLS]\n",
      "Question: Which polymerase transcribes pri-miRNAs?\n",
      "Answer: rna polymerase ii\n",
      "Question: What is the cause of Tardive dyskinesia?\n",
      "Answer: chronic therapy with classical antipsychotic medications\n",
      "Question: Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?\n",
      "Answer: cp - 690, 550 ( tofacitinib\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: ep - dnn\n",
      "Question: Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?\n",
      "Answer: antiparallel\n",
      "Question: Which treatment methods were compared in the EXCEL Trial?\n",
      "Answer: evaluation of xience everolimus eluting stent versus coronary artery bypass surgery\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: Which are the most widely reported side-effects in the treatment of Crohn's disease?\n",
      "Answer: [CLS] which are the most widely reported side - effects in the treatment of crohn's disease? [SEP]\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: \n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 223, mir - 146a and mir - 155\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: junctate is a newly identified integral er / sr membrane calcium binding protein, which is an alternative splicing form of the same gene generating aspartyl beta - hydroxylase and junctin\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: junctin, calsequestrin, triadin\n",
      "Question: Which class of genes are mutated in Diamond Blackfan Anemia patients?\n",
      "Answer: ribosomal protein encoding genes\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: [CLS]\n",
      "Question: What genes are related to breast cancer?\n",
      "Answer: p53 and brca1\n",
      "Question: List FDA approved treatments for androgenetic allopecia\n",
      "Answer: finasteride\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which syndromes are associated with heterochromia iridum?\n",
      "Answer: waardenburg syndrome\n",
      "Question: Which mutations of phopspholamban have been found in patients with cardiomyopathy?\n",
      "Answer: dominant arg - - > cys missense\n",
      "Question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.\n",
      "Answer: \n",
      "Question: What are the known families of deadenylases?\n",
      "Answer: ccr4 - like family of proteins constitute a novel class of rna - dna exonucleases\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: facial paralysis, facial oedema, and lingua plicata\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria\n",
      "Question: Which diseases can Oncotype DX be used for?\n",
      "Answer: breast cancer\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: varicella and uvb\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase ( th ), aromatic l - amino acid decarboxylase ( aaad ), dopamine - β - hydroxylase ( dbh ) and phenylethanolamine n - methyltransferase ( pnmt )\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: vkorc1 and cyp2c9\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38 + multiple myeloma cells\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: murine chd1 ( chromodomain helicase dna - binding protein 1\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: congenital bone marrow failure ( cbmf ) disorders\n",
      "Question: Dracorhodin perchlorate was tested for treatment of which cancers?\n",
      "Answer: [CLS]\n",
      "Question: How many tissue kallikrein genes are present in the human genome?\n",
      "Answer: hk1 - hk15\n",
      "Question: Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?\n",
      "Answer: medial forebrain bundle, habenula\n",
      "Question: List invertebrates where ultraconserved elements have been identified.\n",
      "Answer: diptera\n",
      "Question: Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?\n",
      "Answer: piggybac\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid function\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: [CLS] which are the known human transmembrane nucleoporins? [SEP]\n",
      "Question: Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?\n",
      "Answer: e - cadherin\n",
      "Question: What condition is usually represented by the acronym SUDEP?\n",
      "Answer: sudden unexpected death in epilepsy\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia\n",
      "Answer: sf3b1, zmym3, mapk1, fbxw7, and ddx3x ). sf3b1, which functions at the catalytic core of the spliceosome, was the second most frequently mutated gene\n",
      "Question: List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.\n",
      "Answer: crs type 1 = acute worsening of heart function leading to kidney injury and / or dysfunction ; crs type 2 = chronic abnormalities in heart function leading to kidney injury or dysfunction ; crs type 3 = acute worsening of kidney function leading to heart injury and / or dysfunction ; crs type 4 = chronic kidney disease leading to heart injury, disease and / or dysfunction, and crs type 5\n",
      "Question: Mutation of which gene is implicated in the Christianson syndrome?\n",
      "Answer: slc9a6\n",
      "Question: Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?\n",
      "Answer: frontometaphyseal dysplasia\n",
      "Question: List bacterial species identified in the iceman tissues.\n",
      "Answer: bacteria\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: glycoprotein gp210\n",
      "Question: List genes associated with hypolipidemia.\n",
      "Answer: angptl3 gene cause familial combined hypolipidemia\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent\n",
      "Question: Which type of GTPases is required for amino acid-dependent activation of mTORC1?\n",
      "Answer: heterodimeric rag gtpases\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: hp1 and polycomb proteins\n",
      "Question: Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?\n",
      "Answer: d22s1 and d22s15\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: chromosomes 10 ( acta2 ) and 17\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: Which disorder is rated by Palmini classification?\n",
      "Answer: \n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 155 and mir - 146a\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: trancription database and analysis tools\n",
      "Question: List symptoms of congenital toxoplasmosis triad.\n",
      "Answer: hydrocephalus, cerebral calcification and chorioretinitis\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which cell types are known to be driving Rheumatoid Arthritis?\n",
      "Answer: synovial fibroblasts\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: \n",
      "Question: What hand deformities do patients with Apert syndrome present with?\n",
      "Answer: a short thumb with radial clinodactyly, complex syndactyly with a bony fusion involving the index, long and ring fingers, symphalangism and simple syndactyly of the fourth web space\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kcnq1 ( kv7. 1 )\n",
      "Question: List diseases associated with the  Dopamine Receptor D4 (DRD4).\n",
      "Answer: neuropsychiatric diseases\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: crebbp, myt1l, nfia, nfib, tead1 and tgif2\n",
      "Question: Please list the 3 findings in HELLP syndrome.\n",
      "Answer: hemolysis, elevated liver enzymes, low platelets\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: \n",
      "Question: List the releases of JASPAR database\n",
      "Answer: \n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: striae distensae and striae gravidarum\n",
      "Question: What are the symptoms of Rotor syndrome?\n",
      "Answer: conjugated hyperbilirubinemia, coproporphyrinuria, and near - absent hepatic uptake of anionic diagnostics\n",
      "Question: What is being measured with an accelerometer in back pain patients\n",
      "Answer: activity levels\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: epilepsy and developmental delay\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: \n",
      "Question: Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?\n",
      "Answer: [CLS] which are the major intramolecular phosphorylation sites of human chk2 involved in cell cycle control? [SEP] despite distinct time - dependent autophosphorylation kinetics by monitoring the phosphorylation of amino acid residues t68, s19, s33 / 35, t432, in chk2 wildtype and chk2 mutants ( t68a, t68d and q69e ) they gave identical specific activities. however, upon gel filtration of chk2 wildtype and the mutants, only chk2 wildtype and the t68d mutant led to the formation of a'pure'dimer ; dephosphorylated wildtype chk2 eluted as a monomer. transfection of hek293 cells with chk2 wildtype and chk2 mutants in the absence or presence of dna damage showed significant t68 phosphorylation already in the absence of dna damaging reagents. upon dna damage, phosphorylation of additional chk2 sites was observed ( s19, s33 / 35\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: nuclear factor - kappa b ( nfκb ) signaling cascade\n",
      "Question: Which is the gene most commonly mutated in Tay-Sachs disease?\n",
      "Answer: hexa\n",
      "Question: Which syndrome is associated with OATP1B1 and OATP1B3 deficiency?\n",
      "Answer: human rotor syndrome\n",
      "Question: How early during pregnancy does non-invasive cffDNA testing allow sex determination of the fetus?\n",
      "Answer: first trimester\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: mammalian\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: scratching, surgical scars, radiotherapy, burns, irritation from drug use and laser therapy\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: sodium - calcium exchanger\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: [SEP]\n",
      "Question: Where is base J found in the genome of Leishmania tarentolae?\n",
      "Answer: in telomeric repeats\n",
      "Question: List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.\n",
      "Answer: \n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: \n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: \n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: \n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: gait ataxia, ophthalmoplegia, and confusion\n",
      "Question: Which species may be used for the biotechnological production of itaconic acid?\n",
      "Answer: aspergillus terreus\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: What tissue is most affected in Ehlers-Danlos syndromes?\n",
      "Answer: skin\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: \n",
      "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
      "Answer: nanog, pou5f1 and soxb1\n",
      "Question: Orteronel was developed for treatment of which cancer?\n",
      "Answer: prostate cancer\n",
      "Question: Which enzyme is inhibited by Orteronel?\n",
      "Answer: cyp17a1\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella species, acinetobacter baumannii, pseudomonas aeruginosa, and enterobacter species\n",
      "Question: List protein gel staining methods visualizing the entire protein set.\n",
      "Answer: quantitative proteome analyses suggest that the well - established stain colloidal coomassie blue, when used as an infrared dye, may provide sensitive, post - electrophoretic in - gel protein detection\n",
      "Question: Which genes are associated with Ehlers-Danlos syndrome type I/II?\n",
      "Answer: col5a1\n",
      "Question: List scaffold proteins of the ERK signaling pathway.\n",
      "Answer: kinase suppressor of ras ( ksr )\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: neurofibromin\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: the plasma membrane na ( + ) / ca ( 2 + ) exchanger\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS] how many tap73 isoforms have been identified in humans? [SEP]\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: Which enzyme is inhibited by Orteronel?\n",
      "Answer: 17, 20 - lyase\n",
      "Question: Which mutated genes are associated with the Tourette's syndrome?\n",
      "Answer: hdc\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: 5q - syndrome\n",
      "Question: Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins.\n",
      "Answer: [CLS]\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: rls / wed\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: List programs suitable for pharmacophore modelling\n",
      "Answer: discovery studio\n",
      "Question: List FDA approved treatments for androgenetic allopecia\n",
      "Answer: topical minoxidil 2 % - 5 % 1 ml twice daily or finasteride 1 mg daily are recommended as first line treatments\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: hdac2\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: otx2\n",
      "Question: Which histone modification discriminates between active and poised enhancers?\n",
      "Answer: h3k27ac\n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: dnmt3 family\n",
      "Question: Which are the smallest known subviral pathogens of plants?\n",
      "Answer: viroids\n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: List available methods for transmembrane protein topology prediction.\n",
      "Answer: metatm\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: severe retardation of growth and psychomotor development, chill - like seizures, bronchial asthma, urticaria, a proneness to skin infections and transient nail dystrophy\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: ptch1, sufu\n",
      "Question: List scaffold proteins of the ERK signaling pathway.\n",
      "Answer: kinase suppressor of ras\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: rassf1a, hic1 and casp8\n",
      "Question: What is the inheritance pattern of Apert syndrome?\n",
      "Answer: autosomal dominant\n",
      "Question: List core circadian clock genes.\n",
      "Answer: clock, bmal1, and cklε\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter in a child with moyamoya. a 7 - year - old white girl presented with left hemiparesis and ischemic stroke secondary to moyamoya syndrome, a progressive cerebrovascular occlusive disorder of uncertain but likely multifactorial etiology. past medical history revealed hearing loss and developmental delay / intellectual disability. routine karyotype demonstrated extra chromosomal material on 6p. single nucleotide polymorphism microarray revealed a previously unreported complex de novo genetic rearrangement involving subtelomeric segments on chromosomes 6p and 12q\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl35a, rpl5, rpl11, rps7, rps10, rps26, and rpl26 and gata1\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: confusion, oculomotor disturbance and ataxia\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: List human proteins that are subject to a dimer-to-tetramer transition.\n",
      "Answer: shmt2\n",
      "Question: List the three main structures of the cytoskeleton.\n",
      "Answer: actin filaments, microtubules, and intermediate filaments\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: List non-surgical treatment modalities that are included in the Stupp protocol.\n",
      "Answer: surgical resection, radiotherapy, and chemotherapy\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: List functional roles of the FtsZ protein.\n",
      "Answer: cell elongation, gtpase, cell division, and bacterial cytoskeleton\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: tdp - 43\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: melanoma or angiosarcoma\n",
      "Question: Please list 3 diseases associated with the PIEZO2 gene.\n",
      "Answer: two distinct piezo2 mutations in patients with a subtype of distal arthrogryposis type 5 characterized by generalized autosomal dominant contractures with limited eye movements, restrictive lung disease, and variable absence of cruciate knee ligaments\n",
      "Question: What is the mode of inheritance of Acromicric dysplasia?\n",
      "Answer: autosomal dominant\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.\n",
      "Answer: bapineuzumab\n",
      "Question: Is the transcriptional regulator BACH1 an activator or a repressor?\n",
      "Answer: repressor\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which protein does empagliflozin inhibit?\n",
      "Answer: sodium glucose cotransporter 2\n",
      "Question: Which are the clinical characteristics of Diamond-Blackfan anemia?\n",
      "Answer: red cell aplasia, congenital anomalies, and a predisposition to cancer\n",
      "Question: Symptoms of which disorder are evaluated with the Davidson Trauma Scale?\n",
      "Answer: ptsd\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban\n",
      "Question: What are the major classes of retrotransposons active in the human genome?\n",
      "Answer: long and short interspersed elements\n",
      "Question: List the main proteases used for sample digestion in proteomics.\n",
      "Answer: chymotrypsin, single or in combination with trypsin\n",
      "Question: Which proteins act as histone-like molecules in prokaryotes?\n",
      "Answer: hu\n",
      "Question: Which server is used for simulation of macromolecular diffusional association?\n",
      "Answer: websda\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 146a, mir - 155 and mir - 223\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline and topiramate\n",
      "Question: Please list the 3 findings in HELLP syndrome.\n",
      "Answer: . hellp syndrome is a collection of symptoms described as hemolysis, elevated liver enzymes and low platelets\n",
      "Question: What is the main component of the Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: List Hemolytic Uremic Syndrome Triad.\n",
      "Answer: hemolytic uremic syndrome ( hus ) consists ofa triad of acquired hemolytic anemia, thrombocytopenia, and renal failure\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: What chromosome is affected in Turner's syndrome?\n",
      "Answer: 45, x\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: il - 1β\n",
      "Question: What is the cause of Phthiriasis Palpebrarum?\n",
      "Answer: louse pthirus pubis\n",
      "Question: What is the incidence of cystic fibrosis in the caucasian population?\n",
      "Answer: 4 times more to 40 times less common than the generally accepted figure of 1 : 2000\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: mtor, raptor, mlst8 / gbetal and pras40\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: xq28\n",
      "Question: Which protein complexes contain mitofilin?\n",
      "Answer: mitofilin, minos1, and chchd3\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which proteins participate in the formation of the Notch transcriptional activation complex?\n",
      "Answer: mastermind - like transcriptional co - activators\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: mrc1 and ctf4\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which proteins cause cytoplasmic sequestration of NF-kB?\n",
      "Answer: inhibitory, iκb proteins\n",
      "Question: Borden classification is used for which disease?\n",
      "Answer: davf\n",
      "Question: Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?\n",
      "Answer: phospholamban\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: \n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: Which library is used for fixed-length approximate string matching?\n",
      "Answer: libflasm\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: d145e drastically alters calcium binding by the c - domain of cardiac troponin c. the role of the c - domain sites of cardiac troponin c in the modulation of the calcium signal remains unclear. in this study, we investigated the effects of hypertrophic cardiomyopathy - linked mutations a8v, e134d, and d145e\n",
      "Question: List human diseases involving genomic imprinting.\n",
      "Answer: [CLS]\n",
      "Question: Which are the smallest known subviral pathogens of plants?\n",
      "Answer: viroids and viroidlike satellite rnas\n",
      "Question: Name five programs for transcript quantification from RNASeq experiments\n",
      "Answer: averaging\n",
      "Question: What is the generic name of Gliolan?\n",
      "Answer: 5 - aminolevulinic acid\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: the triad of situs inversus, bronchiectasis and sinusitis\n",
      "Question: Which are the clinical symptoms of left ventricular noncompaction?\n",
      "Answer: heart failure, systemic emboli, and ventricular arrhythmias\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1\n",
      "Question: Which neuroendocrine tumors are associated with specific tumor syndromes?\n",
      "Answer: pheochromocytomas ( pccs ) and paragangliomas ( pgls ) are rare neuroendocrine tumors of the adrenal glands and the sympathetic and parasympathetic paraganglia\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid function\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: human immunodeficiency virus ( hiv\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: two largest ( 6, 629 and 4, 419 base pairs ) encode full - length protein and differ only in the use of alternative polyadenylation signals. the smallest bah - related transcript ( 2, 789 base pairs ) uses an alternative 3'terminal exon, resulting in a protein lacking a catalytic domain. evolutionary conservation of this noncatalytic isoform of bah ( humbug ) is demonstrated in mouse, man, and drosophila\n",
      "Question: Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?\n",
      "Answer: protein kinases have been found to phosphorylate phospholamban and affect its biological activity? [SEP] neonatal rat cardiac myocytes in vitro were subjected to 2. 5 h simulated ischemia ( si ) followed by 2 h reoxygenation. cell viability was tested by trypan blue exclusion assay. pkg activity of cardiac myocytes was assessed by phospholamban ( plb\n",
      "Question: Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?\n",
      "Answer: marfanoid - craniosynostosis\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3, 6, 8, 12, and 17\n",
      "Question: Which drugs are included in TAS-102?\n",
      "Answer: tft and tipiracil hydrochloride\n",
      "Question: Which variables are included in the SPAN-100 score?\n",
      "Answer: age and nih stroke scale ( span ) index by combining age in years plus nih stroke scale\n",
      "Question: Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?\n",
      "Answer: thyroid\n",
      "Question: List features of the Kaufman Oculocerebrofacial Syndrome.\n",
      "Answer: severe mental retardation, microcephaly, long narrow face, ocular anomalies, and long thin hands and feet\n",
      "Question: Which is the most known bacterium responsible for botulism (sausage-poisoning)?\n",
      "Answer: clostridium botulinum\n",
      "Question: List sclerostin interaction partners.\n",
      "Answer: several previously unidentified full - length sclerostin - interacting proteins such as alkaline phosphatase, carbonic anhydrase, gremlin - 1, fetuin a, midkine, annexin a1 and a2, and collagen α1\n",
      "Question: What is the indication for isradipine?\n",
      "Answer: superiority of ambulatory vs casual blood pressure measurement\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: preexisting vitiligo, psoriasis and lichen planus\n",
      "Question: Which are the state-of-the-art computational tools for the prediction of gene fusion events?\n",
      "Answer: multiple sequence alignments\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which genome browser database for DNA shape annotations is available?\n",
      "Answer: gbshape\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: melanoma or angiosarcoma\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: bronchiectasis, sinusitis and situs inversus\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: noxa1\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: [CLS]\n",
      "Question: List interaction partners for the protein GATA1.\n",
      "Answer: gata - 1 / fog - 1 and gata - 1 / tal - 1 complexes. we also provide evidence that distinct gata - 1 complexes are associated with specific gata - 1 functions in erythroid differentiation, for example, gata - 1 / gfi - 1b with the suppression of cell proliferation and gata - 1 / fog - 1 / mecp1 with the repression of other hematopoietic transcription programs. we next applied the biotinylation tag to ldb - 1, a known partner of gata - 1, and characterized a number of novel interaction partners that are essential in erythroid development, in particular, eto - 2, lmo4, and cdk9.\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?\n",
      "Answer: scfbeta - trcp\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil ( 5fu ) 500 mg / m2, cyclophosphamide 500 mg / m2, and epirubicin 50 mg / m2 ( fec 50 ) and 5fu 500 mg / m2, cyclophosphamide 500 mg / m2, and epirubicin\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: transcriptional activators nf - kappa b ( p50 / p65 ), atf - 2 / c - jun, irf - 3 and irf - 7\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: strain rf4t\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: scohet1 of 37 kda and scohet2 of 44 kda\n",
      "Question: Mutations in which gene determine response to both erlotinib and gefitinib?\n",
      "Answer: epidermal growth factor receptor\n",
      "Question: Borden classification is used for which disease?\n",
      "Answer: davfs and the ncs davfs\n",
      "Question: Which mutated genes are associated with the Tourette's syndrome?\n",
      "Answer: hdc\n",
      "Question: Which kinase is inhibited by the small molecule KN-93?\n",
      "Answer: cam kinase ii\n",
      "Question: Which cell type has the protein Chromogranin A as marker?\n",
      "Answer: sinonasal intestinal\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: myc amplification and isochromosome 17q\n",
      "Question: Which polymerase transcribes pri-miRNAs?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which genes are implicated in short QT syndrome?\n",
      "Answer: cacna2d1\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: glial cell line - derived neurotrophic factor\n",
      "Question: Name synonym of Acrokeratosis paraneoplastica.\n",
      "Answer: bazex syndrome\n",
      "Question: What does mTOR stands for?\n",
      "Answer: mammalian target of rapamycin\n",
      "Question: Which enzyme is inhibited by a drug fostamatinib?\n",
      "Answer: spleen tyrosine kinase\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: hedgehog, ( hh ) notch, and wnt\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: 13 - 15, 21, and 22\n",
      "Question: What are the properties of super-enhancers?\n",
      "Answer: magnitude of size, transcription factor density, and binding of transcriptional machinery\n",
      "Question: Tumor-treating fields are effective for treatment of which cancers?\n",
      "Answer: recurrent glioblastoma\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: digeorge syndrome ( dgs ) and the velo - cardio - facial syndrome ( vcfs )\n",
      "Question: Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?\n",
      "Answer: pse - in - one\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: swr1\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: What are the mobile applications fields of use for patients ?\n",
      "Answer: [CLS]\n",
      "Question: Which DNA sequences are more prone for the formation of R-loops?\n",
      "Answer: unusual sequence features at promoter cpg islands\n",
      "Question: Which is the most common cause of sudden cardiac death in young athletes?\n",
      "Answer: hypertrophic cardiomyopathy\n",
      "Question: What is the major adverse effect of adriamycin(doxorubicin)?\n",
      "Answer: severe cardiotoxicity\n",
      "Question: What is the triple screening test performed during pregnancy measuring?\n",
      "Answer: chromosomal anomalies and open neural tube defects\n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: q55x\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: thrombolysis for acute ischaemic stroke suggests that alteplase is the most promising treatment for acute ischaemic stroke\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: developmental delay, epilepsy and neonatal diabetes\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndrome ( mds ) and acute nonlymphocytic leukemia ( anll )\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: h3, as well as cse4, h4, h2a, and h2b\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?\n",
      "Answer: ret\n",
      "Question: List co-morbidities that may occur together with \"Stiff man Syndrome\"\n",
      "Answer: disabling shoulder subluxation and wrist ankylosis, in association with breast cancer\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: discuss the etiology and the clinical and electromyography findings of this syndrome\n",
      "Question: What tissue is most affected in Ehlers-Danlos syndromes?\n",
      "Answer: connective tissue\n",
      "Question: Which genes are regulated by TRalpha2  in the heart?\n",
      "Answer: tak1 and p38\n",
      "Question: RTS S AS01 vaccine was developed to prevent which disease?\n",
      "Answer: malaria\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban or warfarin\n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: 5 - aza - 2 - deoxycytidine\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: all four scoring systems\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: List peptide fragmentations methods in mass spectrometry\n",
      "Answer: \n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: \n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: dnm2\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: episodic headache, excessive sweating and palpitation\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: \n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: alzheimer's disease\n",
      "Question: In which kingdom do microsporidia belong, according to their current classification scheme?\n",
      "Answer: fungi\n",
      "Question: Which kinase is inhibited by Tripolin A?\n",
      "Answer: aurora a\n",
      "Question: List tele monitoring applications of miniaturised sensors\n",
      "Answer: mobile telemonitoring has potential for delivering intensified care to improve blood pressure control, and its use may be associated with reduced exposure to hyperglycemia\n",
      "Question: DX-88 is investigational name of which drug?\n",
      "Answer: ecallantide\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: chromosome 6\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: [CLS]\n",
      "Question: Which are the supplemental antioxidant in athletes?\n",
      "Answer: 1, 000 mg quercetin + 1, 000 mg vitamin c ( qc ) ; 1, 000 mg quercetin, 1, 000 mg vitamin c, 400 mg isoquercetin, 30 mg epigallocatechin gallate, and 400 mg n - 3 fatty acids\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zfhx1b\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts - facial dysmorphism - neuropathy\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: indian hedgehog\n",
      "Question: Which are the most frequent syndromes associated with inherited bone marrow failure?\n",
      "Answer: fanconi anemia, dyskeratosis congenita, shwachman - diamond syndrome, and amegakaryocytic thrombocytopenia\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: \n",
      "Question: Where is the TAZ (G4.5) is located in humans?\n",
      "Answer: xq28\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: mersacidin\n",
      "Question: Which factors are considered in the FUNC score for intracerebral hemorrhage?\n",
      "Answer: [CLS]\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria and hypokinetic dysarthria\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: inbred mice\n",
      "Question: Which transcription factors are involved in E-cadherin repression during EMT?\n",
      "Answer: snail1 and snail2 zinc fingers\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: set domain\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: a8v, c84y, e134d, and d145e\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: 1, 4 - benzothiazepine\n",
      "Question: In which diseases have electronic patient diaries been applied ?\n",
      "Answer: chronic obstructive pulmonary disease\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: caveolin - 1\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: jnk\n",
      "Question: Which are the supplemental antioxidant in athletes?\n",
      "Answer: zinc\n",
      "Question: Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?\n",
      "Answer: mdm two binding protein\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: betaa4 ( 1 - 42 )\n",
      "Question: Which heat shock protein is found to be upregulated during Hsp90 inhibition?\n",
      "Answer: hsp70\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS]\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: rob ( 14q21q ) and rob ( 13q14q )\n",
      "Question: What is the target of the drug Olaparib?\n",
      "Answer: parpi\n",
      "Question: What are the side effects of Nalmefene?\n",
      "Answer: fatigue, lightheadedness, nausea and vomiting\n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: right bundle branch block and st - segment elevation in the right precordial ecg leads. familial transmission is frequent and approximately 25 % of cases exhibit mutations in the scn5a gene. we analyzed the sequence of this gene in 25 spanish patients with brugada syndrome. in 4 ( 16 % ), we found mutations that had not previously been described : three were amino acid changes ( i. e. ala2 > thr, ala735 > thr and val1340 > ile\n",
      "Question: Which are the main clinical features of Fanconi anemia?\n",
      "Answer: congenital abnormalities, defective haemopoiesis, and a high risk of developing acute myeloid leukaemia and certain solid tumours\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: autosomal recessive\n",
      "Question: Symptoms of which disorder are evaluated with the Davidson Trauma Scale?\n",
      "Answer: post - traumatic stress disorder\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: pmp22, mpz, litaf, and egr2\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: egf, betacellulin, epiregulin, heparin - binding egf, transforming growth factor - α [ tgf - α ], amphiregulin, and epigen\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: the treatment of pe consists of primarily off - label use of oral selective serotonin reuptake inhibitors ( ssris ) via either on - demand or daily delivery\n",
      "Question: Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?\n",
      "Answer: anti - thyroid drugs combined with steroids\n",
      "Question: Neurostimulation of which nucleus is used for treatment of dystonia?\n",
      "Answer: globus pallidus internus\n",
      "Question: List peptide fragmentations methods in mass spectrometry\n",
      "Answer: the combination of dia analysis and etd fragmentation with supplemental cid energy\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: transcriptional activators nf - kappa b ( p50 / p65 ), atf - 2 / c - jun, irf - 3 and irf - 7\n",
      "Question: Which are the known human transmembrane nucleoporins?\n",
      "Answer: net3\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: negative elongation factor nelf\n",
      "Question: What is being measured with an accelerometer in back pain patients\n",
      "Answer: activity levels\n",
      "Question: Which is the largest metabolic gene cluster in yeast?\n",
      "Answer: the dal cluster\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: il - 1ri\n",
      "Question: List invertebrates where ultraconserved elements have been identified.\n",
      "Answer: [CLS]\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: [CLS] list braf inhibitors that have been tested in clinical trials for treatment of melanoma patients [SEP]\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: \n",
      "Question: Which diseases that can be treated using the focused ultrasound thalamotomy.\n",
      "Answer: neurologic disorders\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 223\n",
      "Question: Entresto is composed of which two drugs?\n",
      "Answer: sacubitril and valsartan\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: chromosomes 10 ( acta2 ) and 17\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: \n",
      "Question: Which R package is used for visualization of linear and circular karyotypes?\n",
      "Answer: chromdraw\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: In which condition was protein S100A7 originally identified?\n",
      "Answer: psoriasis\n",
      "Question: Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins.\n",
      "Answer: proteomic analyses have revealed proteins associated with the triple - negative breast cancers\n",
      "Question: RTS S AS01 vaccine was developed to prevent which disease?\n",
      "Answer: malaria\n",
      "Question: Against which protein is the antibody used for immonostaining of Lewy bodies raised?\n",
      "Answer: \n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical features, duration of symptoms and diabetes\n",
      "Question: Which are the most widely reported side-effects in the treatment of Crohn's disease?\n",
      "Answer: myelosuppression and liver toxicity\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: essential initiation and elongation factor, cdc45, the checkpoint mediator mrc1\n",
      "Question: Which myosin isozymes are located within the pericuticular necklace of the hair cell?\n",
      "Answer: ibeta, - vi, and - viia\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: calsequestrin, and triadin\n",
      "Question: Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?\n",
      "Answer: tofacitinib\n",
      "Question: Which receptors are targeted by a drug Macitentan?\n",
      "Answer: endothelin\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: nuclear chromodomain proteins\n",
      "Question: List symptoms of Gradenigo's syndrome.\n",
      "Answer: suppurative otitis media, abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve\n",
      "Question: Which enzyme is targeted by Evolocumab?\n",
      "Answer: proprotein convertase subtilisin / kexin type 9\n",
      "Question: What condition is usually represented by the acronym SUDEP?\n",
      "Answer: sudden unexpected death in epilepsy\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25. 3\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: met1, met2a, met2b, met3\n",
      "Question: Name five programs for transcript quantification from RNASeq experiments\n",
      "Answer: poisson mixed - effects\n",
      "Question: By which methods can we evaluate the reliability of a phylogenetic tree?\n",
      "Answer: bootstrapping of 100 replicates of the original sequence alignments\n",
      "Question: List core circadian clock genes.\n",
      "Answer: clock, bmal1, and cklε\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which protein phosphatase has been found to interact with the heat shock protein, HSP20?\n",
      "Answer: pp1\n",
      "Question: What is the role of eteplirsen in DMD patients?\n",
      "Answer: induces skipping of dystrophin exon 51\n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: co2\n",
      "Question: What are the main indications of lacosamide?\n",
      "Answer: generalized tonic - clonic and partial - onset epilepsies\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: cervical cancer\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: episodic headache, increased sweating, and palpitations\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: t ( 13 ; 22 ) robertsonian translocation constitutes a rare form of rearrangement between acrocentric human chromosomes\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: ulcerative colitis ( uc ) and crohn's disease ( cd )\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: cavity program\n",
      "Question: List all the available databases of super enhancers\n",
      "Answer: super - enhancer archive\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: chromosome 6\n",
      "Question: Which receptors are bound by Tasimelteon?\n",
      "Answer: mt2 receptor\n",
      "Question: What tissue is commonly affected in Marfan's syndrome\n",
      "Answer: connective tissue\n",
      "Question: Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?\n",
      "Answer: free t ( 3 )\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline, topiramate, and placebo\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Where can you find the annulus of Zinn?\n",
      "Answer: inside valsalva's opera omnia published in 1740\n",
      "Question: Which enzyme is inhibited by a drug fostamatinib?\n",
      "Answer: luciferase\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: cardiac β - myosin heavy chain gene ( myh7 )\n",
      "Question: Which R package could be used for the identification of pediatric brain tumors?\n",
      "Answer: methped\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: bronchiectasis, sinusitis and situs inversus\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline, topiramate, and placebo\n",
      "Question: List omics technologies comprised in system biology.\n",
      "Answer: \n",
      "Question: Which gene is responsible for the development of Sotos syndrome?\n",
      "Answer: nsd1\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?\n",
      "Answer: oct4, klf4, sox2 and c - myc\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: List protein gel staining methods visualizing the entire protein set.\n",
      "Answer: sypro ruby\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: [CLS] which are the different homologs or family members of the hedgehog proteins in mammals? [SEP]\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: [CLS]\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: ryr ), calsequestrin, and triadin 1\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: 5\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: \n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: ncx\n",
      "Question: Which enzyme does MLN4924 inhibit?\n",
      "Answer: nedd8\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl\n",
      "Question: List human proteins that are subject to a dimer-to-tetramer transition.\n",
      "Answer: human orai1 and orai3 channels\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: carbapenemase - producing enterobacteriaceae showed high rates of resistance to most antimicrobial agents tested.\n",
      "Question: Which gene strand is targeted by transcription-coupled repair (TCR)?\n",
      "Answer: transcribed strand\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid function and morphology in patients affected by williams syndrome. objective : to evaluate the prevalence of abnormalities of thyroid function and morphology in a cohort of patients with williams syndrome ( ws ). methods : serum concentrations of free - t3, free - t4, tsh, thyroperoxidase antibodies ( tpoa ) and thyroglobulin antibodies ( tga ), as well as ultrasonographic data, of 20 patients with ws ( 12 females and eight males ), aged 1. 7 - 34. 9 years, were evaluated. results : three cases ( 15 % ) of subclinical hypothyroidism were identified. overt hypothyroidism was diagnosed in two cases ( 10 % ). thyroid antibodies were negative in all patients. fourteen patients ( 70 % ) showed thyroid hypoplasia involving the entire gland. in these patients, the left thyroid lobe appeared usually, but not significantly, reduced compared with the right thyroid lobe. one patient ( 5 % ) showed thyroid hemiagenesis. only five patients ( 25 % ) showed a thyroid with normal volume, and of these five, one patient showed marked thyroid hypoplasia of the left lobe. in all ws patients with diagnosis of subclinical or overt hypothyroidism, thyroid hypoplasia was detected. no cases of subclinical or overt hypothyroidism were found in ws with normal thyroid volume. conclusions : this study confirms the presence of alterations of thyroid function in ws and also suggests the frequent occurrence of abnormalities of thyroid morphology\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: treatment of bulimia, benzodiazepine / alcohol dependence, fibromyalgia, central nervous system degenerative diseases ( behavioral disorders in dementia and other organic disorders ), schizophrenia, chronic pain disease and diabetic neuropathy, sexual dysfunction\n",
      "Question: Which receptors are targeted by a drug Macitentan?\n",
      "Answer: endothelin\n",
      "Question: Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?\n",
      "Answer: gata4, mef2c and tbx5\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: episodic headache, excessive sweating and palpitation\n",
      "Question: Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?\n",
      "Answer: diabetes mellitus\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: [CLS] list the components of a replisome progression complex ( rpc ). [SEP] a key role for ctf4 in coupling the mcm2 - 7 helicase to dna polymerase alpha within the eukaryotic replisome. the eukaryotic replisome is a crucial determinant of genome stability, but its structure is still poorly understood. we found previously that many regulatory proteins assemble around the mcm2 - 7 helicase at yeast replication forks to form the replisome progression complex ( rpc ), which might link mcm2 - 7 to other replisome components. here, we show that the rpc associates with dna polymerase alpha that primes each okazaki fragment during lagging strand synthesis. our data indicate that a complex of the gins and ctf4 components\n",
      "Question: List symptoms of congenital toxoplasmosis triad.\n",
      "Answer: hydrocephalus, cerebral calcification and chorioretinitis\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: peripheral facial nerve palsy, recurrent or persistent oral or facial swelling, and fissured tongue\n",
      "Question: Which drugs are included in TAS-102?\n",
      "Answer: tft and tipiracil hydrochloride ( thymidine phosphorylase inhibitor )\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: everolimus\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: situs inversus, chronic rhinosinusitis, and bronchiectasis\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: 3, 5 - diiodo - 4 - hydroxyphenylpropionic acid\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?\n",
      "Answer: t68a, t68d and q69e\n",
      "Question: Which are the different members/isoforms of the Ras oncogenes?\n",
      "Answer: h - ras, k - ras, and n - ras\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl protein\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gdnf, nrtn, artn, and pspn\n",
      "Question: List inflammatory caspase proteins?\n",
      "Answer: caspase - 1\n",
      "Question: Which are the most frequent syndromes associated with inherited bone marrow failure?\n",
      "Answer: fanconi anemia ( fa ), dyskeratosis congenita ( dc ), diamond - blackfan anemia ( dba ), and shwachman - diamond syndrome ( sds )\n",
      "Question: Which polymerase transcribes pri-miRNAs?\n",
      "Answer: rna polymerase ii\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: a8v, c84y, e134d, and d145e\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: recurrent facial nerve palsy, facial swelling, and fissured tongue\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: ligendock\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism syndrome\n",
      "Question: Which drugs may interfere thyroxine absorption?\n",
      "Answer: sevelamer hydrochloride ( renagel, a phosphate - binding medication used in the treatment of hyperphosphatemia ), chromium picolinate ( an over - the - counter nutritional supplement ), or ezetimibe ( zetia, a drug used in the treatment of hypercholesterolemia ). serum thyroxine was measured at intervals over a 6 - hour period following drug ingestion. main outcome : sevelamer hydrochloride and chromium picolinate each significantly ( p < 0. 05 ) decreased the area under the serum thyroxine concentration curve, while ezetimibe had no effect. conclusion : hypothyroid patients taking sevelamer hydrochloride or chromium picolinate\n",
      "Question: Which is the protein implicated in Spinocerebellar ataxia type 3?\n",
      "Answer: ataxin - 3\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: Do archaeal genomes contain one or multiple origins of replication?\n",
      "Answer: multiple\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: \n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: r27h, e901k, g1743r ( detected in three families ), v728i, n1443s and e1152x\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: breast cancer\n",
      "Question: What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?\n",
      "Answer: men2a ( c618s\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin ( trd ) and junctin ( jnc )\n",
      "Question: Which are the different members/isoforms of the Ras oncogenes?\n",
      "Answer: h - ras, k - ras, and n - ras\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: y chromosome\n",
      "Question: Aleglitazar is agonist of which receptor?\n",
      "Answer: α / γ\n",
      "Question: List receptors of the drug Cilengitide\n",
      "Answer: αvβ3 and αvβ5 integrin receptors\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: rituximab\n",
      "Question: What genes are related to breast cancer?\n",
      "Answer: p53 and brca1\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical features, duration of symptoms and diabetes\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: wnt, myc, and rb\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?\n",
      "Answer: nrd1 and nab3\n",
      "Question: Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?\n",
      "Answer: rngtt and rnmt\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dnmt1\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: familial parkinsonism associated with central hypoventilation, mental depression, and weight loss\n",
      "Question: Which genes does thyroid hormone receptor beta1 regulate in the heart?\n",
      "Answer: beta - myhc, serca, and trbeta1\n",
      "Question: Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?\n",
      "Answer: \n",
      "Question: What tissue is commonly affected in Marfan's syndrome\n",
      "Answer: connective tissue\n",
      "Question: Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?\n",
      "Answer: antiparallel\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which human genes are more commonly related to craniosynostosis?\n",
      "Answer: nell - 1\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: silver syndrome / spastic paraplegia 17, distal hereditary motor neuropathy type v, and charcot - marie - tooth disease type 2 ( cmt2 ) with predominant hand involvement\n",
      "Question: Which post-translational histone modifications are characteristic of facultative heterochromatin?\n",
      "Answer: mutually exclusive\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: hypomyelination, hypogonadotropic hypogonadism, and hypodontia\n",
      "Question: Which diseases can Oncotype DX be used for?\n",
      "Answer: breast cancer\n",
      "Question: What are the reported adverse effects of gabapentin used in children?\n",
      "Answer: somnolence, dizziness, ataxia, fatigue\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: rls / wed\n",
      "Question: What is SCENAR therapy used for?\n",
      "Answer: treatment of 103 patients with duodenal ulcer\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: sinusitis, situs inversus and bronchiectasis\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: high affinity\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38 + multiple myeloma cells\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin and junctin\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: \n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: maltt\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: ten and sjs\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: \n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: hic1 and casp8\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: galactocerebrosidase\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: dextrocardia, bronchiectasis and paranasal sinusitis\n",
      "Question: Which factors are considered in the FUNC score for intracerebral hemorrhage?\n",
      "Answer: age, glasgow coma scale, ich location, volume\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl35a, rpl5, rpl11, rps7, rps10, rps26, and rpl26 and gata1 in about 60 - 65 % of patients. here, we report a novel large deletion in rpl15, a gene not previously implicated to be causative in dba. like rpl26, rpl15 presents the distinctive feature of being required both for 60s subunit formation and for efficient cleavage of the internal transcribed spacer 1. in addition, we detected five deletions in rp genes in which mutations have been previously shown to cause dba : one each in rps19, rps24, and rps26, and two in rps17. pre - ribosomal rna processing was affected in cells established from the patients bearing these deletions, suggesting a possible molecular basis for their pathological effect. these data identify rpl15\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: List interaction partners for the protein GATA1.\n",
      "Answer: eto - 2, lmo4, and cdk9\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter species\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25\n",
      "Question: Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?\n",
      "Answer: hsp90\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: List processes which are under the control of the YAP protein.\n",
      "Answer: inhibition of the pathway promotes yap / taz translocation to the nucleus, where they interact with transcriptional enhancer associate domain ( tead ) transcription factors and coactivate the expression of target genes, promoting cell proliferation\n",
      "Question: Which diseases are associated with Alu element insertion?\n",
      "Answer: autosomal dominant optic atrophy\n",
      "Question: List interaction partners for the protein GATA1.\n",
      "Answer: ski negatively regulates erythroid differentiation through its interaction with gata1. the ski oncoprotein dramatically affects cell growth, differentiation, and / or survival. recently, ski was shown to act in distinct signaling pathways including those involving nuclear receptors, transforming growth factor beta, and tumor suppressors. these divergent roles of ski are probably dependent on ski's capacity to bind multiple partners with disparate functions\n",
      "Question: Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?\n",
      "Answer: uvra, uvrb, uvrc, the uvrd helicase, dna polymerase i, and ligase\n",
      "Question: Which syndromes are associated with heterochromia iridum?\n",
      "Answer: sensorineural hearing loss\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: bss\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?\n",
      "Answer: nuclear exosome\n",
      "Question: What are the reported adverse effects of gabapentin used in children?\n",
      "Answer: urticarial rash and irritability 10 and 4 days\n",
      "Question: Which class of genes are mutated in Diamond Blackfan Anemia patients?\n",
      "Answer: ribosomal protein\n",
      "Question: Which effects create neighborhoods of transcriptional regulation in eukaryotes?\n",
      "Answer: enhancer sharing\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?\n",
      "Answer: marfanoid - craniosynostosis\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 10 ( acta2 ) and 17\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: Which species may be used for the biotechnological production of itaconic acid?\n",
      "Answer: aspergillus terreus\n",
      "Question: Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?\n",
      "Answer: secondary hypogammaglobulinemia in waldmann's disease\n",
      "Question: Which R/bioconductor package is used for integrative genomics visualizations?\n",
      "Answer: sushi. r\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: List RNA modifications databases\n",
      "Answer: rmbase\n",
      "Question: What histone trimethylation has been associated to RNA splicing?\n",
      "Answer: h3 lys36\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: ribonucleoprotein complexes\n",
      "Question: Which are the most under-represented oligonucleotides in higher eukaryote genomes?\n",
      "Answer: [CLS]\n",
      "Question: Which interleukin is blocked by Siltuximab?\n",
      "Answer: 6\n",
      "Question: Which NGS alignment software implement the Burrows-Wheeler Transform?\n",
      "Answer: burrows - wheeler alignment tool\n",
      "Question: Which proteins act as histone-like molecules in prokaryotes?\n",
      "Answer: hu\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS]\n",
      "Question: How many times is CLAST faster than BLAST?\n",
      "Answer: 80. 8\n",
      "Question: Which R / bioconductor package is used for enrichment analysis of genomic regions?\n",
      "Answer: lola\n",
      "Question: Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?\n",
      "Answer: mir - 510 and mir - 509 - 5p\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?\n",
      "Answer: ryr2 - g230c\n",
      "Question: Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?\n",
      "Answer: dhx32 and rgs12\n",
      "Question: What condition is usually represented by the acronym SUDEP?\n",
      "Answer: sudden unexpected death in epilepsy\n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: \n",
      "Question: What imaging modalities have been listed as method of choice  to diagnose CSF leak?\n",
      "Answer: 3d - ciss\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: serotonin 5 - ht2a receptors\n",
      "Question: Entresto is composed of which two drugs?\n",
      "Answer: sacubitril / valsartan\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: familial parkinsonism associated with central hypoventilation, mental depression, and weight loss\n",
      "Question: Which species may be used for the biotechnological production of itaconic acid?\n",
      "Answer: aspergillus terreus\n",
      "Question: What is the mode of inheritance of nemaline myopathy?\n",
      "Answer: \n",
      "Question: Which type of cells is affected in Amyotrophic Lateral Sclerosis?\n",
      "Answer: motor neurons\n",
      "Question: List the results of mutated casein kinase 1 epsilon. \n",
      "Answer: results in a short circadian period, abnormal entrainment to light cycles, and potentiated resetting responses to light\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: il - 1β\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: sin1\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: pou5f1, myc, klf4, and sox2\n",
      "Question: Which is the most widely used model for the study of multiple sclerosis (MS)?\n",
      "Answer: experimental autoimmune encephalomyelitis ( eae )\n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: 5 - azacytidine and 2 - ( 1h ) - pyrimidinone riboside ( zebularine )\n",
      "Question: What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?\n",
      "Answer: \n",
      "Question: For which type of diabetes can empagliflozin be used?\n",
      "Answer: type 2\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: facioscapulohumeral disease\n",
      "Question: Which gene is mutated in the Karak syndrome?\n",
      "Answer: pla2g6\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: epidermal growth factor ( egf ), transforming growth factor - α, and heparin binding - egf\n",
      "Question: Which two drugs are included in the Harvoni pill?\n",
      "Answer: ledipasvir / sofosbuvir\n",
      "Question: What personality traits can be evaluated with the Ten Item Personality Inventory.\n",
      "Answer: five major facets of personality : openness, extroversion, conscientiousness, agreeableness and neuroticism\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1\n",
      "Question: Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?\n",
      "Answer: [CLS] tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? [SEP]\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: human genome harbours variants that influence susceptibility of the egfr pathway to oncogenic mutation\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: iron\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: lrsam1\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, c - myc\n",
      "Question: List the main proteases used for sample digestion in proteomics.\n",
      "Answer: [CLS]\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: fbn1\n",
      "Question: which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?\n",
      "Answer: family history of sudden death, massive left ventricular hypertrophy, nonsustained ventricular tachycardia on holter monitoring, and unexplained prior syncope\n",
      "Question: How many and which are the different isoforms for the ryanodine receptor?\n",
      "Answer: three\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: alirocumab ( praluent® ; sanofi / regeneron ) and evolocumab ( repatha® ; amgen )\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: secondary myelodysplastic syndrome\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: [CLS]\n",
      "Question: Which histone modification discriminates between active and poised enhancers?\n",
      "Answer: monomethylation of histone h3 on lys 4 ( h3k4me1 ) and acetylation of histone h3 on lys 27 ( h3k27ac )\n",
      "Question: Which syndromes are associated with mutations in the EZH2 gene?\n",
      "Answer: weaver syndrome\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: mds\n",
      "Question: List representatives of the major fungal hypoxanthine-adenine-guanine transporter families.\n",
      "Answer: fungal purine transporter azga.\n",
      "Question: List symptoms of Hakim Triad.\n",
      "Answer: dementia, gait disturbances and urinary incontinence\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: jaspar core - - an expanded version of the original, non - redundant collection of annotated, high - quality matrix - based transcription factor binding profiles, jaspar fam - - a collection of familial tfbs models and jaspar phylofacts - - a set of matrices computationally derived from statistically overrepresented, evolutionarily conserved regulatory region motifs from mammalian genomes. jaspar phylofacts serves as a non - redundant extension to jaspar core, enhancing the overall breadth of jaspar for promoter sequence analysis. the new release of jaspar is available at http : / / jaspar. genereg. net\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: chronic maxillary sinusitis, bronchiectasis and \" situs inversus totalis \"\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: ichthyosis follicularis ; atrichia and photophobia\n",
      "Question: Which diseases can Oncotype DX be used for?\n",
      "Answer: node - negative ( n - ) and node - positive ( n + ), endocrine - sensitive breast cancer\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: x - linked dystonia - parkinsonism\n",
      "Question: How many tissue kallikrein genes are present in the human genome?\n",
      "Answer: 15\n",
      "Question: What is the role of eteplirsen in DMD patients?\n",
      "Answer: induces skipping of dystrophin exon 51\n",
      "Question: List types of avoided words in bacterial genomes\n",
      "Answer: short palindromic sequences\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: fxa\n",
      "Question: Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?\n",
      "Answer: gata4, mef2c and tbx5\n",
      "Question: Which are the thyroid hormone analogs utilized in human studies?\n",
      "Answer: 3, 3?, 5 - triiodo - thyroacetic acid\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: pedla\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: stage iv metastatic melanoma\n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: park7\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts facial dysmorphism\n",
      "Question: Name five programs for transcript quantification from RNASeq experiments\n",
      "Answer: mitie\n",
      "Question: Pridopidine has been tested for treatment of which disorder?\n",
      "Answer: huntington disease\n",
      "Question: List all the available databases of super enhancers\n",
      "Answer: dbsuper lists genes associated with super - enhancers and also links to external databases such as genecards, uniprot and entrez\n",
      "Question: List cardinal features of the Triple A syndrome.\n",
      "Answer: adrenal insufficiency due to acth insensitivity, achalasia and alacrima\n",
      "Question: List core circadian clock genes.\n",
      "Answer: rev - erbα, per1, per2, bmal1 and cry1\n",
      "Question: What is the synonym of the lubag disease?\n",
      "Answer: dystonia - parkinsonism\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: \n",
      "Question: Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?\n",
      "Answer: ca ( 2 + ) - calmodulin - dependent protein kinase ii\n",
      "Question: Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?\n",
      "Answer: hsp90\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: modified tokuhashi and tomita scores\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: Which microRNAs are involved in exercise adaptation?\n",
      "Answer: mir - 494\n",
      "Question: Which CDK targets control cytokinesis?\n",
      "Answer: \n",
      "Question: Which gene controls the expression of GATA-1 isoforms?\n",
      "Answer: pu. 1\n",
      "Question: List the neurotransmitters that are metabolized by MAOA.\n",
      "Answer: serotonin and dopamine metabolism\n",
      "Question: Which is the transcript responsible for X-chromosome inactivation?\n",
      "Answer: xist\n",
      "Question: By which methods can we evaluate the reliability of a phylogenetic tree?\n",
      "Answer: bootstrap and jackknife techniques\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which proteins act as factors that promote transcription-coupled repair in bacteria?\n",
      "Answer: transcription - repair coupling factor / rna polymerase\n",
      "Question: Which proteins act as factors that promote transcription-coupled repair in bacteria?\n",
      "Answer: mfd\n",
      "Question: What are the symptoms of Rotor syndrome?\n",
      "Answer: chronic fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia with normal hepatic histology\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: vancomycin\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: ctf4\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: dopamine beta - hydroxylase and phenylethanolamine n - methyltransferase\n",
      "Question: What personality traits can be evaluated with the Ten Item Personality Inventory.\n",
      "Answer: extraversion, agreeableness, conscientiousness, emotional stability, openness to experience\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: lc3, gabarap, and gate - 16\n",
      "Question: PBT2 has been tested for which disorder?\n",
      "Answer: alzheimer's disease\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: [CLS]\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: [CLS] which are the different proteins / isoforms encoded but the asph ( aspartate beta - hydroxylase ) gene in humans? [SEP]\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: autosomal recessive\n",
      "Question: List symptoms of Meigs' Syndrome.\n",
      "Answer: ascites and pleural effusion\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which disease is treated with ZMapp?\n",
      "Answer: ebola virus disease\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: [CLS] list braf inhibitors that have been tested in clinical trials for treatment of melanoma patients [SEP] dabrafenib\n",
      "Question: What are the reported adverse effects of gabapentin used in children?\n",
      "Answer: behavioral side effects\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: fifth\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: mpz, inf2, dnm2, yars, gnb4, nefl, and mfn2\n",
      "Question: Magnetic beads has been used in numerous applications. List some coatings used.\n",
      "Answer: affinity capture involved enzymatic assay for thrombin by using peptide aptamers as affinity ligands on magnetic beads\n",
      "Question: List sclerostin interaction partners.\n",
      "Answer: several previously unidentified full - length sclerostin - interacting proteins such as alkaline phosphatase, carbonic anhydrase, gremlin - 1, fetuin a, midkine, annexin a1 and a2, and collagen α1\n",
      "Question: Which cellular processes are regulated by Nanog?\n",
      "Answer: primordial germ cell migration\n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: cgrp\n",
      "Question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.\n",
      "Answer: eto - 2, lmo4, and cdk9\n",
      "Question: What are the computational methods for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: hidden markov model\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: cytochrome p450 ( cyp ) 2c9 ( cyp2c9 ) and vitamin k epoxide reductase complex subunit 1 ( vkorc1 )\n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: r27h, e901k, g1743r ( detected in three families ), v728i, n1443s and e1152x\n",
      "Question: Which protein complexes contain mitofilin?\n",
      "Answer: the mitochondrial inner membrane organizing system\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1\n",
      "Question: Which genome browser database for DNA shape annotations is available?\n",
      "Answer: gbshape\n",
      "Question: PBT2 has been tested for which disorder?\n",
      "Answer: alzheimer's disease\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dmap1\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gdnf, ntn, artn, pspn, and susceptibility to hirschsprung disease. purpose : hirschsprung disease ( hscr ) is a developmental disorder caused by a failure of neural crest cells to migrate, proliferate, and / or differentiate during the enteric nervous system development. it presents a multifactorial, nonmendelian pattern of inheritance, with several genes playing some role in its pathogenesis. its major susceptibility gene is the ret protooncogene, which encodes a receptor tyrosine kinase activating several key signaling pathways in the enteric nervous system development. given the pivotal role of ret in hscr, the genes encoding their ligands ( gdnf, nrtn, artn, and pspn\n",
      "Question: From which sequence does the Alu repeat originate from?\n",
      "Answer: 7sl rna - derived retroposing monomeric element\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: alirocumab and evolocumab\n",
      "Question: Which are the Atg8 homologs in human?\n",
      "Answer: atg13 and fip200\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: helicase dna - binding protein 1 ( chd1 ) remodeler are necessary and sufficient for sliding nucleosomes\n",
      "Question: List omics technologies comprised in system biology.\n",
      "Answer: proteomics\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: rofecoxib and valdecoxib\n",
      "Question: What fruit causes Jamaican vomiting sickness?\n",
      "Answer: ackee\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: cytoplasmic stress granules where it is able to bind and sequester wild - type fus\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: mcd1\n",
      "Question: List non-surgical treatment modalities that are included in the Stupp protocol.\n",
      "Answer: radiochemotherapy\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: elvitegravir, cobicistat, emtricitabine and tenofovir\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl5, rpl11, rps7, rpl35a, rps10 and rps26\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct4, sox2, klf4, and c - myc\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: trisomy 8\n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: ivs18 - 1g > a\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: unresponsive to sulfonylureas\n",
      "Question: List available databases containing information about conserved noncoding elements.\n",
      "Answer: tfcones\n",
      "Question: Which are the components of the pre-replication complex (pre-RC) in eukaryotes?\n",
      "Answer: cdc6 / cdc18, mcm, orc and cdt1\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: mds\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: 1, 4 - benzothiazepine\n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: cgrp\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: tyrosine\n",
      "Question: What molecule is targeted by suvorexant?\n",
      "Answer: orexin - a and orexin - b\n",
      "Question: What is the functional role of the protein Drp1?\n",
      "Answer: a mitochondrial fission protein\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin, calsequestrin\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: caveolin - 1\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts facial dysmorphism neuropathy\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: autosomal dominant parkinsonism, depression, severe weight loss, and hypoventilation\n",
      "Question: Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?\n",
      "Answer: increased cytotoxicity\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: 3p13 - 14. 1 deletion of four genes\n",
      "Question: Which are the causes of the Koebner phenomenon?\n",
      "Answer: \n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid structural and functional anomalies\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: everolimus ( rad001 )\n",
      "Question: Which genetic defects are observed in Prader-Willi syndrome?\n",
      "Answer: 15q11 - 13 deletions of paternal origin and maternal chromosome 15 uniparental disomy\n",
      "Question: What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?\n",
      "Answer: selenocysteine incorporating sequence\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: nlmof\n",
      "Question: Hy's law measures failure for what organ?\n",
      "Answer: \n",
      "Question: Which is the process that Conserved noncoding elements mostly regulate?\n",
      "Answer: transcription\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: mental status changes, ocular signs, and ataxia\n",
      "Question: Which protein complexes contain mitofilin?\n",
      "Answer: \n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: nf1\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: [CLS] what is the characteristic domain of histone methyltransferases? [SEP] catalytic properties and kinetic mechanism of human recombinant lys - 9 histone h3\n",
      "Question: For the constructions of which organs has 3D printing been tested?\n",
      "Answer: meniscus\n",
      "Question: How many and which are the different isoforms for the ryanodine receptor?\n",
      "Answer: ryr1 and ryr2\n",
      "Question: Which enzyme does MLN4924 inhibit?\n",
      "Answer: nedd8\n",
      "Question: What is MRSA?\n",
      "Answer: methicillin - resistant staphylococcus aureus\n",
      "Question: Which is the transcript responsible for X-chromosome inactivation?\n",
      "Answer: xist\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: thyroid function\n",
      "Question: Which R / bioconductor package is used for enrichment analysis of genomic regions?\n",
      "Answer: lola\n",
      "Question: List inflammatory caspase proteins?\n",
      "Answer: caspase - 1\n",
      "Question: How many periods of regulatory innovation led to the evolution of vertebrates?\n",
      "Answer: three\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts1 and mutl\n",
      "Question: Which gene is involved in Giant Axonal Neuropathy?\n",
      "Answer: gan\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: met, cmt, and drm classes\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: amphiregulin and heparin - binding epidermal growth factor - like growth factor ( hb - egf ), from airway epithelial cells. amphiregulin and hb - egf were expressed in airway epithelium of patients with asthma. histamine up - regulated their mrna expression ( amphiregulin 3. 2 - fold, p < 0. 001 ; hb - egf 2. 3 - fold, p < 0. 05 ) and triggered their release ( amphiregulin ec ( 50 ) 0. 50 μm, 31. 2 ± 2. 7 pg / ml with 10 μm histamine, p < 0. 01 ; hb - egf ec ( 50 ) 0. 54 μm, 78. 5 ± 1. 8 pg / ml with 10 μm histamine, p < 0. 001 ) compared to vehicle control ( amphiregulin 19. 3 ± 0. 9 pg / ml ; hb - egf 60. 2 ± 1. 0 pg / ml ), in airway epithelial cells. histamine increased egfr phosphorylation ( 2. 1 - fold by western blot analysis ) and induced goblet cell differentiation ( clca1 up - regulation by real - time qpcr ) in normal human bronchial epithelial ( nhbe ) cells. moreover, amphiregulin and hb - egf caused proliferation and migration of both nhbe cells and human airway smooth muscle cells. these results suggest that histamine may induce airway remodeling via the epithelial - derived egfr ligands amphiregulin and hb - egf\n",
      "Question: Which is the E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation?\n",
      "Answer: beta - transducin repeat - containing protein\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: blistering\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which gene fusion is the result of the \"philadelphia translocation\" or the \"philadelphia chromosome\" mutation?\n",
      "Answer: bcr / abl\n",
      "Question: List variants of the MC1R gene.\n",
      "Answer: [CLS]\n",
      "Question: Which are the components of the pre-replication complex (pre-RC) in eukaryotes?\n",
      "Answer: origin recognition complex, cdc6, and cdt1\n",
      "Question: Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?\n",
      "Answer: iranges, genomicranges, and genomicfeatures\n",
      "Question: Which fusion protein is involved in the development of Ewing sarcoma?\n",
      "Answer: ews / fli1\n",
      "Question: List the existing methods for genetic manipulation of cells.\n",
      "Answer: bacterial artificial chromosomes\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: brooke - spiegler syndrome\n",
      "Question: Which could be some of the possible causes of hypersomnia?\n",
      "Answer: sleep - wake disturbances ( swd ) are common after traumatic brain injury\n",
      "Question: List proteins of lipids droplets\n",
      "Answer: [CLS]\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: tpm1\n",
      "Question: List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).\n",
      "Answer: thrombocytopenia, haemolysis, fever, coma and renal failure\n",
      "Question: Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"\n",
      "Answer: delta - distances\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: 5 - ht2a\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: direct factor xa\n",
      "Question: By which methods can we evaluate the reliability of a phylogenetic tree?\n",
      "Answer: \n",
      "Question: What is the triple screening test performed during pregnancy measuring?\n",
      "Answer: maternal serum\n",
      "Question: What molecule is targeted by Avelumab?\n",
      "Answer: pd - l1\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kcnq1\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil : 500 mg / m ( 2 ), epirubicin : 75 mg / m ( 2 ), and cyclophosphamide\n",
      "Question: Which is the gene most commonly mutated in Tay-Sachs disease?\n",
      "Answer: beta - hexoseaminidase a\n",
      "Question: List angiocrine factors\n",
      "Answer: tumor suppressive\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: active crohn's disease\n",
      "Question: Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?\n",
      "Answer: uvrd\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: chromosome 6\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: atf - 2 / c - jun, irf - 3 / irf - 7, nf - kappab and hmgi ( y )\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25. 3\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: set\n",
      "Question: List angiocrine factors\n",
      "Answer: vascular endothelial growth factor\n",
      "Question: Which disease phenotypes are associated to PRPS1 mutations?\n",
      "Answer: macular coloboma - like lesions with retinal dystrophy, severe short stature and diabetes insipidus\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium ulcerans\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: \n",
      "Question: Are most driver gene mutations synonymous or non-synonymous?\n",
      "Answer: non - synonymous\n",
      "Question: Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?\n",
      "Answer: diastolic ca ( 2 + ) leak, after - depolarizations, and arrhythmia\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: cpsrp43\n",
      "Question: What is the drug target for Simtuzumab?\n",
      "Answer: lysyl oxidase - like 2 ( loxl2 ) enzyme\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: 5\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: tokuhashi, tomita, bauer, and oswestry scores\n",
      "Question: List programs suitable for pharmacophore modelling\n",
      "Answer: catalyst / hiphop\n",
      "Question: What disease is Velcade (bortezomib) mainly used for?\n",
      "Answer: multiple myeloma\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: warfarin\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: \n",
      "Question: Which is the molecular target of the immunosuppressant drug Rapamycin?\n",
      "Answer: mtor\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: autosomal recessive\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: noxo1 phosphorylation on serine 154 is critical for optimal nadph oxidase 1\n",
      "Question: By which methods can we evaluate the reliability of a phylogenetic tree?\n",
      "Answer: bootstrap, jackknife or operational taxonomic unit - jackknife analysis\n",
      "Question: Which are the inhibitors of histone methyltransferases?\n",
      "Answer: h3k27me3 and h4k20me3\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban when compared with warfarin\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: [CLS] which clotting factor is inhibited by betrixaban? [SEP] new anticoagulants : focus on venous thromboembolism. anticoagulation is recommended for prophylaxis and treatment of venous thromboembolism ( vte ) ( deep vein thrombosis and pulmonary embolism ) and / or arterial thromboembolism. the therapeutic arsenal of anticoagulants available to clinicians is mainly composed by unfractionated heparin ( ufh ), low - molecular - weight heparin ( lmwh ), fondaparinux and oral vitamin k antagonists ( vka ) ( i. e. warfarin and acenocumarol ). these anticoagulants are effective, but they require parenteral administration ( ufh, lmwh, fondaparinux ) and / or frequent anticoagulant monitoring ( intravenous ufh, oral vka ). novel anticoagulants in clinical testing include orally active direct factor ii inhibitors [ dabigatran etexilate ( bibr 1048 ), azd0837 ) ], parenteral direct factor ii inhibitors ( flovagatran sodium ), orally active direct factor x\n",
      "Question: which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?\n",
      "Answer: previous cardiac arrest or sustained ventricular tachycardia\n",
      "Question: Borden classification is used for which disease?\n",
      "Answer: ncsdavfs\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: developmental delay, epilepsy and neonatal diabetes\n",
      "Question: Borden classification is used for which disease?\n",
      "Answer: davf\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: sodium - calcium exchanger\n",
      "Question: List chromosomes that have been linked to Arnold Chiari syndrome in the literature.\n",
      "Answer: chromosome 15\n",
      "Question: Matuzumab has been tested for treatment of which cancers?\n",
      "Answer: oesophago - gastric cancer\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter in a child with moyamoya. a 7 - year - old white girl presented with left hemiparesis and ischemic stroke secondary to moyamoya syndrome, a progressive cerebrovascular occlusive disorder of uncertain but likely multifactorial etiology. past medical history revealed hearing loss and developmental delay / intellectual disability. routine karyotype demonstrated extra chromosomal material on 6p. single nucleotide polymorphism microarray revealed a previously unreported complex de novo genetic rearrangement involving subtelomeric segments on chromosomes 6p and 12q\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: btbr t + tf / j strain\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter species\n",
      "Question: List two most common symptoms of Aagenaes syndrome.\n",
      "Answer: \n",
      "Question: Which is the methyl donor of histone methyltransferases?\n",
      "Answer: s - adenosyl - l - methionine\n",
      "Question: Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?\n",
      "Answer: tofacitinib\n",
      "Question: Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?\n",
      "Answer: p16ink4, p15ink4b\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: cdyl\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: dermatitis herpetiformis\n",
      "Question: List common symptoms of patients with the DOORS syndrome.\n",
      "Answer: [CLS]\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gdnf, neurturin, or artemin\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl35a, rpl5, rpl11, rps7, rps10, rps26, and rpl26 and gata1\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: [CLS]\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: modified tokuhashi and tomita scores\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: α - synuclein\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: dsif ) and negative elongation factor ( nelf )\n",
      "Question: Which are the clinical characteristics of Tuberous Sclerosis?\n",
      "Answer: pulmonary manifestations, most commonly spontaneous pneumothorax, were the primary events leading to the diagnosis in 86. 5 % of cases. nearly 55 % of the subjects were being treated with a progesterone derivative. an obstructive pattern on pulmonary function testing was observed in 57. 3 % of the subjects, whereas 33. 9 % had normal spirometric results. women with tuberous sclerosis - related lymphangioleiomyomatosis were younger and had less impaired lung function compared with those with the sporadic form\n",
      "Question: Which proteins does the yeast Cleavage and Polyadenylation Complex contain?\n",
      "Answer: parnafungins\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: p73\n",
      "Question: Which tool is used for promoterome mining using CAGE data?\n",
      "Answer: cager\n",
      "Question: How is active neurotoxin of Clostridium botulinum detected?\n",
      "Answer: bioassay\n",
      "Question: Which are the clinical characteristics of TSC?\n",
      "Answer: neurological clinical symptoms\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: sox2, oct3 / 4 ( pou5f1 ), klf4, and c - myc\n",
      "Question: Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?\n",
      "Answer: hsp90\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: junctin and 35 - 107 of human aspartyl beta - hydroxylase\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: set domain\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: mrc1 subunit\n",
      "Question: Which hormone receptor function is altered in patients with Donohue syndrome?\n",
      "Answer: insulin\n",
      "Question: List Hemolytic Uremic Syndrome Triad.\n",
      "Answer: microangiopathic hemolytic anemia, thrombocytopenia, and renal failure\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: tomita scores more accurately predicted survival than tokuhashi scores\n",
      "Question: Which is the most widely used model for the study of multiple sclerosis (MS)?\n",
      "Answer: experimental autoimmune encephalomyelitis\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which syndromes are associated with heterochromia iridum?\n",
      "Answer: sensorineural hearing loss\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: ulcerative colitis and crohn's disease\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: elvitegravir / cobicistat / emtricitabine / tenofovir single tablet formulation ( stribild ). literature searches were performed in medline ( 1948 - september 2012 ) and pubmed ( 1966 - september 2012 ) using the search terms gs - 9137, elvitegravir, gs 9350, cobicistat, quad pill, stribild, and integrase inhibitors\n",
      "Question: What is the mode of inheritance of Wilson's disease?\n",
      "Answer: autosomal recessive gene\n",
      "Question: In which yeast chromosome does the rDNA cluster reside?\n",
      "Answer: chromosome xii\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kvlqt1\n",
      "Question: What is the role of the UBC9 enzyme in the protein sumoylation pathway?\n",
      "Answer: enhance ets - 1 sumoylation\n",
      "Question: List autoimmune disorders associated with GAD65 autoantibodies.\n",
      "Answer: [CLS]\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: What molecule is targeted by brodalumab?\n",
      "Answer: interleukin - 17\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38 + multiple myeloma cells\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: Is Rheumatoid Arthritis more common in men or women?\n",
      "Answer: men ( n = 67 ) and women\n",
      "Question: What are the computational methods for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: hidden markov model\n",
      "Question: Where can you find the annulus of Zinn?\n",
      "Answer: the orbital surface of the medial rectus and inferior rectus are exposed from the annulus of zinn to a position close to where the muscles penetrate tenons\n",
      "Question: Which proteins participate in the formation of the Notch transcriptional activation complex?\n",
      "Answer: \n",
      "Question: Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?\n",
      "Answer: chaperone - mediated autophagy\n",
      "Question: List the main proteases used for sample digestion in proteomics.\n",
      "Answer: trypsin\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: ditpa and gc - 1\n",
      "Question: List the results of mutated casein kinase 1 epsilon. \n",
      "Answer: \n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: ampicillin\n",
      "Question: Which is the most known bacterium responsible for botulism (sausage-poisoning)?\n",
      "Answer: clostridium botulinum\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: il - 1ri\n",
      "Question: Which are the smallest known subviral pathogens of plants?\n",
      "Answer: viroid\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: pcdh10\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: acute ischaemic stroke in the united kingdom. however, the cochrane systematic review of thrombolysis for acute ischaemic stroke suggests that alteplase is the most promising treatment for acute ischaemic stroke\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: orofacial swelling, facial palsy, and fissured tongue\n",
      "Question: What is the gold standard treatment for Iatrogenic male incontinence?\n",
      "Answer: artificial urethral sphincter\n",
      "Question: What is the gene mutated in the Gaucher disease?\n",
      "Answer: n370s glucocerebrosidase\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: y\n",
      "Question: Which antibodies cause Riedel thyroiditis?\n",
      "Answer: igg4\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: n88s and s90l\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: desert hedgehog ( dhh ), indian hedgehog ( ihh ) and sonic hedgehog ( shh )\n",
      "Question: What are the computational tools for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: \n",
      "Question: Which SLC family is FLVCR1 a member of?\n",
      "Answer: slc49\n",
      "Question: Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?\n",
      "Answer: \n",
      "Question: How is oprozomib administered?\n",
      "Answer: orally\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: raptor and mlst8\n",
      "Question: List the components of a Replisome Progression Complex (RPC).\n",
      "Answer: essential initiation and elongation factor, cdc45, the checkpoint mediator mrc1\n",
      "Question: Which are the most abundant human lincRNA?\n",
      "Answer: neat2\n",
      "Question: List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system.\n",
      "Answer: crs type 1 = acute worsening of heart function leading to kidney injury and / or dysfunction ; crs type 2 = chronic abnormalities in heart function leading to kidney injury or dysfunction ; crs type 3 = acute worsening of kidney function leading to heart injury and / or dysfunction ; crs type 4 = chronic kidney disease leading to heart injury, disease and / or dysfunction, and crs type 5\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical features, duration ( abcd - score ), and diabetes\n",
      "Question: Which transcription factors are involved in E-cadherin repression during EMT?\n",
      "Answer: deltaef1\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa, and enterobacter species\n",
      "Question: Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?\n",
      "Answer: apoe4\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: sin1\n",
      "Question: What is the indication for isradipine?\n",
      "Answer: antihypertensive drug in blacks with essential hypertension\n",
      "Question: Please list 3 diseases associated with the PIEZO2 gene.\n",
      "Answer: [CLS] please list 3 diseases associated with the piezo2 gene. [SEP] familial gordon syndrome associated with a piezo2 mutation. gordon syndrome or distal arthrogryposis type 3 is a rare autosomal dominant disorder characterized by contractures of upper and lower limbs. it is distinguishable from other forms of distal arthrogryposis by cleft palate and short stature. recently, gordon syndrome has been associated to heterozygous mutations in the piezo - type mechanosensitive ion channel component 2 gene ( piezo2 ). different mutations of this gene also cause distal arthrogryposis type 5 and marden - walker syndrome\n",
      "Question: Which protein complexes contain mitofilin?\n",
      "Answer: minos subunits\n",
      "Question: Which enzyme does MLN4924 inhibit?\n",
      "Answer: nedd8 - activating enzyme\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: galactocerebrosidase\n",
      "Question: What is the mode of inheritance of Wilson's disease?\n",
      "Answer: autosomal recessive\n",
      "Question: How many genes are imprinted in the human genome?\n",
      "Answer: fewer than 100\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl35a, rpl5, rpl11, rps7, rps10, rps26, and rpl26 and gata1 in about 60 - 65 % of patients. here, we report a novel large deletion in rpl15, a gene not previously implicated to be causative in dba. like rpl26, rpl15 presents the distinctive feature of being required both for 60s subunit formation and for efficient cleavage of the internal transcribed spacer 1. in addition, we detected five deletions in rp genes in which mutations have been previously shown to cause dba : one each in rps19, rps24, and rps26, and two in rps17. pre - ribosomal rna processing was affected in cells established from the patients bearing these deletions, suggesting a possible molecular basis for their pathological effect. these data identify rpl15\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: gdap1 q218e mutation in autosomal dominant charcot - marie - tooth disease. a wide range of phenotypes have been reported in autosomal recessive ( ar ) charcot - marie - tooth disease ( cmt ) patients carrying mutations in the ganglioside - induced differentiation - associated protein 1 ( gdap1 )\n",
      "Question: Which antibodies cause Riedel thyroiditis?\n",
      "Answer: immunoglobulin g4\n",
      "Question: Which genes are regulated by MEF-2 in the heart?\n",
      "Answer: \n",
      "Question: List available biomedical question answering systems.\n",
      "Answer: three\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: catalytic set domain\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts, facial dysmorphism and peripheral neuropathy\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: calsequestrin, and triadin 1\n",
      "Question: What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?\n",
      "Answer: secis )\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndrome ( mds ) characterized by monosomy 7\n",
      "Question: List 3 indications for Bupropion\n",
      "Answer: management of smoking cessation. unlabelled : sustained release bupropion ( amfebutamone ) is a non - nicotine agent that is indicated as an aid to smoking cessation\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: to review available studies of empagliflozin, a sodium glucose co - transporter - 2 ( sglt2 ) inhibitor approved in 2014 by the european commission and the united states food and drug administration\n",
      "Question: Which human disease is associated with mutated UBQLN2\n",
      "Answer: amyotrophic lateral sclerosis\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: What tyrosine kinase, involved in a Philadelphia- chromosome positive chronic myelogenous leukemia, is the target of Imatinib (Gleevec)?\n",
      "Answer: bcr - abl1 fusion protein\n",
      "Question: List variants of the MC1R gene.\n",
      "Answer: [CLS]\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fibrillin - 1\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: set domain\n",
      "Question: What is the main component of the Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: chronic\n",
      "Question: Which is the most prevalent form of arrhythmia worldwide?\n",
      "Answer: atrial fibrillation\n",
      "Question: Which proteins are the different isoforms of the p38 MAP kinase?\n",
      "Answer: p38α, p38β, p38γ, and p38δ\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: cse4\n",
      "Question: What are the computational tools for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: tmbpro : secondary structure, beta - contact and tertiary structure\n",
      "Question: What organism causes tularemia?\n",
      "Answer: francisella tularensis\n",
      "Question: Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?\n",
      "Answer: mir - 510 and mir - 509 - 5p\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: stevens - johnson syndrome ( sjs ), toxic epidermal necrolysis ( ten ), and drug reaction with eosinophilia and systemic symptoms ( dress )\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: triad\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: rituximab / cyclophosphamide / doxorubicin / vincristine / prednisone\n",
      "Question: Which enzyme is inhibited by Orteronel?\n",
      "Answer: cyp17a1\n",
      "Question: Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?\n",
      "Answer: antiparallel\n",
      "Question: Against which protein is the antibody used for immonostaining of Lewy bodies raised?\n",
      "Answer: alpha - synuclein\n",
      "Question: Is the transcriptional regulator BACH1 an activator or a repressor?\n",
      "Answer: repressor\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: What tissue is most affected in Ehlers-Danlos syndromes?\n",
      "Answer: connective\n",
      "Question: Which enzyme is targeted by Evolocumab?\n",
      "Answer: proprotein convertase subtilisin / kexin type 9\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: \n",
      "Question: Which deficiency is the cause of restless leg syndrome?\n",
      "Answer: iron\n",
      "Question: Which R package is used for the detection of chromosomal abnormalities from microarray data?\n",
      "Answer: cafe\n",
      "Question: What is the main component of the Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: [CLS]\n",
      "Question: Which enzyme is inhibited by a drug fostamatinib?\n",
      "Answer: spleen tyrosine kinase\n",
      "Question: Which are the main NMD factors in Saccharomyces cerevisiae?\n",
      "Answer: upf1 protein\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zinc finger homeo box 1b\n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: Name monoclonal antibody against SLAMF7.\n",
      "Answer: elotuzumab\n",
      "Question: List variants of the MC1R gene.\n",
      "Answer: [CLS]\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which human disease is associated with mutated UBQLN2\n",
      "Answer: \n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: \n",
      "Question: What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?\n",
      "Answer: acvr1 / alk2\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: raptor and rictor\n",
      "Question: Which mutations of SCN5A gene are implicated in Brugada syndrome?\n",
      "Answer: c. 4810 + 3 _ 4810 + 6dupgggt\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: prader - willi syndrome and angelman syndrome\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase - related oculocutaneous albinism ( oca1 ). mutations of the tyrosinase\n",
      "Question: Which package is available for analysing genomic interactions in R/Bioconductor?\n",
      "Answer: r3cseq\n",
      "Question: Which are the side effects during tacrine administration in patients with Alzheimer's Disease?\n",
      "Answer: hepatotoxicity\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline and topiramate\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: List 3 features of IRVAN syndrome.\n",
      "Answer: idiopathic retinal vasculitis, aneurysm, and neuroretinitis\n",
      "Question: List available biomedical question answering systems.\n",
      "Answer: indoc\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 146a rs2910164\n",
      "Question: Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?\n",
      "Answer: interferon regulatory factor 3\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: zdock program for rigid - body protein - protein docking\n",
      "Question: Where can we find the protein lacritin?\n",
      "Answer: lacrimal gland\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts1 and mutl\n",
      "Question: What is the role of TAD protein domain?\n",
      "Answer: promoting peripheral neurogenesis\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: vemurafenib\n",
      "Question: List the existing methods for genetic manipulation of cells.\n",
      "Answer: agrobacterium - mediated as well as direct delivery methods\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: evolocumab\n",
      "Question: Which eye condition is managed by the athens protocol?\n",
      "Answer: keratoconus\n",
      "Question: Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?\n",
      "Answer: amyotrophic lateral sclerosis ( als ) and frontotemporal dementia ( ftd )\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: [CLS] list the human acrocentric chromosomes that are involved in robertsonian translocation. [SEP]\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: gdap1 q218e\n",
      "Question: What is the name of the stem loop present in the 3' end of genes encoding for selenoproteins?\n",
      "Answer: proximal stem - loop promotes sec insertion in the native context but not when positioned far from the uga / sec codon in a heterologous mrna. in contrast, the 140 nucleotides downstream of the secis element inhibit sec insertion. we also show that endogenous sels\n",
      "Question: Which are the bioinformatics tools for gene structure prediction?\n",
      "\n",
      "Answer: geneseqer and splicepredictor\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: PBT2 has been tested for which disorder?\n",
      "Answer: alzheimer's disease\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25. 3\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: ep - dnn\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: swr1\n",
      "Question: What are the main indications of lacosamide?\n",
      "Answer: refractory epilepsy\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: [CLS]\n",
      "Question: Which drugs are included in TAS-102?\n",
      "Answer: tft and tipiracil hydrochloride\n",
      "Question: Which are the supplemental antioxidant in athletes?\n",
      "Answer: [CLS] which are the supplemental antioxidant in athletes? [SEP]\n",
      "Question: What is being measured with an accelerometer in back pain patients\n",
      "Answer: body movement\n",
      "Question: Which are the types of viral meningitis?\n",
      "Answer: mumps meningitis, 11 children with other types of viral meningitis\n",
      "Question: Which tool is available for predicting regulatory interactions from ChIP-seq data?\n",
      "Answer: cismapper\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: everolimus\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: benzothiazepine\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: rivaroxaban, an oral direct factor xa - inhibitor was non - inferior to adjusted dose warfarin\n",
      "Question: List symptoms of the IFAP syndrome.\n",
      "Answer: ichthyosis follicularis with atrichia and photophobia\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: pr / set domain\n",
      "Question: Which protein is found to be mutated in Friedreich's ataxia?\n",
      "Answer: frataxin\n",
      "Question: List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).\n",
      "Answer: thrombocytopenia, coombs - negative hemolytic anemia, neurologic changes, renal impairment, and fever\n",
      "Question: Which genes are associated with Ehlers-Danlos syndrome type I/II?\n",
      "Answer: col5a1 and the col5a2\n",
      "Question: Which diseases that can be treated using the focused ultrasound thalamotomy.\n",
      "Answer: essential tremor\n",
      "Question: List all the available databases of super enhancers\n",
      "Answer: super - enhancer archive\n",
      "Question: Which syndrome is associated with mutations in the LYST gene?\n",
      "Answer: chediak - higashi syndrome\n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: co2\n",
      "Question: What is the presumed key event in Fanconi anemia pathogenesis?\n",
      "Answer: dna damage - induced fancd2 monoubiquitination, a key event for cellular resistance to dna damage\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: oct3 / 4, sox2, klf4, and c - myc\n",
      "Question: In which yeast chromosome does the rDNA cluster reside?\n",
      "Answer: xii\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: 5\n",
      "Question: Which is the major RNA editing enzyme in Drosophila melanogaster?\n",
      "Answer: adar1\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: acute ischaemic stoke.\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: Which is the major RNA editing enzyme in Drosophila melanogaster?\n",
      "Answer: adar\n",
      "Question: What is a miR?\n",
      "Answer: micrornas\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: rivaroxaban\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline, topiramate, and placebo\n",
      "Question: List inhibtors targeting the mitochondrial permeability transition pore.\n",
      "Answer: [CLS]\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which is the main regulatory molecule of SERCA2A function in the cardiac muscle?\n",
      "Answer: phospholamban\n",
      "Question: Which are the human glutamate transporters?\n",
      "Answer: eaac1\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: kras\n",
      "Question: What is the characteristic domain of histone methyltransferases?\n",
      "Answer: carboxyl - terminal set domain\n",
      "Question: Hy's law measures failure for what organ?\n",
      "Answer: liver\n",
      "Question: Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?\n",
      "Answer: piggybac\n",
      "Question: Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?\n",
      "Answer: homozygous truncating mutation\n",
      "Question: Which polymerase transcribes pri-miRNAs?\n",
      "Answer: rna polymerase ii\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: clinical features\n",
      "Question: Which gene is responsible for the development of Sotos syndrome?\n",
      "Answer: nsd1\n",
      "Question: Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?\n",
      "Answer: catecholaminergic polymorphic ventricular tachycardia ( cpvt - 2 )\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: episodic headache, increased sweating, and palpitations\n",
      "Question: Which is the vector of Louping ill virus?\n",
      "Answer: ticks\n",
      "Question: Which deep learning-based algorithms are used for enhancer prediction?\n",
      "Answer: ep - dnn\n",
      "Question: What is generic name of drug Adempas?\n",
      "Answer: riociguat\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which is the transcript responsible for X-chromosome inactivation?\n",
      "Answer: xist\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: silver syndrome / spastic paraplegia 17, distal hereditary motor neuropathy type v, and charcot - marie - tooth disease type 2 ( cmt2 ) with predominant hand involvement\n",
      "Question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.\n",
      "Answer: [CLS] list the human acrocentric chromosomes that are involved in robertsonian translocation. [SEP]\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: ophthalmoplegia, ataxia and confusion\n",
      "Question: Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?\n",
      "Answer: p16ink4a / p14arf\n",
      "Question: The CXCR2 receptor is targeted in cancer. Name five antagonists.\n",
      "Answer: sch - 527123\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kcnq1 and kcnh2 ( herg )\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: active ulcerative colitis\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: ser154\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: \n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: kras\n",
      "Question: Which E3 ubiquitin ligase mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1)?\n",
      "Answer: scfbeta - trcp\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: microrna - 146a\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: dexamethasone, cytosine arabinoside and cisplatin\n",
      "Question: Which tool employs self organizing maps for analyzing synonymous codon usage?\n",
      "Answer: interactive codon usage analysis\n",
      "Question: Name triad of Wernicke encephalopathy.\n",
      "Answer: confusion, ophthalmoplegia, and ataxia\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kcnq1 and kcnh2\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: clustering algorithms using six different interaction datasets. we parameterized the mcl, spectral, rnsc and affinity propagation algorithms\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fibrillin - 1\n",
      "Question: Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?\n",
      "Answer: \n",
      "Question: What are the indications for alteplase?\n",
      "Answer: pulmonary thromboembolism and peripheral vascular disease\n",
      "Question: Which transcription factors are involved in E-cadherin repression during EMT?\n",
      "Answer: deltaef1 is a transcriptional repressor of e - cadherin and regulates epithelial plasticity in breast cancer cells. downregulation of e - cadherin is a crucial event for epithelial to mesenchymal transition ( emt ) in embryonic development and cancer progression. using the epfoser mammary tumour model we show that during emt, upregulation of the transcriptional regulator deltaef1\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: microrna - 223\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: geobacter\n",
      "Question: Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?\n",
      "Answer: gata4, mef2c and tbx5\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which growth factors are known to be involved in the induction of EMT?\n",
      "Answer: igf - ii\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: galactocerebrosidase\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts1 and mutl\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: [CLS]\n",
      "Question: Which are the most under-represented oligonucleotides in higher eukaryote genomes?\n",
      "Answer: octanucleotides\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: re - ly, rocket - af\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3p24. 2 - p26 and 17q25\n",
      "Question: List drugs withdrawn from the market for cardiovascular adverse events.\n",
      "Answer: clobutinol\n",
      "Question: Which are the supplemental antioxidant in athletes?\n",
      "Answer: zinc\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: rictor\n",
      "Question: Which are the clinical characteristics of Tuberous Sclerosis?\n",
      "Answer: [CLS]\n",
      "Question: Viliuisk encephalomyelitis is diagnosed in which geographical area?\n",
      "Answer: northeast siberia\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: xk gene\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: mersacidin\n",
      "Question: Which is the most known bacterium responsible for botulism (sausage-poisoning)?\n",
      "Answer: clostridium botulinum\n",
      "Question: Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?\n",
      "Answer: chaperone - mediated autophagy\n",
      "Question: Which R package is used for the detection of chromosomal abnormalities from microarray data?\n",
      "Answer: cafe\n",
      "Question: Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?\n",
      "Answer: levodopa / carbidopa\n",
      "Question: What is the treatment of neuropathic pain in children?\n",
      "Answer: [CLS]\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fibrillin - 1\n",
      "Question: Which ApoE isoform is associated with hyperlipoproteinemia?\n",
      "Answer: apoe2\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: rs1799853 ( * 2 ) and rs1057910 ( * 3 ) of the cyp2c9 gene, as well as rs9923231 of the vkorc1 gene\n",
      "Question: Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?\n",
      "Answer: gata4, mef2c and tbx5\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: rna polymerase ii\n",
      "Question: List mutations that are implicated in the Gray Platelet Syndrome.\n",
      "Answer: nbeal2\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: mtor - raptor ( regulatory associated protein of mtor ) - mlst8\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: Which is the main calcium pump of the sarcoplasmic reticulum?\n",
      "Answer: serca\n",
      "Question: Which is the most common type of pediatric cerebellar tumor?\n",
      "Answer: medulloblastoma\n",
      "Question: Which anticancer drugs target human topoisomerase II?\n",
      "Answer: etoposide ( vp - 16 ) and teniposide ( vm - 26 )\n",
      "Question: Which protein is associated with hyperemesis gravidarum during pregrancy?\n",
      "Answer: β - hcg\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: [CLS]\n",
      "Question: What disease is Velcade (bortezomib) mainly used for?\n",
      "Answer: multiple myeloma\n",
      "Question: What is the drug target for Simtuzumab?\n",
      "Answer: [CLS]\n",
      "Question: Which enzyme is inhibited by Imetelstat?\n",
      "Answer: telomerase\n",
      "Question: Which major signaling pathways are regulated by RIP1?\n",
      "Answer: necroptosis, apoptosis, and pro - survival / inflammation nf - κb\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil, epirubicin, and cyclophosphamide\n",
      "Question: Which types of cancer can be recognized and treated by the use of immunotherapy?\n",
      "Answer: primary and 206 metastatic tumors\n",
      "Question: Which genes are associated with Ehlers-Danlos syndrome type I/II?\n",
      "Answer: collagen alpha1 ( v ) ( col5a1 )\n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: co2\n",
      "Question: What does the SAGA complex acronym stands for?\n",
      "Answer: spt - ada - gcn5 - acetyltransferase\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: x - linked dominant disorder\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: type 2 diabetes\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase ( th ), aromatic l - amino acid decarboxylase ( aaad ), dopamine - β - hydroxylase ( dbh ) and phenylethanolamine n - methyltransferase ( pnmt )\n",
      "Question: What are the computational tools for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: hidden markov model\n",
      "Question: What are the major classes of retrotransposons active in the human genome?\n",
      "Answer: alu, l1, and sva families\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: mtcp1 / mtcp1nb and brcc3\n",
      "Question: List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.\n",
      "Answer: [CLS]\n",
      "Question: Which enzyme is deficient in Krabbe disease?\n",
      "Answer: human galactocerebrosidase\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: \n",
      "Question: Which disease phenotypes are associated to PRPS1 mutations?\n",
      "Answer: arts syndrome and x - linked charcot - marie - tooth disease - 5 ( cmtx5 )\n",
      "Question: Which genes are implicated in short QT syndrome?\n",
      "Answer: kcnh2, kcnq1 and kcnj2\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: [CLS] list algorithms suitable for predicting protein complexes [SEP]\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: triadin, calsequestrin\n",
      "Question: Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?\n",
      "Answer: protein kinase a ( pka )\n",
      "Question: Is APOBEC3B protein predominantly cytoplasmic or nuclear?\n",
      "Answer: nuclear\n",
      "Question: Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?\n",
      "Answer: neuronal alterations\n",
      "Question: Which are the different members/isoforms of the Ras oncogenes?\n",
      "Answer: h - ras, n - ras, k - ras4a, and k - ras4b\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: c - myc\n",
      "Question: Which diseases have been associated with the PTPN22 620W allele?\n",
      "Answer: type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus, and hashimoto thyroiditis\n",
      "Question: List diseases where protein citrullination plays an important role.\n",
      "Answer: [CLS]\n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: melanoma or angiosarcoma\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 6p25. 3 - > p23 and 12q24. 32 - > qter in a child with moyamoya. a 7 - year - old white girl presented with left hemiparesis and ischemic stroke secondary to moyamoya syndrome, a progressive cerebrovascular occlusive disorder of uncertain but likely multifactorial etiology. past medical history revealed hearing loss and developmental delay / intellectual disability. routine karyotype demonstrated extra chromosomal material on 6p. single nucleotide polymorphism microarray revealed a previously unreported complex de novo genetic rearrangement involving subtelomeric segments on chromosomes 6p and 12q\n",
      "Question: Which variables are included in the SPAN-100 score?\n",
      "Answer: age and nih stroke scale ( span ) index by combining age in years plus nih stroke scale\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: calsequestrin, and triadin 1\n",
      "Question: Which anticancer drugs target human topoisomerase II?\n",
      "Answer: \n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: oligodeoxyribonucleotides containing dzcyt\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv\n",
      "Question: Which genes does thyroid hormone receptor beta1 regulate in the liver?\n",
      "Answer: [CLS]\n",
      "Question: Which tool is used for promoterome mining using CAGE data?\n",
      "Answer: cager\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: licensed indication\n",
      "Question: Which syndromes are associated with mutations in the EZH2 gene?\n",
      "Answer: myelodysplastic syndrome ( mds )\n",
      "Question: Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?\n",
      "Answer: catecholaminergic polymorphic ventricular tachycardia ( cpvt ) is a familial cardiac arrhythmia\n",
      "Question: Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?\n",
      "Answer: bilateral lambdoid and sagittal\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS]\n",
      "Question: Which mutated genes are associated with isolated ectopia lentis?\n",
      "Answer: adamtsl4 and fbn1\n",
      "Question: Which are the genes responsible for Dyskeratosis Congenita?\n",
      "Answer: dkc1\n",
      "Question: List clinical features of the IMAGe syndrome.\n",
      "Answer: [CLS]\n",
      "Question: List inhibtors targeting the mitochondrial permeability transition pore.\n",
      "Answer: [CLS]\n",
      "Question: List the components of mTOR Complex 2 (mTORC2).\n",
      "Answer: rictor\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: factor xa\n",
      "Question: Which RNA polymerase is used for the replication of viroids?\n",
      "Answer: dna - dependent rna polymerase ii\n",
      "Question: Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?\n",
      "Answer: nanog, pou5f1 and soxb1\n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: cytotoxic mechanisms of the london - type abetapp\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: serotonin 5 - ht2a receptor\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age, blood pressure, clinical features, duration ( abcd - score ), and diabetes\n",
      "Question: What is the role of TAD protein domain?\n",
      "Answer: essential for retaining p53 in the cytoplasmic body\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: childhood spinal muscular atrophy\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: distal hereditary motor neuropathy type v ( dhmn - v ) and charcot - marie - tooth syndrome ( cmt ) type 2\n",
      "Question: Which database is available for the identification of chorion proteins in Lepidopteran proteomes?\n",
      "Answer: lepchoriondb\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: o ( 6 ) - mg : t replication intermediates\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: \n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: facial paralysis, facial oedema, and lingua plicata\n",
      "Question: What molecule is targeted by suvorexant?\n",
      "Answer: orexin\n",
      "Question: Which are the synonyms of prostate-specific antigen?\n",
      "Answer: psa\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: fifth\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: prader - willi syndrome ( pws ) and angelman syndrome ( as )\n",
      "Question: Which virus type causes Molluscum contagiosum?\n",
      "Answer: human poxvirus\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: mir - 124a\n",
      "Question: Which transcription factors are involved in E-cadherin repression during EMT?\n",
      "Answer: zeb1\n",
      "Question: Against which protein is the antibody used for immonostaining of Lewy bodies raised?\n",
      "Answer: alpha - synuclein\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: sox2, oct3 / 4 ( pou5f1 ), klf4, and c - myc\n",
      "Question: Which protein complexes recognize centromeric (CEN) DNA in yeast?\n",
      "Answer: cse4\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: 1, 4 - benzothiazepine\n",
      "Question: List two common features of Tay syndrome.\n",
      "Answer: low birth weight, short stature, mental retardation, delayed neuromuscular development and other cns anomalies\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: List features of the Kaufman Oculocerebrofacial Syndrome.\n",
      "Answer: reduced growth, microcephaly, ocular anomalies ( microcornea, strabismus, myopia, and pale optic disk ), distinctive facial features ( narrow palpebral fissures, telecanthus, sparse and laterally broad eyebrows, preauricular tags, and micrognathia ), mental retardation, and generalised hypotonia\n",
      "Question: Which are the triad symptoms of pheochromocytoma?\n",
      "Answer: headache, sweating and palpitations\n",
      "Question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.\n",
      "Answer: gata - 1 / fog - 1 and gata - 1 / tal - 1 complexes\n",
      "Question: What is targeted by monoclonal antibody Pembrolizumab?\n",
      "Answer: programmed cell death 1 ( pd - 1 ) immune checkpoint and has antitumor activity in patients with advanced melanoma\n",
      "Question: Which interleukin is blocked by Siltuximab?\n",
      "Answer: il - 6\n",
      "Question: What is the inheritance of hypophosphatemic rickets?\n",
      "Answer: x - linked dominant disorder\n",
      "Question: Which proteins act as factors that promote transcription-coupled repair in bacteria?\n",
      "Answer: mfd\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: [CLS]\n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: List co-morbidities that may occur together with \"Stiff man Syndrome\"\n",
      "Answer: breast cancer\n",
      "Question: Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?\n",
      "Answer: hypotonia, obstructive apnea, foot deformity, and congenital weakness of the abdominal wall\n",
      "Question: Which hormone abnormalities are common in Williams syndrome ?\n",
      "Answer: hypercalcemia, hypercalciuria, hypothyroidism, and early puberty\n",
      "Question: Which species may be used for the biotechnological production of itaconic acid?\n",
      "Answer: aspergillus terreus\n",
      "Question: Which human genes are more commonly related to craniosynostosis?\n",
      "Answer: fibroblast growth factor receptor 2\n",
      "Question: What are the side effects of Nalmefene?\n",
      "Answer: nausea, dizziness, and insomnia\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: drug rash with eosinophilia and systemic symptoms ( dress ), stevens - johnson syndrome ( sjs ) and toxic epidermal necrosis ( ten )\n",
      "Question: List non-surgical treatment modalities that are included in the Stupp protocol.\n",
      "Answer: [CLS]\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3p24. 2 - p26 and 17q25\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban compared with warfarin\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: inflammatory bowel disease\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Idarucizumab is an antidote of which drug?\n",
      "Answer: dabigatran\n",
      "Question: LY450139 is investigational name of which drug?\n",
      "Answer: semagacestat\n",
      "Question: What memory problems are reported in the \" Gulf war syndrome\"?\n",
      "Answer: severe cognitive impairment especially concerning memory\n",
      "Question: Which genes are implicated in short QT syndrome?\n",
      "Answer: kcnh2\n",
      "Question: Where can we find the protein lacritin?\n",
      "Answer: human lacrimal gland\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: airway inflammation\n",
      "Question: What tissue is most affected in Ehlers-Danlos syndromes?\n",
      "Answer: skin\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: nelf and dsif\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?\n",
      "Answer: fhc ( r403q\n",
      "Question: Which interleukins are inhibited by Dupilumab?\n",
      "Answer: interleukin - 4 and interleukin - 13\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: secondary myelodysplastic syndrome\n",
      "Question: List inflammatory caspase proteins?\n",
      "Answer: caspase - 1\n",
      "Question: Dracorhodin perchlorate was tested for treatment of which cancers?\n",
      "Answer: prostate cancer\n",
      "Question: Which protein is the main marker of Cajal bodies?\n",
      "Answer: coilin\n",
      "Question: List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients\n",
      "Answer: vemurafenib and dabrafenib\n",
      "Question: Which is the defective protein causing the lysosomal storage disease Fabry?\n",
      "Answer: lysosomal alpha - galactosidase a\n",
      "Question: List fish anti-freeze proteins.\n",
      "Answer: [CLS]\n",
      "Question: Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?\n",
      "Answer: microrna - 221 / 222 and microrna - 323 - 3p\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: fifth\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: sinusitis, bronchiectasis and situs inversus with dextrocardia\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: dermatitis herpetiformis\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: discuss the etiology and the clinical and electromyography findings of this syndrome\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: rooke - spiegler syndrome, familial cylindromatosis, and familial trichoepithelioma\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: geobacter\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban was superior to warfarin\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: \n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: jaspar core - - an expanded version of the original, non - redundant collection of annotated, high - quality matrix - based transcription factor binding profiles, jaspar fam - - a collection of familial tfbs models and jaspar phylofacts - - a set of matrices computationally derived from statistically overrepresented, evolutionarily conserved regulatory region motifs from mammalian genomes. jaspar phylofacts serves as a non - redundant extension to jaspar core, enhancing the overall breadth of jaspar for promoter sequence analysis. the new release of jaspar is available at http : / / jaspar. genereg. net\n",
      "Question: Which is the most prevalent form of arrhythmia worldwide?\n",
      "Answer: atrial fibrillation\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: List signaling molecules (ligands) that interact with the receptor EGFR?\n",
      "Answer: plasma epidermal growth factor receptor\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q11. 2\n",
      "Question: List tele monitoring applications of miniaturised sensors\n",
      "Answer: [CLS] list tele monitoring applications of miniaturised sensors [SEP]\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl35a, rpl5, rpl11, rps7, rps10, rps26, and rpl26 and gata1\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: \n",
      "Question: Intetumumab has been tested in clinical trials for treatment of which cancers?\n",
      "Answer: metastatic castration - resistant prostate cancer\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: n - terminal kinase\n",
      "Question: Which are the Yamanaka factors?\n",
      "Answer: pou5f1, myc, klf4, and sox2\n",
      "Question: Which protein does empagliflozin inhibit?\n",
      "Answer: sglt2\n",
      "Question: Which is the  subcellular localization of ERAP2?\n",
      "Answer: luminal side of the endoplasmic reticulum\n",
      "Question: Is the transcriptional regulator BACH1 an activator or a repressor?\n",
      "Answer: repressor\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterococcus faecium, staphylococcus aureus, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and enterobacter spp.\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: ampicillin, d - cycloserine, or fosfomycin\n",
      "Question: List 3 features of IRVAN syndrome.\n",
      "Answer: \n",
      "Question: List features of the Kaufman Oculocerebrofacial Syndrome.\n",
      "Answer: psychomotor retardation, microcephaly, blepharophimosis and delayed growth\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: 245 mg of tenofovir, 200 mg of emtricitabine, 150 mg of elvitegravir and 150 mg of cobicistat\n",
      "Question: which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?\n",
      "Answer: d145e drastically alters calcium binding by the c - domain of cardiac troponin c. the role of the c - domain sites of cardiac troponin c in the modulation of the calcium signal remains unclear. in this study, we investigated the effects of hypertrophic cardiomyopathy - linked mutations a8v, e134d, and d145e\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: oestrogen receptor - negative breast cancer\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: swr1\n",
      "Question: Which proteins act as histone-like molecules in prokaryotes?\n",
      "Answer: hu\n",
      "Question: List three major features of the CCFDN syndrome.\n",
      "Answer: congenital cataracts facial dysmorphism\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: dnmt3ak44me2\n",
      "Question: What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?\n",
      "Answer: alemtuzumab\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: dna - binding protein 8\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which extra thyroid tissues have thyrotropin (TSH) receptors?\n",
      "Answer: [CLS] which extra thyroid tissues have thyrotropin ( tsh ) receptors? [SEP]\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: direct factor xa\n",
      "Question: Which is the E3 ubiquitin ligase which ubiquitinates IkB leading to its proteasomal degradation?\n",
      "Answer: e3rs\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: p19 ( arf ) - p53 pathway\n",
      "Question: Which gene harbors the mutation T790M?\n",
      "Answer: epidermal growth factor receptor\n",
      "Question: Where can we find the protein lacritin?\n",
      "Answer: sds - page\n",
      "Question: List the diseases for which there are point-of-care breath tests\n",
      "Answer: there has been no point of care tool for assessing the underlying airway inflammation\n",
      "Question: Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?\n",
      "Answer: distal hereditary motor neuropathy type v and silver's syndrome\n",
      "Question: Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?\n",
      "Answer: apobec3g ( a3g ) and apobec3f ( a3f )\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: kras\n",
      "Question: What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations?\n",
      "Answer: fanconi anemia\n",
      "Question: Which genes were found to be methylated in bladder cancer cells?\n",
      "Answer: rarβ ( 2 ) and apc\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: [CLS]\n",
      "Question: Which are the state-of-the-art computational tools for the prediction of gene fusion events?\n",
      "Answer: [CLS] which are the state - of - the - art computational tools for the prediction of gene fusion events? [SEP]\n",
      "Question: Which genes have been associated with Cerebral Cavernous Malformation?\n",
      "Answer: krit1 / ccm1\n",
      "Question: Which fusion protein is involved in the development of Ewing sarcoma?\n",
      "Answer: ews / fli1\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: two distinct multiprotein complexes\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts1 and mutl\n",
      "Question: Which bacteria cause diphtheria?\n",
      "Answer: corynebacterium diphtheriae\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: active crohn's disease\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil, epirubicin, and cyclophosphamide\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: nh2 - terminal kinase\n",
      "Question: Mutation of which gene is implicated in the Brain-lung-thyroid syndrome?\n",
      "Answer: nkx2 - 1\n",
      "Question: The small molecule SEA0400 is an inhibitor of which ion antiporter/exchanger?\n",
      "Answer: ncx\n",
      "Question: Which is the enzyme that degrades decapped mRNAs?\n",
      "Answer: xrn1\n",
      "Question: Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?\n",
      "Answer: swr1 / srcap complex\n",
      "Question: Which proteins form part of the NRD complex in S. cerevisiae?\n",
      "Answer: hdac1, mta1, and mta2\n",
      "Question: Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?\n",
      "Answer: p65 and p50\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: bone collagen\n",
      "Question: What are the main indications of lacosamide?\n",
      "Answer: generalized tonic - clonic and partial - onset epilepsies\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: List the classical triad of symptoms of the Melkersson–Rosenthal syndrome.\n",
      "Answer: the classical triad of recurrent facial paralysis, swelling of the face, lips and deep furrowed tongue\n",
      "Question: Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?\n",
      "Answer: pse - in - one\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: c - myc ( myc )\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q25. 3\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: rituximab, dexamethasone, aracytine, and cisplatin\n",
      "Question: List types of avoided words in bacterial genomes\n",
      "Answer: palindromes in a particular genome, indicating a direct connection between the avoidance of short oligonucleotide words and restriction - modification systems with the respective specificity. palindromes corresponding to sites for restriction enzymes from other species are also avoided, albeit less significantly, suggesting that in the course of evolution bacterial dna has been exposed to a wide spectrum of restriction enzymes, probably as the result of lateral transfer mediated by mobile genetic elements, such as plasmids and prophages. palindromic words appear to accumulate in dna once it becomes isolated from restriction - modification systems, as demonstrated by the case of organellar genomes. by combining these observations with protein sequence analysis, we show that the most avoided 4 - palindrome and the most avoided 6 - palindrome\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: atp13a2\n",
      "Question: Which diseases is microRNA 132 (miR-132) implicated in?\n",
      "Answer: [CLS] which diseases is microrna 132 ( mir - 132 ) implicated in? [SEP]\n",
      "Question: From which tissue was the NCI-H520 cell-line derived?\n",
      "Answer: \n",
      "Question: List causative genes for autosomal recessive forms of monogenic Parkinson's disease\n",
      "Answer: loss - of - function mutations in parkin, pink1, dj - 1 and atp13a2 cause autosomal recessive parkinsonism with early - onset\n",
      "Question: List two common features of Tay syndrome.\n",
      "Answer: clinical features, complementary exams\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: geobacteraceae\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: \n",
      "Question: Which metabolite activates AtxA?\n",
      "Answer: co ( 2 ) / bicarbonate\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3p24. 2 - p26\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: dna - binding protein\n",
      "Question: Symptoms of which disorder are evaluated with the Davidson Trauma Scale?\n",
      "Answer: posttraumatic stress disorder\n",
      "Question: Which is the genome browser database for DNA shape annotations?\n",
      "Answer: gbshape\n",
      "Question: What are the indications for alteplase?\n",
      "Answer: treatment of thrombus - related venous catheter occlusion in pediatric patients\n",
      "Question: List the three most prevalent pathogenic species of Borrelia in Europe.\n",
      "Answer: 18. 9 % b. burgdorferi s. s., 11. 9 % b. afzelii, and 3. 5 % b. garinii\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: pharmacological treatment of fibromyalgia\n",
      "Question: List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.\n",
      "Answer: canagliflozin was the first sglt2 inhibitor to be approved by the us fda for use in the treatment of type 2 diabetes, and recently dapagliflozin has also been approved\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1 tumor - suppressor gene\n",
      "Question: Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?\n",
      "Answer: parathyroid glands and the pancreas\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: epof\n",
      "Question: Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?\n",
      "Answer: nrd1 - exosome - tramp complexes\n",
      "Question: Which growth factors are known to be involved in the induction of EMT?\n",
      "Answer: c - myc and cdx2\n",
      "Question: Which two drugs are included in the Harvoni pill?\n",
      "Answer: ledipasvir / sofosbuvir\n",
      "Question: Which neuroendocrine tumors are associated with specific tumor syndromes?\n",
      "Answer: pheochromocytomas\n",
      "Question: List selective estrogen receptor degraders.\n",
      "Answer: fulvestrant\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: myelodysplastic syndromes\n",
      "Question: Which is the causative agent of malaria?\n",
      "Answer: plasmodium spp.\n",
      "Question: List selective estrogen receptor degraders.\n",
      "Answer: [CLS] list selective estrogen receptor degraders. [SEP] evaluation of the pharmacological activities of rad1901\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: What organism causes tularemia?\n",
      "Answer: francisella tularensis\n",
      "Question: Which genes does thyroid hormone receptor alpha1 regulate in the heart?\n",
      "Answer: kcnq1 and its regulatory beta - subunit kcne1\n",
      "Question: List diseases where protein citrullination plays an important role.\n",
      "Answer: neurodegenerative diseases\n",
      "Question: Which proteins act as histone-like molecules in prokaryotes?\n",
      "Answer: hu\n",
      "Question: Which are the subtypes of Pfeiffer syndrome?\n",
      "Answer: severely affected\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban when compared with warfarin\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: autosomal microdeletion syndromes, x - linked microdeletion syndromes, and microduplication syndromes\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which are the different homologs or family members of the hedgehog proteins in mammals?\n",
      "Answer: desert hedgehog ( dhh ), indian hedgehog ( ihh ) and sonic hedgehog ( shh )\n",
      "Question: List programs suitable for protein docking\n",
      "Answer: sol\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: List kinases that phosphorylates the protein Bora.\n",
      "Answer: cdk1\n",
      "Question: Which hormone deficiency is implicated in the Costello syndrome ?\n",
      "Answer: growth\n",
      "Question: Dracorhodin perchlorate was tested for treatment of which cancers?\n",
      "Answer: human prostate cancer, human gastric tumor cells and human melanoma\n",
      "Question: Which agents are included in the FLAMSA chemotherapy regimen?\n",
      "Answer: fludarabine, amsacrine, and cytarabine\n",
      "Question: Which compounds exist that are thyroid hormone analogs?\n",
      "Answer: 3, 5 - diiodothyropropionic acid and cgs 23425\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: chronic sinusitis, bronchiectasis and situs inversus with dextrocardia\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: facioscapulohumeral muscular dystrophy\n",
      "Question: Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?\n",
      "Answer: p16ink4a\n",
      "Question: Which drug was tested in the TEMSO Trial for multiple sclerosis?\n",
      "Answer: teriflunomide\n",
      "Question: Which ones are the ESKAPE organisms?\n",
      "Answer: enterobacter species\n",
      "Question: Which extra thyroid tissues have thyrotropin (TSH) receptors?\n",
      "Answer: white adipose tissues\n",
      "Question: Which MAP kinase phosphorylates the transcription factor c-jun?\n",
      "Answer: n - terminal kinase\n",
      "Question: Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?\n",
      "Answer: muts, mutl and muth\n",
      "Question: What is the typical rash associated with gluten ?\n",
      "Answer: dermatitis herpetiformis\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: ataxia, hypomyelination, hypodontia, and hypogonadotropic hypogonadism\n",
      "Question: Which tool is used for the identification of recurrent variants in noncoding regions?\n",
      "Answer: larva\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: abetah ( aspartyl - beta - hydroxylase ), a structural protein of the sarcoplasmic reticulum membrane ( junctin ), and an integral membrane calcium binding protein ( junctate )\n",
      "Question: Which protein is found to be mutated in Friedreich's ataxia?\n",
      "Answer: frataxin\n",
      "Question: Which is the gene mutated in type 1 neurofibromatosis?\n",
      "Answer: nf1\n",
      "Question: Which disease the London mutation involved in?\n",
      "Answer: ad\n",
      "Question: Which genes are affected in ROMANO-WARD syndrome?\n",
      "Answer: kvlqt1, herg, scn5a, kcne1, and kcne2\n",
      "Question: How is active neurotoxin of Clostridium botulinum detected?\n",
      "Answer: receptor - binding ( hc ) domain, while the amino - terminal ( hn ) domain is linked by a critical disulfide bond to a light chain ( l - chain ) of ~ 50 kda. although the mouse bioassay ( mba ) is traditionally used to confirm the presence of toxin in serum or food, its sensitivity is insufficient to detect low toxin levels in approximately 30 to 60 % of botulism patients. a novel fdc ( functional dual coating ) microtitre plate immuno - biochemical assay, which quantifies botulinum toxicity by measuring the hc domain linked with l - chain endopeptidase activity, was modified to allow human serum ( lysed or unlysed ) to be tested without interference from the matrix, with toxin detection down to 0. 03 mouse ld50 per ml serum or 0. 13 pg ml ( - 1 ) using just 100 µl of clinical samples\n",
      "Question: Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?\n",
      "Answer: encode, roadmap, blueprint and deep\n",
      "Question: Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?\n",
      "Answer: fcgr2a and functionally related genes\n",
      "Question: What fruit causes Jamaican vomiting sickness?\n",
      "Answer: ackee fruit\n",
      "Question: Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia\n",
      "Answer: sf3b1, zmym3, mapk1, fbxw7, and ddx3x ). sf3b1, which functions at the catalytic core of the spliceosome, was the second most frequently mutated gene\n",
      "Question: Which proteins are the different isoforms of the p38 MAP kinase?\n",
      "Answer: p38α, p38β, p38γ, and p38δ\n",
      "Question: Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?\n",
      "Answer: proximal limb muscle weakness, fatigability, decreased deep - tendon reflexes, and autonomic symptoms\n",
      "Question: Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product?\n",
      "Answer: brg1\n",
      "Question: Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?\n",
      "Answer: [CLS]\n",
      "Question: Which 2 medications are included in the Qsymia pill?\n",
      "Answer: lorcaserin hcl ( belviq ) and phentermine / topiramate\n",
      "Question: Which are the different members/isoforms of the Ras oncogenes?\n",
      "Answer: h - ras, n - ras, k - ras4a, and k - ras4b\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which are the clinical symptoms of left ventricular noncompaction?\n",
      "Answer: arrhythmia and sudden cardiac death\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: crohn's disease\n",
      "Question: Which syndromes are associated with heterochromia iridum?\n",
      "Answer: sensorineural hearing loss\n",
      "Question: Which tumor suppressor is referred to as \"the guardian of the genome\"?\n",
      "Answer: p53\n",
      "Question: Which is the defective protein causing the lysosomal storage disease Fabry?\n",
      "Answer: lysosomal alpha - galactosidase a\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: age [ a ], blood pressure [ b ], clinical features [ weakness / speech disturbance ] [ c ], transient ischemic attack duration [ d ], and diabetes history [ d ]\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: chriz and the zinc - finger protein z4\n",
      "Question: What are the reported adverse effects of gabapentin used in children?\n",
      "Answer: urticarial rash and irritability\n",
      "Question: Please list 3 diseases associated with the PIEZO2 gene.\n",
      "Answer: distal arthrogryposis 3\n",
      "Question: List active ingredients of the Stribild polypill.\n",
      "Answer: [CLS]\n",
      "Question: List drugs included in the DHAP-R chemotherapy regiment.\n",
      "Answer: rituximab\n",
      "Question: Which antibiotics target peptidoglycan biosynthesis?\n",
      "Answer: ramoplanin\n",
      "Question: Which signaling pathway is activating the dishevelled proteins?\n",
      "Answer: wnt\n",
      "Question: Which species of bacteria did the mitochondria originate from?\n",
      "Answer: alpha - proteobacterium\n",
      "Question: Which mitochondrial genes are regulated by thyroid hormone?\n",
      "Answer: nadh dehydrogenase subunit 3 ( nd3 )\n",
      "Question: List symptoms of 4H leukodystrophy.\n",
      "Answer: hypogonadotropic hypogonadism\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: met1, met2a, met2b, met3\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: e327k\n",
      "Question: What is the cause of Phthiriasis Palpebrarum?\n",
      "Answer: louse pthirus pubis\n",
      "Question: Which oncogenes are able to induce cellular senescence?\n",
      "Answer: hdac2\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: cmt1 and 2\n",
      "Question: Where is the TAZ (G4.5) is located in humans?\n",
      "Answer: xq28\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: [CLS] list bacteria that may be useful in uranium bioremediation. [SEP] analysis of the genetic potential and gene expression of microbial communities involved in the in situ bioremediation of uranium and harvesting electrical energy from organic matter. the proposed research will investigate two microbial communities that are of direct relevance to department of energy interests. one is the microbial community associated with the in situ bioremediation of uranium - contaminated groundwater. the second is a microbial community that harvests energy from waste organic matter in the form of electricity. these studies will address doe needs for ( 1 ) remediation of metals and radionuclides at doe sites and ( 2 ) the development of cleaner forms of energy and biomass conversion to energy. our previous studies have demonstrated that the microbial communities involved in uranium bioremediation and energy harvesting are both dominated by microorganisms in the family geobacteraceae\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which gene mutations cause the Marfan syndrome?\n",
      "Answer: fbn1\n",
      "Question: Which enzyme is inhibited by niraparib?\n",
      "Answer: poly ( adp - ribose ) polymerase\n",
      "Question: Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?\n",
      "Answer: tia - 1 immunoreactive\n",
      "Question: Which receptors can be evaluated with the [18F]altanserin?\n",
      "Answer: 5 - ht2a\n",
      "Question: Which are the DNA (cytosine-5-)-methyltransferases inhibitors?\n",
      "Answer: procaine and procainamide\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: aspartyl beta - hydroxylase, junctin and junctate\n",
      "Question: Name monoclonal antibody against SLAMF7.\n",
      "Answer: elotuzumab\n",
      "Question: Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?\n",
      "Answer: tyrosinase\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dna methyltransferase - 1\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: [CLS]\n",
      "Question: List programs suitable for pharmacophore modelling\n",
      "Answer: \n",
      "Question: Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?\n",
      "Answer: dnmt3a and 3b\n",
      "Question: Which annotated database of A-to-I RNA editing is available?\n",
      "Answer: radar\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: [CLS]\n",
      "Question: List available methods for transmembrane protein topology prediction.\n",
      "Answer: [CLS]\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: Name synonym of Acrokeratosis paraneoplastica.\n",
      "Answer: bazex syndrome\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: vkorc1 and cyp2c9\n",
      "Question: In which proteins is the chromodomain present?\n",
      "Answer: cbx3\n",
      "Question: Which gene is involved in Giant Axonal Neuropathy?\n",
      "Answer: gan\n",
      "Question: Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?\n",
      "Answer: calsequestrin, and triadin\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: everolimus\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: Selexipag is used for which disease?\n",
      "Answer: pulmonary arterial hypertension\n",
      "Question: Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?\n",
      "Answer: let - 7i\n",
      "Question: Willis-Ekbom disease is also known as?\n",
      "Answer: restless legs syndrome\n",
      "Question: Which bone protein is used in archaelogy for dating and species identification?\n",
      "Answer: collagen\n",
      "Question: List clinical features of EEM syndrome.\n",
      "Answer: [CLS]\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: Which library is used for fixed-length approximate string matching?\n",
      "Answer: libflasm\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: vkorc1 and cyp2c9\n",
      "Question: List scales that are used for scoring of patients with spinal metastasis?\n",
      "Answer: modified tokuhashi score was the highest among all four scoring systems\n",
      "Question: Which are the genes thought to be regulated by EWS/FLI?\n",
      "Answer: nkx2. 2\n",
      "Question: Which fusion protein is involved in the development of Ewing sarcoma?\n",
      "Answer: ews / fli1\n",
      "Question: How is OCT3 associated with serotonin?\n",
      "Answer: clearance\n",
      "Question: Mutation of which gene and which chromosome cause Neurofibromatosis type I?\n",
      "Answer: 17\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: Which disease phenotypes are associated to PRPS1 mutations?\n",
      "Answer: non - syndromic to syndromic hearing loss\n",
      "Question: Which molecule is targeted by a monoclonal antibody Mepolizumab?\n",
      "Answer: interleukin - 5\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: developmental delay, epilepsy and neonatal diabetes\n",
      "Question: List peptide fragmentations methods in mass spectrometry\n",
      "Answer: [CLS] list peptide fragmentations methods in mass spectrometry [SEP]\n",
      "Question: Which proteins have been identified as RET ligands?\n",
      "Answer: gdnf, neurturin, artemin, and persephin\n",
      "Question: What is the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hisrchsprung disease?\n",
      "Answer: ret\n",
      "Question: Which enzyme does MLN4924 inhibit?\n",
      "Answer: nedd8\n",
      "Question: Which receptor is targeted by telcagepant?\n",
      "Answer: calcitonin gene - related peptide receptor blockers. this compound exerts its effects by blocking receptors for the calcitonin - gene - related peptide\n",
      "Question: Which are the typical symptoms of Ménière's disease?\n",
      "Answer: cochlear sensorineural hearing loss, tinnitus, and intermittent vertigo attacks\n",
      "Question: Which diseases can Oncotype DX be used for?\n",
      "Answer: estrogen receptor - positive node - negative breast cancer\n",
      "Question: What molecule is targeted by Avelumab?\n",
      "Answer: pd - l1\n",
      "Question: Which factors play a role in promoter proximal pausing of RNA polymerase II?\n",
      "Answer: nelf\n",
      "Question: What are the computational tools for the prediction of beta-barrel transmembrane proteins?\n",
      "Answer: [CLS] what are the computational tools for the prediction of beta - barrel transmembrane proteins? [SEP] a consensus algorithm to screen genomes for novel families of transmembrane beta barrel proteins. the ability to search sequence datasets for membrane spanning proteins is an important requirement for genome annotation. however, the development of algorithms to identify novel types of transmembrane beta - barrel ( tmb ) protein has proven substantially harder than for transmembrane helical proteins, owing to a shorter tm domain in which only alternate residues are hydrophobic. although recent reports have described important improvements in the development of such algorithms, there is still concern over their ability to confidently screen genomes. here we describe a new algorithm combining composition and hidden markov model topology based classifiers\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: [CLS]\n",
      "Question: Which proteins participate in the formation of the Notch transcriptional activation complex?\n",
      "Answer: csl, icn, and a specialized co - activator of the mastermind family\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: th, dbh, and aadc\n",
      "Question: Andexanet Alfa is an antidote of which clotting factor inhibitors?\n",
      "Answer: direct thrombin inhibitors as well as direct factor xa inhibitors\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 3p24. 2 - 26\n",
      "Question: Where can you find the annulus of Zinn?\n",
      "Answer: a simulation of the procedure in a cadaver and en bloc resection of the orbital apex are performed to demonstrate the subdural plane of dissection\n",
      "Question: Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?\n",
      "Answer: q1065h\n",
      "Question: List fluorescent reporter proteins.\n",
      "Answer: egfp )\n",
      "Question: What medication were compared in the ROCKET AF Trial?\n",
      "Answer: rivaroxaban\n",
      "Question: Which molecule is targeted by the drug Gevokizumab?\n",
      "Answer: il - 1β\n",
      "Question: Which CDK targets control cytokinesis?\n",
      "Answer: \n",
      "Question: Which hormone concentrations are altered in patients with the Allan–Herndon–Dudley syndrome?\n",
      "Answer: thyroid hormone\n",
      "Question: Which signaling pathways have been associated with medulloblastoma formation and growth?\n",
      "Answer: wnt\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: breast cancer\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: apixaban compared with warfarin\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: flaccid, spastic, or spastic - flaccid\n",
      "Question: Which are the main NMD factors in Saccharomyces cerevisiae?\n",
      "Answer: upf1p, nmd2p, and upf3p\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: List cardinal features of the Triple A syndrome.\n",
      "Answer: adrenal insufficiency due to acth insensitivity, achalasia and alacrima\n",
      "Question: Which two drugs were compared in the ARISTOTLE Trial?\n",
      "Answer: [CLS]\n",
      "Question: What family do mDia proteins belong in?\n",
      "Answer: formin\n",
      "Question: Which NADPH oxidase family member requires interaction with NOXO1 for function?\n",
      "Answer: nox1\n",
      "Question: Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?\n",
      "Answer: hs\n",
      "Question: Is the transcriptional regulator BACH1 an activator or a repressor?\n",
      "Answer: repressor\n",
      "Question: Which disease is treated with taliglucerase alfa?\n",
      "Answer: gaucher disease. taliglucerase alfa is a plant cell - expressed beta - glucocerebrosidase approved in the united states, israel, australia, canada, and other countries for enzyme replacement therapy in adults with type 1 gaucher disease\n",
      "Question: List symptoms of Meigs' Syndrome.\n",
      "Answer: pelvic mass, pleural effusion and ascites with normal cytology, increased ca125 levels\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: What is the gold standard treatment for Iatrogenic male incontinence?\n",
      "Answer: artificial urethral sphincter\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: epilepsy and developmental delay\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: Which growth factors are known to be involved in the induction of EMT?\n",
      "Answer: wnt and ras\n",
      "Question: Which are the major types of the motor speech disorder dysarthria?\n",
      "Answer: [CLS]\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: List features of the Perry syndrome.\n",
      "Answer: weight loss, parkinsonism, central hypoventilation, and psychiatric disturbances\n",
      "Question: Which tool is available for predicting regulatory interactions from ChIP-seq data?\n",
      "Answer: cismapper\n",
      "Question: What is the target of daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which proteins are involved in actin bundling and filopodia formation and function?\n",
      "Answer: fascin - free zone of bundles increased, but fascin\n",
      "Question: Which R / bioconductor package is used for enrichment analysis of genomic regions?\n",
      "Answer: lola\n",
      "Question: Which genes are involved in patient response to warfarin?\n",
      "Answer: cyp2c9 * 2 and cyp2c9 * 3\n",
      "Question: Which transcription factor is considered as a master regulator of lysosomal genes?\n",
      "Answer: transcription factor eb\n",
      "Question: Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?\n",
      "Answer: alirocumab ( praluent ) and evolocumab ( repatha )\n",
      "Question: Which mutated gene is associated with Waardenburg and Tietz syndromes?\n",
      "Answer: mitf\n",
      "Question: List the releases of JASPAR database\n",
      "Answer: jaspar core - - an expanded version of the original, non - redundant collection of annotated, high - quality matrix - based transcription factor binding profiles, jaspar fam - - a collection of familial tfbs models and jaspar phylofacts - - a set of matrices computationally derived from statistically overrepresented, evolutionarily conserved regulatory region motifs from mammalian genomes. jaspar phylofacts serves as a non - redundant extension to jaspar core, enhancing the overall breadth of jaspar for promoter sequence analysis. the new release of jaspar is available at http : / / jaspar. genereg. net\n",
      "Question: Which pipelines are used for analyzing data from ChIP-nexus experiments?\n",
      "Answer: q - nexus\n",
      "Question: Which are the main components of mTORC1?\n",
      "Answer: raptor, rictor, or mlst8\n",
      "Question: Which mutated genes are associated with the Tourette's syndrome?\n",
      "Answer: histidine decarboxylase\n",
      "Question: List algorithms suitable for predicting protein complexes\n",
      "Answer: \n",
      "Question: Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?\n",
      "Answer: [CLS]\n",
      "Question: Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?\n",
      "Answer: tolcapone and entacapone\n",
      "Question: List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma\n",
      "Answer: exist - 1\n",
      "Question: Which pathological conditions are caused by mutations in the CYLD gene?\n",
      "Answer: brooke - spiegler syndrome\n",
      "Question: Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?\n",
      "Answer: \n",
      "Question: Which gene harbors the mutation T790M?\n",
      "Answer: h1975\n",
      "Question: Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\n",
      "List the most frequent carbapenemases found in Enterobacteriaceae.\n",
      "Answer: [CLS]\n",
      "Question: Which protein is affected by dusp8 activation?\n",
      "Answer: jnk\n",
      "Question: Which histone modifications are associated with constitutive heterochromatin?\n",
      "Answer: h3s10p\n",
      "Question: Which is the cellular localization of the protein Opa1?\n",
      "Answer: mitochondrial intermembrane space\n",
      "Question: Which genes are associated with autosomal dominant Charcot-Marie-Tooth?\n",
      "Answer: cmt1 and 2\n",
      "Question: Which are the key players on radial glial specification to ependymal cells?\n",
      "Answer: mcidas and gemc1 / lynkeas\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline and topiramate\n",
      "Question: Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?\n",
      "Answer: stevens - johnson syndrome ( sjs ), toxic epidermal necrolysis ( ten ), acute generalized exanthematous pustulosis ( agep ) and drug reaction with eosinophilia and systemic symptoms complex ( dress )\n",
      "Question: Which genes does thyroid hormone receptor alpha1 regulate in the heart?\n",
      "Answer: kcnd3\n",
      "Question: Which polymerase transcribes pri-miRNAs?\n",
      "Answer: rna polymerase ii\n",
      "Question: List interaction partners for the protein GATA1.\n",
      "Answer: eto - 2, lmo4, and cdk9\n",
      "Question: List functional roles of the FtsZ protein.\n",
      "Answer: cell division\n",
      "Question: List cardinal features of the Triple A syndrome.\n",
      "Answer: alacrima, achalasia, adrenal failure, progressive neurodegenerative disease\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: p11. 2p13. 1\n",
      "Question: The drug JTV519 is derivative of which group of chemical compounds?\n",
      "Answer: 1, 4 - benzothiazepine\n",
      "Question: Which are the available biomedical text mining tools for the detection of protein-protein interactions?\n",
      "Answer: biomap\n",
      "Question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?\n",
      "Answer: abetah - j - j locus is a genomic sequence which generates three functionally distinct proteins, the enzyme aspartyl - beta - hydroxylase ( abetah ), the structural protein of sarcoplasmic reticulum junctin, and the membrane - bound calcium binding protein junctate\n",
      "Question: What are the main indications of lacosamide?\n",
      "Answer: inhibit nmda - induced seizures in mice and showed full efficacy in the homocysteine model of epilepsy\n",
      "Question: Which human disease is associated with mutated UBQLN2\n",
      "Answer: amyotrophic lateral sclerosis\n",
      "Question: Where do the Schwann cells and melanocytes originate from?\n",
      "Answer: the skin\n",
      "Question: List co-morbidities that may occur together with \"Stiff man Syndrome\"\n",
      "Answer: progressive dementia\n",
      "Question: In which genomic positions is the histone variant macroH2A enriched?\n",
      "Answer: inactive x chromosome\n",
      "Question: SPAG5 was implicated in which cancers?\n",
      "Answer: male breast cancers\n",
      "Question: Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?\n",
      "Answer: [CLS]\n",
      "Question: Which genes are known to be involved in Diamond-Blackfan anemia?\n",
      "Answer: rps19, rps24, rps17, rpl5, rpl11, and rpl35a\n",
      "Question: What is the treatment of neuropathic pain in children?\n",
      "Answer: adjunctive therapy\n",
      "Question: Which clotting factor is inhibited by betrixaban?\n",
      "Answer: factor xa\n",
      "Question: Which enzymes synthesize catecholamines in adrenal glands?\n",
      "Answer: tyrosine hydroxylase, dopamine - ß - hydroxylase and phenylethanolamine n - methyltransferase\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: two\n",
      "Question: How many periods of regulatory innovation led to the evolution of vertebrates?\n",
      "Answer: three\n",
      "Question: List bacteria that may be useful in uranium bioremediation.\n",
      "Answer: sulfate - reducing bacteria\n",
      "Question: How many periods of regulatory innovation led to the evolution of vertebrates?\n",
      "Answer: three\n",
      "Question: Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?\n",
      "Answer: catecholamine - induced polymorphic ventricular tachycardia\n",
      "Question: Which is the major RNA editing enzyme in Drosophila melanogaster?\n",
      "Answer: adar\n",
      "Question: Which is the main calcium pump of the sarcoplasmic reticulum?\n",
      "Answer: the sarcoplasmic reticulum caz atpase\n",
      "Question: List Kartagener Syndrome Triad.\n",
      "Answer: situs inversus, bronchiectasis and sinusitis\n",
      "Question: List mouse models for autism spectrum disorder (ASD).\n",
      "Answer: c57bl / 6j strain\n",
      "Question: Which medication should be administered when managing patients with suspected acute opioid overdose?\n",
      "Answer: naloxone\n",
      "Question: List the off-label use of SSRIs\n",
      "Answer: preliminary results on the off - label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy\n",
      "Question: Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?\n",
      "Answer: gata4 / mef2c / tbx5\n",
      "Question: What disease in Loxapine prominently used for?\n",
      "Answer: schizophrenia\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: List symptoms of congenital toxoplasmosis triad.\n",
      "Answer: hydrocephalus, retinochoroiditis and encephalitis\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: epirubicin 75 mg / m2\n",
      "Question: Which molecule is targeted by Daratumumab?\n",
      "Answer: cd38\n",
      "Question: Which factors are considered in the ABCD2 score?\n",
      "Answer: [CLS]\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: crebbp, myt1l, nfia, nfib, tead1 and tgif2\n",
      "Question: Which is the primary protein component of Lewy bodies?\n",
      "Answer: alpha - synuclein\n",
      "Question: Which are the subunits of the IkB protein kinase (IKK)?\n",
      "Answer: ikkalpha and ikkbeta\n",
      "Question: Which drugs are included in the FEC-75 regimen?\n",
      "Answer: fluorouracil 500 mg / m ( 2 ), epirubicine 75 mg / m ( 2 ), and cyclophosphamide 500 mg / m ( 2 )\n",
      "Question: Mutation of which gene is implicated in the Christianson syndrome?\n",
      "Answer: slc9a6\n",
      "Question: Which infection can be prevented with Dapivirine?\n",
      "Answer: hiv\n",
      "Question: List symptoms of EAST syndrome.\n",
      "Answer: [CLS] list symptoms of east syndrome. [SEP]\n",
      "Question: Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?\n",
      "Answer: hax - 1\n",
      "Question: Mutation of which gene is associated with McLeod syndrome?\n",
      "Answer: e327k\n",
      "Question: Which gene controls the expression of GATA-1 isoforms?\n",
      "Answer: c / ebpepsilon\n",
      "Question: Which gene(s) should be genotyped in order to prescribe the drug Cetuximab (anti-EGFR)?\n",
      "Answer: braf\n",
      "Question: For the treatment of which conditions can atypical neuroleptic drugs be used?\n",
      "Answer: schizophrenia, schizoaffective disorder, or delusional disorder\n",
      "Question: Which neuroendocrine tumors are associated with specific tumor syndromes?\n",
      "Answer: medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma\n",
      "Question: Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?\n",
      "Answer: dna methyltransferase 1\n",
      "Question: Which protein is affected by dusp8 activation?\n",
      "Answer: jnk\n",
      "Question: Which disease is treated with Nusinersen?\n",
      "Answer: spinal muscular atrophy\n",
      "Question: How many TAp73 isoforms have been identified in humans?\n",
      "Answer: [CLS]\n",
      "Question: How many genera comprise the Flaviviridae family?\n",
      "Answer: three\n",
      "Question: Which gene is responsible for the development of the Mowat-Wilson syndrome?\n",
      "Answer: zeb2\n",
      "Question: Which drug should be used as an antidote in benzodiazepine overdose?\n",
      "Answer: flumazenil\n",
      "Question: List the diseases that can be treated using Vedolizumab.\n",
      "Answer: ulcerative colitis ( uc ) and crohn's disease ( cd )\n",
      "Question: Which genes are thought to be involved in medulloblastoma development?\n",
      "Answer: tumor suppressor genes\n",
      "Question: Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?\n",
      "Answer: fshd\n",
      "Question: For the constructions of which organs has 3D printing been tested?\n",
      "Answer: human ear\n",
      "Question: Is the transcriptional regulator BACH1 an activator or a repressor?\n",
      "Answer: repressor\n",
      "Question: Which are the side effects during tacrine administration in patients with Alzheimer's Disease?\n",
      "Answer: nausea, vomiting, diarrhea, anorexia, and dizziness\n",
      "Question: List features of the DEND syndrome.\n",
      "Answer: the most severe form, which includes epilepsy and developmental delay, is called developmental delay, epilepsy, and neonatal diabetes\n",
      "Question: List drug that were evaluated in the CHAMP trial for migraine.\n",
      "Answer: amitriptyline, topiramate, and placebo\n",
      "Question: Abnormalities in which chromosomes were linked to the Moyamoya disease?\n",
      "Answer: 17q11. 2\n",
      "Question: Which is the chromosome area that the human gene coding for the dopamine transporter (DAT1) is located to?\n",
      "Answer: 5p15. 32\n",
      "Question: Which are the plant DNA (cytosine-5) methyltransferase families?\n",
      "Answer: two\n"
     ]
    }
   ],
   "source": [
    "tokens = []\n",
    "q = df['question']\n",
    "p = df[\"context\"]\n",
    "# print(q[:50])\n",
    "#for i in range(len(p)):\n",
    "answers = []\n",
    "for i in range(len(q)):\n",
    "    inputs = tokenizer(q[i], p[i], add_special_tokens=True, return_tensors=\"tf\")\n",
    "    # print(inputs)\n",
    "    input_ids = inputs[\"input_ids\"].numpy()[0]\n",
    "\n",
    "    outputs = model(inputs)\n",
    "    answer_start_scores = outputs.start_logits\n",
    "    answer_end_scores = outputs.end_logits\n",
    "    answer_start = tf.argmax(answer_start_scores, axis=1).numpy()[0]  # Get the most likely beginning of answer with the argmax of the score\n",
    "    answer_end = (tf.argmax(answer_end_scores, axis=1) + 1).numpy()[0]  # Get the most likely end of answer with the argmax of the score\n",
    "    answer = tokenizer.convert_tokens_to_string(tokenizer.convert_ids_to_tokens(input_ids[answer_start:answer_end]))\n",
    "    answers.append(answer)\n",
    "    print(f\"Question: {q[i]}\")\n",
    "    print(f\"Answer: {answer}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "ouFaYgYtPRud"
   },
   "source": [
    "### PERFORMANCE EVALUATION"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "R7FMnXbAPRud"
   },
   "source": [
    "Using Rouge score to evaluate precision, recall and F-1 score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "x4dhNL2w0HLp",
    "outputId": "960d415b-6574-4c91-8d46-245a507dd851"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.7071067811860148"
      ]
     },
     "execution_count": 85,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "count = 0\n",
    "score = 0\n",
    "for i in range(len(df.answer)):\n",
    "    try:\n",
    "        score += nltk.translate.bleu_score.sentence_bleu([df.answer[0].lower().split()],answers[0].split())\n",
    "        count += 1\n",
    "    except:\n",
    "        continue\n",
    "# scores = score /len(df.answer)\n",
    "scores = score / count\n",
    "scores"
   ]
  }
 ],
 "metadata": {
  "accelerator": "GPU",
  "colab": {
   "collapsed_sections": [],
   "name": "BiomedQA.ipynb",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  },
  "widgets": {
   "application/vnd.jupyter.widget-state+json": {
    "0f4003882ad446f9bbf0b143996b9bef": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "0ffc567f09a54b048d97ba1f0df4f1c4": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": "initial"
     }
    },
    "12883e0b70c34dcead9d2d23a6d652cf": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "29522003c73e4ad7a64d40557f31a3b8": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "3140ccdc23844960b900999992b29133": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_c41809e4c7574dc09794fdb9771a7cc5",
      "placeholder": "​",
      "style": "IPY_MODEL_79140fd422ff4b65be8a723d7c4d0583",
      "value": " 443/443 [00:00&lt;00:00, 989B/s]"
     }
    },
    "32662d0c5a144fa8bbdb42775dde4da2": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_af51752b13344cdda32d4e624f18a5db",
       "IPY_MODEL_8bcf3e2656dd4d29b3010aa148356e0e"
      ],
      "layout": "IPY_MODEL_e06163d0cdb749e0a911ccca37391813"
     }
    },
    "4d58fd777ba248fba5fc5cd715f12db1": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "51b3c3a1152049d7bf86f0cf3dc6ccc1": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "5654be802fef4fd38708401579275bc1": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "5b4fec121b414af88d342af401404d4e": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_90949f61c18848d1993ea7ea7b2f4a1d",
       "IPY_MODEL_3140ccdc23844960b900999992b29133"
      ],
      "layout": "IPY_MODEL_93786ab1189c4216a84824836f9a01bf"
     }
    },
    "6c7932f43a78445abe53f8fd56aa30e7": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": "initial"
     }
    },
    "79140fd422ff4b65be8a723d7c4d0583": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "7da7904811574b87b346d08c9d3d9e02": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": "initial"
     }
    },
    "7fdec03f16644691b9d80a148d0a577c": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_ce9b47f041074b24b5b5192cf59c246e",
      "placeholder": "​",
      "style": "IPY_MODEL_d653135e5f03472b951109d65a441d15",
      "value": " 1.34G/1.34G [00:38&lt;00:00, 35.1MB/s]"
     }
    },
    "8813981eb1c043359684b9edfb3cc981": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "Downloading: 100%",
      "description_tooltip": null,
      "layout": "IPY_MODEL_90387d98cb7e49d6a163470d6f1a994c",
      "max": 231508,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_7da7904811574b87b346d08c9d3d9e02",
      "value": 231508
     }
    },
    "8bcf3e2656dd4d29b3010aa148356e0e": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_a077d23a80ab47ad8cae6b4f28f36ab8",
      "placeholder": "​",
      "style": "IPY_MODEL_51b3c3a1152049d7bf86f0cf3dc6ccc1",
      "value": " 466k/466k [00:01&lt;00:00, 398kB/s]"
     }
    },
    "8bd9a3ef24ad4de9938d24b5469319da": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "8cbab68b9c514a75a850fa3e919757f8": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "90387d98cb7e49d6a163470d6f1a994c": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "90949f61c18848d1993ea7ea7b2f4a1d": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "Downloading: 100%",
      "description_tooltip": null,
      "layout": "IPY_MODEL_f578af6b1e294e12917782058cbd1fb8",
      "max": 443,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_a366a274843843eabb84a941522f5020",
      "value": 443
     }
    },
    "933173b68595402b8ed0d3e54deb665e": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "93786ab1189c4216a84824836f9a01bf": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "a077d23a80ab47ad8cae6b4f28f36ab8": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "a1ea464ffe5f476b8f49720c74c0b63e": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "a366a274843843eabb84a941522f5020": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": "initial"
     }
    },
    "aaea45e6f2fd45a0ac8949b488a48333": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_fcf55c27666a41518774ea50e0317507",
       "IPY_MODEL_d4ebd7fcf49c41d8b126b0603739230b"
      ],
      "layout": "IPY_MODEL_29522003c73e4ad7a64d40557f31a3b8"
     }
    },
    "af51752b13344cdda32d4e624f18a5db": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "Downloading: 100%",
      "description_tooltip": null,
      "layout": "IPY_MODEL_8cbab68b9c514a75a850fa3e919757f8",
      "max": 466062,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_6c7932f43a78445abe53f8fd56aa30e7",
      "value": 466062
     }
    },
    "c41809e4c7574dc09794fdb9771a7cc5": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "c8585febbb5c4fcab0c7601ef760fd54": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": "initial"
     }
    },
    "c92417d178454f5babd6b07eddc74827": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_0f4003882ad446f9bbf0b143996b9bef",
      "placeholder": "​",
      "style": "IPY_MODEL_8bd9a3ef24ad4de9938d24b5469319da",
      "value": " 232k/232k [00:01&lt;00:00, 125kB/s]"
     }
    },
    "ce9b47f041074b24b5b5192cf59c246e": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "d4ebd7fcf49c41d8b126b0603739230b": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_933173b68595402b8ed0d3e54deb665e",
      "placeholder": "​",
      "style": "IPY_MODEL_5654be802fef4fd38708401579275bc1",
      "value": " 28.0/28.0 [00:45&lt;00:00, 1.61s/B]"
     }
    },
    "d60ec5a0f64649fb95455fc2da2e1fa9": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "d653135e5f03472b951109d65a441d15": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "e06163d0cdb749e0a911ccca37391813": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "e0f4b0a77aa24c6d86de94109ee83a73": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "Downloading: 100%",
      "description_tooltip": null,
      "layout": "IPY_MODEL_d60ec5a0f64649fb95455fc2da2e1fa9",
      "max": 1341090760,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_c8585febbb5c4fcab0c7601ef760fd54",
      "value": 1341090760
     }
    },
    "e8f47a9e3c4d44498ed5ba806a1de264": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_8813981eb1c043359684b9edfb3cc981",
       "IPY_MODEL_c92417d178454f5babd6b07eddc74827"
      ],
      "layout": "IPY_MODEL_4d58fd777ba248fba5fc5cd715f12db1"
     }
    },
    "f091e98f1ca0465f98ad2f2d43f4d2e1": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_e0f4b0a77aa24c6d86de94109ee83a73",
       "IPY_MODEL_7fdec03f16644691b9d80a148d0a577c"
      ],
      "layout": "IPY_MODEL_12883e0b70c34dcead9d2d23a6d652cf"
     }
    },
    "f578af6b1e294e12917782058cbd1fb8": {
     "model_module": "@jupyter-widgets/base",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "fcf55c27666a41518774ea50e0317507": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "Downloading: 100%",
      "description_tooltip": null,
      "layout": "IPY_MODEL_a1ea464ffe5f476b8f49720c74c0b63e",
      "max": 28,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_0ffc567f09a54b048d97ba1f0df4f1c4",
      "value": 28
     }
    }
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
